<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Shareville</title>
    <link>https://cr.abgsc.com/feed/shareville/</link>
    <description>News and articles from cr.abgsc.com</description>
    <generator>ABG Sundal Collier - Commissioned research (cr.abgsc.com)</generator>
    <copyright>ABG Sundal Collier - Commissioned research (cr.abgsc.com)</copyright>
    <atom:link href="https://cr.abgsc.com/feed/shareville/" rel="self" type="application/rss+xml" />
    <managingEditor>research@abgsc.com (cr.abgsc.com)</managingEditor>
    <webMaster>research@abgsc.com (cr.abgsc.com)</webMaster>
    <lastBuildDate>Mon, 12 Oct 2026 19:15:04 GMT</lastBuildDate>
    <item>
      <title>I-tech - Expecting broad-based growth</title>
      <description>&lt;a id="bm-comp-0a829ff4-2432-45fc-abe0-69d6518c1216" name="bm-comp-0a829ff4-2432-45fc-abe0-69d6518c1216" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0a829ff4-2432-45fc-abe0-69d6518c1216" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q3e: +29% organic growth, EBIT SEK 17m (11m)&lt;/li&gt;&lt;li&gt;'27e-'28e adj. EBIT raised by 6-8% on FX&lt;/li&gt;&lt;li&gt;EU vote ahead; '27e/'28e EV/EBIT of 6x/4x, ~60-80% below peers&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7e118320-6b01-4176-9fe9-948cfa1fdf6c" name="bm-comp-7e118320-6b01-4176-9fe9-948cfa1fdf6c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7e118320-6b01-4176-9fe9-948cfa1fdf6c" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q3 expectations&lt;/h3&gt;&lt;p&gt;We estimate Q3 sales of SEK 54m, +31% y-o-y (+29% org., +2% FX). We expect growth to slow from the record Q2 (+91% org.) on tougher comps, but to remain solid, driven by CMP (+35% org. in H1), the recovery of the second-largest customer, which cut its offtake last year due to financial constraints, and continued growth among smaller customers such as PPG and Jotun. FX turns into a slight tailwind for the first time in five quarters in Q3 (+2%). We forecast EBIT of SEK 17m (11m), for a 31% (27%) margin.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;We raise '26e/'27e/'28e adj. EBIT by 1%/6%/8%, mainly on FX, as sales are predominantly USD-denominated while opex is largely SEK-based. We will listen for an update on the newly acquired antifouling technology for aquaculture net coatings, where management sees commercial sales a few years out. Given the early stage and limited information on its potential, we have not included it in our estimates. With SEK 165m in net cash, the balance sheet remains strong.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Waiting for the EU decision&lt;/h3&gt;&lt;p&gt;The key event is the SCBP vote on the Commission&amp;#8217;s proposed non-renewal of medetomidine, which management sees as most likely at the December meeting or by written procedure. The current approval expires on 31 December. In a negative outcome, I-Tech is prepared to appeal, and the direct impact would be limited, as Europe accounts for 2-4% of sales. Meanwhile, higher charter rates and fuel prices underline the value of premium antifouling, and Selektope is still only on ~3,500 of ~110,000 commercial vessels. The company is trading at &amp;#8216;26e/'27e/'28e EV/EBIT of 10x/6x/4x, i.e. ~60-80% below peers.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/i-tech/Equity-research/2026/10/i-tech---expecting-broad-based-growth/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 12 Oct 2026 19:15:04 GMT</pubDate>
      <isin>SE0011167725</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nexam Chemical - Seasonal dip, broader Recycling base</title>
      <description>&lt;a id="bm-comp-3264810c-11f6-441a-9cb1-0f1e54ae99f1" name="bm-comp-3264810c-11f6-441a-9cb1-0f1e54ae99f1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3264810c-11f6-441a-9cb1-0f1e54ae99f1" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Report out 16 October&lt;/li&gt;&lt;li&gt;Q3e sales of SEK 49m (+7% y-o-y), EBIT SEK -2.6m (-3.3m)&lt;/li&gt;&lt;li&gt;Two more Recycling customers in commercial production&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d3c85bdd-5b04-444c-906a-bdc093ccfe56" name="bm-comp-d3c85bdd-5b04-444c-906a-bdc093ccfe56" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d3c85bdd-5b04-444c-906a-bdc093ccfe56" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q3 expectations&lt;/h3&gt;&lt;p&gt;We estimate Q3 sales of SEK 49m, up 7% y-o-y, but down 18% q-o-q, as Q3 is usually a seasonally-weaker holiday quarter. Growth should again come from Recycling, with the US food-packaging customer at a ~SEK 11m annual run-rate and two new customers entering commercial production over the summer. We expect a gross margin of 48% (46%), in line with recent quarters. On a seasonally lower sales base, we expect EBIT to fall back to SEK -2.6m (-3.3m) after a break-even Q2.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We leave total '26e-'28e EBIT roughly unchanged. We continue to forecast positive full-year EBIT from &amp;#8216;27e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Recycling pipeline building&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;In August, Nexam announced that two additional customers, one in Canada and one in Europe, had moved from industrial evaluation to commercial use over the summer. Further up the funnel, the number of samples shipped to prospective customers rose more than 80% in June-July vs the same period last year, excluding samples distributed via Palmer Holland, with qualified enquiries from Europe, the Americas, Asia and Africa. Key for Q3 is the volume ramp at these customers and whether management will reiterate its ambition to double Recycling sales in &amp;#8216;26 vs. '25. The stock is trading at 1.0x/0.9x '26e/&amp;#8216;28e EV/Sales on our estimates.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nexam-chemical/Equity-research/2026/10/nexam-chemical---seasonal-dip-broader-recycling-base/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 12 Oct 2026 19:00:05 GMT</pubDate>
      <isin>SE0005101003</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Alligo - Tooled up for continued margin recovery</title>
      <description>&lt;a id="bm-comp-f129faf1-9757-441f-bb22-fef5e1e4ecb8" name="bm-comp-f129faf1-9757-441f-bb22-fef5e1e4ecb8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f129faf1-9757-441f-bb22-fef5e1e4ecb8" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q3e: Sales SEK 2,346m and adj. EBITA SEK 177m&lt;/li&gt;&lt;li&gt;Estimates trimmed by 4/2% for '26e/'27e&lt;/li&gt;&lt;li&gt;12x/10x '26e/'27e adj. EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9d1e16d4-02c3-4294-bb32-1dce95f6a73b" name="bm-comp-9d1e16d4-02c3-4294-bb32-1dce95f6a73b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9d1e16d4-02c3-4294-bb32-1dce95f6a73b" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q3 expectations&lt;/h3&gt;&lt;p&gt;We expect the company to deliver sales of SEK 2,346m, up 7% y-o-y (3% organic, 2% FX and 2% M&amp;amp;A). We forecast an adj. EBITA of SEK 177m, +12% y-o-y, for a margin of 7.5%. We are cautiously optimistic on Sweden. While we see tough comps ahead in Q3'26, as Q3'25 marked the start of the recovery in the market and a return to earnings growth after a prolonged downturn, we also see positive data points. The Swedish building material index increased 9.5% in Q2 (its highest since Q1'22) and Swedish manufacturing PMI sat at a solid 58.1 in September. We expect the market in Norway to remain similar to H1, with subdued oil and gas activity (~7% of group sales) as large offshore developments near completion. This should be partly offset by Q3 historically being a seasonally stronger quarter for margins. We remain upbeat on further margin improvement in Finland, driven by a stronger industrial cycle and high defence exposure.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates lowered by 4/2% for '26e/'27e&lt;/h3&gt;&lt;p&gt;We make only minor revisions to our sales estimates but lower our '26e-27e adj. EBITA by 4/2%, mainly due to revised margin assumptions for Sweden following a change of analyst. We reduce Sweden&amp;#8217;s '26e adj. EBITA margin to 9.2% from 9.7% and trim Finland&amp;#8217;s by 12bps. Meanwhile, favourable FX effects lift our Norwegian earnings estimates by 2-4%. We expect activity in Norway to remain low but stable in H2.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Share trading at 12x/10x '26e/'27e adj. EV/EBITA&lt;/h3&gt;&lt;p&gt;We continue to see the margin recovery story as appealing and are encouraged by management's communication. The share is currently trading at 11.7/9.6x '26e/'27e adj. EV/EBITA. Returning -6% the L3M, it has underperformed OMXSALLS which has returned +1%. The Q3 report is due on Friday 23 October.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/Alligo/Equity-research/2026/10/alligo---tooled-up-for-continued-margin-recovery/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 07 Oct 2026 15:46:32 GMT</pubDate>
      <isin>SE0009922305</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Cavotec - MoorMaster order adds to positive momentum</title>
      <description>&lt;a id="bm-comp-cb262e10-a1dd-4e33-8215-8856779f80a9" name="bm-comp-cb262e10-a1dd-4e33-8215-8856779f80a9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cb262e10-a1dd-4e33-8215-8856779f80a9" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q3 report due Tuesday 6 November&lt;/li&gt;&lt;li&gt;Order intake to remain positive&lt;/li&gt;&lt;li&gt;13-9x '27e-'28e EV/EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-2940ad4a-f6cc-47ab-8c63-644db734d54e" name="bm-comp-2940ad4a-f6cc-47ab-8c63-644db734d54e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2940ad4a-f6cc-47ab-8c63-644db734d54e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q3 expectations&lt;/h3&gt;&lt;p&gt;We expect order momentum to remain positive in Q3, albeit at a slower pace than in Q1 and Q2. We expect Cavotec deliver an order intake of EUR 38.1m (+5% y-o-y) for a book-to-bill of 1.01. The R12m book-to-bill should land at 1.18 in Q3 following the strong consecutive order figures in Q1 and Q2. The company has announced three orders in Q3, of which two are attributable to the Q3 order intake. All three came from existing customer relationships. We forecast sales of EUR 37.9m, up 5.9% y-o-y (o/w 3.9% organic and 2.0% FX). Industry should drive most of this growth, given its solid Q2 order intake and significantly shorter backlog lead times vs. P&amp;amp;M. We expect the company to return to an adj. EBIT growth in the quarter, landing at EUR 0.2m (+0.3m y-o-y). This corresponds to an adj. EBIT margin of 0.4%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;MoorMaster order raises '27e-'28e EBIT 5-4%&lt;/h3&gt;&lt;p&gt;We raise our order estimates by 1% following the MoorMaster order for the Indian Port Authority, having already incorporated the shore power order from a global leading shipping company announced on July 15. This leads to 2-3% upgrades on '27e-'28e sales and 5-4% on EBIT. Minor changes to '26e are made following updated FX and slight adjustments to group costs.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;We recognise the potential of the exclusive distribution agreement with EVIAS, announced in September, for its automatic charging technology for port vehicles. This should broaden P&amp;amp;M's product portfolio and strengthen its position in port electrification. On reporting day, we look for more details on the agreement, in addition to the conversion of the record EUR 156m order book (end-Q2) and progress on the cost-savings programme. The share is currently trading at 13-9x '27e EV/EBIT vs. the peer median of 13-11x. The report is due on 6 November.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/cavotec/Equity-research/2026/10/cavotec---moormaster-order-adds-to-positive-momentum/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 07 Oct 2026 15:45:28 GMT</pubDate>
      <isin>CH0136071542</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Coeli Private Equity - NAV growth continues, discount widens</title>
      <description>&lt;a id="bm-comp-987c4ff8-9864-4543-96c0-8d7112f85f39" name="bm-comp-987c4ff8-9864-4543-96c0-8d7112f85f39" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="987c4ff8-9864-4543-96c0-8d7112f85f39" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;NAV per share +7.2% y-o-y&lt;/li&gt;&lt;li&gt;Buyback and net cash position support continued 5-7% dividend&lt;/li&gt;&lt;li&gt;~35% NAV discount vs ~22% average; fair value range SEK 100-136&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a8d4e0c9-bfea-4242-912f-2bbc09b9870a" name="bm-comp-a8d4e0c9-bfea-4242-912f-2bbc09b9870a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a8d4e0c9-bfea-4242-912f-2bbc09b9870a" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;NAV growth &amp;amp; portfolio activity&lt;/h3&gt;&lt;p&gt;NAV/share and net profit growth during the year were strong. NAV/share rose to SEK 178.77 from SEK 172.32 (+7.2% incl. the SEK 6/common share dividend paid in Mar.), and net profit increased to SEK 88.7m (SEK 14.5m). This was driven by a rise in portfolio revaluations (SEK 108.2m vs SEK 31.2m) incl. gains from exits such as PHM Group and Francks Kylindustri, partly offset by a SEK 49.8m unrealised markdown on the existing portfolio. The same pattern was seen in FY'24/'25 (SEK 131.4m realised gains vs SEK 83.3m unrealised markdowns), meaning two consecutive years of growth driven by closed exits while retained portfolio value keeps declining. Deployment also picked up, with 27 new portfolio companies added (25 prior year). 13 exits were completed (nine prior year).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;What is driving the portfolio?&lt;/h3&gt;&lt;p&gt;The year's results point to broad-based portfolio strength after a weaker prior year, though the deployment rate remains somewhat below historical levels despite the increase in new holdings. The ongoing buyback programme (286,530 shares repurchased in FY'25/'26 at an avg price of ~SEK 119, taking treasury holdings to ~3.3% of shares by Aug. 2026) supports NAV/share. The improved net cash position (SEK 27.3m, up from a net debt of SEK -12.2m) also strengthens the case for continuing the 5-7% annual dividend target.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;NAV discount and outlook&lt;/h3&gt;&lt;p&gt;The share traded at SEK 116 against the reported NAV of SEK 178.77 at fiscal year-end close, implying a discount of ~35% vs a historical avg of ~22% since Feb. 2020. Applying a discount of 25-45% to the latest NAV (Aug.) implies a fair value range of SEK 100-136. Key catalysts ahead include capital deployment from newer fund vintages, the pace of further exits, and the potential for further buybacks and dividends. These could all influence the discount going forwa&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/company-name2/Equity-research/2026/10/coeli-private-equity---nav-growth-continues-discount-widens/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 07 Oct 2026 15:30:04 GMT</pubDate>
      <isin>SE0012012268</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Qliro - Growth moderates, scaling continues</title>
      <description>&lt;a id="bm-comp-bed69172-ee1f-4ed0-bf50-8fa3f21004e3" name="bm-comp-bed69172-ee1f-4ed0-bf50-8fa3f21004e3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bed69172-ee1f-4ed0-bf50-8fa3f21004e3" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Steady growth despite Enterprise caution&lt;/li&gt;&lt;li&gt;Earnings trajectory shifts further out&lt;/li&gt;&lt;li&gt;Scaling to drive profitability&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-4f863318-aa6d-4a20-8ad9-972c53e625cf" name="bm-comp-4f863318-aa6d-4a20-8ad9-972c53e625cf" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4f863318-aa6d-4a20-8ad9-972c53e625cf" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Steady growth despite near-term Enterprise caution&lt;/h3&gt;&lt;p&gt;We expect a third consecutive profitable quarter from Qliro in Q3, with SEK 2.8m in operating profit. We expect TPV at SEK 6.6bn, up 26% y-o-y, supported by merchant onboarding and SME growth, albeit at a more moderate pace than in H1. We believe Enterprise activity could remain cautious ahead of CCD2 in November, before picking up thereafter. Our estimates imply total income of SEK 120.6m (+22% y-o-y) and costs of SEK 93.7m. While near-term growth is more measured, we see stronger earnings potential in 2027-28e as scaling translates into profitability.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Near-term estimates lowered, long-term earnings raised&lt;/h3&gt;&lt;p&gt;Ahead of Q3, we make modest top-line revisions but reshape our earnings trajectory to reflect more measured near-term growth and stronger profitability further out. For 2026e, total income is lowered by 1.8% and costs by 1.1%, reducing operating profit by 48%. Conversely, we raise 2027e-28e operating profit by 27% and 35%, reflecting stronger operating leverage as the business scales. Our forecasts imply 21% income growth in 2026e and 14-16% in 2027e-28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Scaling supports long-term earnings growth&lt;/h3&gt;&lt;p&gt;Despite a more measured near-term growth trajectory, scaling looks set to drive profitability, supported by merchant onboarding, BNPL penetration and loan book growth. We forecast operating profit to increase from SEK 13m in 2026e to SEK 44m in 2027e and SEK 81m in 2028e, alongside a C/I improvement from 78% to 64%. Qliro is trading at 20x and 10x P/E for 2027e and '28e, respectively, and ~0.8x P/BV. The PPRO partnership provides an additional growth channel from 2027. Lastly, Hannes Wadell joins the company as CFO on 3 November, bringing a permanent CFO into the management team ahead of the next phase of scaling and profitability.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/qliro/Equity-research/2026/10/qliro---growth-moderates-scaling-continues/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 07 Oct 2026 05:00:05 GMT</pubDate>
      <isin>SE0013719077</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Gentoo Media - Guidance downgrade and new financing</title>
      <description>&lt;a id="bm-comp-c272443e-d00e-4714-b1ca-b400b6ea6cfd" name="bm-comp-c272443e-d00e-4714-b1ca-b400b6ea6cfd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c272443e-d00e-4714-b1ca-b400b6ea6cfd" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Guidance downgrade following Brazil ban&lt;/li&gt;&lt;li&gt;New financing includes both a new loan and an equity raise&lt;/li&gt;&lt;li&gt;Trading at 4x '27e P/E at the subscription price of the equity issue&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7d149cf5-b059-4e86-b245-44d4cc78deeb" name="bm-comp-7d149cf5-b059-4e86-b245-44d4cc78deeb" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7d149cf5-b059-4e86-b245-44d4cc78deeb" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Brazil ban leads to guidance downgrade&lt;/h3&gt;&lt;p&gt;Following the Brazilian President's decree banning sports betting and online gaming, Gentoo Media downgraded its 2026 guidance. The ban carries immediate effect but has to be approved by Brazil's Congress within 120 days prior to becoming official legislation. This means that there technically is a chance that Brazil's Congress rejects the President's decree. However, it is difficult to quantify that probability. During January-August '26, Brazil contributed to just shy of EUR 4m in revenue. On an annualised basis, that implies nearly EUR 6m in revenue. Unlike its peer Better Collective, Gentoo's earnings contribution from Brazil was lower due to its investments in the country. Moreover, Gentoo's exposure to Brazil was relatively smaller at around 6% of revenue (Better Collective's was 2x that). Gentoo's lowered guidance for 2026 is as follows: revenue of EUR 92m (97-100m), adj. EBITDA 40m (44-47m), and operating cash flow of EUR 30m (32-36m).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Our updated estimates exclude Brazil&lt;/h3&gt;&lt;p&gt;Following the news of the guidance downgrade and new financing arrangement, we have revised our estimates. We cut '26e-'28e revenue by 8% and adj. EBITDA by 11-12%. Even though there is a chance that the President's actions are overturned by Congress, we are unable to assess the probability of that and have therefore incorporated a Brazil ban in both '27 and '28.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;New financing coming up&lt;/h3&gt;&lt;p&gt;The new financing consists of a EUR 50m loan (EURIBOR 3m + 7.5% with a 2% EURIBOR floor) and a fully subscribed directed share issue of EUR 50m at a subscription price of SEK 6.16 per share (nearly 60% above the closing price on 30 September). The loan matures in December '29 and is amortised 10m each year, with the remaining EUR 30m due at maturity.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/gentoo-media/Equity-research/2026/10/gentoo-media---guidance-downgrade-and-new-financing/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 02 Oct 2026 16:15:04 GMT</pubDate>
      <isin>US36467X2062</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Svedbergs Group - Swedish savings boost '27e EBITA by 2%</title>
      <description>&lt;a id="bm-comp-9c858ce4-51e6-4cfd-b8f3-6ad3f0b9a48e" name="bm-comp-9c858ce4-51e6-4cfd-b8f3-6ad3f0b9a48e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9c858ce4-51e6-4cfd-b8f3-6ad3f0b9a48e" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q3e EBITA +11% y-o-y to SEK 88m&lt;/li&gt;&lt;li&gt;We raise '27e EBITA 2% on Svedbergs savings&lt;/li&gt;&lt;li&gt;We reiterate our fair value range of SEK 57-77&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-81ec537b-1684-4afe-a535-27b5013e37c7" name="bm-comp-81ec537b-1684-4afe-a535-27b5013e37c7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="81ec537b-1684-4afe-a535-27b5013e37c7" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;We expect EBITA +11% y-o-y in Q3&lt;/h3&gt;&lt;p&gt;We expect Q3 to be dictated by 1) tough comps in segment Nordics, driven by an expanded ROT deduction scheme in H2'25. We forecast a 4% organic decline for the segment in Q3'26; 2) The well-communicated logistics-related issues in Roper Rhodes (UK). UK EBITA margins declined by 180bp y-o-y in Q2, of which half related to logistics. We forecast a 200bp decline y-o-y in Q3, expecting some extra costs for e.g. freight; 3) UBC Group's first full quarter as part of Svedbergs Group, where we expect it to add SEK 81m in sales and 15pp to Group growth. All in all, we forecast net sales of SEK 624m, +18% y-o-y (of which 2pp organic). We expect dual logistics costs in the UK and the inclusion of dilutive UBC to weigh on margins for 1pp lower EBITA margins y-o-y. Q3'26e EBITA of SEK 88m is +11% y-o-y.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;'26e EBITA cut 1%, '27e up 2%&lt;/h3&gt;&lt;p&gt;We raise '27e/'28e EBITA by 2%/2%, driven primarily by the initiated cost savings programmes in Svedbergs. We do not expect Nordics EBITA margins of 15% until beyond 2028 without a broader improvement in markets, and we take a cautious view despite targeted savings of SEK 25m. We keep our UK org. growth forecasts unchanged, as CPA forecasts for RM&amp;amp;I are unchanged since May (at market growth of -8% for '26e). We expect UK to weigh on y-o-y profitability until YE'26, after which point the new warehouse segment should contribute positively.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We reiterate our fair value range of SEK 57-77&lt;/h3&gt;&lt;p&gt;We reiterate our fair value range of SEK 57-77 on limited estimate revisions. This range corresponds to 10.4x-14x '27e P/E, the upper half of the company's L5Y trading range of 8x-14x NTM. We align with the upper half due to Svedbergs' now-larger size, better market outlook and strong M&amp;amp;A track record. The current 13x/10x P/E '26e/'27e can be compared to a Nordic peer median 11x P/E '27e.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/svedbergs/Equity-research/2026/10/svedbergs-group---swedish-savings-boost-27e-ebita-by-2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 02 Oct 2026 05:00:05 GMT</pubDate>
      <isin>SE0000407991</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ovzon - Lukewarm Q3 on the cards</title>
      <description>&lt;a id="bm-comp-1a4cd8ee-0480-4b01-b338-12bda9e4ac97" name="bm-comp-1a4cd8ee-0480-4b01-b338-12bda9e4ac97" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1a4cd8ee-0480-4b01-b338-12bda9e4ac97" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sequential sales decline, but order activity has improved&lt;/li&gt;&lt;li&gt;We cut '26e-'28e EBIT by 11-8% on lower sales assumptions&lt;/li&gt;&lt;li&gt;16-13x '26e-'27e EV/EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-230ffe6a-037c-4f0d-8d86-0a111b3fa886" name="bm-comp-230ffe6a-037c-4f0d-8d86-0a111b3fa886" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="230ffe6a-037c-4f0d-8d86-0a111b3fa886" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Sequential sales decline&lt;/h3&gt;&lt;p&gt;We expect Q3 to see a sequential decline in sales, as Ovzon has not been able to fill the gaps from previously expiring contracts. Nevertheless, the terminal backlog remains robust, so we anticipate Q3 terminal sales of SEK 70m (vs. SEK 74m in Q2), as well as SATCOM sales of SEK 158m (vs. SEK 171m in Q2). This indicates a weaker product mix, which will negatively impact the gross margin. Nevertheless, we expect costs to remain well managed, and estimate Q3 EBIT of SEK 43m for a margin of 19%. Furthermore, we expect some normalisation of the NWC in Q3, following the receipt of a milestone payment in Q2. We anticipate Q3 FCF of SEK 23m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Negative estimate revisions&lt;/h3&gt;&lt;p&gt;&lt;a data-bm-trackable="false" href="http://cr.abgsc.com/link/48ec0993fdc94aa79dea1d918c1fb3eb.aspx" target="_blank"&gt;Yesterday's order signing is positive&lt;/a&gt;, especially as it relates to a US customer, and supports our estimates. Nevertheless, given the high demand for SATCOM in general and Ovzon's strong momentum in 2025, we had expected Ovzon to sign more orders in 2026. It is difficult to gain a full understanding of the situation, but we believe this is due to the fact that 1) Ovzon is a small company bidding for large contracts, and 2) procurement has become more complex as countries increasingly seek to collaborate on SATCOM projects. Q4 is traditionally a strong quarter for order intake, so there could be more announcements before the end of the year. However, we are taking a more cautious view on sales, and therefore cut '26e-'28e EBIT by 11-8%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Ovzon is active in an attractive niche&lt;/h3&gt;&lt;p&gt;Modern warfare is increasingly fought across domains where satellite connectivity has become mission-critical, driving a structural, multi-year uplift in space investments. Ovzon has a proven track record, which bodes well for the future. The stock is trading at 16-13x '26e-'27e EV/EBIT.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ovzon/equity-research/2026/9/ovzon---lukewarm-q3-on-the-cards/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 29 Sep 2026 17:30:05 GMT</pubDate>
      <isin>SE0010948711</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ovzon - Signs new US government customer</title>
      <description>&lt;a id="bm-comp-87f01b1d-4b6f-4151-a832-ef783d60aff5" name="bm-comp-87f01b1d-4b6f-4151-a832-ef783d60aff5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="87f01b1d-4b6f-4151-a832-ef783d60aff5" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;New 12m SEK 90m order from a new US gov customer&lt;/li&gt;&lt;li&gt;SEK 84m SATCOM service, SEK 6m terminals&lt;/li&gt;&lt;li&gt;Key positives: supports estimates, first new US customer on Ovzon-3&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-371107a9-8b44-447b-a557-c432c128bb3f" name="bm-comp-371107a9-8b44-447b-a557-c432c128bb3f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="371107a9-8b44-447b-a557-c432c128bb3f" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;A new customer, not a renewal&lt;/h3&gt;&lt;p&gt;Ovzon has received a SEK 90m (USD 9.1m) order for its integrated SATCOM platform from a new US government customer. The order is for 12m and includes service on Ovzon-3, third-party capacity and mobile terminals. The split between Ovzon-3 and third-party capacity is not disclosed. Service will start immediately. Only SEK 34m (USD 3.4m) will be booked as order intake in Q3'26, with the remaining recognised once the full funding has been formally processed. This structure is common for US federal contracts, and we do not view it as an indication of risk to the order. However, it does mean that Q3 order intake will appear smaller than the headline value.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Supportive to estimates&lt;/h3&gt;&lt;p&gt;Following a quiet period, this announcement is highly welcome, both because it supports our estimates and because it signals a new US customer. Since 2022, Ovzon has seen annual US-related sales drop from ~200m to ~30m, but we now see reasons for this market to recover. The stock is currently trading at 15x '26e EV/EBIT on our latest estimates.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-16f9b81f-d1ec-4981-8f3a-97a9f62f04da" name="bm-comp-16f9b81f-d1ec-4981-8f3a-97a9f62f04da" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="16f9b81f-d1ec-4981-8f3a-97a9f62f04da" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-e02d9fcd-35e8-465d-b493-923c2404928a" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Sales, quarterly (SEKm)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-5f0efbdd-b91d-4e6e-9dd1-8c99065c4ca9" name="bm-comp-5f0efbdd-b91d-4e6e-9dd1-8c99065c4ca9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5f0efbdd-b91d-4e6e-9dd1-8c99065c4ca9" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-0dd03e74-ec64-445a-be74-2eedfe648350" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Sales breakdown (SEKm)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a775b219-6ff2-4b2d-a4ac-6866b8ca77ac" name="bm-comp-a775b219-6ff2-4b2d-a4ac-6866b8ca77ac" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a775b219-6ff2-4b2d-a4ac-6866b8ca77ac" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-6efcb533-0e6e-4e5e-8f37-c7d74b5d7834" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Net sales (SEKm) and EBIT margins&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ovzon/equity-research/2026/9/ovzon---signs-new-us-government-customer/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 28 Sep 2026 06:30:02 GMT</pubDate>
      <isin>SE0010948711</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nepa - Likely a quiet quarter ahead</title>
      <description>&lt;a id="bm-comp-f67c0759-fae3-4219-a0cc-7e90de9ce407" name="bm-comp-f67c0759-fae3-4219-a0cc-7e90de9ce407" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f67c0759-fae3-4219-a0cc-7e90de9ce407" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q3e: 4% sales growth and a 6% adj. EBITDA margin&lt;/li&gt;&lt;li&gt;Seasonally a small quarter&lt;/li&gt;&lt;li&gt;We make limited estimate changes, trading at 6x adj. EBITDA '27e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-b39ed1e8-01e3-45fb-ad8b-9a8b52c16fdf" name="bm-comp-b39ed1e8-01e3-45fb-ad8b-9a8b52c16fdf" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b39ed1e8-01e3-45fb-ad8b-9a8b52c16fdf" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;A seasonally thin sales quarter&lt;/h3&gt;&lt;p&gt;Seasonally, Q3 has come in below Q2 in each of the past six years, at 22-24% of full-year sales, and we see no reason for 2026 to break this pattern. Subscription project work is delivered by people, and Swedish holidays compress both delivery capacity and client-side decision-making in July and August. RFP processes typically run over the summer and convert later, and marketing budgets tend to be released as companies approach year-end, both of which push activity into Q4. This is offset by personnel costs being seasonally lowest in Q3 due to the holiday effect.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;ARR provides some foresight&lt;/h3&gt;&lt;p&gt;Subscription revenue is relatively steady at ~25% of ARR, which means the SEK 141m ARR base exiting Q2'26 effectively locks in around 70% of Q3 revenue before the quarter starts. Ad hoc has been the historical swing factor, but as Nepa intends to decrease its ad hoc focus, we now expect H2 to be less volatile. We expect Q3 to deliver organic sales growth of 4% to SEK 51m, implying -4% q-o-q (on account of ad hoc). On opex, we assume a broadly flat underlying base versus Q2, with the headquarters relocation and the reduced UK cost base now in the run rate. As such, we estimate adj. EBITDA of SEK 3.2m for a margin of 6.3% (vs. SEK -1m in Q3'25), which lifts LTM adj. EBITDA to SEK 9m from SEK 6m in Q2.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 6.4x EBITDA adj.&lt;/h3&gt;&lt;p&gt;We make limited estimate revisions, slightly trimming sales by 0.5-1.1% in '26e-'27e and assuming lighter net ARR generation in Q3 than in H1. We also slightly trim our opex base, which partly offsets the negative sales revisions, while adj. EBITDA is trimmed by 2-1%. Keep in mind that Nepa's business model is highly scalable and that the earnings revisions reflect small changes in absolute terms ('26e adj. EBITDA down 0.2m). Nepa is currently trading at 6.4x '27e EV/EBITDA adj.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/Nepa/Equity-research/2026/9/nepa---likely-a-quiet-quarter-ahead/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 24 Sep 2026 16:45:04 GMT</pubDate>
      <isin>SE0008066302</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Midsona - Small steps forward on tougher comps</title>
      <description>&lt;a id="bm-comp-f757a245-f9c2-483f-a6cc-bbfcc7d76c96" name="bm-comp-f757a245-f9c2-483f-a6cc-bbfcc7d76c96" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f757a245-f9c2-483f-a6cc-bbfcc7d76c96" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q3e: 1% organic growth and 5% EBIT margin&lt;/li&gt;&lt;li&gt;The report should answer long-term questions&lt;/li&gt;&lt;li&gt;Trading at NTM EV/EBITA of 7x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-4c108636-71f4-4c9f-b0a7-12b82263e03e" name="bm-comp-4c108636-71f4-4c9f-b0a7-12b82263e03e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4c108636-71f4-4c9f-b0a7-12b82263e03e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Growth should return in South&lt;/h3&gt;&lt;p style="text-align:left;"&gt;We anticipate organic growth of 1% in Q3'26, implying sales of SEK 948m and EBIT of SEK 49m, for a 5% margin. The organic growth, coupled with a 4% M&amp;amp;A contribution and a 1% FX effect, puts top-line growth at 6%. We expect the Nordics to sustain org. growth at the same pace as in Q2 (0.5%), as we believe the warm summer likely favoured impulse consumption over dry and organic ranges. South Europe should reach 4% organic growth as comps will no longer include the old Spanish factory. We see the GM at 28% (28.7% adj. in Q3'25), roughly half on Risenta mix, which has a lower margin and still includes a transitional supply markup in COGS, and half on packaging and freight inflation into a channel with fixed pricing windows.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;We look for long-term answers in Q3 report&lt;/h3&gt;&lt;p style="text-align:left;"&gt;This is the first quarter with Risenta consolidated, and we will look for commentary on how much it will contribute to EBIT, specifically considering insourcing timing, the size of the transitional COGS markup, and how the organisation will be built. We also hope for a decision on the long-term plan for Spain, which since Q1 has been flagged as due soon, and look for an update on Nordic B2B after several quarters of exited contracts. On costs, we will look for how much input inflation the company intends to recover in the coming price negotiations, due to oil prices.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Small estimate cuts&lt;/h3&gt;&lt;p&gt;We cut '26e adj. EBIT by 2%, while '27e-'28e is lifted by FX. Our cuts reflect a softer Nordic category backdrop over the summer, acquired volumes that dilute mix before they contribute to profit, and input cost inflation into a channel that reprices slowly, all in the first quarter of the year against a strong comp (5% adj. EBIT margin). On our revised estimates Midsona is trading at 8x-6.5x '26e-'27e adj. EV/EBITA.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/midsona/Equity-research/2026/9/midsona---small-steps-forward-on-tougher-comps/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 23 Sep 2026 16:00:05 GMT</pubDate>
      <isin>SE0000565228</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>NYAB - A powerful addition to the order book</title>
      <description>&lt;a id="bm-comp-dde02327-d5ec-4ae7-872f-9e1ac614681f" name="bm-comp-dde02327-d5ec-4ae7-872f-9e1ac614681f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="dde02327-d5ec-4ae7-872f-9e1ac614681f" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Signs Phase 2 with Svenska kraftn&amp;#228;t worth SEK 1.6bn&lt;/li&gt;&lt;li&gt;We expect consensus to raise 2027e-2028e EBIT by 5-10%&lt;/li&gt;&lt;li&gt;Share has done well, but still trades at 9x EBIT 2027e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-0b0961a3-f129-4831-9c06-6fb0f9d2b485" name="bm-comp-0b0961a3-f129-4831-9c06-6fb0f9d2b485" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0b0961a3-f129-4831-9c06-6fb0f9d2b485" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Largest power line project to date, with limited price risk&lt;/h3&gt;&lt;p&gt;NYAB announced this morning that it has signed an agreement with Svenska kraftn&amp;#228;t to build a new 400 kV power line in northern Sweden between Letsi and Svartbyn. The order value is SEK 1.6bn (EUR 142m). The contract is structured as a partnering agreement (Sv: &lt;em&gt;samverkan&lt;/em&gt;), meaning that NYAB assumes relatively little price risk, as it is largely based on a cost-plus model. Construction will begin immediately, and we expect consensus EBIT estimates for 2027e-2028e to increase by 5-10% as a result of the order. The project will be included in NYAB&amp;#8217;s order book in Q3&amp;#8217;26, which should lift the order book substantially above the record-high level reported in Q2.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Positive for growth, but also strengthens credibility&lt;/h3&gt;&lt;p&gt;This is NYAB&amp;#8217;s second major power line project with Svenska kraftn&amp;#228;t, following the Aurora Line, a ~SEK 1.0bn project completed in Q4&amp;#8217;25. NYAB began working on Phase 1 (planning) of Letsi&amp;#8211;Svartbyn shortly after completing the Aurora Line. Although the company indicated that it also expected to secure the larger Phase 2 execution contract, this had not been confirmed until today. The order therefore not only supports growth and positive estimate revisions but also strengthens management&amp;#8217;s credibility, in our view.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;The order book de-risks strong earnings growth f12m&lt;/h3&gt;&lt;p&gt;Before this order, we already expected &amp;gt;20% earnings growth f12m. Adding this new order, we could now see ~25-30% growth f12m. The share has done well, but still trades at 9x EBIT on 2027e. Longer term, we believe that NYAB remains well-positioned towards infrastructure niches with strong demand, and its capital-light operating model facilitates a combination of high growth and high cash generation.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nyab/Equity-research/2026/9/nyab---a-powerful-addition-to-the-order-book/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 23 Sep 2026 06:45:04 GMT</pubDate>
      <isin>SE0022242434</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Careium - Not much should rock the Q3 boat </title>
      <description>&lt;a id="bm-comp-6c0d6c11-3957-4733-8993-a54d674aa452" name="bm-comp-6c0d6c11-3957-4733-8993-a54d674aa452" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="6c0d6c11-3957-4733-8993-a54d674aa452" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q3e: 13.5% organic sales growth, 8% EBITA margin&lt;/li&gt;&lt;li&gt;H2 faces fewer GM headwinds&lt;/li&gt;&lt;li&gt;Trading at 9x '27e EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1a5e61ba-b5e3-4c51-91eb-fdeee3d49def" name="bm-comp-1a5e61ba-b5e3-4c51-91eb-fdeee3d49def" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1a5e61ba-b5e3-4c51-91eb-fdeee3d49def" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong GM, but growth investments might sting a bit&lt;/h3&gt;&lt;p&gt;We expect 13.5% organic growth in Q3e despite facing a much tougher comp than the previous two quarters. Given the H1'26 development, we expect Q3e service sales roughly in line with Q2'26 (SEK 179m), driving the mid-teen growth despite a relatively strong comp here as well. We expect adj. EBIT growth of 7% y-o-y on a relatively flat opex base q-o-q. This implies a margin contraction of 0.6pp y-o-y, mainly on investments in growth. We expect Q3 sales and EBIT of SEK 245m and SEK 20m, respectively, corresponding to y-o-y sales growth of 15% and a margin of 8.2%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We expect H2 to drive the full-year margin&lt;/h3&gt;&lt;p&gt;We expect the Nordics to deliver an improved gross margin, as the onboarding costs for the Norwegian contract should be behind us. The UK and Ireland margin was weighed down in H1'26 due to a large amount of low-margin A2D-related installation projects, which we see no reason to extrapolate into H2e. We expect the segment's GM to come in at 39.5% (10bps y-o-y lift), compared to the 240bps decrease y-o-y in Q2 to 36.9%. Moreover, Q4'25 EBIT was heavily weighed down by timing of accruals between quarters in the UK &amp;amp; Ireland, and we expect a normalisation in 2026.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;EBITA estimates slightly raised&lt;/h3&gt;&lt;p&gt;We make limited organic revisions to our sales estimates, but updated FX movements lead us to raise '26e-'27e sales by 1% and 1.5%, respectively. Moreover, we do not make any major changes to our opex estimates in absolute terms, which causes our '26e-'27e EBIT estimates to increase by 2-1%. On our updated estimates, Careium is trading at '26e-'27e multiples of 12x-9x EV/EBITA adj. and 13x-10x P/E, and we highlight '25-'28e sales and adj. EBITA CAGRs of 9% and 25%, respectively. Careium has historically traded at an average of 8x EBITA and 11x P/E, NTM.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/careium/Equity-research/2026/9/careium---not-much-should-rock-the-q3-boat-/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 22 Sep 2026 17:00:06 GMT</pubDate>
      <isin>SE0017131824</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Petrolia Noco - Estimate changes from Crude Quarterly</title>
      <description>&lt;a id="bm-comp-62239004-2949-4afe-a022-25873b49960a" name="bm-comp-62239004-2949-4afe-a022-25873b49960a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="62239004-2949-4afe-a022-25873b49960a" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;We raise our '26e oil price forecast to USD 93/bbl (prev. 84). Our '27e price forecast is raised to USD 79/bbl (75), and we reiterate our long-term oil price forecast of USD 75/bbl for '28e-'30e.&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;We raise our '26e gas price forecast to USD 18.8/MMBtu (prev. 14.4). We raise our '27e gas price forecast to USD 14.9/MMBtu and reiterate our long-term gas price forecast of USD 9.0/MMBtu for '28e-'30e.&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;We lower our USD/NOK assumption to 9.5 (10.0) from Q4'26e onwards.&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Please see the table below for a summary of the estimate changes and refer to our Crude Quarterly report for further details.&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;br /&gt;&lt;p&gt;&lt;font color="#000000"&gt;&lt;font color="#000000"&gt;In our 22 September Crude Quarterly report, we update our oil and gas price assumptions for our covered E&amp;amp;Ps. See the report for more details on our new oil market estimates and our updated price assumptions. Also, see below in this report for quarterly and annual company estimates.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-999a7652-20e1-4e34-ba6d-2413e9fbdadc" name="bm-comp-999a7652-20e1-4e34-ba6d-2413e9fbdadc" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="999a7652-20e1-4e34-ba6d-2413e9fbdadc" style="vertical-align: top; width:100.000000%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/petrolia-noco/Equity-research/2026/9/petrolia-noco---estimate-changes-from-crude-quarterly/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 22 Sep 2026 04:30:03 GMT</pubDate>
      <isin>CY0102630916</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Alligo - ABGSC's Small &amp; Mid cap seminar</title>
      <description>&lt;a id="bm-comp-02c827a2-6f5e-4a11-9673-9933b217954c" name="bm-comp-02c827a2-6f5e-4a11-9673-9933b217954c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="02c827a2-6f5e-4a11-9673-9933b217954c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;ABGSC hosted CEO Samuel Alteborg at our SMC seminar&lt;/li&gt;&lt;li&gt;Finland and Sweden driving recovery...&lt;/li&gt;&lt;li&gt;...while Norway remains sluggish&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7bcd11dd-47a9-496b-8c34-fb26ce2dcc79" name="bm-comp-7bcd11dd-47a9-496b-8c34-fb26ce2dcc79" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7bcd11dd-47a9-496b-8c34-fb26ce2dcc79" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;New CEO, strategy firmly anchored&lt;/h3&gt;&lt;p&gt;Today, CEO Samuel Alteborg presented at ABGSC's Small &amp;amp; Mid Cap Seminar in Stockholm. He took up the CEO post on 1 June, joining from Cramo, a facility and equipment rental company. Mr Alteborg made a confident impression at the presentation. He was explicit about not intending to start a cultural revolution, with the operational strategy and financial targets left unchanged (organic growth above 5%, adj. EBITA margin above 10%, ND/EBITDA below 3x and a 30-50% payout ratio). He confirmed his commitment both to the core offering (Swedol and Tools, ~80% of sales) and to continued expansion of the non-integrated businesses (~20% of sales), acquired across separate technology areas since the group was formed. Asked about new verticals of interest for the non-integrated segment, he named chemicals.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Finland's recovery ahead of plan&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Finland's margin recovery has run ahead of our expectations, with an adj. EBITA margin of 7.0% in Q2'26, up 2.3pp y-o-y and 4.5pp sequentially. Management described the recovery as broad-based, spanning industrial customers and a returning SME segment. We find it particularly impressive, given that two large industrial customers were phased out during Q1. The strong development in Finland matches what serial acquirer Karnell said at an earlier seminar today, also displaying a strong Q2 in the country. Norway stayed sluggish, with oil and gas held back by lower investment. In Sweden, management continues to describe customers as cautious, with smaller basket sizes. This is mainly attributed to lower volume per visit and is concentrated in the SME cohort that has historically been the core of the segment. Mr Alteborg argued that broadening the customer base should reduce that sensitivity. The quarter was nonetheless the third consecutive quarter of organic growth, and management sees the marke&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/Alligo/Equity-research/2026/9/alligo---abgscs-small--mid-cap-seminar/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 17 Sep 2026 15:01:03 GMT</pubDate>
      <isin>SE0009922305</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Viscaria - New financing and a raised copper price</title>
      <description>&lt;a id="bm-comp-344819eb-a730-40f9-bb39-4927ff432e3a" name="bm-comp-344819eb-a730-40f9-bb39-4927ff432e3a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="344819eb-a730-40f9-bb39-4927ff432e3a" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We add the recent equity raise to our numbers...&lt;/li&gt;&lt;li&gt;...and raise long-term copper price while delaying mine restart&lt;/li&gt;&lt;li&gt;Feedback from ABGSC Small &amp;amp; Mid Cap Seminar&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-0fa5d037-8834-4f2c-83e5-80b92cfb334d" name="bm-comp-0fa5d037-8834-4f2c-83e5-80b92cfb334d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0fa5d037-8834-4f2c-83e5-80b92cfb334d" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Adding equity raise to estimates&lt;/h3&gt;&lt;p&gt;Since our latest update, Viscaria completed a directed share issue of ~SEK 1.7bn at SEK 16.60 per share, split in two tranches with the first booked in Q2, and the second pending for Q3. Moreover, the transaction included debt-to-equity conversion of outstanding shareholder loans, which take the total transaction size to ~SEK 2.4bn, for a dilution of 37.5%, which we now add to our numbers. Apart from existing shareholders, the directed share issue brought in InfraVia Capital Partners, a PE firm specialising in real assets. Combined with the pending debt financing package of up to SEK 4.8bn, this should leave Viscaria fully financed.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Copper price raised, and mine ramp-up delayed&lt;/h3&gt;&lt;p&gt;Apart from the revisions above, which are related to the financing side, we make other changes to our operational assumptions. First, given big moves on metals &amp;amp; FX rates, we raise our long-term copper price assumption from USD 9,500/t to 11,000/t, while lowering our USD/SEK rate from 10.34 to 9.77, resulting in a +10% revision to the price in SEK. Second, we delay the mine restart to '28e, but keep our operational estimates at full run-rate production (from '29e) unchanged. At full run-rate, with our new inputs, we model annual revenue and EBITDA for the Viscaria mine of SEK 2.9bn and 2.0bn, respectively.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Feedback from Small &amp;amp; Mid Cap Seminar&lt;/h3&gt;&lt;p&gt;Finally, we highlight that ABGSC hosted CEO J&amp;#246;rgen Olsson at our Small &amp;amp; Mid Cap Seminar on 17 September. Mr. Olsson noted that both construction and finalising of the debt financing are progressing according to plan. Moreover, he pointed to the current macro backdrop, which is highly supportive for Viscaria's economics. At spot prices and FX rates, Viscaria would generate a full run-rate EBITDA of SEK 2.8bn, by our estimation.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/viscaria/Equity-research/2026/9/viscaria---new-financing-and-a-raised-copper-price/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 17 Sep 2026 15:00:06 GMT</pubDate>
      <isin>SE0021148160</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>NYAB - ABGSC’s Small &amp; Mid Cap Seminar</title>
      <description>&lt;a id="bm-comp-3f1a324a-6619-437e-810a-3f51a7395135" name="bm-comp-3f1a324a-6619-437e-810a-3f51a7395135" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3f1a324a-6619-437e-810a-3f51a7395135" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We hosted CEO Johan Larsson&lt;/li&gt;&lt;li&gt;Strong market conditions while NYAB continues to gain share&lt;/li&gt;&lt;li&gt;&amp;gt;20% earnings growth both R12m and F12m at 10x EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d98ef5a0-1e09-4646-b47f-068c5d458661" name="bm-comp-d98ef5a0-1e09-4646-b47f-068c5d458661" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d98ef5a0-1e09-4646-b47f-068c5d458661" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong outlook intact&lt;/h3&gt;&lt;p&gt;We hosted NYAB's co-founder and CEO, Johan Larsson at ABGSC's Small &amp;amp; Mid Cap Seminar. As usual, he made a strong impression, emphasising good demand within NYAB's key markets (including power grid, transportation, data centres and defence), and its ability to execute supported by its capital-light and scalable business model. Our conclusion is that the strong momentum in Q2 (orders +18% and organic sales +19% y-o-y) is likely to continue in H2e. Although the company targets growth of &amp;gt;10% per year, Mr. Larsson believes it has the managerial and financial capabilities to grow at more than 20% per year organically, without sacrificing margins. For a construction-oriented company, sustaining this level of growth is exceptional. However, as we have highlighted previously, NYAB's model differs from traditional construction firms as it outsources &amp;gt;90% of the construction work, focusing instead mostly on the design and project management aspects. The project risk is also mitigated by the fact that only ~30% of projects are based on fixed prices, and ~70% partnering, which is more like a cost-plus model. Even so, NYAB can still generate higher project margins on its partnering contracts compared to peers on fixed prices. We think this is evident in NYAB's historical EBIT margins of ~8% avg. in its Civil Engineering business 2015-2025 (compared to traditional construction peers at ~3-4%) while delivering a &amp;gt;30% sales CAGR. To put NYAB's growth into perspective, Mr. Larsson says that the company still has &amp;lt;1% market share.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&amp;gt;20% EBIT growth both R12m and F12m&lt;/h3&gt;&lt;p&gt;On an LTM basis, NYAB has grown EBIT by 21%, organically. With a record order backlog at Q2'26, we currently forecast 24% EBIT growth F12m. However, note that our estimates do not fully account for potential larger projects that the company is wo&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/nyab/Equity-research/2026/9/nyab---abgscs-small--mid-cap-seminar/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 17 Sep 2026 05:30:05 GMT</pubDate>
      <isin>SE0022242434</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Svedbergs Group - Svedbergs saves in Dalstorp</title>
      <description>&lt;a id="bm-comp-d2069c23-e4fd-438f-8710-dbdfca9ad524" name="bm-comp-d2069c23-e4fd-438f-8710-dbdfca9ad524" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d2069c23-e4fd-438f-8710-dbdfca9ad524" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Saves SEK 25m annually from Q2'27, 6% of our '27e EBITA&lt;/li&gt;&lt;li&gt;...to reach 15% margin in Svedbergs (the brand)&lt;/li&gt;&lt;li&gt;We see this as part of a longer trend and not a Q3 signal&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9f16da8d-a2d5-44e5-bc5c-d2b7f008725e" name="bm-comp-9f16da8d-a2d5-44e5-bc5c-d2b7f008725e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9f16da8d-a2d5-44e5-bc5c-d2b7f008725e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Svedbergs aims to save SEK 25m per annum from Q2'27...&lt;/h3&gt;&lt;p&gt;This morning, Svedbergs initiated a cost-savings programme with the aim to simplify the organisation, clarify areas of responsibility and lower the operating cost base, according to the company. The cost-savings programme is aimed to save around SEK 25m per annum with full effect from Q2'27: we expect the savings programme to entail a headcount reduction of ~20 employees (ABGSCe). Our impression is that affected staff is mostly white-collar. We do not expect the company to book any NRI related to this initiative, the company is typically very restrictive on NRIs and there is no mention in the press release.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;...to reach a 15% margin in Dalstorp, too&lt;/h3&gt;&lt;p&gt;Evaluating historical performance for Svedbergs (the brand) specifically, we note that it has not delivered 15% EBITA margins except 2021-2022, which was an unrepresentative demand environment. Realising the full cost savings programme would mean Svedbergs (the brand) is then set up structurally to deliver a ~15% EBITA margin should the markets keep improving, i.e. in line with the Group's financial targets, even without exceptional demand. For context, the brand reported EBITA of SEK 28m in '25, for a 7% margin. SEK 25m in savings correspond to 6% of our forecasted '27e EBITA for the Group.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Timing?&lt;/h3&gt;&lt;p&gt;We see this cost-savings initiative as the next step on a journey that has lasted a number of years, and not as a signal of rapidly deteriorating markets near-term. In 2023, it installed a new wood processing line in Dalstorp, and in 2024 when we visited the factory it had recently installed a new machine for edge banding, i.e. protecting the edges of wood panels from moisture. Both these initiatives have been said to improve capacity in the Dalstorp factory. In April 2025, Svedbergs' MD was furthermore replaced. As such,&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/svedbergs/Equity-research/2026/9/svedbergs-group---svedbergs-saves-in-dalstorp/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 15 Sep 2026 07:00:05 GMT</pubDate>
      <isin>SE0000407991</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Proact - Meeting with the CEO</title>
      <description>&lt;a id="bm-comp-b0c91443-5a71-47cc-97c1-37546ecf76a9" name="bm-comp-b0c91443-5a71-47cc-97c1-37546ecf76a9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b0c91443-5a71-47cc-97c1-37546ecf76a9" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;AI is increasing demand for hardware-based storage infrastructure&lt;/li&gt;&lt;li&gt;NetApp confirmed Dell's report, record order and sales growth&lt;/li&gt;&lt;li&gt;Focus on West and Central margins, growth ambitions to be covered on CMD&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d579a159-ce62-4ddc-921d-2c9577ab125f" name="bm-comp-d579a159-ce62-4ddc-921d-2c9577ab125f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d579a159-ce62-4ddc-921d-2c9577ab125f" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Increasing demand for hardware infrastructure&lt;/h3&gt;&lt;p&gt;Yesterday, we met with Proact's CEO Magnus L&amp;#246;nn for a lunch in town. AI is increasing enterprise awareness on hardware infrastructure while decreasing apetite for large software investments, benfitting hardware providers like Proact. Data needs to be stored safely and structured, and with high regulation requirements among certain sectors. The US/European polarisation is also increasingly driving some demand from US cloud providers to European-based hardware solutions, that Proact can offer. Operationally, Magnus reiterated the focus to drive margins upwards in West (Netherlands) and Central (Germany) to acceptable levels, before chasing growth in these regions. Magnus was previously Head of Nordics &amp;amp; Baltics, where he increased EBITA margins from 6% in 2022 to 10% in 2025, when he was appointed group CEO. He certainly has found a way to increase margins, and the trend looks promising in the underperforming segments recently.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;NetApp confirmed Dell's momentum&lt;/h3&gt;&lt;p&gt;Late last week, Proact's US hardware supplier NetApp reported its Q1'27 report (calendar Q2'26), delivering the strongest order and sales growth for at least five years, confirming &lt;a data-bm-trackable="false" href="https://abg-portal.bluematrix.com/links2/pdf/c39689e9-899d-42ad-91b8-1da67cc71902?firmId=45691" target="_blank"&gt;Dell's similar strength&lt;/a&gt;. Sales grew 30% y-o-y, orders 36% and NetApp lifted its FY guidance. Continued price increases on components drive the strong growth rates, but underlying demand looks to be solid as well. NetApp is expected to show decelerating growth rates ahead, indicating that they may have peaked in Q2, although remain double-digit for the rest of 2026. This is positive for Proact's system sales, as a European partner of NetApp products. We understood from Magnus that order demand remains good, and clients that postponed purchases in H1 in hopes for lower prices in H2 more and &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/proact/Equity-research/2026/9/proact---meeting-with-the-ceo/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 09 Sep 2026 15:00:03 GMT</pubDate>
      <isin>SE0015961222</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Infrea - From local roots to larger routes</title>
      <description>&lt;a id="bm-comp-a11c4bf9-c7a1-488e-ad28-b3355e6c165d" name="bm-comp-a11c4bf9-c7a1-488e-ad28-b3355e6c165d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a11c4bf9-c7a1-488e-ad28-b3355e6c165d" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Becoming a company with SEK 5bn in sales...&lt;/li&gt;&lt;li&gt;...and saving SEK 50m in cost synergies&lt;/li&gt;&lt;li&gt;Structural demand supporting the market&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-3a46706d-5951-434e-9045-51635595b503" name="bm-comp-3a46706d-5951-434e-9045-51635595b503" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3a46706d-5951-434e-9045-51635595b503" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Scale meets local strength&lt;/h3&gt;&lt;p&gt;The proposed merger between Infrea and Netel creates a Northern European infrastructure services group with ~SEK 5bn of revenue and around 1,200 employees across Infra, Power, Telecom and Paving. We see a strategic fit where the companies have complementary geographic footprints and capabilities, while greater scale should allow the combined group to compete for larger contracts without losing the local presence and relationships that remain important in smaller projects.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;SEK 50m of synergies provides meaningful earnings leverage&lt;/h3&gt;&lt;p&gt;The boards target SEK 50m of annual cost synergies within 12&amp;#8211;24 months, equivalent to c. 60% of the companies&amp;#8217; combined '25 adj. EBITA. Savings are expected from overlapping group functions, larger operating units, procurement, and removing duplicate listing costs. Revenue synergies are unquantified, but we see opportunities from cross-selling complementary capabilities and taking greater responsibility for larger, whole-of-scope projects.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;The strategic logic is clear &amp;#8211; execution is the key test&lt;/h3&gt;&lt;p&gt;The market backdrop looks favourable, with substantial investment needs in the Nordic countries across transport infrastructure, power grids and digital networks. However, both companies enter the merger after periods of weak profitability and consolidation, and neither has consistently delivered on their profitability ambitions in recent years. We therefore see restoring underlying margins and delivering targeted synergies as more important near-term value drivers than growth. If execution improves, the combination should emerge with a stronger competitive position and broader avenues for growth.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/infrea/Equity-research/2026/9/infrea---from-local-roots-to-larger-routes/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 08 Sep 2026 10:45:04 GMT</pubDate>
      <isin>SE0010600106</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Petrolia Noco - Brage shutdown masked by price and liftings</title>
      <description>&lt;a id="bm-comp-3dfde5c5-bc76-4efb-8072-41bdf0e13195" name="bm-comp-3dfde5c5-bc76-4efb-8072-41bdf0e13195" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3dfde5c5-bc76-4efb-8072-41bdf0e13195" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 EBITDA NOK 100m vs. ABGSCe NOK 85m on overlift&lt;/li&gt;&lt;li&gt;Limited underlying long-term production changes&lt;/li&gt;&lt;li&gt;Fair value range NOK 1.5-4.5&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7b9cf4a8-bc8f-4815-ab01-bac16adf8f39" name="bm-comp-7b9cf4a8-bc8f-4815-ab01-bac16adf8f39" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7b9cf4a8-bc8f-4815-ab01-bac16adf8f39" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 production 1.88 kboe/d, impacted by Brage shutdown&lt;/h3&gt;&lt;p&gt;Q2'26 production of 1.88 kboe/d came in marginally below ABGSCe of 1.96 kboe/d, with the quarter down 1.46 kboe/d q-o-q on a five-week planned maintenance shutdown at Brage. The production shortfall was offset by strong realised prices of USD 105.8/bbl, driving revenues to NOK 218m vs. ABGSCe NOK 171m. The revenue beat was almost entirely driven by an overlift, and EBITDA landed at NOK 100m vs. ABGSCe NOK 85m. Adjusting for lifting effects, all underlying operational metrics were in line with our estimates. Petrolia Noco repaid NOK 48.3m of debt in Q2 and still grew its cash pile from NOK 98m to NOK 145m, cutting gross debt to NOK 187m. We estimate a cash position of NOK 200m by end-Q3.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Minor H2'26e tweaks and Q2 beat prompts '26e EBITDA up 7%&lt;/h3&gt;&lt;p&gt;The somewhat lower production was partly pre-flagged; we track monthly data from Lime Petroleum (34% interest in Brage), which showed April below expectations and May fully shut in, with maintenance running longer than initially scheduled. Production restarted on 3 June, and the July update from Lime confirms output has returned to more normalised levels. Minor moving parts in our H2'26 modelling net to an unchanged '26e production figure. The stronger Q2 numbers drives our '26e EBITDA up 7%, while our '27e-'28e estimates are broadly untouched. Talisker (H2 2027 start-up target) provides the next production step-up, though we await more details before including it in our estimates. Our oil price deck is unchanged; we reiterate USD 75/bbl from '27e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of NOK 1.5-4.5/sh&lt;/h3&gt;&lt;p&gt;Assuming a long-term Brent price of USD 50-85/bbl, we estimate a NAV of NOK 1.5-4.5/sh for Petrolia. Using a 13% WACC, the current share price implies a discounted oil price of USD 60/bbl on ABGSC estimates.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/petrolia-noco/Equity-research/2026/9/petrolia-noco---brage-shutdown-masked-by-price-and-liftings/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 06 Sep 2026 17:15:02 GMT</pubDate>
      <isin>CY0102630916</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nepa - Marketing measurement on a recurring base</title>
      <description>&lt;a id="bm-comp-9ec127f8-3a6d-4107-8534-42b7bd33c2c3" name="bm-comp-9ec127f8-3a6d-4107-8534-42b7bd33c2c3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9ec127f8-3a6d-4107-8534-42b7bd33c2c3" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Helps brands to market efficiently through insights&lt;/li&gt;&lt;li&gt;Underlying ARR +8% y-o-y in 2025 carries into 2026e&lt;/li&gt;&lt;li&gt;We set a fair value range of SEK 17-30&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-40e1925c-a613-495c-bb98-a8a2fea43690" name="bm-comp-40e1925c-a613-495c-bb98-a8a2fea43690" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="40e1925c-a613-495c-bb98-a8a2fea43690" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Improving marketing efficiency for consumer companies&lt;/h3&gt;&lt;p&gt;Nepa is a marketing intelligence company combining survey data, sales data, and marketing investment analysis to help global brands optimise short- and long-term growth. Its product suite is based around three products: MMM, which helps brands to optimise their marketing channel mix; its most popular product Brand Tracking, which measures brand strength; and Campaign Pulse, a live feedback tool for campaigns. In 2025, 61% of net sales came from subscriptions, with the rest from ad hoc services. It has ~115 subscribing customers, including several well-known brands, with an ARPU of SEK 1.1m. With a 20-year history of tracking brands, Nepa has amassed a large proprietary dataset, which increases the value and switching costs for its customers in addition to limiting AI disruption risk.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Turning a corner to become more scalable&lt;/h3&gt;&lt;p&gt;Nepa made significant changes in 2025 to become more scalable, including putting greater focus on the subscription part of its offering. We expect its strong underlying ARR growth (+8% in 2025 vs -17% reported) to carry into our forecast period, driven by improved customer outreach. Combined with leverage on the now-reduced opex base, this could lift EBITDA to SEK 6m in 2026e and SEK 15m in 2027e, vs SEK -5m in 2025. Seeing no capex needs, we expect cash flow to improve similarly.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We set a fair value range of SEK 17-30&lt;/h3&gt;&lt;p&gt;Nepa is currently trading at 20x/7x our '26e/'27e EV/EBITDA. Our fair value range of SEK 17-30 per share is derived by applying the average EV/EBITDA of its closest peers (6.6x) on '27e EBITDA for the lower figure, while the higher end is based on a DCF. Our range corresponds to 7x-14x '27e EV/EBITDA, a wide range that reflects our view of 2027e EBITDA as not yet representative of the company&amp;#8217;s normalised earnings potential.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/Nepa/Equity-research/2026/9/nepa---marketing-measurement-on-a-recurring-base/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 04 Sep 2026 04:45:07 GMT</pubDate>
      <isin>SE0008066302</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Qben Infra - Needs more time to convert growth to earnings</title>
      <description>&lt;a id="bm-comp-9e7df946-ffe4-4bc1-958a-cae01ecefd10" name="bm-comp-9e7df946-ffe4-4bc1-958a-cae01ecefd10" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9e7df946-ffe4-4bc1-958a-cae01ecefd10" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Focus on the Power segment&lt;/li&gt;&lt;li&gt;Sales held up, earnings was weak&lt;/li&gt;&lt;li&gt;Divestment of Construction expected to close in Q3&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-4572afb2-ece6-46b5-a27f-b75a73ce7c86" name="bm-comp-4572afb2-ece6-46b5-a27f-b75a73ce7c86" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4572afb2-ece6-46b5-a27f-b75a73ce7c86" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Power improves, Construction masks underlying progress&lt;/h3&gt;&lt;p&gt;Qben infra reported solid sales but a weaker cost base weighed on earnings. Sales were SEK 344m and EBITA SEK -24m, including ~SEK 30m of IAC. The largest was a SEK 14m write-down of unfinished Team Bygg projects, while acquisition and integration costs related to B45 also weighed on earnings. Adjusted EBITA was SEK 6m. Power increased sales by 6% to SEK 202m and returned to positive EBITA of SEK 5m, corresponding to a 2.6% margin. While profitability was softer than we would have liked, the order book now exceeds NOK 1bn. Inspekt increased sales by 39% to SEK 63m and narrowed its EBITA loss to SEK 2m from SEK 6m in Q1'26. Construction remained the main drag, with sales of SEK 81m and EBITA of SEK -27m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Construction exit sharpens the portfolio but we cut earnings&lt;/h3&gt;&lt;p&gt;Qben has made two important portfolio decisions: it cancelled the planned Inspekt divestment and subsequently signed an LOI to divest Construction for ~NOK 50m, with closing expected in Q3. Following Q2, we leave our sales estimates broadly unchanged but make sizeable cuts to group earnings. Qben expanded rapidly last year and now needs more time than we previously expected to adjust its cost base. We therefore lower our earnings estimates across all segments.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Execution and liquidity now take centre stage&lt;/h3&gt;&lt;p&gt;Following the disposals of Rail and Kvalitetsbygg and the planned Construction exit, Qben is increasingly focused on Power, complemented by Inspekt approaching breakeven. Power's &amp;gt;NOK 1bn order book supports revenue visibility, while margins and liquidity remain key watch points. Management has extended the Songa owner loan to January 2027 and raised ~SEK 74m in convertibles. Power margins, working-capital control and completion of the Construction sale are the main near-term milestones.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/qben-infra/Equity-research/2026/9/qben-infra---needs-more-time-to-convert-growth-to-earnings/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 02 Sep 2026 16:00:05 GMT</pubDate>
      <isin>SE0023114012</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Xplora Technologies - A setback, but long-term potential intact</title>
      <description>&lt;a id="bm-comp-2c790b99-ac22-41d6-a419-95e104c5879c" name="bm-comp-2c790b99-ac22-41d6-a419-95e104c5879c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2c790b99-ac22-41d6-a419-95e104c5879c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We cut '26e EBIT by 15% and '27e by 32%&lt;/li&gt;&lt;li&gt;Long-term potential still intact, but likely to take more time&lt;/li&gt;&lt;li&gt;EV/EBIT drops from 12.0x in '26e to 5.7x in '28e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-acf050ff-61de-409c-b8eb-f9654a7faac2" name="bm-comp-acf050ff-61de-409c-b8eb-f9654a7faac2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="acf050ff-61de-409c-b8eb-f9654a7faac2" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Lower volumes and slow retail roll-out...&lt;/h3&gt;&lt;p&gt;Xplora delivered a disappointing Q2 report, with revenues down 9% y-o-y and a flat adj. EBITDA of NOK 61m, which led to a 30% share price drop. There were two main disappointments: first, senior device volumes declined 17% y-o-y on tough comps from last year's 2G shutdown boost. This was bound to normalise at some point, but the share reaction shows the market had extrapolated the strong 2025 performance. Second, the Doro Connect rollout has taken longer than the market expected. At the November '25 CMD, Xplora guided for a 900-store rollout from January '26. The result so far is one store pilot complete, with a rollout to ~135 Norwegian Power stores starting in September. The company had clearly underestimated the necessary preparations, including building a new POS system for SIM activation.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;...lead us to cut estimates materially&lt;/h3&gt;&lt;p&gt;In our view, the long-term potential remains, but with a delayed retail roll-out the ramp-up in conversion rate will be slower than initially anticipated. We do a complete reset, cutting '26e, '27e and '28e EBIT by 15%, 32% and 34%, respectively. We still expect a 12% senior conversion rate long term, but we do not expect this to be reached until '29e, rising gradually from ~1% at YE'26e to 3% in '27e and 7% in '28e. We expect the first milestone of 10k senior subscriptions in Q1'27, and forecast 126k senior subscriptions at YE'28e. Combined with NOK 50m in cost synergies we forecast EBIT to increase by ~80% from NOK 144m in '26e to NOK 263m in '28e. For '27e we forecast an EBIT of NOK 187m vs. FactSet consensus of NOK 170m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;But long-term potential still exciting&lt;/h3&gt;&lt;p&gt;Xplora is now trading at 12.0x '26e EV/EBIT, but when senior subscriptions start to have a meaningful impact in '28e this drops to 5.7x. Our DCF points to NOK 39-101/share.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/xplora_technologies/Equity-research/2026/9/xplora-technologies---a-setback-but-long-term-potential-intact/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 02 Sep 2026 11:00:04 GMT</pubDate>
      <isin>NO0010895782</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Proact - Dell Q2: Storage sales +12% vs cons</title>
      <description>&lt;a id="bm-comp-5a6a284b-7dd3-4dec-a307-b4e7abf948c5" name="bm-comp-5a6a284b-7dd3-4dec-a307-b4e7abf948c5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5a6a284b-7dd3-4dec-a307-b4e7abf948c5" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Dell Storage sales +26% y-o-y driven by data center modernisation&lt;/li&gt;&lt;li&gt;Decent correlation to Proact System sales (partner to Dell), positive for Q3-Q4e&lt;/li&gt;&lt;li&gt;Delivery times the uncertain factor, but demand continues to surprise positively&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-02938b06-1399-4cfb-b627-ab118650e504" name="bm-comp-02938b06-1399-4cfb-b627-ab118650e504" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="02938b06-1399-4cfb-b627-ab118650e504" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Dell Q2'27 with strong growth rates across the board&lt;/h3&gt;&lt;p&gt;Dell reported its Q2'27 numbers yesterday after market close in the US, with sales +58% y-o-y and +5% vs cons, while EPS beat cons by 43%. AI-optimized servers, networking, storage and PC segments (both commercial and consumer) all with strong growth rates. Guides for Q3 sales +80% y-o-y and +18% vs cons, accelerating growth vs Q2 in all segments. Dell commented on the conf call for example: "&lt;em&gt;AI is an important catalyst, but the opportunity extends well beyond AI optimised infrastructure. AI requires modern, disaggregated architectures that keep data accessible and in motion across compute, storage, and networking. It is also accelerating investment across traditional IT environments as customers seek greater performance, efficiency and resiliency&lt;/em&gt;." Share +10% in after-market, and a positive read-across to most Nordic IT hardware peers.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Storage revenues accelerating - positive read-across to Proact&lt;/h3&gt;&lt;p&gt;For Proact, there is a positive read-across from the 26% growth in storage revenues (in the Infrastructure Solutions Group segment), up from 8% in Q1 and clearly above cons 8%. Likely positive price development (driven by memory) and pre-buying from customers behind the strong growth figure. Correlates relatively well with Proact system sales, as Proact is re-selling both Dell EMC and NetApp storage hardware. Proact has said that it experiences longer delivery times, but it looks like Dell is good at getting products out to partners, supporting continued strong growth for Proact in Q3-Q4e. Strong growth attracts new competition and increased price awareness among customers, so gross margin is likely not expanding although sales figures should be supported. We view Dell's storage revenue beat and accele&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/proact/Equity-research/2026/9/proact---dell-q2-storage-sales-12-vs-cons/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 02 Sep 2026 07:45:04 GMT</pubDate>
      <isin>SE0015961222</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Gentoo Media - Deleveraging focus in H2'26</title>
      <description>&lt;a id="bm-comp-412c263a-85da-4a3f-a588-b4c07779a9f4" name="bm-comp-412c263a-85da-4a3f-a588-b4c07779a9f4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="412c263a-85da-4a3f-a588-b4c07779a9f4" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sports margin flat y-o-y as FIFA World Cup...&lt;/li&gt;&lt;li&gt;...did not aid the operations as much as we had expected&lt;/li&gt;&lt;li&gt;Trading 30-35% below peers at 3.8x '26e EV/EBITDA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ee877441-d7e5-48dc-ae80-25da08bab37b" name="bm-comp-ee877441-d7e5-48dc-ae80-25da08bab37b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ee877441-d7e5-48dc-ae80-25da08bab37b" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;World Cup did not aid Q2&lt;/h3&gt;&lt;p&gt;Q2 was a bit softer than we had anticipated on both revenue and adj. EBITDA, as these were roughly 10% below our estimates. As such, the company also cut its revenue, adj. EBITDA and cash flow guidance. The sports margin was flat y-o-y, and Gentoo's customers were relatively active in terms of offering incentives and bonuses to players. While this is likely to benefit turnover in Q3, it puts some risk on the sports margin for the quarter. That said, we continue to expect a return to growth in H2, but it is likely that growth will be held back by the ongoing deleveraging work.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate revisions&lt;/h3&gt;&lt;p&gt;We cut '26e-'28e revenue and adj. EBITDA by 3% and 5%, respectively. This means that our '26e revenue of EUR 100m is in line with the upper end of the updated guidance range, while our '26e adj. EBITDA is just below the mid-point of the guidance. Our new estimates reflect a somewhat more cautious growth outlook, as the deleveraging focus will likely shift the focus from growth to cash flow even more. That said, the comps are becoming easier, and we believe that Gentoo could return to growth if the underlying iGaming market turns more favourable.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 3.8x '26e EV/EBITDA&lt;/h3&gt;&lt;p&gt;Gentoo is trading at 3.8x '26e EV/EBITDA, below Better Collective (7.5x) but in line with Gambling.com (3.8x). This means that Gentoo is trading 30-35% below the average of Better Collective and Gambling.com. Moreover, we highlight that Gentoo is trading at a '26e lease-adj. FCF yield excl. M&amp;amp;A of roughly 25%, as it should be noted that the company is largely focused on deleveraging.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/gentoo-media/Equity-research/2026/8/gentoo-media---deleveraging-focus-in-h226/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 28 Aug 2026 17:00:07 GMT</pubDate>
      <isin>US36467X2062</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Lumi Gruppen - Margins strong, but softer intake weighs</title>
      <description>&lt;a id="bm-comp-9933b91f-e1b3-4de6-89a2-d6141c4eb7c8" name="bm-comp-9933b91f-e1b3-4de6-89a2-d6141c4eb7c8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9933b91f-e1b3-4de6-89a2-d6141c4eb7c8" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;H1 above expectations, driven by strong margins and cost control&lt;/li&gt;&lt;li&gt;Soft autumn intake guidance leads to cuts in '26e-'28e estimates&lt;/li&gt;&lt;li&gt;Fair value range of NOK 14-20&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-8f63b2e5-7a51-4e6c-a4e9-d6868a4f41fc" name="bm-comp-8f63b2e5-7a51-4e6c-a4e9-d6868a4f41fc" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8f63b2e5-7a51-4e6c-a4e9-d6868a4f41fc" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;H1'26 strong&lt;/h3&gt;&lt;p style="text-align:left;"&gt;Group revenue was NOK 277m, 5% above our estimate of NOK 265m. Adj. EBITA was NOK 56m (for a 20.1% margin), above our estimate of NOK 46m. The margin beat was mainly driven by Sonans, which delivered lower-than-expected opex, and by ONH, which grew by ~15%, supported by new online programmes and a higher share of recurring revenues. This implies AY'25/26 revenues of NOK 549m, +16% y-o-y, and adj. EBITA of NOK 109m (19.8% margin).&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimate cuts based on soft autumn intake&lt;/h3&gt;&lt;p style="text-align:left;"&gt;For the 2026/27 intake, Sonans is guided to end the academic year 10-15% behind the prior year, compared to our estimate of +5%. Edrupt (EnkelEksamen) is consolidated from February 2026, and remains on track for continued double-digit growth. ONH is expected to be broadly flat, with growth in recurring revenue from continuing students offsetting softer new intake. As a result, we cut our '27e-'28e revenue estimates by 12-14% and adj. EBITA by 17-21%. The lower opex in Q2 shows solid cost control, and together with margin accretion from Bj&amp;#248;rknes and synergies, partly mitigates the margin decline from lower volume. The company now states there is an indication of impairment and that it will update its goodwill impairment assessment for Sonans after the enrolment period is closed. A trading update covering the final autumn intake is likely to be issued by Lumi in six to eight weeks.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of NOK 14-20&lt;/h3&gt;&lt;p&gt;A peer valuation on '26e-'28e multiples points to NOK 14-20/sh. Lumi is trading at '27e/'28e EV/EBIT of ~12x/10.8x and a P/E of ~19x/17.9x. Given Lumi's strong position in the Norwegian market, we believe that a premium could be justified, with an implied value range of 14&amp;#8211;20, equating to an EV/EBIT of 9.4&amp;#8211;12.5.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/lumi-gruppen/Equity-research/2026/8/lumi-gruppen---margins-strong-but-softer-intake-weighs/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 27 Aug 2026 20:00:07 GMT</pubDate>
      <isin>NO0010927288</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Lumi Gruppen - Delivering on H1, H2 looks more challenging</title>
      <description>&lt;a id="bm-comp-1f1c3da0-8c76-4bcd-b542-a083bfabe51f" name="bm-comp-1f1c3da0-8c76-4bcd-b542-a083bfabe51f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1f1c3da0-8c76-4bcd-b542-a083bfabe51f" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;H1 above driven by strong margins and cost control...&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;... but AY 26/27 outlook looks soft&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Cons to lower revenue estimates, EBITA offset by cost actions&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-45f83629-aa0f-4c55-a82c-e8334cbb1de6" name="bm-comp-45f83629-aa0f-4c55-a82c-e8334cbb1de6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="45f83629-aa0f-4c55-a82c-e8334cbb1de6" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Revenues +5%, adj. EBITA well above estimate&lt;/h3&gt;&lt;p&gt;Group revenues was NOK 277m, 5% above our estimate NOK 265m. Adj EBITA was NOK 56m (20.1% margin), above our estimate of NOK 46m. The margin beat is mainly driven by Sonans, which delivered lower opex than expected, and by ONH, which grew ~15%, supported by new online programmes and a higher share of recurring revenues. EnkelEksamen (Edrupt), consolidated from February, added NOK 18.5m revenue and NOK 4.2m adj. EBITA (22.6% margin) in the period, and is on track for continued double-digit growth in 2026/27&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Sonans fall intake guided down 10-15%&lt;/h3&gt;&lt;p&gt;For the 2026/27 intake, Sonans is guided to end the academic year 10-15% behind the prior year (we had +5%). ONH is expected to be broadly flat, as growth in recurring revenue from continuing students offsets a softer new intake. The company has implemented cost measures aimed at protecting profitability, alongside ongoing growth initiatives including continued programme portfolio development, pursuit of institutional accreditation for ONH, acceleration of the Bj&amp;#248;rknes integration, and continued double-digit growth expected at EnkelEksamen. Lumi will issue a trading update covering the final fall intake later, likely in 6-8 weeks.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Cons down on softer guidance, but cost measures help&lt;/h3&gt;&lt;p&gt;Post-period, Sonans sales for 2026/27 have developed materially below expectations. The company now states this is an indication of impairment and will update its goodwill impairment assessment for the Sonans after the enrolment period is closed. Revenue estimates are expected to be revised down to reflect the new softer guidance, but EBITA estimates partly offset by solid cost control.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;pagebreak &lt;a id="bm-comp-138e5e61-2696-486e-a46d-72f78f10266d" name="bm-comp-138e5e61-2696-486e-a46d-72f78f10266d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="138e5e61-2696-486e-a46d-72f78f10266d" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-a82c2c63-7d13-403a-ae14-6402dce22c78" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Lumi Gruppen: Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/lumi-gruppen/Equity-research/2026/8/lumi-gruppen---delivering-on-h1-h2-looks-more-challenging/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 27 Aug 2026 07:00:05 GMT</pubDate>
      <isin>NO0010927288</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Inission - Power turnaround progressing well</title>
      <description>&lt;a id="bm-comp-4865075b-ca00-4e0c-8cb8-bba70fdeef4e" name="bm-comp-4865075b-ca00-4e0c-8cb8-bba70fdeef4e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4865075b-ca00-4e0c-8cb8-bba70fdeef4e" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Orders +5%, adj. EBITA +5% above us on higher Power margin&lt;/li&gt;&lt;li&gt;'26e-'28e adj. EBITA up 1-2%; expect company to beat FY guidance&lt;/li&gt;&lt;li&gt;M&amp;amp;A pipeline strengthening, aims to close an acquisition this year&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-10314d76-3ef6-4cb2-85dd-39fe72b288c2" name="bm-comp-10314d76-3ef6-4cb2-85dd-39fe72b288c2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="10314d76-3ef6-4cb2-85dd-39fe72b288c2" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Inission delivered a strong Q2, with adj. EBITA of SEK 41m +5% vs. our estimate with a 6.4% margin (4.5%) on sales of SEK 635m (3% below ABGSCe, but still +19% y-o-y). Order intake of SEK 719m was up 39% and 5% above our forecast for a book-to-bill of 1.13x. Inission Power (Enedo) drove the beat, with EBITA reaching SEK 3.8m (-4.7m) against our SEK 2.3m, representing a 3.1% margin in its third straight profitable quarter. Cash flow was held back by inventory built-up; this was partly seasonal, but also partly due to safeguarding against PCB and component shortages.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We raise '26e-'28e adj. EBITA by 1%/2%/2%, mainly on a stronger Inission Power margin, as the turnaround in that segment continues to exceed our expectations. Our H2 estimate implies SEK 215m of sales per month, the middle of the company's flagged SEK 210-220m range. Management left the FY'26 sales guidance of SEK 2,300-2,500m at a &amp;gt;6% EBITA margin unchanged. However, on the call, they said that this was mainly out of prudence and that they are confident of reaching SEK 2.5bn. They added that there is a good chance of exceeding this target. We forecast SEK 2,588m at 6.9%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;The near-term margin case rests on Inission Power, which management expects to improve further in H2 compared to H1. The M&amp;amp;A pipeline is at a record and the CEO reiterated the ambition to close a deal this year. We raise our fair value range to SEK 60-100 (55-95). The share is trading at 14x-10x '26e-'28e P/E vs. a 10-year median of 13x-9x and Nordic EMS peers at 15x-12x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/inission/Equity-research/2026/8/inission---power-turnaround-progressing-well/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 26 Aug 2026 15:45:05 GMT</pubDate>
      <isin>SE0016275069</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Gentoo Media - A bit softer than expected</title>
      <description>&lt;a id="bm-comp-4fe58668-52c6-4609-9cf4-2bfeaad4583f" name="bm-comp-4fe58668-52c6-4609-9cf4-2bfeaad4583f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4fe58668-52c6-4609-9cf4-2bfeaad4583f" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 adj. EBITDA 19% below FactSet consensus&lt;/li&gt;&lt;li&gt;'26 adj. EBITDA guidance down to EUR 44-47m (49-54m)&lt;/li&gt;&lt;li&gt;Value of deposits up 3% q-o-q to EUR 207m&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7e63a9b0-afb2-4b61-a818-f0cfc5ed11c6" name="bm-comp-7e63a9b0-afb2-4b61-a818-f0cfc5ed11c6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7e63a9b0-afb2-4b61-a818-f0cfc5ed11c6" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Q2 outcome&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Gentoo reported Q2 revenue of EUR 22.9m, corresponding to a -9% y-o-y decline. This was 12% below both ABGSCe and Factset consensus. Moreover, adj. EBITDA of EUR 8.9m was 11% below ABGSCe and 19% below consensus. One part of the revenue miss was a timing matter, as revenue from some newly acquired revenue-share players didn't get recognised during Q2. The other part was that the sports margin was soft this quarter, suggesting that Gentoo's customer base contained operators with sports books that didn't perform well during the World Cup. That said, value of deposits was EUR 207m, up 3% q-o-q, suggesting that the underlying momentum is relatively intact.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Guidance revised downward&lt;/h3&gt;&lt;p&gt;The Q2 report was a bit softer than expected, and Gentoo has therefore cut its '26 guidance. The new revenue guidance is EUR 97-100m (100-115m), and the new adj. EBITDA guidance is EUR 44-47m (49-54m). The new OCF guidance was also downgraded to EUR 32-36m (37-41m), in line with the EBITDA guidance revision. The consensus estimates already implied an adj. EBITDA guidance downgrade, meaning that the downgrade as such was not a surprise. Operating cash flow was EUR 6.4m, down EUR 1m y-o-y, but helping deleverage the balance sheet as the leverage ratio closed just shy of 2.6x LTM EBITDA (down 0.1x sequentially).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Mechanically negative consensus estimate revisions&lt;/h3&gt;&lt;p&gt;The Gentoo share is down 3% YTD, compared to OMXSGI, which is up 12% YTD. Based on our unrevised estimates, Gentoo is trading at 4.0x '26e EV/EBITDA. Following the report, which was a bit below consensus' expectations, as well as the revised guidance ranges, we anticipate consensus to trim its revenue and EBITDA estimates by low single-digits. More details are likely to be presented on the conference call at 10.00 CET. Link to the webcast &lt;a data-bm-trackable="false" href="https://www.redeye.se/events/1169852/live-q-gentoo-media-8" target="_blank"&gt;here&lt;/a&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ba07f1c7-5614-4af6-90b9-f732b43d3412" name="bm-comp-ba07f1c7-5614-4af6-90b9-f732b43d3412" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ba07f1c7-5614-4af6-90b9-f732b43d3412" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-3d8b7823-6f32-4912-be24-d31d1c2df902" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data,&lt;/td&gt;&lt;/tr&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/gentoo-media/Equity-research/2026/8/gentoo-media---a-bit-softer-than-expected/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 26 Aug 2026 07:00:05 GMT</pubDate>
      <isin>US36467X2062</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Inission - Inission Power drives beat, demand still strong</title>
      <description>&lt;a id="bm-comp-c2db8469-ebec-4b59-a957-ab43a7b4c070" name="bm-comp-c2db8469-ebec-4b59-a957-ab43a7b4c070" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c2db8469-ebec-4b59-a957-ab43a7b4c070" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Orders +39% y-o-y and 5% above ABGSCe for a book-to-bill of 1.13&lt;/li&gt;&lt;li&gt;EBITA adj. of SEK 41m, 5% above ABGSCe, 6.4% margin (4.8%)&lt;/li&gt;&lt;li&gt;FY guidance unchanged, but expected run-rate implies higher sales&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-cbe50055-1304-433d-ae20-5c075a9bbc9e" name="bm-comp-cbe50055-1304-433d-ae20-5c075a9bbc9e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cbe50055-1304-433d-ae20-5c075a9bbc9e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Orders were up 39% y-o-y and 5% above our estimate. Sales grew 19% y-o-y and were 3% below our estimate. With a margin of 6.4%, 0.5pp above our estimate, EBITA adj. was 5% above our estimate. Lease adj. FCF was -22m, bringing the R12m figure to 68m, i.e. 85% of net income. Inission Power (Enedo) drove the beat, with EBITA of SEK 3.8m (-4.7m) against our 2.3m, a third consecutive positive quarter at a 3.1% margin on higher volumes, pricing and a lower cost base. EMS EBITA of 37.1m (28.8m) was close to our 36.6m, despite weaker sales in April and May, with disruption in European PCB supply affecting the phasing of sales within the quarter. There is a conference call at 09:00 CET: &lt;a data-bm-trackable="false" href="https://www.inissiongroup.com/sv/webcasts-inission-ab/" target="_blank"&gt;webcast&lt;/a&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;The Q2 numbers in isolation imply EBITA adj. comes up 1%. Inission left its FY'26 guidance of SEK 2,300-2,500m at a &amp;gt;6% EBITA margin unchanged, even though it flagged that it expects a run-rate of SEK 210-220m per month, implying SEK 2,589m at the midpoint, lending support to our view that the company will finish the year above guidance. Management sees strong demand in defence and data centre, weaker in industrial and electrification, and higher M&amp;amp;A activity, with the ambition to complete one acquisition this year.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Company valuation&lt;/h3&gt;&lt;p&gt;Over the past three months, the share has returned -12%, compared to the Nordic EMS peer median of -15% and the +5% of the OMX Stockholm Allshare. The share is currently trading at 13x-9.7x '26e-'28e P/E, compared to its 10-year historical median of 13x-8.9x and peers at 16x-12x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-647832fd-7a9d-4e79-a44d-ab1704a0dbcd" name="bm-comp-647832fd-7a9d-4e79-a44d-ab1704a0dbcd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="647832fd-7a9d-4e79-a44d-ab1704a0dbcd" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-eb1c9497-63b3-439e-a349-dd6e1ae506ac" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. estimates Q2'26&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/inission/Equity-research/2026/8/inission---inission-power-drives-beat-demand-still-strong/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 26 Aug 2026 06:15:06 GMT</pubDate>
      <isin>SE0016275069</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Isofol Medical - Maximising the dose before Phase 2</title>
      <description>&lt;a id="bm-comp-45de29d7-eeb3-481c-af3f-4dbcf10c973f" name="bm-comp-45de29d7-eeb3-481c-af3f-4dbcf10c973f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="45de29d7-eeb3-481c-af3f-4dbcf10c973f" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Financials fairly in line&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#1B2634"&gt;&lt;font color="#000000"&gt;Entering the final stage of Phase 1b, Phase 2 expected by YE'26&lt;/font&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fairly neutral share price reaction expected&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-2d97dafe-195e-4fec-852a-b8bf00398ed4" name="bm-comp-2d97dafe-195e-4fec-852a-b8bf00398ed4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2d97dafe-195e-4fec-852a-b8bf00398ed4" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#000000"&gt;Financials fairly in line&lt;/font&gt;&lt;/h3&gt;&lt;p style="text-align:left;"&gt;&lt;font color="#000000"&gt;For Q2'26, net income was in line with expectations at SEK -16m (vs. ABGSCe at SEX -15m and SEK -15m in Q1'&lt;font color="#000000"&gt;26) as&lt;/font&gt; opex remained well controlled, with a slight beat on CF from operating activities at SEK -14m (vs. ABGSCe at SEK -15m and SEK -16m in Q1'26). Cash and cash equivalents came in at SEK 115m (SEK 111m in Q1'&lt;font color="#000000"&gt;26),&lt;/font&gt; as the ~SEK 18m in net proceeds from the TO1 warrant exercise received in the quarter more than offset the operating cash burn.&lt;/font&gt; &lt;font color="#000000"&gt;Together with proceeds from the TO2 warrants due in November 2026, we continue to estimate a financial runway into 2028e.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#1B2634"&gt;&lt;font color="#000000"&gt;Entering the final stage of Phase 1b&lt;/font&gt;&lt;/font&gt;&lt;/h3&gt;&lt;p style="text-align:left;"&gt;&lt;font color="#000000"&gt;During the quarter, Isofol continued to advance the Phase 1b dose-escalation part of its ongoing Phase 1b/2 trial of arfolitixorin in metastatic colorectal cancer, successfully evaluating the third dose cohort at 300 mg/m&amp;#178; without dose-limiting toxicities and maintaining a consistently favourable safety profile across all three dose levels tested to date (120, 200 and 300 mg/m&amp;#178;). In April, the company also received BfArM approval for an optimise&lt;font color="#000000"&gt;d study design, including broader Phase 2 inclusion criteria, a direct comparison with leucovorin (&lt;/font&gt;the standard folate component of current 5-FU-based chemotherapy regimens), and the addition of further study centres to address slower-than-expected recruitment. After the quarter, Isofol opened the fourth and highest dose cohort at 500 mg/m&amp;#178; in July &lt;font color="#000000"&gt;following safety committee approval, moving directly to this dose based on the favourable safety data from the preceding cohorts.&lt;/font&gt; Yesterday, the company reiterated that it still expects to enter Phase 2 before year-end and noted that two new university hospitals in Germany have been added to strengthen study execution and recruitment. Phase 2 is planned to involve 10-15 hospitals across several European countries, al&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/isofol-medical/Equity-research/2026/8/isofol-medical---maximising-the-dose-before-phase-2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 25 Aug 2026 07:00:05 GMT</pubDate>
      <isin>SE0009581051</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Skolon - Broad-based growth continues</title>
      <description>&lt;a id="bm-comp-1e550ddf-f884-4d9b-9594-88e14cd942f8" name="bm-comp-1e550ddf-f884-4d9b-9594-88e14cd942f8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1e550ddf-f884-4d9b-9594-88e14cd942f8" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales grew 26% organically, ahead of expectations&lt;/li&gt;&lt;li&gt;Sweden remains a clear profit driver despite mix effects&lt;/li&gt;&lt;li&gt;'26e EV/gross profit of ~6x, fair value range of SEK 25-40&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-bb58091a-c96f-4e4d-8cb5-5eb7d6a7178a" name="bm-comp-bb58091a-c96f-4e4d-8cb5-5eb7d6a7178a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bb58091a-c96f-4e4d-8cb5-5eb7d6a7178a" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Larger customers, international traction drive a strong Q2&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Skolon delivered a strong Q2'26, with sales of SEK 69m corresponding to organic growth of 26%. Growth was broad-based across markets, while Skolon continued to attract larger school organisations to its platform. The gross margin (less capitalised work) came in at 22% (24% in Q2'25), likely reflecting a higher share of partner revenue. Sweden stayed solidly EBITDA-positive (SEK 2.7m in Q2'26), while international markets remain in an investment phase, and we continue to model a gradual normalisation of this gap over time.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Slightly raising our estimates&lt;/h3&gt;&lt;p&gt;We raise our '26e/'27e/'28e sales estimates by 3%, 2% and 1%, reflecting the stronger-than-expected paying user intake and continued momentum in framework agreement rollouts, which we expect to contribute meaningfully from Q3. We see the newly launched Skolon AI Studio as a longer-term option for partner revenue, but do not yet include a contribution in our estimates given limited visibility on monetisation.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Implied valuation&lt;/h3&gt;&lt;p&gt;Based on our revised estimates, the company is trading at '26e-'27e 6-4x EV/gross profit (GP less capitalised work). In the UK, Skolon continues to build momentum outside the Swedish procurement cycle, as evidenced by agreements covering 60 schools signed during Q2. Germany remains at an earlier stage and smaller scale but, in our view, offers longer-term potential. We see the underlying growth drivers, larger customers in the platform, continued expansion in the UK, and early-stage progress in Germany as strengths of the company, even if quarterly results can be lumpy around contract timing. We maintain our fair value range at SEK 25-40.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/company-name/Equity-research/2026/8/skolon---broad-based-growth-continues/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 24 Aug 2026 07:45:03 GMT</pubDate>
      <isin>SE0017615784</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Gentoo Media - FCF generation remains top priority</title>
      <description>&lt;a id="bm-comp-8d24409b-ead7-452b-bf02-7be7231a1c28" name="bm-comp-8d24409b-ead7-452b-bf02-7be7231a1c28" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8d24409b-ead7-452b-bf02-7be7231a1c28" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2e: 6% revenue growth y-o-y&lt;/li&gt;&lt;li&gt;'26e adj. EBITDA just below the low end of '26 guidance&lt;/li&gt;&lt;li&gt;Trading ~30% below peers at ~4x '26e EV/EBITDA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-35427c0c-c3e2-49ec-8604-4c47636ff77e" name="bm-comp-35427c0c-c3e2-49ec-8604-4c47636ff77e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="35427c0c-c3e2-49ec-8604-4c47636ff77e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;World Cup unlikely to be a significant tailwind&lt;/h3&gt;&lt;p&gt;We expect Q2 revenue of EUR 26m, implying 6% y-o-y growth. This means that we expect adj. EBITDA of EUR 10m, corresponding to a 38% margin. Listed iGaming companies have provided mixed commentary in relation to the World Cup. However, the sports book performance and corresponding sports margins have largely been a function of which sports book solution an operator uses.. Given that Gentoo has a diverse set of customers, we believe that the sports margin is likely to be broadly in line with the historical average. This is corroborated, for example, by the recent Q2 earnings report from key peer Better Collective. Finally, we expect Gentoo to deliver free cash flow just shy of EUR 4m for the quarter.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate revisions&lt;/h3&gt;&lt;p&gt;We trim '26e-'28e EBITDA by 1-2%, as we incorporate somewhat more cautious operator outcome related to the FIFA World Cup. Our new estimates imply that we are just shy of the lower end of the company's '26 guidance for both revenue and EBITDA (guidance is '26 revenue of EUR 105-110m and adj. EBITDA of EUR 49-54m). That said, we expect the company's cash generation to help deleverage the balance sheet, which is a higher priority than revenue growth.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 4x '26e EV/EBITDA&lt;/h3&gt;&lt;p&gt;Gentoo is trading at nearly 4x '26e EV/EBITDA, well below Better Collective (7.4x) but slightly above Gambling.com (3.8x). This means that Gentoo is trading 30% below the average of Better Collective and Gambling.com. It is worth noting that Gentoo Media is trading at a 23% lease-adj. FCF yield excl. M&amp;amp;A for '26e in the context of a deleveraging focus.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/gentoo-media/Equity-research/2026/8/gentoo-media---fcf-generation-remains-top-priority/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 24 Aug 2026 07:00:42 GMT</pubDate>
      <isin>US36467X2062</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Impact Coatings - Backlog to carry H2e</title>
      <description>&lt;a id="bm-comp-d9af0106-029c-4e61-9169-b58f79b22956" name="bm-comp-d9af0106-029c-4e61-9169-b58f79b22956" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d9af0106-029c-4e61-9169-b58f79b22956" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 sales SEK 10m (vs. ABGSCe SEK 16m, 6.5m &lt;font style="background-color:#ffff00;"&gt;&lt;/font&gt;Q2'25)&lt;/li&gt;&lt;li&gt;No machine deliveries in Q2, but two machine orders de-risk '26e&lt;/li&gt;&lt;li&gt;China yet to convert, but 11 new customers added, three in SOFC&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-8aabc716-c819-4e40-8b41-92c58c605340" name="bm-comp-8aabc716-c819-4e40-8b41-92c58c605340" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8aabc716-c819-4e40-8b41-92c58c605340" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Q2 sales were SEK 9.7m (vs. ABGSCe SEK 16m), all from Coating Services (SEK 9.1m vs 4.4m Q2'25) and aftermarket (SEK 0.6m vs 2.1m). No machine revenue was recognised. Aftermarket stayed weak on low activity at system customers. EBIT was SEK -13m (vs. ABGSCe SEK -8.5m). The cost base continues to come down, with personnel costs at SEK -12.3m (-15.3m Q2'25) and 41 FTEs (57). Impact has SEK 29.4m of system deliveries in backlog, with one machine shipped and installed during Q3. The company ended Q2 with a cash balance of SEK 15m (31m Q2'25), of which only SEK 8m is unrestricted, which can be compared to its R12m FCF of SEK -41m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;We lower '26e/'27e/'28e sales by 9%/4%/4%, mainly on Coating Services cuts. Services doubled y-o-y in H1 to SEK 21m (10m) but landed below our run rate in Q2. Impact has two IC500s in backlog. HJWAVE went out in mid-July and Lindberg is scheduled for early Q4, so both '26 deliveries land in H2e. In total, we model two machine deliveries for FY'26e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Market backdrop still mixed&lt;/h3&gt;&lt;p&gt;Electrolyser consolidation should work in Impact's favour, with most leading international players already paying customers as the market enters its next investment phase, and the LT Metal LOI on iridium oxide coated PTLs adds value per component. China is the offset, where the March pilot programme has yet to convert into fuel cell orders, which management reads as timing rather than a change in underlying conditions. Management flags automotive activity as still soft, in line with the weaker car industry, and Europe remains structurally lagging on hydrogen. That said, a substantial part of the 11 new customers added in the quarter were European, with five in electrolysis and three in solid-oxide fuel cells (SOFC).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/impact_coatings/Equity-research/2026/8/impact-coatings---backlog-to-carry-h2e/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 24 Aug 2026 07:00:02 GMT</pubDate>
      <isin>SE0001279142</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>I-tech - Beyond a single molecule</title>
      <description>&lt;a id="bm-comp-f8388bcb-4136-461e-8014-17a6223978c0" name="bm-comp-f8388bcb-4136-461e-8014-17a6223978c0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f8388bcb-4136-461e-8014-17a6223978c0" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 organic growth of +91% marks a record quarter&lt;/li&gt;&lt;li&gt;We raise '26e-'28e sales by 7% and EBIT by 23%, 13% &amp;amp; 9%&lt;/li&gt;&lt;li&gt;New aquaculture market entered; EU vote still pending&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-b4e85ae0-fc7b-4d49-9d52-ba5e0eabb90d" name="bm-comp-b4e85ae0-fc7b-4d49-9d52-ba5e0eabb90d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b4e85ae0-fc7b-4d49-9d52-ba5e0eabb90d" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Record quarter, easy comps aside&lt;/h3&gt;&lt;p&gt;I-Tech delivered very strong Q2 results, with 91% organic growth, representing a record quarter despite easy comps. Growth was driven by I-Tech's top two customers, where CMP continues to demonstrate strong growth (+35% org. growth in H1) and the customer that previously had financial constraints has recovered and should now be at a stable run-rate, according to management. The gross margin held up at 59% (59% LY), which management attributes to production-cost work and price adjustments.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;We raise '26e/'27e/'28e sales by 7%, on higher organic growth assumptions. We continue to expect support from rising CMP volumes and momentum among smaller customers (PPG, Jotun, Kansai Paints). On EBIT, we raise '26e/'27e/'28e by 23%, 13% &amp;amp; 9%, reflecting operating leverage on a stable cost base, albeit partly offset by the expected EOGRT study costs (SEK 10m, phased across '26e-'27e and weighted to '27e).&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Diversifying beyond Selektope&lt;/h3&gt;&lt;p&gt;Selektope is on ~3,500 of ~110,000 vessels, with room in new-build and drydocking (the latter being ~10x larger and the key opportunity), and China under-penetrated. On the EU re-registration, a vote is likely in Q4, approval runs to end-'26, and a legal appeal is prepared. Separately, I-Tech entered a new market via a nature-derived antifouling additive for aquaculture net coatings, a ~20m-litre market (Western hemisphere) vs. the ~75m-litre ship-coatings market it addresses today, with faster qualification cycles and read-across to yachts and shipping over time. Notably it is not medetomidine-based and works through a physical rather than a biocidal effect. This is a genuine diversification from the Selektope regulatory risk, though sales remain years out. The company is trading at '26e-'28e EV/EBIT of 10x-5x &amp;amp; 15x-9x P/E, ~5&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/i-tech/Equity-research/2026/8/i-tech---beyond-a-single-molecule/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 24 Aug 2026 06:15:02 GMT</pubDate>
      <isin>SE0011167725</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Catella - Signs of improvement, but delivery still pending</title>
      <description>&lt;a id="bm-comp-e53fe676-bc59-419c-bd3a-e9a13403e6af" name="bm-comp-e53fe676-bc59-419c-bd3a-e9a13403e6af" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e53fe676-bc59-419c-bd3a-e9a13403e6af" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q2 softer than expected, but underlying activity improving&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;2026-27 estimates down on softer earnings&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Recovery still needs to materialise&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-14988d19-55ee-416e-973d-7184d3cd2d65" name="bm-comp-14988d19-55ee-416e-973d-7184d3cd2d65" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="14988d19-55ee-416e-973d-7184d3cd2d65" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 misses, but we see signs of a gradually improving market&lt;/h3&gt;&lt;p&gt;Catella's Q2 EBIT came in at SEK 8m, below ABGSCe of SEK 26m and FactSet consensus of SEK 15m, mainly reflecting weaker-than-expected earnings in Investment Management, while Corporate Finance was broadly in line. Despite the miss, we see encouraging signs, with AUM broadly stable and transaction activity gradually improving across several markets. We expect this to increasingly support Corporate Finance, while transaction-related fees within Investment Management are likely to follow with some lag.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We trim our estimates following the Q2 earnings shortfall&lt;/h3&gt;&lt;p&gt;Following Q2, we lower our EBIT estimates by 25% for 2026e and 4% for 2027e, while raising 2028e by 1%. The near-term cuts reflect softer earnings in IM and CF, while our longer-term view is largely unchanged. Although activity is expected to remain subdued in the short term, Catella highlights a robust pipeline. As transaction markets normalise, improved transaction evidence should support property valuations, AUM, investor inflows and fee generation. We therefore expect a more meaningful earnings recovery through 2027-28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Recovery still to be proven&lt;/h3&gt;&lt;p&gt;Catella is trading at 8.3x 2027e and 6.5x 2028e P/E, while its strong balance sheet continues to support capital returns. However, earnings remain subdued, and the expected recovery has been pushed further into the future. Positively, Catella repurchased 2.5m shares for SEK 52m during Q2 and, following the report, announced the early redemption of its SEK 600m 2028 bond. We view these measures as further evidence of disciplined capital allocation, but believe stronger earnings delivery is needed before we can take a more constructive view.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/catella/Equity-research/2026/8/catella---signs-of-improvement-but-delivery-still-pending/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 23 Aug 2026 18:30:36 GMT</pubDate>
      <isin>SE0000188518</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ogunsen - Some signs of stabilisation</title>
      <description>&lt;a id="bm-comp-5b06816b-b513-4ae9-a587-9440d21d7baf" name="bm-comp-5b06816b-b513-4ae9-a587-9440d21d7baf" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5b06816b-b513-4ae9-a587-9440d21d7baf" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Positive organic growth will take time&lt;/li&gt;&lt;li&gt;We slightly lower our sales estimates due to a reduction in FTEs&lt;/li&gt;&lt;li&gt;Trading ~10% below peer median&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f671a4bc-6370-49bb-8445-9b03663d98d9" name="bm-comp-f671a4bc-6370-49bb-8445-9b03663d98d9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f671a4bc-6370-49bb-8445-9b03663d98d9" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2'26 report&lt;/h3&gt;&lt;p&gt;Ogunsen reported Q2'26 sales of SEK 108m, marking a y-o-y decrease of 3%. It is worth keeping in mind that returning to positive growth is tough for consulting firms, as growth depends on billable hours, which is affected by lower headcount, and average FTEs at Ogunsen are down to 362 from 370 a year ago. Demand in the consulting segment was stable y-o-y, although fewer consultants, slightly lower utilisation and lower hourly rates weighed on sales. Recruitment demand remained slightly below last year but improved sequentially, indicating tentative signs of stabilisation. Adj. EBIT came in at SEK 4.6m (3.3m in Q2'25), with a higher margin of 4.3% (3.0%), likely driven by some cost control at the company.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Slightly lowering our sales estimates&lt;/h3&gt;&lt;p&gt;The market remains tough, and we slightly lower our sales estimates by 4% for '26e-'28e on the back of the report. Consequently, we also lower our adj. EBIT estimates by 28% for &amp;#8217;26e, as lower sales and fewer billable FTEs result in negative operating leverage, partly offset by continued cost control. A recovery in the consulting market will likely take time, with stronger margins eventually following from that.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Getting better, but it takes time&lt;/h3&gt;&lt;p&gt;Ogunsen is trading at 10x-5x EV/adj. EBIT for '26e-'28e, ~10% below the peer median valuation. We see some demand KPIs improving, but we emphasise that Swedish wage agreements push salaries higher every year, so margin expansion remains a challenge in this environment. What still needs to return, in our view, is demand at normalised levels, along with positive net recruitment and room for price increases. That said, the improving demand trend and a leaner cost base provide a more supportive foundation for a gradual recovery.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ogunsen/Equity-research/2026/8/ogunsen---some-signs-of-stabilisation/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 23 Aug 2026 18:30:03 GMT</pubDate>
      <isin>SE0008406151</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Clavister - Strong quarter strengthens the outlook</title>
      <description>&lt;a id="bm-comp-622aa21f-634d-4cac-a735-7715731eaf0d" name="bm-comp-622aa21f-634d-4cac-a735-7715731eaf0d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="622aa21f-634d-4cac-a735-7715731eaf0d" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Order book at a record high ~SEK 640m...&lt;/li&gt;&lt;li&gt;...with ~SEK 225m expected to roll out in the next 12m&lt;/li&gt;&lt;li&gt;Underlying business solid as recurring revenue continues to grow&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f26ccb7f-4e7d-4ef0-b265-abd110170939" name="bm-comp-f26ccb7f-4e7d-4ef0-b265-abd110170939" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f26ccb7f-4e7d-4ef0-b265-abd110170939" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong headline numbers&lt;/h3&gt;&lt;p&gt;Clavister reported a strong Q2'26, with sales up 63% y-o-y. The growth was mainly driven by the NDMA contract, which we expected, but likely also by other defence deliveries. The underlying business remains solid and ARR grew 5% y-o-y in the quarter. The public sector takes longer to break into, but these customers are sticky once won, and contribute to recurring revenue. The energy sector, however, is faster to break into and therefore easier to win, and we see good potential for this end-segment to grow in the coming quarters. Adj. EBITDA came in at SEK 27m for a margin of 30% (17% in Q2'25), and adj. EBIT was also positive in the quarter at SEK 15m (-2m in Q2'25) for a margin of 17%. Order intake decreased by 25% y-o-y, but we do not read too much into this, as defence orders tend to be lumpy. The order backlog reached a record ~SEK 640m, of which ~SEK 225m is expected to be delivered over the next 12 months, giving strong revenue visibility.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Increasing our estimates&lt;/h3&gt;&lt;p&gt;We increase our '26-'28 estimates on the back of the strong report. We now expect net sales to reach SEK 490m by '28e off the sharply higher 2026 base, with the adj. EBITDA margin reaching ~31% (18% in '25).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Working capital release in H2&lt;/h3&gt;&lt;p&gt;Working capital tied up cash in the quarter, as deliveries on the NDMA contract ran ahead of milestone payments. We expect the WC trend to reverse in H2'26, as the cash from the NDMA contract should bring in at least SEK 60m. The tax deferrals were refinanced into a five-year facility right after the quarter, ND/EBITDA is at ~1.0x in Q3'26e, and the balance sheet looks well-positioned to fund continued growth. Clavister is now trading at 19-11x EV/adj. EBITDA for '26e-'28e, around 28% below its peer average.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/clavister/Equity-research/2026/8/clavister---strong-quarter-strengthens-the-outlook/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 21 Aug 2026 14:45:08 GMT</pubDate>
      <isin>SE0005308558</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Generic - Investing while growing</title>
      <description>&lt;a id="bm-comp-82a1b775-197f-47b5-87e6-565481df4c53" name="bm-comp-82a1b775-197f-47b5-87e6-565481df4c53" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="82a1b775-197f-47b5-87e6-565481df4c53" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;A better mix of growth drivers&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Costs reflect investments in the organisation&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;EV/adj. EBIT of 10-9x '26e-'27e, 55% below its peers&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-cf1b4fb3-fd57-492d-9754-8ebf6c2d5fdd" name="bm-comp-cf1b4fb3-fd57-492d-9754-8ebf6c2d5fdd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cf1b4fb3-fd57-492d-9754-8ebf6c2d5fdd" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Growth on a broader base&lt;/h3&gt;&lt;p&gt;Generic Sweden reported Q2 sales of SEK 49m, up 10% y-o-y, in line with our expectations. Messaging, the largest at 73% of sales, grew 11% y-o-y, which supports our view that the volume cycle likely bottomed out in Q1. Operator solutions grew 7% y-o-y, up from 3% in Q1 and following a declining 2025. We think the turn reflects a security environment where customers are placing more value on a nationwide network that works independently of the mobile operators. Digitalisation solutions increased by 11% y-o-y, affected by some timing effects, as one larger municipality went live later than planned. Reported EBIT was SEK 9m, for a margin of 19%, and adjusted for SEK 0.6m of one-off costs, adj. EBIT was SEK 10m, for a margin of 20% (21%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Costs likely to increase due to scaling&lt;/h3&gt;&lt;p&gt;We see '26 as an investment year rather than one of margin expansion, as Generic increases costs to grow. It is adding capacity in product management and platform operations, which we think is needed to reach new customer groups and sell more licences into the existing base. We keep our view of Generic reaching 21-22% EBIT margins over time, and make only marginal changes to our estimates after the report.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading 55% below peers&lt;/h3&gt;&lt;p&gt;Generic is trading at 10-9x EV/adj. EBIT on '26e-'27e, around 55% below CPaaS peers, despite higher sales growth and higher EBIT margins. Looking further ahead, we still see DOCS as the most important growth driver; it is now in around 31% of Swedish municipalities. In the nearer term, we highlight RCS, where the company reports increased customer interest and notes that the flows carried out during the quarter delivered a high return on investment for customers. We think a richer message format should support margins over time, although we see the effect taking hold beyond '26e.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/generic/Equity-research/2026/8/generic---investing-while-growing/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 21 Aug 2026 14:15:08 GMT</pubDate>
      <isin>SE0001790791</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Impact Coatings - A quarter driven by Coating Services</title>
      <description>&lt;a id="bm-comp-3ebc4ff4-0bdc-46c2-8003-b397c5d2aa7e" name="bm-comp-3ebc4ff4-0bdc-46c2-8003-b397c5d2aa7e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3ebc4ff4-0bdc-46c2-8003-b397c5d2aa7e" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales SEK 10m (vs. ABGSCe 16m) driven by Coating Services&lt;/li&gt;&lt;li&gt;No system deliveries in Q2, but two IC500s booked for Q3/Q4&lt;/li&gt;&lt;li&gt;Adj. EBIT SEK -13m (vs. ABGSCe -8.5m)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1e3142bc-d18d-4381-b42e-f4e56c10a35e" name="bm-comp-1e3142bc-d18d-4381-b42e-f4e56c10a35e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1e3142bc-d18d-4381-b42e-f4e56c10a35e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Sales came in at SEK 10m (vs. ABGSCe 16m, 6.5m LY). Sales was driven by Coating Services, with no machine deliveries in the quarter (in line with estimates). Although the quarter was absent of deliveries, the company has two orders pending for deliveries in its backlog. EBIT was SEK -13m (vs. ABGSCe -8.5m), with the loss narrowing y-o-y on a lower personnel run-rate as the 2024 cost programme reaches full effect. The company ended the quarter with a cash balance of SEK 15m (31m LY).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates and outlook&lt;/h3&gt;&lt;p&gt;On numbers alone, '26e-'28e sales change by -6%, and EBIT adj. changes by SEK -5m. After the quarter, Impact completed the HJWAVE IC500 delivery; that system and LINDBERG/Kering IC500 sit in backlog. Management states the 11 new paying customers (three in SOFC) point to growing solid-oxide opportunities, while noting volumes are still low. It views automotive as cautious in line with the weaker end-market, and the soft Chinese fuel-cell order intake as a timing shift rather than a change in demand.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;The share has returned -2% L3M (vs. peer median +0% and OMX Stockholm Allshare +4%), and is currently trading at 3.1x-2.1x '26e-'28e EV/Sales on our pre-report estimates vs. the peer median of 2.3x-0.8x. The company will be hosting a presentation in connection with its Q2 report at 11:00 CEST. Link &lt;a data-bm-trackable="false" href="https://www.finwire.tv/webcast/impact-coatings/q2-2026/" target="_blank"&gt;here&lt;/a&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-73f91cfe-d9f6-44aa-894e-d23a48627152" name="bm-comp-73f91cfe-d9f6-44aa-894e-d23a48627152" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="73f91cfe-d9f6-44aa-894e-d23a48627152" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-4b872f94-628f-49f0-a213-06aafc4d8724" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/impact_coatings/Equity-research/2026/8/impact-coatings---a-quarter-driven-by-coating-services/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 21 Aug 2026 07:15:09 GMT</pubDate>
      <isin>SE0001279142</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Skolon - Sweden profitability gains continue</title>
      <description>&lt;a id="bm-comp-37657951-695f-4d75-8644-8c2288e58678" name="bm-comp-37657951-695f-4d75-8644-8c2288e58678" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="37657951-695f-4d75-8644-8c2288e58678" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 sales 11% higher than ABGSCe SEK 62m&lt;/li&gt;&lt;li&gt;Gross margin down slightly, likely due to unfavourable mix&lt;/li&gt;&lt;li&gt;Likely modestly positive consensus estimate revisions&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9888b33b-433d-4b0f-b39d-4f1506889bba" name="bm-comp-9888b33b-433d-4b0f-b39d-4f1506889bba" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9888b33b-433d-4b0f-b39d-4f1506889bba" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2'26 report&lt;/h3&gt;&lt;p&gt;Skolon reported net sales of SEK 69m (+11% vs ABGSC 62m), which was better than we expected, corresponding to organic growth of 26%. The ARPPU came in at SEK 201 (+2% vs ABGSC 197), with the number of paying users increasing to 1,083k, above our expectation of 1,073k. The gross margin declined a little bit y-o-y (likely due to a relatively higher share of partner revenues), from just over 24% to roughly 22%. From a geographic point of view, this was due to the gross margin in Sweden compressing from nearly 33% to nearly 30%, and that's consistent with the notion that the share of partner revenues had increased y-o-y, as Sweden is a relatively more mature market in terms of user penetration.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Thoughts and outlook&lt;/h3&gt;&lt;p&gt;The company continues to invest in international markets as Sweden increasingly becomes a mature market. Although the EBITDA was negative, due to the expansionary, international investments in new geographies such as Germany, Sweden delivered a positive EBITDA of SEK 2.7m. In Q2 Skolon launched Skolon AI Studio, letting partners distribute AI based tools through its school network, which fits the existing partner revenue model. The contribution is not yet quantifiable.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Consensus estimate revisions and valuation&lt;/h3&gt;&lt;p&gt;The share is down 23% YTD and is trading at 6-4x '26e-'27e EV/Gross profit on our unrevised estimates. Following the report, we believe that consensus could increase sales estimates by low single-digits.&lt;/p&gt;&lt;table id="bm-img-4a83b09c-f370-4104-874d-8cb7602a8338" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/company-name/Equity-research/2026/8/skolon---sweden-profitability-gains-continue/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 21 Aug 2026 07:00:09 GMT</pubDate>
      <isin>SE0017615784</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>I-tech - Strongest quarter on record</title>
      <description>&lt;a id="bm-comp-adf3281c-5462-47db-bc79-d09dcf9598c0" name="bm-comp-adf3281c-5462-47db-bc79-d09dcf9598c0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="adf3281c-5462-47db-bc79-d09dcf9598c0" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales +21&lt;font color="#000000"&gt;% vs. ABGSCe, EBIT SEK 21m vs. ABGSCe 13m&lt;/font&gt;&lt;/li&gt;&lt;li&gt;Easy comps, but +91% organic growth still very strong&lt;/li&gt;&lt;li&gt;Gross margin held at 59%; raw-material pressure mitigated so far&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-800f9f8a-8cc4-42ba-b063-83eb52757970" name="bm-comp-800f9f8a-8cc4-42ba-b063-83eb52757970" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="800f9f8a-8cc4-42ba-b063-83eb52757970" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;I-tech reported very strong Q2 numbers. Sales came in at SEK 59m (+21% vs. ABGSCe 48m) with 91% organic growth. The growth was driven by continued positive development among existing customers, as well as the recovery of the customer that saw volumes fall in 2025. EBIT adj. was SEK 21m (vs. ABGSCe 13m), for a margin of 36% (ABGSCe 27%); the gross margin held at 59% (59%) and the company writes that the raw-material cost pressure has so far been mitigated. FCF came in at SEK 23m (SEK 2.7m LY).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates and outlook&lt;/h3&gt;&lt;p&gt;On numbers alone, '26e-'28e sales change by +5%, and EBIT adj. changes by +15%. CEO writes that strong H1 provides a solid foundation for the remainder of 2026, with continued focus on customer growth, regulatory and business development, and strengthening Selektope's market position. On the EU process, I-Tech notes the Commission's draft act proposes non-renewal of medetomidine, the WTO-TBT consultation began in July, and an SCBP vote is likely in Q4.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;The share has returned +12% L3M (vs. peer median -1% and OMXSSMAC -9%), and is currently trading at 17x-9.1x '26e-'28e P/E on our pre-report estimates vs. the peer median of 30x-20x. T&lt;font style="background-color:#ffffff;"&gt;&lt;font style="background-color:#ffffff;"&gt;&lt;font color="#212529"&gt;he company will host a&lt;/font&gt; &lt;a data-bm-trackable="false" href="https://www.youtube.com/live/-Z1xbtdES9Y" style="color: rgb(0, 123, 255); box-sizing: border-box; text-decoration: none; font-family: Arial, &amp;quot;Unifont Calibri&amp;quot;, &amp;quot;Unifont Helvetica&amp;quot;, &amp;quot;Unifont Gotham&amp;quot;, &amp;quot;Unifont Arial&amp;quot;, Unifont !important;" target="_blank"&gt;presentation&lt;/a&gt; &lt;font color="#212529"&gt;of the Q2 results at&lt;/font&gt;&lt;/font&gt;&lt;/font&gt; &lt;font color="#000000"&gt;&lt;font style="background-color:#ffffff;"&gt;&lt;font style="background-color:#ffffff;"&gt;&lt;font style="background-color:#ffffff;"&gt;13:00 CET.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-8f85b475-fe73-4138-90d7-a40bc2be5a37" name="bm-comp-8f85b475-fe73-4138-90d7-a40bc2be5a37" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8f85b475-fe73-4138-90d7-a40bc2be5a37" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-1d438ab5-b38f-4ea5-9907-824f4f740e73" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/i-tech/Equity-research/2026/8/i-tech---strongest-quarter-on-record/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 21 Aug 2026 06:45:07 GMT</pubDate>
      <isin>SE0011167725</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Tempest Security - Patrols below plan</title>
      <description>&lt;a id="bm-comp-aa3d7ca3-c1da-40aa-957f-8148e5eb5839" name="bm-comp-aa3d7ca3-c1da-40aa-957f-8148e5eb5839" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="aa3d7ca3-c1da-40aa-957f-8148e5eb5839" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2: +6% sales growth, 2.2% EBITDA margin&lt;/li&gt;&lt;li&gt;'26e EBITDA down SEK 9m&lt;/li&gt;&lt;li&gt;Guarding continues to take steps forward, although slower&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-2ad09eee-4868-4bd9-9dd7-fffc96e89911" name="bm-comp-2ad09eee-4868-4bd9-9dd7-fffc96e89911" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2ad09eee-4868-4bd9-9dd7-fffc96e89911" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Some development but we hoped for more&lt;/h3&gt;&lt;p&gt;Tempest continues to deliver y-o-y improvements, although below our expectations. Guarding, the largest business area, grew sales by ~12%, while EBITDA improved from SEK 6.9m to SEK 7.4m. This was a bit below our expectations, the miss driven by some contracts that have not yet started. The company says the focus now is on improving sales growth. The SOC business is improving and contributing positively. Risk Solutions saw a top-line decline y-o-y of SEK 6.5m (adj.) and an EBITDA decline y-o-y from SEK 1.6m to SEK 0.9m in Q2'26, owing to the transition and start-up phase, going from ad hoc-driven operations to a more stable business with recurring revenue.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Lower '26e on the miss, '27e-'28e slightly lower&lt;/h3&gt;&lt;p&gt;We lower '26e-'28e sales by 4% on the slower growth pace in Guarding, a clear focus area for Tempest going forward. We expect continued improvement from the internal work done, though a slightly slower '26e sales pace than before. On EBITDA, we cut '26e by SEK 9m on the miss in Guarding and Risk Solutions and the current contract portfolio's profitability. Pricing has been a challenge in security, but improving demand is lifting market pricing. Having scaled into a credible player, Tempest can now bid for new contracts more easily.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Focus on core operations&lt;/h3&gt;&lt;p&gt;We believe the company took important steps throughout '25 with the divestment of the US and the turnaround in Denmark. There are further efficiencies to be gained from the newly-signed contracts in Guarding, as profitability typically increases gradually after the initial start-up period. This is because the additional costs associated with extra hiring fall, while planning and efficiency improve and Tempest may be able to sell additional services that improve profitability.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/tempest-security/Equity-research/2026/8/tempest-security---patrols-below-plan/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 20 Aug 2026 18:30:09 GMT</pubDate>
      <isin>SE0010469221</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Tempest Security - Progress made but expectations ahead of delivery</title>
      <description>&lt;a id="bm-comp-3f72a658-792c-4079-af82-d474fcd30c5b" name="bm-comp-3f72a658-792c-4079-af82-d474fcd30c5b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3f72a658-792c-4079-af82-d474fcd30c5b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales -SEK 16m, EBITDA -SEK 4.6m vs. ABGSCe&lt;/li&gt;&lt;li&gt;'26e-'28e EBITDA estimates likely down&lt;/li&gt;&lt;li&gt;Share to focus on margin miss&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9d39d30b-42d5-4e67-9e37-e657d782af44" name="bm-comp-9d39d30b-42d5-4e67-9e37-e657d782af44" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9d39d30b-42d5-4e67-9e37-e657d782af44" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 details&lt;/h3&gt;&lt;p&gt;Tempest delivered a Q2 report with both sales and EBITDA y-o-y growth. Sales came in at SEK 153m (-10% vs. ABGSCe at SEK 169m), +6% y-o-y, driven by Guarding, and partly offset by Risk Solutions. EBITDA grew by SEK 9m y-o-y to SEK 3.4m (-4.6m, vs. ABGSCe at SEK 8.0m), for a margin of 2.2% (ABGSCe 4.7%, 3.2% Q2'26) driven by both Guarding and Risk Solutions. Looking at y-o-y development, we see positive progress in Guarding. Guarding, the largest segment, continued to show improvements as a result of the internal work done in 2025, with management noting continued good momentum in the SOC business. Risk Solutions was affected by the transition and start-up phase, going from an ad hoc-driven operations to more stable business with recurring revenue.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;Looking ahead, management is not providing a formal outlook, but acknowledges that the focus now is on accelerating sales, developing existing customer relationships, and capitalising on the Group-wide opportunities available in the Nordic market. We view Tempest's positive internal development as a sign that the company is taking important steps in the right direction. However, growth was slower than we expected and the margin lower, and we therefore expect consensus estimates for '26e&amp;#8211;'28e adj. EBITDA to come down.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;A report in the right direction with sales and profitability growth. The share has underperformed the broader market into numbers (-14% YTD vs. OMXSGI +8%). We believe that the market will recognise stabilisation of the business and the margin improvements, even though the expectations were high.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;pagebreak &lt;a id="bm-comp-5cdbffb8-b399-4af5-9385-90d4cd0de5c7" name="bm-comp-5cdbffb8-b399-4af5-9385-90d4cd0de5c7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5cdbffb8-b399-4af5-9385-90d4cd0de5c7" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-b2ed9843-83b9-4473-88fb-4355c6e5066d" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. expectations&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/tempest-security/Equity-research/2026/8/tempest-security---progress-made-but-expectations-ahead-of-delivery/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 20 Aug 2026 07:30:07 GMT</pubDate>
      <isin>SE0010469221</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ascelia Pharma - Still alive: Fighting to reverse the FDA setback</title>
      <description>&lt;a id="bm-comp-9525cde2-3a90-4877-8d8f-01a629c6e53a" name="bm-comp-9525cde2-3a90-4877-8d8f-01a629c6e53a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9525cde2-3a90-4877-8d8f-01a629c6e53a" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Type A meeting with the FDA scheduled for September 9&lt;/li&gt;&lt;li&gt;Implementing cost-saving measures&lt;/li&gt;&lt;li&gt;&lt;a data-bm-trackable="false" href="https://ascelia-pharma.events.inderes.com/q2-report-2026/register" target="_blank"&gt;Conf call&lt;/a&gt; at 10am CET&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-86b1ffa7-61f0-49cd-994a-30ce1340f4f7" name="bm-comp-86b1ffa7-61f0-49cd-994a-30ce1340f4f7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="86b1ffa7-61f0-49cd-994a-30ce1340f4f7" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Recent and upcoming relevant events&lt;/h3&gt;&lt;p&gt;Following the July 2, 2026 Complete Response Letter for Orviglance, which cited concerns over the SPARKLE re-read (potential reader bias and a T1-only scoring scope) alongside small product documentation questions, Ascelia disputed both clinical grounds while acknowledging the product quality points, and moved to request an expedited Type A meeting. The FDA has now accepted that request and scheduled the meeting for September 9, 2026. Ahead of it, Ascelia has submitted a briefing package addressing each CRL topic, confirming it has aligned with and implemented the FDA's product quality recommendations, and defending the scientific rationale for the SPARKLE re-read, including reader training and the use of T1-weighted imaging as the basis for assessing lesion visualisation. Management reiterates confidence in the overall data package, with an update expected once official meeting minutes are received following the September 9 meeting (issued within 30 days, i.e. by mid-September).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Implementing cost-saving measures&lt;/h3&gt;&lt;p&gt;Operating cash flow was SEK -14m (SEK -16m in Q1'26), as opex decreased 30% q-o-q. Following a directed share issue of gross SEK 20m in the quarter, cash and cash equivalents came in at SEK 34m (SEK 38m in Q1'26). After quarter's end, Ascelia has implemented cost-saving measures including the departure of the CFO to provide flexibility for supporting activities related to the CRL, which is stated to extend the cash runway into Q2'27.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Conference call at 10am&lt;/h3&gt;&lt;p&gt;Ascelia will host a &lt;a data-bm-trackable="false" href="https://ascelia-pharma.events.inderes.com/q2-report-2026/register" target="_blank"&gt;conference call&lt;/a&gt; at 10am CET today.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ascelia-pharma/Equity-research/2026/8/ascelia-pharma---still-alive-fighting-to-reverse-the-fda-setback/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 20 Aug 2026 07:00:33 GMT</pubDate>
      <isin>SE0010573113</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Clavister - Defence drives record quarter</title>
      <description>&lt;a id="bm-comp-bcc402d5-c667-4346-98df-aa99857686ff" name="bm-comp-bcc402d5-c667-4346-98df-aa99857686ff" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bcc402d5-c667-4346-98df-aa99857686ff" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales of SEK 89m (+17% vs. ABGSCe 76m), a 63% y-o-y growth&lt;/li&gt;&lt;li&gt;Order book at a record at SEK ~640m&lt;/li&gt;&lt;li&gt;Acceleration is here&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c66e2c10-7c2d-47ae-b113-5ef92fc858b7" name="bm-comp-c66e2c10-7c2d-47ae-b113-5ef92fc858b7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c66e2c10-7c2d-47ae-b113-5ef92fc858b7" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong Q2'26 results&lt;/h3&gt;&lt;p&gt;Clavister reported Q2'26 sales of SEK 89m (+17% vs ABGSCe 76m), implying a 63% y-o-y growth. Although order intake decreased 25% (affected by multi-year contracts won last year), the order backlog remains strong at SEK 642m (375m Q2'25), with SEK 226m expected to be delivered coming next twelve months. Adj. EBITDA came in at SEK 27m (+47% vs ABGSCe). EBIT turned positive at SEK 13m (-5m in Q2'25). Adjusted for one-offs of SEK 2.5m, mostly related to the ongoing legal dispute, adj. EBIT came in at SEK 15m, growing from -2m in Q2'25.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Underlying business continues to grow&lt;/h3&gt;&lt;p&gt;ARR increased by 4.5%, a cautious but stable growth rate, and keep in mind that the recurring base remains an important underlying business for Clavister. Gross margin improved to 82.5% (81.1%) driven by a better mix, mainly supported by the NDMA (Norwegian defence) contract.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Keeping our view of accelerating from here&lt;/h3&gt;&lt;p&gt;On our unrevised estimates, Clavister is trading at 19-12x adj. EV/EBITDA for '26e-'28e. Management will host a presentation of the report CEST 09:00 (&lt;a data-bm-trackable="false" href="https://register.gotowebinar.com/register/9109880904010535767" target="_blank"&gt;link&lt;/a&gt;).&lt;/p&gt;&lt;table id="bm-img-57958e57-7db7-4b31-b784-b754c96932bf" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/clavister/Equity-research/2026/8/clavister---defence-drives-record-quarter/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 20 Aug 2026 07:00:06 GMT</pubDate>
      <isin>SE0005308558</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Catella - Q2 softer than expected, but underlying trends improving</title>
      <description>&lt;a id="bm-comp-da36495d-3c2f-4add-9953-1b3e294910a4" name="bm-comp-da36495d-3c2f-4add-9953-1b3e294910a4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="da36495d-3c2f-4add-9953-1b3e294910a4" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 EBIT of SEK 8m, vs. ABGSC of SEK 26m and cons. SEK 15m&lt;/li&gt;&lt;li&gt;AUM of SEK 161bn bang in line, while transaction activity continues to improve&lt;/li&gt;&lt;li&gt;Negative consensus revisions to follow&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-391a176d-27d4-4843-af64-ba3cce97e4d5" name="bm-comp-391a176d-27d4-4843-af64-ba3cce97e4d5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="391a176d-27d4-4843-af64-ba3cce97e4d5" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Q2 EBIT SEK 8, vs. ABGSC at 26m &amp;amp; consensus at 15m&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;The Q2&amp;#8217;26 underlying EBIT improved by SEK 43m y-o-y whe adjusting for one-offs, and came in at SEK 8m, which was 18m below ABGSC and 7m below FactSet consensus. Looking at underlying development, the Investment Management segment delivered weaker than expected results in Q2, while Corporate Finance was more broadly in line.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;AUM of SEK 160.8 bn in Q2, bang in line with both ABGSC &amp;amp; consensus forecast&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Net sales in Q2 came in at SEK 400m (722m), which was 7% above ABGSC's forecast and 8% above consensus. Reported EBITDA came in at SEK 27m, 19m below both ABGSC and FactSet consensus. The AUM came in at SEK 160.8bn, up 1% q-o-q (SEK 159.8bn), which was bang in line with both ABGSC forecast and consensus. The slight increase of 1bn sequentially is driven by FX tailwind, offsetting both capital outflow and lowered valuations in the underlying portfolios.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Negative cons. revisions to follow&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;We expect consensus to cut their &amp;#8216;26e EBIT by ~1-3% mainly reflecting the Q1 and Q2 earnings shortfall in IM, while improving activity and solid AUM should limit revisions to 2027-&amp;#8216;28. Regarding the SEK 100m share buyback program announced in Q1, Catella repurchased 2.5m shares during Q2 for c. SEK 52m, corresponding to 2.95% of total shares outstanding. Call at 10.00.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;pagebreak &lt;a id="bm-comp-25bf0a90-358e-4677-83f4-eb5020e80888" name="bm-comp-25bf0a90-358e-4677-83f4-eb5020e80888" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="25bf0a90-358e-4677-83f4-eb5020e80888" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-67a197e9-5497-4941-a524-c9ef6c88602c" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/catella/Equity-research/2026/8/catella---q2-softer-than-expected-but-underlying-trends-improving/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 20 Aug 2026 06:30:06 GMT</pubDate>
      <isin>SE0000188518</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Generic - Volumes continue to grow</title>
      <description>&lt;a id="bm-comp-2ca46816-bb68-4eec-8b69-61f4bd3b5599" name="bm-comp-2ca46816-bb68-4eec-8b69-61f4bd3b5599" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2ca46816-bb68-4eec-8b69-61f4bd3b5599" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Volumes strong, sales up 10% y-o-y&lt;/li&gt;&lt;li&gt;Adj. EBIT growth of 8% y-o-y, margin of 21%&lt;/li&gt;&lt;li&gt;DOCS now penetrated &amp;gt;30% of municipalities&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a6e7491b-62ac-4d5f-89f9-2a0a6e1e8418" name="bm-comp-a6e7491b-62ac-4d5f-89f9-2a0a6e1e8418" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a6e7491b-62ac-4d5f-89f9-2a0a6e1e8418" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2'26 details&lt;/h3&gt;&lt;p&gt;Generic Sweden reported Q2'26 sales of 48.7m, in line with our expectations (0% vs ABGSCe 48.7m), mostly driven by higher volumes in the SMS business (messaging segment), where we started to see a bottoming out already in Q1. Messaging solutions grew 10.7% y-o-y, and this could potentially be an end to the customer cost cautiousness that has held back the segment. The gross margin came in at 44%, in line with what we thought. Reported EBIT was held back by roughly SEK 1m from the settlement of holiday pay liabilities for older holiday days. Adjusting for this, adj. EBIT was SEK 10.3m, up 8% y-o-y and 10% above our SEK 9.4m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Thoughts&lt;/h3&gt;&lt;p&gt;The DOCS product continues to be a success story, and the penetration rate keeps climbing, with around 31% of Swedish municipalities now having the product. The share of wallet is unknown, but breaking into the public sector often takes time, as municipalities tend to sit on long frameworks. We therefore see this penetration rate as very positive for Generic. Growth in the segment was nevertheless lower this quarter at 11%, partly because much of the focus went to one of Sweden's larger municipalities, which went live later than initially planned.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;The company is valued at 10-9x adj. EBIT on our unrevised numbers for '26e-'27e, around 55% below its peers. Generic continues to operate with 21 employees (22 in Q2'25), making it one of the highest sales-per-employee companies in the Swedish tech sector.&lt;/p&gt;&lt;table id="bm-img-c96a8d3a-2d79-4bf1-ab67-7e831ebad21a" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Dev table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/generic/Equity-research/2026/8/generic---volumes-continue-to-grow/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 20 Aug 2026 05:45:07 GMT</pubDate>
      <isin>SE0001790791</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>SinterCast - Past the trough, but recovery pace uncertain</title>
      <description>&lt;a id="bm-comp-513880b7-7024-4dca-b70d-a55db123a629" name="bm-comp-513880b7-7024-4dca-b70d-a55db123a629" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="513880b7-7024-4dca-b70d-a55db123a629" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales 1% above us, but EBIT 10% below on a softer gross margin&lt;/li&gt;&lt;li&gt;Past the H2'25 trough, larger volume ramp to start in Q4'26&lt;/li&gt;&lt;li&gt;We cut '26e-'28e EBIT by 9-4% on ramp timing and FX&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ab6f6fb8-84d5-412e-afdf-d176287ebf70" name="bm-comp-ab6f6fb8-84d5-412e-afdf-d176287ebf70" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ab6f6fb8-84d5-412e-afdf-d176287ebf70" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Q2 sales were 1% above ABGSCe while EBIT was 10% below, at SEK 27.4m (31.1m) and SEK 7.4m (11.2m), respectively. Volumes were pre-announced in July's H1 update, although Q2 Engine Equivalents of 3.1m (3.4m) were slightly below the 3.2m implied there, likely due to rounding. Unusually high engineering service revenue of SEK 1.0 million (0.3 million) drove the sales beat. The EBIT margin of 27.1% (36.1%) was 3pp below our estimate on a gross margin of 69.4% (71.4%) against our 72.0%. We view this as a quarterly fluctuation in a lower-volume environment rather than something to extrapolate. Despite still constituting a negative y-o-y development, the recovery from the H2'25 trough was confirmed.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We cut '26e/'27e/'28e EBIT by 9%/7%/4%, as we have pushed back the EE ramp somewhat based on management comments that higher production volumes are expected towards the end of H2'26 due to the recovery of the commercial vehicle sector and the ramp-up of new programmes. We now forecast EEs of 3.2m/3.8m in '26e/'27e, with '28e essentially unchanged at 4.5m. Updated FX takes a further ~2% off '27e-'28e sales.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;The expected recovery looks broadly intact to us: H1 EEs were 15% above H2'25, and the company points to global commercial vehicle orders up ~30% y-o-y and ~140% in North America on fleet renewal and the EPA 2027 pre-buy. Further evidence of an increase in volume comes from the new production programmes, some of which are already ramping up with more starting between '27 and '30. These programmes underpin the company's 6m ('29) and 8m ('31) EE milestones. We lower our fair value range to SEK 90-120 (95-125) on our reduced estimates. The share is trading at 26x/15x '26e/'28e P/E vs. its historical median of 22x/14x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/sintercast/Equity-research/2026/8/sintercast---past-the-trough-but-recovery-pace-uncertain/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 19 Aug 2026 13:00:07 GMT</pubDate>
      <isin>SE0000950982</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Xplora Technologies - EBITDA -13% on soft senior device sales</title>
      <description>&lt;a id="bm-comp-5f722c2f-3fc6-46e1-9a82-36a271454af1" name="bm-comp-5f722c2f-3fc6-46e1-9a82-36a271454af1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5f722c2f-3fc6-46e1-9a82-36a271454af1" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 EBITDA 13% below cons on lower senior device sales&lt;/li&gt;&lt;li&gt;Doro Connect first retail pilot complete, Norway rollout from September&lt;/li&gt;&lt;li&gt;Expect cons to lower '26 EBITDA by 4-6%, share to follow&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-5c7cfba6-898a-457c-a259-c833fcc6bbe4" name="bm-comp-5c7cfba6-898a-457c-a259-c833fcc6bbe4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5c7cfba6-898a-457c-a259-c833fcc6bbe4" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;EBITDA NOK 49m, -13% vs cons&lt;/h3&gt;&lt;p&gt;Revenue was NOK 422m, 9% below cons of NOK 462m and 6% below ABGSCe of NOK 447m. The gross margin was 54.1% vs. cons of 51.5% and ABGSCe of 51.9%. Opex was NOK 180m, about in line with ABGSCe of NOK 179m and cons of NOK 182m, and we argue this shows good cost control. This gave an EBITDA of NOK 49m, 13% below cons of 56m and 8% below ABGSCe of NOK 53m, corresponding to an EBITDA margin of 11.5% vs. 12.9% in Q2'25. Capex was NOK 11m (ABGSCe NOK 12m), resulting in EBITDA-capex of NOK 38m, 8% below ABGSCe of NOK 41m. The miss vs cons is driven almost entirely by lower device sales in the Senior segment, which is not very surprising given the exceptionally strong growth the company has had in this segment the past year partly boosted by the shutdown of 2G networks.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Senior device sales 8% below ABGSCe&lt;/h3&gt;&lt;p&gt;Total device revenue was NOK 332m, 6% below ABGSCe of NOK 355m. Kids &amp;amp; Youth device sales of NOK 137m was 1% below ABGSCe, and Senior device sales (Doro) of NOK 198m was 8% below ABGSCe. Kids &amp;amp; Youth service revenue was NOK 90m, 2% below ABGSCe of NOK 92m, corresponding to a growth of 10% y-o-y. Number of Kids subscriptions ended at 502k as pre-announced, of which 310k were Connectivity (ABGSCe 314k), 138k were Premium (ABGSCe 135k), 32k were B2B (ABGSCe 37k), and 22k were Service fee (ABGSCe 19k). This gave a monthly ARPU of NOK 61 vs. ABGSCe of NOK 62, which compares to NOK 72 in Q2'25. Watch activations was 127k in the quarter, in line with sales of 127k units.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Some progress on Doro Connect and a good launch for XploraOne&lt;/h3&gt;&lt;p&gt;During Q2'26, Doro connect saw the first retail pilot launch in Hamar in Norway at Power, and is preparing for full rollout in September. Further, the company is preparing for pilot launch in Sweden in September. Additionally, the kids phone Xpl&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/xplora_technologies/Equity-research/2026/8/xplora-technologies---ebitda--13-on-soft-senior-device-sales/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 19 Aug 2026 07:15:07 GMT</pubDate>
      <isin>NO0010895782</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>SinterCast - Recovery vs H2'25 trough, but still down y-o-y</title>
      <description>&lt;a id="bm-comp-6af66da9-8927-446b-ab22-1e4d6f804ded" name="bm-comp-6af66da9-8927-446b-ab22-1e4d6f804ded" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="6af66da9-8927-446b-ab22-1e4d6f804ded" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Volumes pre-announced, sales +1%, EBIT -10% vs. ABGSCe&lt;/li&gt;&lt;li&gt;Lower quarterly gross margin drives lower EBIT figure&lt;/li&gt;&lt;li&gt;Positive on commercial vehicle sector recovery and pipeline&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-81e56b91-b4ac-4abb-adf2-80c7ac53b78d" name="bm-comp-81e56b91-b4ac-4abb-adf2-80c7ac53b78d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="81e56b91-b4ac-4abb-adf2-80c7ac53b78d" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Sales fell 12% y-o-y and were 1% above our estimate. Annualised engine equivalents produced were 3.1m, falling 9% y-o-y (3% below our estimate due to rounding compared to the pre-announced H1 figure). Sampling cups sold decreased 12% y-o-y, and were also pre-announced. With a margin of 27.0%, 3.1pp below our estimate, EBIT adj. was 10% below our estimate, mainly due to a softer quarterly gross margin.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;The Q2 numbers in isolation imply EBIT adj. comes down 2%. Management expressed optimism as H1 production recovered from the H2'25 trough, and commercial vehicle sector demand has started recovering, citing global new orders being up 30% y-o-y. The company also reiterated that its pipeline of new installation opportunities remains strong.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Company valuation&lt;/h3&gt;&lt;p&gt;Over the past three months, the share has returned +5%, compared to the +6% of the OMX Stockholm Allshare. The share is currently trading at 23x-14x '26e-'28e P/E, compared to its 10-year historical median of 22x-14x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-985fbd05-329e-4e6a-9463-986587ff8166" name="bm-comp-985fbd05-329e-4e6a-9463-986587ff8166" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="985fbd05-329e-4e6a-9463-986587ff8166" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-1449d11d-a39a-494d-939c-8a1243168014" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. estimates Q2'26&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/sintercast/Equity-research/2026/8/sintercast---recovery-vs-h225-trough-but-still-down-y-o-y/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 19 Aug 2026 06:45:05 GMT</pubDate>
      <isin>SE0000950982</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>OssDsign - Soft commercial momentum near-term</title>
      <description>&lt;a id="bm-comp-95aa5a0e-93f8-4c76-9f90-c2e5d9bb1192" name="bm-comp-95aa5a0e-93f8-4c76-9f90-c2e5d9bb1192" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="95aa5a0e-93f8-4c76-9f90-c2e5d9bb1192" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Expected return to growth pushed out to Q4&lt;/li&gt;&lt;li&gt;Adj. EBIT cut by 2.6%-3.6% for '26e-'28e&lt;/li&gt;&lt;li&gt;Fair value range revised down to SEK 3.8-6.2 (4.0-6.3)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a864c934-00c6-4265-bb68-f0bdab7c0b1e" name="bm-comp-a864c934-00c6-4265-bb68-f0bdab7c0b1e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a864c934-00c6-4265-bb68-f0bdab7c0b1e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Small miss on sales, but lower opex in Q2&lt;/h3&gt;&lt;p&gt;OssDsign reported mixed results in Q2: sales were 1% below expectations, but adjusted EBIT was 10% above, despite a lower gross margin (92.1% vs. ABGSCe 95.0%). The organic decline was 16% (ABGSCe -15%) in Q2, driven by the transition of the US sales team and lower activity levels among certain key accounts during contract negotiations. Management highlighted that leading indicators for commercial momentum are pointing in the right direction, suggesting a return to growth later this year. However, Q3 will be negatively impacted by the holiday period in the US, which accounts for 100% of sales. Opex was below our forecast at SEK -46.8m (ABGSCe SEK -49.4m), with sales commissions and fees coming in at 44.8% of sales (vs. ABGSCe at 47.0%). Cash flow generation was better than expected, i.e. less negative, with OCF of SEK -11.8m vs. ABGSCe SEK -15.7m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Sales development in Q3 expected to be subdued&lt;/h3&gt;&lt;p&gt;In our view, the main negative surprise in the Q2 report was the commentary related to the near-term sales development for Q3. After two quarters with flattish sales development, we had expected to see a sequential improvement in Q3 based on management's actions, but now it seems like that improvement has been pushed out to Q4. We are now forecasting an 18% organic decline for Q3, followed by a return to positive organic sales growth in Q4 at 5%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range tweaked down to SEK 3.8-6.2 (4.0-6.3)&lt;/h3&gt;&lt;p&gt;Based on our updated estimates, we lower our DCF-based fair value range to SEK 3.8-6.2 (4.0-6.3). A return to commercial momentum with improved sales growth in Q4'26 remains the key catalyst.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ossdsign/Equity-research/2026/8/ossdsign---soft-commercial-momentum-near-term/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 18 Aug 2026 14:45:06 GMT</pubDate>
      <isin>SE0012570448</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>OssDsign - Beat on EBIT on lower sales</title>
      <description>&lt;a id="bm-comp-a395e69f-0b69-40e1-b4ae-1eda3878c05b" name="bm-comp-a395e69f-0b69-40e1-b4ae-1eda3878c05b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a395e69f-0b69-40e1-b4ae-1eda3878c05b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;10% beat on adj EBIT but lower saIes&lt;/li&gt;&lt;li&gt;-16% organic growth (ABGSCe -15%)&lt;/li&gt;&lt;li&gt;No change in outlook, Q3 seasonally soft&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f6eff328-be2a-45c8-9161-df5f34566950" name="bm-comp-f6eff328-be2a-45c8-9161-df5f34566950" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f6eff328-be2a-45c8-9161-df5f34566950" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;font style="background-color:#ffffff;"&gt;Q2 results&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font style="background-color:#ffffff;"&gt;OssDs&lt;/font&gt;&lt;font color="#212529"&gt;ign reported&lt;/font&gt; a mixed set of numbers in Q2 with 1% lower sales, lower gross margin, but good cost control on opex resulting in a 7% beat on EBIT (+10% on adj. EBIT). Q2 sales came in at SEK 37.8m (-1% vs ABGSCe SEK 38m, no consensus) and adj. EBIT of SEK -12.0m, +10% vs ABGSCe of -13.3m. Organic sales growth in Q2 amounted to -16% (ABGSCe -15%). The beat on adj. EBIT is attributable to lower opex as both sales and gross margin came in below expectations. Q2 gross margin was 92.1% vs ABGSCe 95.0%). We are pleased to see that the 'sales and commission and fees' as percentage of sales continues to come down, was 44.8% in Q2 vs ABGSCe at 47%). Cash flow generation was better than &lt;font style="background-color:#ffffff;"&gt;expected, i.e. less negative, with OCF of SEK -11.8m vs. ABGSCe SEK -15.7m.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates&lt;/h3&gt;&lt;p&gt;Company is not providing any outlook for 2026 or changing its mid-term financial targets of reaching sales of SEK &amp;gt;400m by 2028 and to become cash flow and EBIT positive in the second half of its 'Strategy Period' (2025-2028). However, management talk about seasonal pattern for Q3 related to the US holiday period, but remain confident that the work done will result in tangible results later in the year. We have assumed 3% organic sales growth in Q3'26, and then up to 12% for Q4. Based on the deviation on adj. EBIT in Q2, we expect FY'26e EBIT to be revised up by 1-3%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Share price view&lt;/h3&gt;&lt;p&gt;The stock has traded up 3% into Q2 (-5d), but is down 63% YTD. Based on the deviation on the adj EBIT in Q2, we expect to see a small positive share price reaction today.&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;table id="bm-img-102f5043-9611-4328-a085-5d9d00f0f065" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Q2 deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ossdsign/Equity-research/2026/8/ossdsign---beat-on-ebit-on-lower-sales/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 18 Aug 2026 05:45:05 GMT</pubDate>
      <isin>SE0012570448</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Donkey Republic - Riding with high cadence</title>
      <description>&lt;a id="bm-comp-1aff0e92-17e5-4d33-8671-fcc132f532a8" name="bm-comp-1aff0e92-17e5-4d33-8671-fcc132f532a8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1aff0e92-17e5-4d33-8671-fcc132f532a8" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 growth and profitability much better than expected&lt;/li&gt;&lt;li&gt;We remain in the top end of raised guidance&lt;/li&gt;&lt;li&gt;FVR of DKK 8.0-11.0 reiterated&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a7918453-6939-4de8-a638-2dbd2ef89388" name="bm-comp-a7918453-6939-4de8-a638-2dbd2ef89388" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a7918453-6939-4de8-a638-2dbd2ef89388" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Solid Q2 triggering a raise to guidance&lt;/h3&gt;&lt;p&gt;DONKEY delivered solid +19% revenue growth in Q2'26, driven by +4% fleet growth and a strong +14% improvement in revenue/bike, while rider and trip frequencies also showed healthy trends, up +9% and +6% y-o-y, respectively. EBITDA for the quarter reached DKK 21.5m, significantly above our estimate of DKK 17.0m, and showing strong early benefits from recent efficiency initiatives, proving the operating scale in DONKEY's business model.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;'26e/'27e/'28e EBITDA raised by 2%/1%/1%&lt;/h3&gt;&lt;p&gt;We extrapolate the stronger-than-expected profitability in Q2, raising '26e/'27e/'28e EBITDA by 2%/1%/1%. Although H1 trends and historical seasonality may make the FY guidance look overly conservative on an isolated basis, we are mindful of likely higher costs associated with the German rollouts in H2 as well as a likely dilution in revenue per bike in H2e. We also understand these are the company's own key guidance variables for the rest of the year. We expect FY'26 figures at the upper end of guidance, forecasting revenues of DKK 193m (vs. guidance of DKK 184m-194m), EBITDA of DKK 43m (guidance 38m-45m) and EBIT of DKK 9m (guidance DKK 4m-9m).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;FVR of DKK 8.0-11.0 reiterated&lt;/h3&gt;&lt;p&gt;We continue to see DONKEY offering attractive fundamentals (helped by a solid competitive edge with market tailwinds coupled with a solid pipeline), and forecast a revenue CAGR of 20% in '25-'28e (vs. 35% in '18-'25). With improving operating leverage, we model adj. EBITDA increasing from DKK 30m in '25 to DKK 86m in '28e and adj. EBIT reaching DKK 41m. We reiterate our fair value range to DKK 8.0-11.0/share.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/donkey-republic/Equity-research/2026/8/donkey-republic---riding-with-high-cadence/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 18 Aug 2026 05:15:04 GMT</pubDate>
      <isin>DK0061540770</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Lumi Gruppen - Adding up nicely</title>
      <description>&lt;a id="bm-comp-3c256a19-c9d4-4350-b4c5-41a3d92e4643" name="bm-comp-3c256a19-c9d4-4350-b4c5-41a3d92e4643" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3c256a19-c9d4-4350-b4c5-41a3d92e4643" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;H1'26e adj. EBIT NOK 46m&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Two accretive acquisitions&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range of NOK 18-25&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-fa7ca49f-ef5c-4f33-9f55-72fe5416ef4e" name="bm-comp-fa7ca49f-ef5c-4f33-9f55-72fe5416ef4e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fa7ca49f-ef5c-4f33-9f55-72fe5416ef4e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;H1'26e adj. EBIT NOK 46m&lt;/h3&gt;&lt;p style="text-align:left;"&gt;We pencil in H1'26e revenues of NOK 265m, up 13% y-o-y. This implies AY'25/26e revenues of NOK 536m, +13% y-o-y. We have fine-tuned our revenue estimates, and we see AY'25/'26e revenues of NOK 198m for Sonans and NOK 325m for ONH, implying NOK 525m ex. M&amp;amp;A, compared to Lumi's guidance of NOK 524m. We pencil in adj. EBIT of NOK 99m for AY'25/'26e, which implies NOK 46m for H1'26. Regarding margins, we see a group adj. EBIT margin at 17.4% for H1'26 and 18% for the academic full year. The company has strong revenue visibility, with ~90% of its revenues the following year locked in during autumn. For the full year '26e, we see group revenues of NOK 593m and adj. EBIT of NOK 118m, which implies Sonans and ONH revenues up 6% and 10% y-o-y.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Two accretive acquisitions&lt;/h3&gt;&lt;p&gt;Lumi has added two bolt-ons since December: EnkelEksamen (Edrupt, NOK 40m revenue, NOK 10.5m adj. EBIT), and Bj&amp;#248;rknes, signed in May at just 4.6x '25 EV/EBIT (EV NOK 37m, adj. EBIT NOK 8m), closing in Q3'26e. We lift our '27e-'28e estimates to reflect Bj&amp;#248;rknes' EBIT base, but we have been careful about factoring in the expected synergies as this normally takes time to materialise. The two acquisitions have been accretive to Lumi's multiples, and the positive outcome from these more than offsets NOKUT's 29 April decision not to grant ONH institutional accreditation, a process management has consistently said its shorter-term ambitions do not depend on.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of NOK 18-25&lt;/h3&gt;&lt;p&gt;A peer valuation on '26e-'28e multiples points to NOK 16-21/sh, narrowing to NOK 20-21 looking at '27e-'28e only. Lumi trades at '27e/'28e EV/EBIT of ~10.4x/8.7x and a P/E of ~11.9x/10.7x. Given Lumi's solid position in the Norwegian market, we argue a premium could be justified, and keep our valuation range unchanged, implying '27e EV/EBIT of 10x-12.5x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/lumi-gruppen/Equity-research/2026/8/lumi-gruppen---adding-up-nicely/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 17 Aug 2026 16:00:05 GMT</pubDate>
      <isin>NO0010927288</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>BTS Group - Organic growth momentum to be sustained</title>
      <description>&lt;a id="bm-comp-85d372a9-4fda-47ad-910f-a8af507c84af" name="bm-comp-85d372a9-4fda-47ad-910f-a8af507c84af" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="85d372a9-4fda-47ad-910f-a8af507c84af" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We estimate 5-9% organic growth trend to continue in H2e&lt;/li&gt;&lt;li&gt;Guidance upgrade was needed to meet earnings estimates&lt;/li&gt;&lt;li&gt;EBITA -2% 2026e, +2% 2027e-28e, share at 10.8x EV/EBITA 2026e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a35280be-499c-41bb-99b0-74659f6afe73" name="bm-comp-a35280be-499c-41bb-99b0-74659f6afe73" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a35280be-499c-41bb-99b0-74659f6afe73" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;A solid Q2 report improves confidence&lt;/h3&gt;&lt;p&gt;The guidance upgrade to "significantly better 2026 EBITA than 2025" was needed to meet our estimates, as we had already expected &amp;gt;20% EBITA growth. However, it was encouraging to see 9% organic growth, the highest figure in almost four years, and a clear sign that BTS can also grow significantly in an AI environment as there have been fears around consultants' ability to compete with AI technology. Recovering the slow start to the year in Other markets was also somewhat ahead of our expectations in Q2, and we now expect to see positive organic growth in all regions in Q3-Q4, for group figures of 5-9%. We expect to see a stabilisation in the reduction of headcount and a subsequent return to growth, as it is not sustainable to grow the business and reduce headcount for too long.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Relatively small estimate changes&lt;/h3&gt;&lt;p&gt;On the back of the strong organic growth figure in Q2 and sales beats in all regions, we lift our sales estimates by 4% in 2026e-28e. However, due to the slight Q2 EBITA miss and somewhat lowered margin assumptions in North America, we cut 2026e EBITA by 2%, while our higher organic growth assumptions drive +2% EBITA revisions in 2027e-28e. We cut 2026e reported EPS due to the earn-out provisioned for the Boda acquisition booked in Q2 (SEK 52m).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Share at 10.8x 2026e EV/EBITA&lt;/h3&gt;&lt;p&gt;On our updated estimates, the share is trading at 10.8x NTM EV/EBITA, which compares, for example, to Accenture at 8x but is nevertheless historically low. The balance sheet continues to look solid, and BTS could continue with its bolt-on acquisition strategy ahead, driving estimate revisions further upwards.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/bts-group/Equity-research/2026/8/bts-group---organic-growth-momentum-to-be-sustained/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 17 Aug 2026 12:15:04 GMT</pubDate>
      <isin>SE0000805426</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Donkey Republic - Raising guidance after a strong Q2</title>
      <description>&lt;a id="bm-comp-b451355d-8ccd-4765-8596-566ddb3e7213" name="bm-comp-b451355d-8ccd-4765-8596-566ddb3e7213" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b451355d-8ccd-4765-8596-566ddb3e7213" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 revenues +6% vs. ABGSCe, EBITDA strong at DKK 21.5m&lt;/li&gt;&lt;li&gt;FY'26 guidance raised&lt;/li&gt;&lt;li&gt;Expect consensus '26 EBITDA up 2-5%&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-5116af90-da72-4be6-b51e-6e259793676e" name="bm-comp-5116af90-da72-4be6-b51e-6e259793676e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5116af90-da72-4be6-b51e-6e259793676e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 numbers vs. ABGSCe&lt;/h3&gt;&lt;p&gt;DONKEY delivered a very solid Q2, with +19% y-o-y revenue growth (vs. ABGSCe of +12%). Revenues of DKK DKK 57.7m was 6% above ABGSCe of DKK 54.5m. Revenue/bike was DKK 806, +14% y-o-y (ABGSCe DKK 738), while the fleet grew by +4% to 23.8k bikes (ABGSCe 24.6k). Q2 EBITDA of DKK 21.5m came in 27% above ABGSCe of DKK 17.0m. Finally, DONKEY's contribution margin rose to 52% in H1, up from 45% the year before.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;FY'26 guidance and outlook&lt;/h3&gt;&lt;p&gt;DONKEY lifts its FY'26 guidance. It now expects revenues of DKK 184m-194m (previously 179m-194m, ABGSCe 193m), EBITDA of DKK 38m-45m (previously 34m-45m, ABGSCe 42m) and EBIT DKK 4m-9m (previously 1m-9m, ABGSCe 9m). We understand that the main variables for the remainder of the year are associated with the roll-outs in Germany (including the cost level and utilisation), as well as execution in the important August and September months.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Consensus estimate revisions and share price reaction&lt;/h3&gt;&lt;p&gt;We expect consensus to raise '26 EBITDA by 2-5% to the higher end of the new guidance range.&lt;/p&gt;&lt;table id="bm-img-04c9a472-bd7c-4c5e-9f84-8e17b417a063" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;ABGSCe vs. FY'26 guidance&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table id="bm-img-ec7c78f7-5c4c-4f73-9c9e-0cf1fdef3973" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/donkey-republic/Equity-research/2026/8/donkey-republic---raising-guidance-after-a-strong-q2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 17 Aug 2026 07:00:03 GMT</pubDate>
      <isin>DK0061540770</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Clavister - Accelerating from here</title>
      <description>&lt;a id="bm-comp-89afeb77-8e86-4d28-a0fc-a7786dcd9b9f" name="bm-comp-89afeb77-8e86-4d28-a0fc-a7786dcd9b9f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="89afeb77-8e86-4d28-a0fc-a7786dcd9b9f" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;The journey has just begun&lt;/li&gt;&lt;li&gt;Stronger sales to come, we estimate +39% y-o-y in Q2&lt;/li&gt;&lt;li&gt;Trading 30% below peers on EV/EBITDA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-293ccfa6-5d1c-4026-b13f-6085e982c433" name="bm-comp-293ccfa6-5d1c-4026-b13f-6085e982c433" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="293ccfa6-5d1c-4026-b13f-6085e982c433" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:start;"&gt;And so the journey begins&lt;/h3&gt;&lt;p style="text-align:start;"&gt;Clavister is entering a new era in its history, and we find the journey very exciting. Costs as a share of sales are down. The product focus and the strategy have been sharpened. And the heavy debt? Repaid and refinanced. All cash is now going towards growing the company. We therefore estimate Q2 sales of SEK 76m, for growth of 39% y-o-y, and we expect Clavister to only accelerate from here. We do expect the company to continue being profitable from now on, but the main focus for us is growing the business and winning more deals within defence, energy and the public sector. The cash from the Norwegian deal will come in H2'26, and we expect FCF of ~SEK 40m for '26e (-10m in '25).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Costs come first, scaling comes next&lt;/h3&gt;&lt;p&gt;We keep our sales estimates flat for '26e-'28e but cut EBITDA by 11-33% for the same period, as we think the main focus will be growing the business and the costs that come with it will be incurred. This is usual for a company of this size. Building a foundation and a brand name comes first, and then the scaling potential comes. We therefore now expect EBITDA margins of 28-30% (16% in '25) for '26e-'28e, and EBITDA to grow ~140% y-o-y in '26e.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:start;"&gt;The turnaround is done, the growth begins&lt;/h3&gt;&lt;p style="text-align:start;"&gt;Our estimates reflect the announced defence orders and a stabilisation of the civil market. On these, the company is trading at 22-12x EV/EBITDA for &amp;#8217;26e-&amp;#8217;28e, which is 30% below its peers. But the potential does not stop there. There is also the potential deal regarding BAE Nordic Edition in defence, the shift to European vendors in the public sector, and the energy opening, none of which we have yet factored into our estimates (see pages 3-9).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/clavister/Equity-research/2026/8/clavister---accelerating-from-here/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 16 Aug 2026 20:00:03 GMT</pubDate>
      <isin>SE0005308558</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Skolon - Timing effects to weigh on Q2</title>
      <description>&lt;a id="bm-comp-977f9fdd-e311-4ccc-bbcb-c473858e99d4" name="bm-comp-977f9fdd-e311-4ccc-bbcb-c473858e99d4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="977f9fdd-e311-4ccc-bbcb-c473858e99d4" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We expect 13% organic growth in Q2&lt;/li&gt;&lt;li&gt;Q2 revenues adversely impacted by lower user growth in Q1&lt;/li&gt;&lt;li&gt;FVR of SEK 25-40 reiterated&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f6c10e9f-ff3d-46c6-9193-fe548d31639e" name="bm-comp-f6c10e9f-ff3d-46c6-9193-fe548d31639e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f6c10e9f-ff3d-46c6-9193-fe548d31639e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 expectations&lt;/h3&gt;&lt;p&gt;Skolon reports its Q2 results on 21 August. We expect sales of SEK 62m, corresponding to organic growth of 13% y-o-y. Growth is expected to be affected by contract timing, with some contracts likely to contribute from Q3 rather than in the current quarter (aside from tough growth comps of 40% y-o-y in Q2'25). In the UK, Skolon &lt;a data-bm-trackable="false" href="https://skolon.com/sv/nyhetsrum/skolon-signerar-tre-storre-skolkoncerner-i-storbritannien-omfattar-60-skolor/" target="_blank"&gt;signed three larger school groups&lt;/a&gt; in Q2, comprising around 60 schools in total. In the UK, customers tend to add tools after platform adoption so we expect UK tools revenue to build more gradually, and see this as a tailwind for Skolon; this market could become an important growth pillar. We estimate gross margins of 27% (24% less capitalised work), broadly flat y-o-y. For paying users, we estimate 1,073k at end-Q2'26e (Q1'26 1,038k) and ARPPU of SEK 197 (Q1'26 SEK 196), continuing the steady sequential increase in monetisation per user.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates reflect somewhat more partner revenue&lt;/h3&gt;&lt;p&gt;We cut our sales estimate by 5% for '26, as we now expect revenue to materialise in Q3 rather than this quarter. Consequently, we reduce '26e EBITDA from SEK 15m to SEK 9m given the delayed revenue recognition and as we believe more of the growth will originate from partner revenues.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Implied valuation&lt;/h3&gt;&lt;p&gt;Based on our revised estimates, Skolon is trading at 6x/4x '26e/'27e EV/Gross profit (GP less capitalised work). We maintain our fair value range of SEK 25-40. We continue to expect Skolon to grow gross profit meaningfully faster than the peer group, driven by continued user growth in Norway, the UK and Germany alongside rising ARPPU as customers increase their purchases of tools on top of the platform over time. Skolon has also launched its AI Studio, an agentic coding feature that lets partners and customers build on Skolon's content library, which we see as a further driver of take rates over time.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/company-name/Equity-research/2026/8/skolon---timing-effects-to-weigh-on-q2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 14 Aug 2026 16:15:06 GMT</pubDate>
      <isin>SE0017615784</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>NYAB - Delivering on its promises</title>
      <description>&lt;a id="bm-comp-e32e64f7-349a-4d41-8328-35f365d116b0" name="bm-comp-e32e64f7-349a-4d41-8328-35f365d116b0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e32e64f7-349a-4d41-8328-35f365d116b0" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Another strong report with org. sales +19% and EBIT +45%&lt;/li&gt;&lt;li&gt;'26e-'28e EBIT and EPS raised by 9-12% and 18-19%&lt;/li&gt;&lt;li&gt;Strong outlook with 26% EBIT growth in H2e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-fb653ca6-1d18-4a5e-b0ea-528f780a9c23" name="bm-comp-fb653ca6-1d18-4a5e-b0ea-528f780a9c23" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fb653ca6-1d18-4a5e-b0ea-528f780a9c23" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong growth to continue&lt;/h3&gt;&lt;p&gt;NYAB delivered a strong Q2 (19% organic growth) with some catch-up from the weaker Q1 (-6%) where we understand that the winter impacted production more than usual. EBIT grew 45% y-o-y in Q2 and 46% in H1. With a record order backlog of EUR 502m as of Q2 (+18% y-o-y) and a strong tender pipeline we think NYAB is well-positioned to grow &amp;gt;10% organically in H2 with further margin expansion driving 26%/25% EBIT growth y-o-y in Q3/Q4 and 24% EBIT growth NTM. This growth does not include the profits from the Uppsala Tram JV, which is recognised below EBIT. Overall, we think NYAB continues to execute very well and deliver on its promises (most recently by growing &amp;gt;10%, winning the Uppsala Tram project and improving the Civil Engineering margins again after an investment period).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Significant estimate uplift due to good momentum&lt;/h3&gt;&lt;p&gt;We raise '26e-'28e sales and EBIT by 5-6% and 9-12%, respectively, due to the strong order momentum and margins in Civil Engineering. As mentioned, this does not include profits from the Uppsala Tram JV which we estimate at EUR 1.9-2.5m in '26e-'28e and which leads us to raise net profit and EPS by 18%/19%/18%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;NYAB remains well-positioned towards infrastructure niches with strong demand, and its capital-light operating model facilitates a combination of high growth and high cash generation. The share reacted positively on the report, but we raise our estimates more which means that the multiples are lower now compared to before the report. It is currently at 9-7x EV/EBITA on '26e-'28e compared to the median for construction peers at 11-9x and infrastructure service peers at 12-9x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nyab/Equity-research/2026/8/nyab---delivering-on-its-promises/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 14 Aug 2026 08:15:06 GMT</pubDate>
      <isin>SE0022242434</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>BTS Group - Organic growth beat and raised guidance</title>
      <description>&lt;a id="bm-comp-24e077f8-6b11-4159-88c2-e9775cd4162b" name="bm-comp-24e077f8-6b11-4159-88c2-e9775cd4162b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="24e077f8-6b11-4159-88c2-e9775cd4162b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;9% organic growth (cons 2%), adj. EBITA -5% vs cons&lt;/li&gt;&lt;li&gt;2026 EBITA guidance raised to "significantly better than 2025" (cons at +25%)&lt;/li&gt;&lt;li&gt;Slight positive revisions expected (1-3%), good AI data points, stock up 5-8%&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-0a7f24c5-eea2-43b3-97b9-f22e464e4a76" name="bm-comp-0a7f24c5-eea2-43b3-97b9-f22e464e4a76" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0a7f24c5-eea2-43b3-97b9-f22e464e4a76" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 details&lt;/h3&gt;&lt;p&gt;Sales SEK 767m (9% vs ABG 705m, 8% vs cons 712m), adj. EBITA 94m (-5% vs ABG 99m, -5% vs cons 99m), adj. EBITA margin 12.3% (ABG 14.1%, cons 13.9%). Adj. EBITA -5% y-o-y (ABG 0%, cons 0%). Organic growth 9% (ABG 1%, cons 2%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Organic growth to remain positive ahead is a relief&lt;/h3&gt;&lt;p&gt;Sales beat in all regions (+3-16% vs cons) with &amp;gt;10% organic growth in North America and Europe. Positive results from AI, both revenues (+221% y-o-y, now 10% of group sales) and improved internal efficiency. BTS raises FY guidance to &amp;#8220;significantly higher EBITA in 2026 vs 2025&amp;#8221; vs previous &amp;#8220;higher&amp;#8221; (cons +25% already). Guides for continued momentum in North America, some slowdown in Europe post a strong Q2 and return to growth in Other markets in H2 (-1% in Q2), confirming the positive organic growth trend to stay.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Guidance partly reflected in cons, stock still up on relief today&lt;/h3&gt;&lt;p&gt;We expect consensus to make small positive changes to 2026 EBITA (+1-3%) as estimates already reflect an upgraded guidance, while the organic growth beat and guidance upgrade signalling value should be positive for the sentiment today with valuation at 9x NTM EV/EBITA. We expect the stock to trade +5-8%. Conf call CET 15.00.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-45003a1f-215d-4f39-9b79-ab4128418bd9" name="bm-comp-45003a1f-215d-4f39-9b79-ab4128418bd9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="45003a1f-215d-4f39-9b79-ab4128418bd9" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-e6c652cf-e7fe-4c42-9479-900a5f7ee84f" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, FactSet, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/bts-group/Equity-research/2026/8/bts-group---organic-growth-beat-and-raised-guidance/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 14 Aug 2026 05:15:05 GMT</pubDate>
      <isin>SE0000805426</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>NYAB - Strong earnings beat, +27% vs cons</title>
      <description>&lt;a id="bm-comp-2e0eee9c-5e9e-4461-b924-bcb86a632d19" name="bm-comp-2e0eee9c-5e9e-4461-b924-bcb86a632d19" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2e0eee9c-5e9e-4461-b924-bcb86a632d19" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;EBIT was 35% better than ABGSC and 27% vs cons&lt;/li&gt;&lt;li&gt;Order backlog +18% y-o-y, plus major Uppsala tram order supports growth&lt;/li&gt;&lt;li&gt;We expect estimates to be revised up 5-6% on the Q2 numbers&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-90af9463-308a-49e8-95dd-abeb57bbc80e" name="bm-comp-90af9463-308a-49e8-95dd-abeb57bbc80e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="90af9463-308a-49e8-95dd-abeb57bbc80e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;NYAB delivered a strong report with sales of EUR 162m, up 19% y-o-y (19% organic) and 10% better than FactSet consensus. Margins were also better, resulting in an EBIT of EUR 8.3m, up 45% y-o-y (35% vs ABGSCe 6.1m and 27% vs cons 6.5m). Net profit was EUR 7.7m (65% vs ABGSCe 4.7m and 55% vs cons 5.0m). The strength was driven by the Civil Engineering segment, where EBIT increased by 52% y-o-y while Consulting remained a bit softer due to weakness in the Norwegian offshore market. The order backlog in Civil Engineering reached a new high of EUR 502m, increasing 18% y-o-y, providing good support for continued growth as NYAB enters peak season in H2. The FCF was soft at 0.8m due to working capital increases, but the LTM remained strong at 33m (97% of EBIT).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and preliminary estimate changes&lt;/h3&gt;&lt;p&gt;Management continues to see strong demand in key markets (power grid, transport, industry). Moreover, the Uppsala tram order signed in July will boost the order backlog further and support solid growth in the coming years. Based on the Q2 report, we expect consensus to raise earnings estimates by 5-6%. The Uppsala order is also not likely fully reflected in estimates.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;Overall, the report was strong. The share has been relatively flat into the print and trades at 10x EBIT on 2026e. We see good support for the company to continue growing at a double-digit range in the medium term.&lt;/p&gt;&lt;p&gt;There will be a conference call at 10:00 CET, you can use this &lt;a data-bm-trackable="false" href="https://eur06.safelinks.protection.outlook.com/?url=https%3A%2F%2Fnyabgroup.events.inderes.com%2Fq2-report-2026&amp;amp;data=05%7C02%7Crebecka.kihlstrom%40nyabgroup.com%7C6a67111ed2494b18558708def1314815%7Ca92a623bd03b486bafc98220d89e9821%7C0%7C0%7C639213391124214120%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;amp;sdata=qrKernfUN6lR8jn%2BkVtMx0NZkSETQAxDrOjtzHtrLkA%3D&amp;amp;reserved=0" target="_blank"&gt;link&lt;/a&gt; to participate in the webcast.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-93f8423c-bbbb-4ac2-933a-b8efb3f6af52" name="bm-comp-93f8423c-bbbb-4ac2-933a-b8efb3f6af52" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="93f8423c-bbbb-4ac2-933a-b8efb3f6af52" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-d51b6c33-393b-4b76-a942-c1aced27ec34" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviations&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data, FactSet consensus&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nyab/Equity-research/2026/8/nyab---strong-earnings-beat-27-vs-cons/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 13 Aug 2026 07:15:06 GMT</pubDate>
      <isin>SE0022242434</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>G5 Entertainment - Cost cuts to support earnings growth in H2</title>
      <description>&lt;a id="bm-comp-269e1622-d3ab-41c3-b449-8908b41a46a0" name="bm-comp-269e1622-d3ab-41c3-b449-8908b41a46a0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="269e1622-d3ab-41c3-b449-8908b41a46a0" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Cost savings to offset sales decline in 2026e...&lt;/li&gt;&lt;li&gt;...but we cut 2027e-2028e adj. EBIT by 3-6% on sales trajectory&lt;/li&gt;&lt;li&gt;Trading at 4x NTM EV/adj. EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-921cacde-7c0d-4c85-ba6a-950b499c5fb7" name="bm-comp-921cacde-7c0d-4c85-ba6a-950b499c5fb7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="921cacde-7c0d-4c85-ba6a-950b499c5fb7" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Cost savings now offsetting the sales decline&lt;/h3&gt;&lt;p&gt;Q2 showed that cost savings can offset the sales decline. Adj. EBIT was in line with us despite an 8% sales miss, due to opex reductions. With full effect of the savings in coming quarters, we expect margins to recover. The larger-than-expected sales drop was partly driven by temporary headwinds for Hidden City, where management hopes to see a recovery. Meanwhile, Sherlock continued to show softness despite efforts to stabilise it - as a result, management withdrew its ambition from Q1 to increase user acquisition costs to stabilise it in the near term. The 'Jewels of' series also remained soft, with sales -30% y-o-y. In accordance with what was said last quarter, G5 is therefore implementing another wave of cost cuts. With the new cost cuts reaching full effect in the coming quarters, we expect that it will better offset the sales decline and help improve margins (5% in Q3 and 9% in Q4 compared to ~0% in the last three quarters).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;Even though we lower sales by 7%/9%/10% for '26e-'28e on a larger sequential drop in Q2, larger cuts to the organisation combined with lower user acquisition costs because of management's communication around Sherlock means that adj. EBIT is less affected. 2026e is unchanged and 2027e cut by 3%. However, the effect of the weaker sales trajectory weighs a bit more on 2028e where we cut adj. EBIT by 6%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Navigating troubled waters prudently&lt;/h3&gt;&lt;p&gt;The sales trajectory is arguably the most important long-term factor supporting earnings and the valuation. However, shorter term and in this situation specifically, acting to restore margins combined with prudent capital allocation is key. We think the decision to downsize the organisation by a third whilst distributing all the FCF as dividends and buybacks this year is evidence of that.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/g5-entertainment/Equity-research/2026/8/g5-entertainment---cost-cuts-to-support-earnings-growth-in-h2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 12 Aug 2026 18:30:05 GMT</pubDate>
      <isin>SE0001824004</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ferronordic - Three for three</title>
      <description>&lt;a id="bm-comp-27336e69-6885-4702-8485-43fd59031018" name="bm-comp-27336e69-6885-4702-8485-43fd59031018" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="27336e69-6885-4702-8485-43fd59031018" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Beat across all three segments&lt;/li&gt;&lt;li&gt;34% sales and 65% EBIT beat&lt;/li&gt;&lt;li&gt;'26e/'27e group EBIT raised 16%/8%&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-80f03b3b-8f5f-44cc-a665-08646c64e6d2" name="bm-comp-80f03b3b-8f5f-44cc-a665-08646c64e6d2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="80f03b3b-8f5f-44cc-a665-08646c64e6d2" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Beat across US, Germany &amp;amp; Kazakhstan&lt;/h3&gt;&lt;p&gt;Ferronordic's Q2 sales were SEK 1,558m (+43% y-o-y, +34% vs ABGSCe) and +54% y-o-y organically. EBIT was SEK 68m (+65% vs. ABGSCe 41m) for a margin of 4.4% (ABGSCe 3.6%). This is the highest EBIT print since Q4'22, the last quarter with a contribution from the Russian operations before the divestment. The earnings beat was broad-based across all three segments. In the US, Rudd's equipment sales rose 89% in USD, driven by data center and infrastructure investments, particularly in Volvo's articulated haulers. Encouragingly, Germany remained sequentially profitable, supported by cost control and continued aftermarket strength, while Kazakhstan returned to profit. ND/EBITDA decreased to 3.0x (3.8x in Q1'26), as EBITDA increased (SEK 180m, +45% q-o-q) and net debt decreased from SEK 1,957m to 1,845m. It is the first time since the acquisition of Rudd that leverage is within the target range, and sooner than we had anticipated. All in all, Ferronordic delivered a strong Q2, extending the recovery from a soft Q2'25.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Group '26e/'27e EBIT lifted by 16%/8%&lt;/h3&gt;&lt;p&gt;We raise '26e EBIT across all segments following the convincing Q2 beat. We increase US EBIT by 8%/7%/7% for '26e-'28e, while our German EBIT estimates rise SEK 11m/2m/3m over the same period, as a German recovery in '27e-'28e was already partly incorporated into our forecasts. Group '26e-'28e EBIT is raised by 16%/8%/7%. We share management's positive view on the US construction equipment market, with long-term investments in DC and power plants driving demand across the CE value chain.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;Prior to today's report, the share had returned +13% L1M, compared to the +4% of OMXSGI. The valuation presently sits at 10-9x '26e-'27e P/E, which can be compared to our distributor peer group at 20-17x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ferronordic/Equity-research/2026/8/ferronordic---three-for-three/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 12 Aug 2026 15:00:05 GMT</pubDate>
      <isin>SE0005468717</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>G5 Entertainment - Larger cost savings offsetting sales miss</title>
      <description>&lt;a id="bm-comp-8a87f571-5c3a-4d4a-b585-09bd9f01da8c" name="bm-comp-8a87f571-5c3a-4d4a-b585-09bd9f01da8c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8a87f571-5c3a-4d4a-b585-09bd9f01da8c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Adj. EBIT 0.1m, vs ABGSC 0.1m and FactSet cons -0.2m&lt;/li&gt;&lt;li&gt;Larger sales decline offset by higher cost savings and GM uplift&lt;/li&gt;&lt;li&gt;Estimates largely unchanged, but weaker sales trend to weigh&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-885aca43-6d05-4f1a-b556-2a7deb1cd468" name="bm-comp-885aca43-6d05-4f1a-b556-2a7deb1cd468" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="885aca43-6d05-4f1a-b556-2a7deb1cd468" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Sales were USD 20.1m (-8% vs ABGSCe 21.8m and -4% vs cons 21.0m), down 16% y-o-y and 7% q-o-q. EBIT was -0.2m (vs ABGSC -0.6m, cons -0.2m). Adj. EBIT was 0.1m (vs ABGSC 0.1m, cons -0.2m) vs 1.6m last year, relatively in line with expectations due to higher than expected cost savings and gross margin. Adjustments include 0.8m severance payments and 0.5m positive FX revaluations. Net profit was 0.6m (vs ABGSC -0.4m, cons -0.8m). FCF 0.4m (2.8m last year).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and preliminary estimate changes&lt;/h3&gt;&lt;p&gt;Of the two new games in soft launch, one was terminated, but the other is continuing to scale and management is cautiously optimistic, saying it is showing strong early metrics. A new successful game will be key to stabilise the sales trend in our view, as both Sherlock and Hidden City is declining right now. The 'Jewels of' series of games continues to decline at a rapid pace, and management therefore decided to put it in harvest mode. This also led to a second wave of layoffs and management to raise the guidance for total run-rate cost savings from 6m to 11m. Factoring in the weaker sales trend and the higher cost savings, we expect that consensus EBIT estimates for 2027-2028 will be relatively unchanged.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;The share has performed well into numbers, +9% L1M, +37% L3M. Even though adjusted earnings were relatively in line, and estimates changes should be relatively neutral, we think the weaker sales trend is incrementally negative for the story. The buybacks increased slightly in Q2, to 1.0m (0.4m in Q1) and was 2.6m LTM - we expect continued buybacks. The balance sheet remains strong with 24.4m net cash.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-34e7a78f-0aec-4d43-a22e-8ac307b31c38" name="bm-comp-34e7a78f-0aec-4d43-a22e-8ac307b31c38" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="34e7a78f-0aec-4d43-a22e-8ac307b31c38" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-46266e2f-38b6-42b3-a7fe-d98930f76cd7" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviations&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data, FactSet&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/g5-entertainment/Equity-research/2026/8/g5-entertainment---larger-cost-savings-offsetting-sales-miss/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 12 Aug 2026 07:00:05 GMT</pubDate>
      <isin>SE0001824004</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ferronordic - Earnings beat across the board</title>
      <description>&lt;a id="bm-comp-fc7da625-eae6-48d1-808b-280c3f5f1f03" name="bm-comp-fc7da625-eae6-48d1-808b-280c3f5f1f03" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fc7da625-eae6-48d1-808b-280c3f5f1f03" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales SEK 1,558m &amp;amp; EBIT 68m&lt;/li&gt;&lt;li&gt;Earnings beat across all segments&lt;/li&gt;&lt;li&gt;Share currently trading at 15-10x '26e-'27e EV/EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-db0f1921-d5de-4181-ab0f-c25cc90e973d" name="bm-comp-db0f1921-d5de-4181-ab0f-c25cc90e973d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="db0f1921-d5de-4181-ab0f-c25cc90e973d" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 in brief&lt;/h3&gt;&lt;p&gt;Strong set of numbers from Ferronordic. Sales SEK 1,558m (34% vs. ABGSCe 1,159m), EBIT 68m (65% vs. ABGSCe 41m, -5m in Q2'25) for an EBIT margin 4.4% (ABGSCe 3.6%). Earnings beat across all segments (US, Germany &amp;amp; Kazakhstan). Net debt came down to 1,845m (1,957m in Q1), 3.0x ND/EBITDA (3.8x in Q1), on both lower net debt and higher EBITDA.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and estimate changes&lt;/h3&gt;&lt;p&gt;&lt;font style="background-color:#ffffff;"&gt;The report would mechanically raise EBIT by 14-11% '26e-'27e. Management remains optimistic about US operations and&lt;/font&gt; environment ahead, where infra and data centers investments continue to drive growth. In Germany they expect a gradual recovery as fleet renewal requirements accumulate and a continued strong aftermarket.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;Prior to today's report, the share had returned +13% L1M, compared to the +4% of OMXSGI. The share is currently trading at 15-10x '26e-'27e EV/EBIT on our pre-report estimates vs. the peer median of 17-16x. The company will host a conference call at 10.00 CET, link &lt;a data-bm-trackable="false" href="https://ferronordic.events.inderes.com/q2-report-2026" target="_blank"&gt;here&lt;/a&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;pagebreak &lt;a id="bm-comp-4dea2739-1fab-4c93-ac54-dd9b60639b71" name="bm-comp-4dea2739-1fab-4c93-ac54-dd9b60639b71" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4dea2739-1fab-4c93-ac54-dd9b60639b71" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-17ebb3df-d899-4c35-af6f-b8ecc7cd6dde" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ferronordic/Equity-research/2026/8/ferronordic---earnings-beat-across-the-board/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 12 Aug 2026 06:00:05 GMT</pubDate>
      <isin>SE0005468717</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>OssDsign - Waiting for the growth to return</title>
      <description>&lt;a id="bm-comp-8aa3437d-0294-4328-9c26-052d49b41a6e" name="bm-comp-8aa3437d-0294-4328-9c26-052d49b41a6e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8aa3437d-0294-4328-9c26-052d49b41a6e" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sequentially flattish, but -15% organic drop in sales in Q2e&lt;/li&gt;&lt;li&gt;We assume a recovery in sales growth in H2'26e&lt;/li&gt;&lt;li&gt;Q2'26 results due 18 August&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-b308e6a4-84bf-460b-8709-0c8dd9d5263e" name="bm-comp-b308e6a4-84bf-460b-8709-0c8dd9d5263e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b308e6a4-84bf-460b-8709-0c8dd9d5263e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2'26 expectations&lt;/h3&gt;&lt;p&gt;We expect sales development to have stabilised in Q2, at a similar level to Q1'26, but lower compared with Q2'25, after recent changes in the US sales organisation and negotiation of certain key accounts that caused sales to drop in Q1. For Q2, we are forecasting sales of SEK 38m, equal to USD 4m,&lt;font color="#28AD20"&gt;&lt;/font&gt;which is a similar level in terms of USD to Q1'26, and equal to a 15% organic decline (in USD) compared with Q2'25. We have assumed a small sequential increase in opex in Q2, resulting in EBIT for Q2 of SEK -13.3m with a gross margin of 95%. In terms of cash flow generation, we do not expect to see any major changes compared with the most recent quarters. We forecast OCF of SEK -16m, and for OssDsign to have a cash position of SEK 149m at the end of Q2.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We raise our sales forecast by 2.6%-3.9% for '26e-28e to reflect updated FX assumptions but leave our EBIT forecast largely unchanged as we assume the high level of USD-based opex to offset the uplift in sales. We continue to expect to see gradually improving sales momentum in H2'26.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range tweaked to SEK 4.0-6.3 (4.0-6.2)&lt;/h3&gt;&lt;p&gt;On the back of our updated forecast, our DCF-based fair value range is marginally tweaked up to SEK 4.0-6.3 (4.0-6.2) ahead of the Q2 results. While near-term sales and earnings momentum remain soft, impacted by a lack of sales channel expansion and turnover of certain sales reps, we continue to see meaningful long-term potential, supported by improved adoption of Catalyst in the US, high gross margins, and increasing operating leverage as the sales base scales. However, we expect the share price performance to remain muted until the company shows clear signs of improvements in the ramp-up of sales after three quarters of relatively flat sales before the disappointing decline in Q1.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ossdsign/Equity-research/2026/8/ossdsign---waiting-for-the-growth-to-return/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 11 Aug 2026 18:45:04 GMT</pubDate>
      <isin>SE0012570448</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Arctic Paper - Pulp beats paper II</title>
      <description>&lt;a id="bm-comp-2deb8f82-dc97-4e86-b85d-27493f2e9998" name="bm-comp-2deb8f82-dc97-4e86-b85d-27493f2e9998" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2deb8f82-dc97-4e86-b85d-27493f2e9998" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q2 paper EBIT of PLN -32m&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Pulp prices down, while paper remains challenging&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range of SEK 15-50&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-2fefdd70-b1d9-48c3-be80-28a45131967f" name="bm-comp-2fefdd70-b1d9-48c3-be80-28a45131967f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2fefdd70-b1d9-48c3-be80-28a45131967f" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 paper EBIT of PLN -32m&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Paper EBIT came in at PLN -32m (ABGSCe PLN -20m), with paper sales in line at PLN 514m but down 10% q-o-q. Group EBIT was PLN -30m vs. ABGSCe -24m. As before, the results were hit by subdued demand and higher input costs from the Middle East conflict, while the price hikes meant to offset these fell short amid intense price competition. Paper EBITDA was PLN -8m and group EBITDA PLN 9m (ABGSCe 12m), the latter lifted by improved pulp profitability on lower pulpwood prices and reduced fixed costs. Arctic Paper also strengthened its US presence via a new sales office, targeting 5-10% of paper sales over the coming years. Capex has been 'significantly reduced' and cost-saving initiatives are largely complete, set to deliver ~PLN 6m in 2026. Lower pulpwood prices should further support profitability (lag into P&amp;amp;L), but with demand soft and visibility limited, we forecast Q3 paper EBIT of PLN -10m.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Pulp prices down, while paper remains challenging&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Pulp looks to have peaked for now: Chinese integrated capacity caps the upside once prices clear cash cost (USD 605/t), and Asian HW is up 14% vs H2'25 but down 6% lately (USD 565/t). European pulp prices fell in July, following Chinese pulp futures (HW -3.5%, SW -1.2%). Wood prices are falling across Scandinavia (-15-30%) now. This effect comes with a lag into the P&amp;amp;L. Paper markets are helped by 6% supply cuts in '26e, but slow demand leaves utilisation &amp;lt;80%. We need +3mt more in cuts to reach the historical average of ~89%. Note that the UPM JV with Sappi could fix the paper market balance.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of SEK 15-50&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;The company is trading at an EV/CE multiple of ~0.46x, which is ~40% below its historical average. We have applied three valuation methodologies and arrive at a fair value range of SEK 15-50.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/arctic-paper/Equity-research/2026/8/arctic-paper---pulp-beats-paper-ii/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 11 Aug 2026 18:00:06 GMT</pubDate>
      <isin>PLARTPR00012</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Generic - The growth journey continues</title>
      <description>&lt;a id="bm-comp-53afaa4f-e21d-4647-96bc-503c1aa9d5eb" name="bm-comp-53afaa4f-e21d-4647-96bc-503c1aa9d5eb" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="53afaa4f-e21d-4647-96bc-503c1aa9d5eb" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;We expect growth to return in a seasonally soft quarter&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Estimates unchanged but costs elevated near term&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;EV/adj. EBIT of 10/9x '26e/'27e, ~60% below peers&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-2758a89a-d86c-480a-b4cd-f4b88606075e" name="bm-comp-2758a89a-d86c-480a-b4cd-f4b88606075e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2758a89a-d86c-480a-b4cd-f4b88606075e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Volume recovery holds&lt;/h3&gt;&lt;p&gt;Generic reports its Q2 on 20 August. We think the recovery in Messaging (SMS and related services, 73% of the group's sales) will continue through the quarter, and we estimate sales of SEK 49m, up 10% y-o-y. Q2 is normally the quietest quarter of the year, as Sweden has many public holidays and fewer messages are sent when offices are closed. Some customer groups (logistics in particular) are likely still cautious about spending. At the same time, we think Generic continues to win customers in areas that depend less on the economic cycle, such as e-health, which should gradually tilt sales towards steadier revenue. For Q2 we estimate a gross margin of 44% and adj. EBIT of SEK 9m, for a margin of 19%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Minor changes to estimates&lt;/h3&gt;&lt;p&gt;We leave our estimates broadly unchanged ahead of the report, expecting 8% sales growth for the full year '26e (4% y-o-y in '25e) and an adj. EBIT of SEK 41m, for a margin of 21%. Recruitment and increased use of external resources should keep costs somewhat elevated in the near term, and we see limited room for margin expansion before the mix shift gains scale.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at an EV/adj. EBIT of 10/9x for '26e/'27e&lt;/h3&gt;&lt;p&gt;The stock trades at 10x EV/adj. EBIT on '26e and 9x on '27e, ~60% below CPaaS peers, despite higher growth and EBIT margins of 21% (peers averaging ~10%). With over 30% of Swedish municipalities already penetrated and the offering broadening into regions, authorities and private companies, we expect the shift to lift both recurring revenue and gross margins.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/generic/Equity-research/2026/8/generic---the-growth-journey-continues/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 11 Aug 2026 11:45:05 GMT</pubDate>
      <isin>SE0001790791</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Donkey Republic - Q2 likely to confirm strong growth trajectory</title>
      <description>&lt;a id="bm-comp-3a518e42-d9a5-40b6-bdd3-f662a4c37930" name="bm-comp-3a518e42-d9a5-40b6-bdd3-f662a4c37930" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3a518e42-d9a5-40b6-bdd3-f662a4c37930" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2e: +12% revenue growth, EBITDA of DKK 17.0m&lt;/li&gt;&lt;li&gt;We remain at the top end of the FY'26 guidance&lt;/li&gt;&lt;li&gt;FVR of DKK 8.0-11.0 (7.5-11.0)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-5c6fe14b-8be3-4757-a7de-323f2b37ce7a" name="bm-comp-5c6fe14b-8be3-4757-a7de-323f2b37ce7a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5c6fe14b-8be3-4757-a7de-323f2b37ce7a" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;We expect +12% revenue growth in Q2&lt;/h3&gt;&lt;p&gt;Donkey Republic (DONKEY) will report Q2 on 17 August. We forecast revenues of DKK 54.5m in the seasonally important quarter, for 12% growth y-o-y, driven by a 4% increase in revenue/bike (to DKK 738) and a fleet size of 24.6k bikes, the latter up 8% y-o-y, with roll-outs in Germany beginning to show in the numbers. We forecast Q2 EBITDA of DKK 17.0m, a strong improvement from the DKK 11.3m in Q2'25.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We remain at the top of guidance&lt;/h3&gt;&lt;p&gt;We continue to see DONKEY landing at the top end of its FY'26 guidance, as we expect revenues of DKK 193m (guidance DKK 179m-194m) and EBIT of DKK 8.6m (guidance DKK 1m-9m). However, note that a likely Germany-driven dilution in revenue/bike and higher associated costs from Q3e will likely make the y-o-y uplift less powerful in H2. With our EBIT estimates largely unchanged, DONKEY's recent debt-restructuring is the primary driver of our 15%/6% hike to '27e/'28e EPS.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;+20% sales CAGR and hefty margin uplift; FVR DKK 8.0-11.0&lt;/h3&gt;&lt;p&gt;Europe's bike-sharing fleet, part of the broader shared micromobility market, is projected to grow at +15% CAGR until '30e, and we see DONKEY's competitive edge centred around its high-quality fleet (especially after the roll-out of its Gen4 bike), its lower prices (price/cost is 50% of scoring in EU tenders), and stronger relations with the cities it serves, coupled with solid positions in the Tier 2 and Tier 3 segments. Considering market tailwinds and DONKEY's pipeline and commercial momentum, including two recent large-scale wins in Germany, we forecast a revenue CAGR of 20% in '25-'28e (vs. 35% in '18-'25). With improving operating leverage, we model adj. EBITDA increasing from DKK 30m in '25 to DKK 85m in '28e and adj. EBIT reaching DKK 40m. We raise our fair value range to DKK 8.0-11.0/share (7.5-11.0).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/donkey-republic/Equity-research/2026/8/donkey-republic---q2-likely-to-confirm-strong-growth-trajectory/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 10 Aug 2026 05:45:03 GMT</pubDate>
      <isin>DK0061540770</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Medicover - Divests Medicover Hospitals India</title>
      <description>&lt;a id="bm-comp-e777e793-99f4-45b7-9943-86fac970770f" name="bm-comp-e777e793-99f4-45b7-9943-86fac970770f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e777e793-99f4-45b7-9943-86fac970770f" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sells MHI to KKR; deal expected by management to close in Q4&lt;/li&gt;&lt;li&gt;Agreed EV of EUR 1.2bn corresponds to ~46x EV/EBITDA&lt;/li&gt;&lt;li&gt;Improves financial flexibility for European strategy&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-e711a09a-266e-4558-aa08-d4a57f819098" name="bm-comp-e711a09a-266e-4558-aa08-d4a57f819098" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e711a09a-266e-4558-aa08-d4a57f819098" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;The deal in brief&lt;/h3&gt;&lt;p&gt;Medicover today &lt;a data-bm-trackable="false" href="https://www.medicover.com/media/press-releases?page=/en/pressreleases/medicover-divests-its-india-hospital-business-enabling-accelerated-strategy-execution-in-europe-2472503" target="_blank"&gt;announced&lt;/a&gt; that it has agreed to divest its Indian business Medicover Hospitals India (MHI) to KKR for an enterprise value of EUR 1.2bn. There have been discussions of a potential sale since 17 June, and Medicover was planning an IPO of the Indian business for some time prior, so the announced deal is not a surprise. Medicover owns 66.1% of MHI and will receive EUR 0.74bn in gross cash. This includes EUR 0.1bn related to loans. On an LTM basis (Q2 2026), Medicover Hospitals India generated revenues of EUR 221m with EBITDA margins of 11.8%, for an EBITDA of EUR 26.1m. The suggested LTM EV/EBITDA multiple from the communicated EUR 1.2bn EV paid is thus ~46x. The deal is expected by management to close in Q4'26, conditional on regulatory approval.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Pro-forma implications&lt;/h3&gt;&lt;p&gt;MHI comprises 24 hospitals, ~4,800 beds, and ~11,400 employees, with revenue of EUR 220.5m (LTM Q2'26) and indicative margins well below the group average (11.8% EBITDA margin vs the group's 16.1% and 2.4% EBIT margin vs the group's 7.1%). Because MHI is lower-margin than the rest of the business, removing it lifts the remaining group's profitability on an illustrative pro forma basis. The EBITDA margin rises from 16.1% to 16.5%, and the EBIT margin rises from 7.1% to 7.6%. The divestment is thus margin-accretive for Medicover's continuing European operations. Compared to the reported 2.9x ND/EBITDA ex-IFRS 16 in Q2'26, we expect the pro-forma ND/EBITDA to drop to a level around 0x.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Strategy ahead&lt;/h3&gt;&lt;p&gt;In February, Medicover hosted an Investor Update, in which it expanded on the near-term strategy. Comments by Medicover's management during today's deal presentation make us believe that this strategy remains intact, and the now-stronger balance sheet gives more operational flexibility. It is furthermore possible for Medi&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/medicover/Equity-research/2026/8/medicover---divests-medicover-hospitals-india/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 06 Aug 2026 09:00:03 GMT</pubDate>
      <isin>SE0009778848</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Byggmästaren - Private assets strong, but Green still weighs</title>
      <description>&lt;a id="bm-comp-b0e7be2b-b7ef-442e-b9b6-903486ee1060" name="bm-comp-b0e7be2b-b7ef-442e-b9b6-903486ee1060" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b0e7be2b-b7ef-442e-b9b6-903486ee1060" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 NAV 6% above ABGSCe&lt;/li&gt;&lt;li&gt;DPP and Safe Life continued to impress&lt;/li&gt;&lt;li&gt;Discount still wider than history&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-029a15fc-5f0e-48ae-ab67-d389fe1fa220" name="bm-comp-029a15fc-5f0e-48ae-ab67-d389fe1fa220" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="029a15fc-5f0e-48ae-ab67-d389fe1fa220" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2: NAV beat, but Green Landscaping weighed&lt;/h3&gt;&lt;p&gt;Byggm&amp;#228;staren reported Q2 NAVPS of SEK 64.46, 6% above our estimate. However, NAV declined 4% q-o-q in total-return terms vs SIXRX +9.5%, as the continued weakness in Green Landscaping &amp;#8212; currently 17% of total asset value &amp;#8212; weighed heavily. TSR was flat, as the NAV discount narrowed from 22% to 20%. Ownership activity was high: Infrea announced a merger with Netel, Team Olivia is divesting its Danish operations to Carelink, and Byggm&amp;#228;staren added to its holding in Green Landscaping. The balance sheet remains solid, with around SEK 420m in available liquidity including unutilised credit facilities (ABGSCe net cash SEK 232m). Management reiterated its ambition to add another core holding, while maintaining strict investment criteria, and remains focused on reversing the negative trend in Green Landscaping.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Private portfolio momentum remained strong&lt;/h3&gt;&lt;p&gt;Despite the drag from Green Landscaping, the private portfolio continued to perform well. Private-asset valuations increased by SEK 119m, driven mainly by DP Patterning (DPP) and smaller changes elsewhere. Operationally, DPP delivered substantial sales growth, supported by its largest customers and broader customer demand, while the Q2 EBITDA margin reached 44%. Safe Life also maintained high activity, announcing four acquisitions in Q2, while Q2 YTD sales grew 33% y-o-y, and the trailing pro forma EBITA margin was 9.4%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Discount remains wide&lt;/h3&gt;&lt;p&gt;The shares are trading at a 16% NAV discount, vs an historical average of around 10%, despite the strong private-portfolio performance and Byggm&amp;#228;staren&amp;#8217;s impressive track record. In our view, the weakness in Green Landscaping explains some caution, but not the full discount. We fine-tune our fair value range to SEK 54&amp;#8211;64 (53&amp;#8211;64), reflecting NAV changes since our last update.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/byggmastaren/Equity-research/2026/7/byggmastaren---private-assets-strong-but-green-still-weighs/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 30 Jul 2026 12:30:03 GMT</pubDate>
      <isin>SE0006510491</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Catella - Recovery gradually taking shape</title>
      <description>&lt;a id="bm-comp-22a40c8d-f616-492b-92c2-68e0d04d58ed" name="bm-comp-22a40c8d-f616-492b-92c2-68e0d04d58ed" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="22a40c8d-f616-492b-92c2-68e0d04d58ed" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Transaction activity picking up, while FX supports AUM&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Limited estimate revisions ahead of Q2&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;2027e-28e EV/EBIT of 3-4x with a strong balance sheet&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-02453d86-abc6-4d01-a05c-656c1e98a0b9" name="bm-comp-02453d86-abc6-4d01-a05c-656c1e98a0b9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="02453d86-abc6-4d01-a05c-656c1e98a0b9" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Corporate Finance improves while FX offsets weaker AUM&lt;/h3&gt;&lt;p&gt;Despite a relatively quiet quarter overall, we expect improving transaction activity for Corporate Finance; we forecast total net sales of SEK 373m (vs. SEK 296m in Q1) and a return to positive EBIT of SEK 26m. For Investment Management, we expect AUM to remain broadly stable at SEK 160.4bn, as modest net outflows and the delayed effect of underlying property valuations are largely offset by favourable FX movements from the stronger EUR/SEK. Overall, we expect a stable quarter with improving transaction activity and group EBITDA of SEK 46m, fully offsetting the loss reported in Q1.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;2026e broadly unchanged&lt;/h3&gt;&lt;p&gt;After only minor estimate revisions ahead of Q2, our 2026 earnings scenario remains broadly intact, with net sales down by -1.3%, while EBIT and EPS are up by 2.4% and 6.5%, respectively. We still expect the recovery will accelerate in H2 as (i) transaction activity gradually improves, (ii) underlying property valuations begin to catch up with market conditions, and (iii) variable fee generation recovers. With CEO Rikke Lykke's management team now largely in place, we also expect an increased focus on strategic execution during the second half of the year.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;A recovery in earnings and strong balance sheet&lt;/h3&gt;&lt;p&gt;Despite only modest estimate revisions, we continue to believe Catella offers an attractive combination of recovering earnings and a strong balance sheet. Applying our latest forecasts, the company is trading at 2027-28e EV/EBIT multiples of ~3-4x, while continued bond and share buybacks support capital efficiency. As transaction markets gradually recover and underlying property valuations catch up, we believe the company's earnings profile will improve beyond 2026.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/catella/Equity-research/2026/7/catella---recovery-gradually-taking-shape/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 30 Jul 2026 11:45:03 GMT</pubDate>
      <isin>SE0000188518</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Cavotec - Low-margin legacy orders weigh on Q2</title>
      <description>&lt;a id="bm-comp-65e07f13-859b-4d7f-89fa-f95d72a1fcce" name="bm-comp-65e07f13-859b-4d7f-89fa-f95d72a1fcce" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="65e07f13-859b-4d7f-89fa-f95d72a1fcce" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2: Sales of &lt;font style="background-color:#ffffff;"&gt;EUR 45m&lt;/font&gt; (36m), adj. EBIT of -EUR 1.1m (-0.7m)&lt;/li&gt;&lt;li&gt;P&amp;amp;M drives book-to-bill of 1.2x (R12m)&lt;/li&gt;&lt;li&gt;Upbeat outlook commentary&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9c0143f4-f1a8-471b-a0e2-613e22a34b3e" name="bm-comp-9c0143f4-f1a8-471b-a0e2-613e22a34b3e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9c0143f4-f1a8-471b-a0e2-613e22a34b3e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Growth delivers, mix weighs&lt;/h3&gt;&lt;p&gt;Cavotec reported sales above expectations at EUR 45m, +25% y-o-y (20% vs ABGSCe). P&amp;amp;M: 34% y-o-y, Industry: 12% y-o-y. Similar to in Q1, there was a strong order intake of EUR 49m (11% y-o-y), which was broadly as we expected following the pre-announcement, but it had not been incorporated into our estimates (ABGSCe 36m), as it was announced after our preview was published. With the R12m book-to-bill standing at ~1.2x, we see a healthy demand outlook for P&amp;amp;M. Adj. EBIT was softer than expected at EUR -1.1m vs ABGSCe of EUR 3.5m, with management attributing the adverse mix effects to deliveries of low-margin P&amp;amp;M orders dating back to 2024. &lt;font style="background-color:#ffffff;"&gt;NRIs o&lt;/font&gt;f EUR -1.1m (ABGSCe -2.0m) were incurred in the quarter, relating to restructuring costs under the ongoing cost-savings programme.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;'26e adj. EBIT lowered on earnings miss&lt;/h3&gt;&lt;p&gt;We raise sales by 5%/4%/4% for '26e/'27e/'28e due to the revenue beat in the quarter. The strong order momentum for its shore power solutions de-risks our sales growth in '27-'28e. However, '26e adj. EBIT is lowered ~EUR 4.6m on the miss in the quarter, while we lower by another EUR 3.8m for the remaining two quarters of the year. We expect a sequential return to earnings growth in Q3, as the delivery of motorised cables and hose reels will be delivered to a ship unloader. Importantly, the outlook commentary marks a step-change, with management noting that customers are placing orders again after a long period of hesitancy.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;15-10x '27e-'28e EV/EBIT&lt;/h3&gt;&lt;p&gt;While profitability continued to trail revenue growth in the quarter, we see potential in an increasing backlog with a higher margin profile. However, we believe that some patience is required, as we expect earnings growth to return in '27e. The share is currently trading at 15-10x EV/EBIT on '27e-'28e, vs the peer median of 14-13x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/cavotec/Equity-research/2026/7/cavotec---low-margin-legacy-orders-weigh-on-q2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 24 Jul 2026 12:45:05 GMT</pubDate>
      <isin>CH0136071542</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Cavotec - P&amp;M order momentum sustained</title>
      <description>&lt;p&gt;&lt;a id="bm-comp-22e3ee12-b14f-4994-8e4e-275d40f1c98a" class="BMCustomAnchor" name="bm-comp-22e3ee12-b14f-4994-8e4e-275d40f1c98a"&gt;&lt;/a&gt;&lt;/p&gt;
&lt;table&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; width: 100.000000%;"&gt;
&lt;ul&gt;
&lt;li&gt;Another strong quarter for P&amp;amp;M orders&lt;/li&gt;
&lt;li&gt;Sales EUR 44.7m, adj. EBIT -1.1m&lt;/li&gt;
&lt;li&gt;Improved market outlook&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;a id="bm-comp-4dd7d716-d05e-4da4-bcd6-22baf919e527" class="BMCustomAnchor" name="bm-comp-4dd7d716-d05e-4da4-bcd6-22baf919e527"&gt;&lt;/a&gt;&lt;/p&gt;
&lt;table&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; width: 100.000000%;"&gt;
&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;
&lt;p&gt;&lt;span style="color: #ff0000;"&gt;(Republished with correct adjusted Q2'26 EBIT)&lt;/span&gt;. Cavotec reported a sequentially better Q2 results with a strong order intake and sales while missing on earnings. Order intake came in at EUR 49.4m (36% vs. ABGSCe 36.3m, 11% y-o-y), for a R12m book to bill of 1.2. Strong order beat as expected, driven by two large shore power orders (~EUR 15m in total) announced after the publication of our preview, where EUR 7m is expected to be delivered in 2026. Sales came in at EUR 44.7m (20% vs. ABGSCe 37.2m), 25.3% y-o-y (organic at 24.6%). Adj. EBIT was EUR -1.1m (vs. ABGSCe EUR 3.5m), for a margin of -2.5% (ABGSCe 9.3%). Sales beat driven by Ports &amp;amp; Maritime, while adj. EBIT miss vs ABGSCe driven by mix effects of delayed deliveries of low-margin shore power projects in the same division.&lt;/p&gt;
&lt;h3 class="bm-h3"&gt;Estimates and outlook&lt;/h3&gt;
&lt;p&gt;Q2 is sequentially better on top-line, and while the strong order momentum from Q1 is sustained, profitability continues to trail. Improved outlook comments from management, stating that "underlying markets are healthy".&lt;/p&gt;
&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;
&lt;p&gt;The share has been strong into the numbers, +12% L10D (vs. OMXSALLS 1%), and is currently trading at 24x-10x '26e-'27e EV/EBIT adj. on our pre-report estimates vs. the peer median of 16x-14x. The company is hosting a &lt;a href="https://cavotec.events.inderes.com/q2-report-2026" target="_blank" rel="noopener" data-bm-trackable="false"&gt;conference call&lt;/a&gt; at 10:00 CET.&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;a id="bm-comp-9d23b39d-2b78-4061-93e7-1b57a0844c1a" class="BMCustomAnchor" name="bm-comp-9d23b39d-2b78-4061-93e7-1b57a0844c1a"&gt;&lt;/a&gt;&lt;/p&gt;
&lt;table&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; width: 100.000000%;"&gt;
&lt;table id="bm-img-1232850d-7b91-4ce9-acd3-21af7b5ed98d" class="bm-img-table xslt-img-empty xslt-img-include"&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier estimates, company data&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/cavotec/Equity-research/2026/7/cavotec---pm-order-momentum-sustained/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 24 Jul 2026 05:45:06 GMT</pubDate>
      <isin>CH0136071542</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Inission - Strong trend to continue</title>
      <description>&lt;a id="bm-comp-14ab4170-5c27-4629-8331-9dfea9cad150" name="bm-comp-14ab4170-5c27-4629-8331-9dfea9cad150" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="14ab4170-5c27-4629-8331-9dfea9cad150" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2e: 22% sales growth and adj. EBITA margin of 6.0% (4.8%)&lt;/li&gt;&lt;li&gt;We raise '26e-'28e adj. EBITA by ~1% on updated FX rates&lt;/li&gt;&lt;li&gt;Trading at 14x/10x '26e/'28e P/E vs Nordic EMS peers at 16x/12x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-42df3b33-ea6d-42b7-8393-b98e40146a7b" name="bm-comp-42df3b33-ea6d-42b7-8393-b98e40146a7b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="42df3b33-ea6d-42b7-8393-b98e40146a7b" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 expectations&lt;/h3&gt;&lt;p&gt;We expect Q2'26 sales of SEK 654m, up 22% y-o-y, driven by 13% organic growth, 8% from M&amp;amp;A, and a small FX tailwind, leaving sales roughly flat sequentially vs Q1's underlying level. We forecast an adj. EBITA margin of 6.0% (4.8%), a bit below Q1's very strong 7.0%, as we are slightly cautious of extrapolating that rate fully, as margins have historically swung quite a bit between Q1 and Q2. On a segment level, we expect Inission (EMS) sales of SEK 610m at a 6.0% adj. EBITA margin (6.6%) and Inission Power (OEM) sales of SEK 117m at a 2.0% margin (-6.2%), with Power's recovery continuing against weak comparables.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We raise '26e-'28e adj. EBITA by around 1%, purely as a result of updated FX rates.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;Management guides for '26 sales of SEK 2,300-2,500m at a &amp;gt;6% adj. EBITA margin; we forecast SEK 2,650m at 6.6%, above the top end of the range, which we believe leaves room for a guidance upgrade in connection with either this report or the next, supported by the R12m order intake of SEK 2,500m and a positive growth trend. The share is currently trading at 14x/10x '26e/'28e P/E, versus Nordic EMS peers at 16x-12x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/inission/Equity-research/2026/7/inission---strong-trend-to-continue/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 22 Jul 2026 18:30:08 GMT</pubDate>
      <isin>SE0016275069</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>SinterCast - Q2 still tough, but we see tailwinds from Q3</title>
      <description>&lt;a id="bm-comp-2eb0df8d-83f6-4763-8c34-9bf5ccbee254" name="bm-comp-2eb0df8d-83f6-4763-8c34-9bf5ccbee254" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2eb0df8d-83f6-4763-8c34-9bf5ccbee254" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 volumes pre-announced, we forecast sales -13%, EBIT -28%&lt;/li&gt;&lt;li&gt;Comps ease from Q3, both FX and volumes should turn into tailwinds&lt;/li&gt;&lt;li&gt;We cut '26e EBIT by 4%, but raise '27e-'28e by 2-6%&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d3322e71-cc80-4a06-8cf9-d32af8b4d6ca" name="bm-comp-d3322e71-cc80-4a06-8cf9-d32af8b4d6ca" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d3322e71-cc80-4a06-8cf9-d32af8b4d6ca" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 expectations&lt;/h3&gt;&lt;p&gt;SinterCast's H1 production update effectively pre-announced the Q2 volume data: annualised series production of 3.2m (3.4m) engine equivalents, sampling cup shipments of 50,800 (58,050) and installation revenue of SEK 0.8m (2.1m). We estimate this will result in Q2 sales of SEK 27.2m (31.1m), down 13% y-o-y, where the weaker USD still remains a headwind. We forecast an EBIT margin of 30.1% (36.3%), with the earnings decline driven by lower volumes and FX; as usual, hedge revaluations are a swing factor.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We cut '26e EBIT by 4%, aligning our estimates with the disclosed H1 data. However, we raise '27e-'28e EBIT by 2-6%, as updated FX rates more than offset a somewhat slower assumed ramp of the upcoming programme launches. We expect both FX and organic volumes to turn from headwind to tailwind in Q3.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;The H1 update showed series production regaining 15% vs. H2'25, driven primarily by Europe (+27%), confirming H2'25 as the trough. Furthermore, the July announcement that longstanding licensee Ironcast will supply CGI cylinder blocks for a new 13-litre North American CV platform (SOP late '26) lends additional support to the launch pipeline underpinning our '27e-'28e growth estimates; the company forecasts the combined programme could add around 13% to current series production at mature volumes. The share is currently trading at 24x/14x '26e/'28e P/E, vs. its historical median of 22x/15x. The Q2 report is due at 08:00 CET on 19 August.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/sintercast/Equity-research/2026/7/sintercast---q2-still-tough-but-we-see-tailwinds-from-q3/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 22 Jul 2026 18:15:08 GMT</pubDate>
      <isin>SE0000950982</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Medicover - No symptoms of surprise in Q2</title>
      <description>&lt;a id="bm-comp-c20425ca-d089-4a44-b73e-34814796ae33" name="bm-comp-c20425ca-d089-4a44-b73e-34814796ae33" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c20425ca-d089-4a44-b73e-34814796ae33" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 broadly in line across most line items&lt;/li&gt;&lt;li&gt;'26e-'28e adj. EBITDA -0.7%/-0.4%/-0.4% on weaker Romania&lt;/li&gt;&lt;li&gt;FVR unchanged at SEK 190-270 on minor estimate revisions&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ad12af02-0f71-469d-9c49-c8b3b1dbb994" name="bm-comp-ad12af02-0f71-469d-9c49-c8b3b1dbb994" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ad12af02-0f71-469d-9c49-c8b3b1dbb994" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Broadly in line, Romania weighs&lt;/h3&gt;&lt;p&gt;Revenue grew 7.3% y-o-y to EUR 640m, with org. growth accelerating to 11.8% from Q1's 10.3%, though still below last year's 13.9%. The group adj. EBITDA margin rose 20bps y-o-y to 17.1%. Healthcare Services' (HS) EBITDA margin was 18.4% (18.6%), coming off a strong Q2'25 when HS EBITDA was up 41%. Romania and Polish hospitals were the main drag, while India delivered a strong quarter (+23%, ~40% LCCY). Continued improvement in Polish sports/wellness also contributed positively. Diagnostic Services expanded its margin to 18.8% (+110bps). Growth was broad-based, with FFS and special immunology in Germany, blood-drawing point expansion in Poland, and Synlab integration in Romania, plus a richer test mix and SEE synergies. Romania's political instability and elevated inflation look like being a lasting headwind for HS rather than just a tough quarter, though management remains confident, pointing to six straight quarters of margin gains. Cash generation has stayed strong throughout, with OCF up 28% y-o-y and leverage steady at 2.9x.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Only minor estimate changes&lt;/h3&gt;&lt;p&gt;As the quarter was broadly in line, we make only small adjustments to our estimates. We lower group adj. EBITDA by 0.7%/0.4%/0.4% for '26e-'28e, concentrated in Healthcare Services. We now assume Romania's pressures will persist a little longer, and trim our 2027e organic growth estimate for HS accordingly.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;FVR unchanged at SEK 190-270&lt;/h3&gt;&lt;p&gt;We leave our FVR at SEK 190-270 given the limited scale of our revisions. The share is currently trading at 10.4x/8.8x EV/EBITDA for '26e/'27e, compared with a peer group of developed-market healthcare providers at a median of 7.7x/7.2x EV/EBITDA for '26e/'27e, and a developing-market peer group at 32.2x/26.4x. We estimate a 5.8-7.2% FCF yield for '26e/'27e and a dividend yield of 1.2-1.4%.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/medicover/Equity-research/2026/7/medicover---no-symptoms-of-surprise-in-q2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 22 Jul 2026 16:00:08 GMT</pubDate>
      <isin>SE0009778848</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ework Group - Cautious optimism</title>
      <description>&lt;a id="bm-comp-f1fe3ab7-b8bb-4455-8c41-ac7c78ab4c65" name="bm-comp-f1fe3ab7-b8bb-4455-8c41-ac7c78ab4c65" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f1fe3ab7-b8bb-4455-8c41-ac7c78ab4c65" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Order intake +5% y-o-y &amp;#8211; an early sign of stabilisation?&lt;/li&gt;&lt;li&gt;We keep '26e adj. EBIT broadly unchanged, raise '27e-'28e by 1-2%&lt;/li&gt;&lt;li&gt;9x '27e EV/EBIT adj., in line with peers&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-e71c5549-1258-4256-84e1-16fbe63b76ad" name="bm-comp-e71c5549-1258-4256-84e1-16fbe63b76ad" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e71c5549-1258-4256-84e1-16fbe63b76ad" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Early signs of recovery&lt;/h3&gt;&lt;p&gt;It is still too early to say whether the market is bottoming out, but positive Q2 order intake (+5% y-o-y) could mark an early, tentative sign before we start seeing a broader turnaround in the Nordic consultancy market, particularly as this was the first y-o-y order intake increase since Q3'24. Adj. EBIT came in at SEK 28m, SEK 1m below our forecast, but the report was in line with our expectations overall. Sales continued to decline (-13% y-o-y), with Norway representing the growth pillar (+28% y-o-y) while all other regions declined. The gross margin has also held steady at 4.1% for six consecutive quarters, supported by add-on services and long framework agreements despite continued volume pressure. Peers have also reported negative organic growth, with Knowit, B3, and Prevas averaging around -5% y-o-y. The company has now completed its restructuring, with all costs taken in Q1, and we expect most of the SEK 18m in annual savings to land in EBIT from '27e onwards. Ework is also leaning into the AI shift, launching new AI services to capture rising demand for AI skills.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Small changes to '26 estimates&lt;/h3&gt;&lt;p&gt;On the back of the report, we slightly increase '26 sales estimates but lower adj. EBIT by 1%, as we expect most cost efficiencies to be realised next year rather than in H2'26, alongside a modest sales recovery in the second half. We therefore raise sales and adj. EBIT by 1-2% for '27e-'28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;9x '27e EV/EBIT adj.&lt;/h3&gt;&lt;p&gt;The share is currently trading at 9x '27e EV/EBIT adj., in line with peers. While visibility into the timing and trajectory of the recovery remains limited, the combination of stabilising order intake, resilient gross margins and a fully implemented cost programme provides a stable foundation heading into H2'26. We continue to expect earnings to pick up once demand returns.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ework/Equity-research/2026/7/ework-group---cautious-optimism/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 22 Jul 2026 10:00:08 GMT</pubDate>
      <isin>SE0002402701</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Donkey Republic - Helsinki deal offers further de-risking</title>
      <description>&lt;a id="bm-comp-d2902c43-091d-48a1-aeae-71ccd71c24c3" name="bm-comp-d2902c43-091d-48a1-aeae-71ccd71c24c3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d2902c43-091d-48a1-aeae-71ccd71c24c3" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Launches bike-sharing service with ~700 bikes in Helsinki&lt;/li&gt;&lt;li&gt;Unlikely to trigger material consensus estimate revisions...&lt;/li&gt;&lt;li&gt;...but nevertheless a positive due to de-risking of execution&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f3f01311-867e-4a39-a4ef-b46452dfa6c2" name="bm-comp-f3f01311-867e-4a39-a4ef-b46452dfa6c2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f3f01311-867e-4a39-a4ef-b46452dfa6c2" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Launches bike-sharing service with ~700 bikes in Helsinki&lt;/h3&gt;&lt;p&gt;DONKEY has today announced that it will launch a bike-sharing service in the Finnish capital of Helsinki, deploying ~700 pedal bikes across the city. The first bikes are expected on the streets from late July 2026, and operations will be carried out in partnership with Finnish mobility company Kaakau.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Limited cons revisions, but some de-risking of execution&lt;/h3&gt;&lt;p&gt;700 bikes corresponds to 2-3% of our expected fleet size by YE'26 (29,000 bikes), and several additional contracts will be required to meet estimates for the coming years. That said, although we do not anticipate material consensus estimate revisions on the back of this announcement, we still view the Helsinki deal as a positive on de-risking and validation of Donkey's offering and execution by adding another Nordic capital to the fleet network.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/donkey-republic/Equity-research/2026/7/donkey-republic---helsinki-deal-offers-further-de-risking/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 22 Jul 2026 08:30:08 GMT</pubDate>
      <isin>DK0061540770</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Medicover - In line report, reiterated targets</title>
      <description>&lt;a id="bm-comp-c3ffae86-d31f-4887-8843-11cacb88a9b9" name="bm-comp-c3ffae86-d31f-4887-8843-11cacb88a9b9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c3ffae86-d31f-4887-8843-11cacb88a9b9" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;-1%/0% adj. EBITDA vs ABGSCe/Infront cons in Q2&lt;/li&gt;&lt;li&gt;Cons estimates likely unchanged&lt;/li&gt;&lt;li&gt;Trading at 10.2x '26e EV/EBITDA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-725ab908-af1b-49b3-9664-d03d84edc004" name="bm-comp-725ab908-af1b-49b3-9664-d03d84edc004" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="725ab908-af1b-49b3-9664-d03d84edc004" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results: In line with expectations&lt;/h3&gt;&lt;p&gt;Medicover reported a second quarter in line with cons. Q2 sales were EUR 640m (0% vs ABGSCe, 0% vs cons). Total organic sales growth in the quarter was +12% (ABGSCe +10%). Adj. EBITDA was 109m (-1% vs. ABGSCe, 0% vs. cons), for a margin of 17.1% (ABGSCe 17.3%, cons 17.1%), up 20bps y-o-y. Total NRI in Q2 was EUR -2m (ABGSCe EUR -4m, cons EUR -4m). Healthcare Services had a slightly softer quarter, with organic growth decelerating to 12.2% from 15.6% a year earlier and the EBITDA margin slipping to 18.4% from 18.6%, as continued strength in India, which grew 23.1% (~40% LCCY), and Polish sports/wellness was offset by weaker hospitals in Poland and clinics in Romania. Diagnostic Services performed better, with organic growth of 10.9% and the EBITDA margin improving to 18.8% from 17.7%, supported by double digit FFS growth across key markets and a favourable shift toward more advanced testing. Overall, a solid report with strong organic growth, though margin expansion was smaller than in Q1 as HS offset gains in DS.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Outlook: Softer in Romania&lt;/h3&gt;&lt;p style="text-align:left;"&gt;Management reiterated the 2026-2028 targets (revenue &amp;gt;EUR 3.25bn, adj. organic EBITDA &amp;gt;EUR 600m, leverage &amp;#8804;3.0x) and says it is "in line with plan" six months in. Leverage was 2.9x, flat vs Q1 and down from 3.1x at FY25, inside targets. India remains the growth engine (~40% in LCCY), with the two newest hospitals ramping and new specialised centres plus a 100-bed women's/children's hospital added. A negative is Romania. Medicover highlights post-coalition-collapse political instability, 10.7% inflation and a weaker labour market that are pressuring membership and FFS. Otherwise the outlook commentary is strategic; there is no new numerical H2 guidance.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Conclusion: trading at 10.2x EV/EBITDA '26e&lt;/h3&gt;&lt;p&gt;Based on the Q2 deviation, we find little reason for cons. to move estimates at all. &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/medicover/Equity-research/2026/7/medicover---in-line-report-reiterated-targets/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 22 Jul 2026 06:45:07 GMT</pubDate>
      <isin>SE0009778848</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Embellence Group - Broad progress in the DTC strategy</title>
      <description>&lt;a id="bm-comp-3af2bcc0-1917-4384-977e-350046c92eee" name="bm-comp-3af2bcc0-1917-4384-977e-350046c92eee" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3af2bcc0-1917-4384-977e-350046c92eee" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Net sales -6% y-o-y, EBITA -13% y-o-y&lt;/li&gt;&lt;li&gt;Strategic staffing-up now in comps, DTC progressing well&lt;/li&gt;&lt;li&gt;We trim our fair value range to SEK 35-42 (36-43)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-bac16656-97c3-4929-8272-fb66dc5107e5" name="bm-comp-bac16656-97c3-4929-8272-fb66dc5107e5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bac16656-97c3-4929-8272-fb66dc5107e5" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;A perfect storm hit in Q2, but subsiding in H2&lt;/h3&gt;&lt;p&gt;Embellence's Q2 contained several, but separate, issues operationally. Cole &amp;amp; Son was still weighed down by the same changes to its sales operations as were discussed in Q1, for net sales growth of -12% in this segment. The group CEO said he expected the previous changes to Cole &amp;amp; Son's setup to have a positive impact in H2. Wall &amp;amp; Dec&amp;#242; underperformed through net sales growth of -14%, as far as we understand it due to issues with the sales operations. The group is now reallocating sales and marketing efforts to turn this trend. Lastly, Artscaped faced a very tough comparable quarter, and grew -20%. Driven by these factors, group net sales declined 6% y-o-y despite strong performances by Pappelina and Bor&amp;#229;s Tapetfabrik. Gross margins improved 80bp y-o-y driven by DTC making up a larger share of the mix, which partly offset the negative scale on opex for a Q2 EBITA margin of 12.6%, -1pp y-o-y. The EBITA comps become easier from Q3'26, as recruiting to drive DTC will mostly be in the comps.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;All brands grew DTC sales by double-digits&lt;/h3&gt;&lt;p&gt;During the report presentation, the group CEO said all group brands grew their DTC sales by (at least) "double-digits". Pappelina, which we argue has the best product-channel fit, grew DTC sales by 130% y-o-y. Bor&amp;#229;stapeter, the largest brand, updated its website in April, and in the next few quarters this is a key area to focus on for us.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We trim our fair value range to SEK 35-42&lt;/h3&gt;&lt;p&gt;As we cut '26e/'27e EBITA by 2%/2%, we trim our fair value range to SEK 35-42 (36-43). The share is currently trading at 7x/6x/5x EV/EBITA '26e/'27e/'28e, compared to a historical trading range of 7x-8x NTM and a Swedish peer group of home improvement companies at a median 12x/10x on '26e/'27e. We estimate an 11-13% FCF yield for '26e/'27e, and a dividend yi&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/embellence-group/Equity-research/2026/7/embellence-group---broad-progress-in-the-dtc-strategy/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 21 Jul 2026 16:00:08 GMT</pubDate>
      <isin>SE0013888831</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Eltel - Earnings improve, but less than we hoped</title>
      <description>&lt;a id="bm-comp-f77d3137-c694-4629-9690-2a3f481af4c7" name="bm-comp-f77d3137-c694-4629-9690-2a3f481af4c7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f77d3137-c694-4629-9690-2a3f481af4c7" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Earnings improved materially y-o-y, but less than we estimated&lt;/li&gt;&lt;li&gt;We cut EBITA estimates by EUR 3m for '26e, EUR 1m for '27e-'28e&lt;/li&gt;&lt;li&gt;Share trading at 12-9x '26e-'27e EV/EBITA (adj.)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-613dd5ea-5bfa-45c2-b19b-b4173b2693b0" name="bm-comp-613dd5ea-5bfa-45c2-b19b-b4173b2693b0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="613dd5ea-5bfa-45c2-b19b-b4173b2693b0" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Earnings improvement, but not as much as we hoped&lt;/h3&gt;&lt;p&gt;Eltel reported Q2 net sales of EUR 200m, down 1% y-o-y, with organic growth of -2%. On a sequential basis, emerging services took a step back to 14% of sales compared to a very strong Q1 at 23%, which was driven by strong deliveries to larger solar projects. However, the strong backlog of emerging service contracts suggests that from a mid- to long-term perspective the strong growth should continue. Adj. EBITA amounted to EUR 5.5m, a clear improvement compared to EUR 2.5m in Q2'25, but below our estimate of EUR 8.4m, and it resulted in a margin of 2.8%. Finland and Denmark in particular saw weaker sales than expected, which also trickled down to profitability, and in Denmark Eltel decided to take some restructuring measures as a result. On a positive note, Norway delivered a sharp uplift in margins, showcasing both the internal efficiency measures taken by Eltel in the region, and improved end-market demand.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Adj. EBITA cuts of EUR 3m for '26e and EUR 1m for '27e-'28e&lt;/h3&gt;&lt;p&gt;We lower our EBITA estimates by EUR 3m for '26e, followed by EUR 1m per year for '27e-'28e. Our cuts stem mainly from the Denmark &amp;amp; Germany segment, and are partly offset by estimate upgrades in Norway, which we now take a more positive view on following the larger-than-expected margin uplift in Q2.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Share trading at 12-9x '26e-'27e EV/EBITA (adj.)&lt;/h3&gt;&lt;p&gt;The share is now trading at 12x '26e EV/EBITA (adj.), and we model an adj. EBITA CAGR of 22% for '26e-'28e, mainly driven by continued margin improvements. At the end of the quarter, r12m net debt/EBITDA (lease adj.) stood at 2.2x, and we model this going to 1.7x by year-end. As such, we think this may put Eltel in a position where it can start paying out dividends, something that the balance sheet has not supported in recent years.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/eltel/Equity-research/2026/7/eltel---earnings-improve-but-less-than-we-hoped/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 21 Jul 2026 15:00:08 GMT</pubDate>
      <isin>SE0006509949</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>CTT Systems - Getting closer to lift-off</title>
      <description>&lt;a id="bm-comp-00100ddd-66f0-469e-95f6-016755627bff" name="bm-comp-00100ddd-66f0-469e-95f6-016755627bff" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="00100ddd-66f0-469e-95f6-016755627bff" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;OEM ramping up, encouraging aftermarket&lt;/li&gt;&lt;li&gt;'26e-'27e EBIT down 3%; ~55% EBIT CAGR '25-'28e&lt;/li&gt;&lt;li&gt;21-11x EBIT '26e-'27e, ~25-40% ROCE, net cash&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-896615ba-528b-443a-996b-c238461b7488" name="bm-comp-896615ba-528b-443a-996b-c238461b7488" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="896615ba-528b-443a-996b-c238461b7488" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Good OEM+AM activity partly offset by VIP&lt;/h3&gt;&lt;p&gt;CTT's Q2 sales declined y-o-y, but by less than we feared (-4% organically vs. ABGSCe -10%). OEM revenues grew organically for the ninth quarter in a row and by ~120% y-o-y in Q2, further supporting the combination of increased production rates (next step-up expected in Q1'27) and higher CTT content per aircraft. Although we expect OEM sales to remain flat in H2'26 vs. H1'26, growth will continue y-o-y. In addition, distributor inventories have normalised, the installed base continues to grow and flight traffic has been resilient, so we expect CTT's aftermarket sales to reverse the negative trend seen since mid-2024 and return to organic growth in Q3. Private jet sales remained low, which will affect 2026 sales but grow again in 2027. Overall, we are optimistic towards CTT's ability to enter a longer period of growth in both sales and earnings. For Q3, we forecast 1% organic growth but ~40% EBIT growth, while Q4 organic sales growth of 24% should support an almost threefold increase in EBIT y-o-y.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Return to earnings growth in Q3'26e&lt;/h3&gt;&lt;p&gt;We lower '26e-'27e EBIT by 3% due to lower Private Jet sales. We believe the visibility from increased aircraft production, higher content per aircraft, resilient air travel, and a growing installed base should support solid earnings. This should in turn drive a ~35% organic sales CAGR and a ~55% EBIT CAGR in '25-'28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Multi-year double-digit growth potential&lt;/h3&gt;&lt;p&gt;Despite seeing tougher headwinds than we had previously anticipated, CTT's core strengths remain: the company benefits from a near-monopolistic position, strong demand, and its margin-accretive AM business. This should drive long-term double-digit earnings growth and ~25-30% margins, while the share is trading at 21-11x EBIT '26e-'27e (23x L10Y), offering 3-6% div. yields and ~25-40% ROCE.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ctt-systems/Equity-research/2026/7/ctt-systems---getting-closer-to-lift-off/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 21 Jul 2026 13:15:08 GMT</pubDate>
      <isin>SE0000418923</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>CTT Systems - Better Q2 and OK FY'26 guidance on OEM+AM</title>
      <description>&lt;a id="bm-comp-008e7f4b-6c23-45df-9ab7-a16358f586c7" name="bm-comp-008e7f4b-6c23-45df-9ab7-a16358f586c7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="008e7f4b-6c23-45df-9ab7-a16358f586c7" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Better organic growth (-4% vs. ABG -10%)&lt;/li&gt;&lt;li&gt;Next phase of OEM ramp-up Q1'27, AM back to y-o-y growth&lt;/li&gt;&lt;li&gt;Share -6% into numbers, trades at 21-11x EBIT '26e-'27e (pre-Q2)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-bc9d97fa-ab76-4845-b428-50aa46b4b0c6" name="bm-comp-bc9d97fa-ab76-4845-b428-50aa46b4b0c6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bc9d97fa-ab76-4845-b428-50aa46b4b0c6" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 details&lt;/h3&gt;&lt;p&gt;Sales were 11% above our expectations, with sales of SEK 76m down 4% y-o-y organically (ABGSCe -10%). This was driven by a 15% reported decline in aftermarket sales (ABG -30% y-o-y), while system sales grew 20% y-o-y (ABG +26%). AM share of sales was 64% (ABG 58%). According to the CEO, growth in system sales was driven by ramp-up in aircraft production rates and increased content value per aircraft. Sales to the private jet segment was low, and below expectations. EBIT declined ~20% y-o-y to SEK 14m (ABG 13m), as the margin came in at 19% (ABG 19%, 25% Q2'25). Free cash flow of 18m was strong (+2m last year).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and estimate changes&lt;/h3&gt;&lt;p&gt;For Q3, the CEO expects net sales (in USD terms) "modestly below Q2'26", where we have (in SEK terms) Q3 sales of SEK 78m vs. the Q2 outcome of 76m. For FY'26, the outlook (in USD terms) is for similar H2'26 OEM sales as in H1'26 as the next ramp-up in production volumes is scheduled for Q1'27, where we have (in SEK terms) H2'26 sales of SEK 43m vs. H1'26 outcome of 38m. The guidance for AM sales is for 5-15% organic growth FY'26 (we currently forecast +14%). For Retrofit, FY'26 revenue is expected to be flat vs. FY'25 (we have SEK 5m vs. ~3m FY'25). Finally, Private jet projects have been postponed, so management now expects "the weakest year in several years", before expecting a "very strong recovery next year". We currently have SEK 25m in FY'26 sales vs. the L5Y average of ~19m. All in all, we believe that the Q3 deviation on EBIT and our impression of the H2'26+FY'26 guidance vs. ABGSCe would mechanically lower our FY'26e EBIT by 5-10%. However, using current FX rates vs. our latest published note, we note that the USD/SEK would raise sales by 2%, with a greater impact on EBIT (which could have a 2-3x impact on EBIT vs. sales).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;A better-than-expecte&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/ctt-systems/Equity-research/2026/7/ctt-systems---better-q2-and-ok-fy26-guidance-on-oemam/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 21 Jul 2026 06:45:46 GMT</pubDate>
      <isin>SE0000418923</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ework Group - Order intake turns the corner</title>
      <description>&lt;a id="bm-comp-89a9a7d8-a137-4a15-95bd-f6aa76fcc890" name="bm-comp-89a9a7d8-a137-4a15-95bd-f6aa76fcc890" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="89a9a7d8-a137-4a15-95bd-f6aa76fcc890" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales +1% vs. ABGSCe (-13% y-o-y), adj. EBIT -2% vs. ABGSCe&lt;/li&gt;&lt;li&gt;Order intake +5.4% y-o-y, the first increase in several quarters&lt;/li&gt;&lt;li&gt;We expect cons to leave '26e-'28e adj. EBIT broadly unchanged&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a2a70ead-e241-4351-87b4-6b207b607ef0" name="bm-comp-a2a70ead-e241-4351-87b4-6b207b607ef0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a2a70ead-e241-4351-87b4-6b207b607ef0" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Q2 sales were SEK 3,131m (+1% vs. ABGSCe 3,103m), -13% y-o-y. Gross profit was SEK 127m (in line vs. ABGSCe 128m), -14% y-o-y, while EBIT was SEK 28m (-2% vs. ABGSCe 29m). The gross margin came in at 4.06% (-0.06pp vs. ABGSCe), essentially flat y-o-y at ~4.1%. Order intake increased 5.4% y-o-y to SEK 4,367m, a clear improvement from Q1'26's -12%, though management is careful to call this an early signal rather than a broad recovery.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Q2 thoughts&lt;/h3&gt;&lt;p&gt;The Nordic consultancy market remains cautious, but we see the first tentative signs of stabilisation. Norway was again the standout, sales +28% y-o-y (+3% vs. ABGSCe) on strength in telecom, public sector and energy, with segment result up 46%. Denmark continues to be weak, sales -24% y-o-y on continued banking weakness, but came in slightly above what we expected. Poland &amp;amp; Slovakia declined 31% following the previously flagged client phase-out, though Slovakia itself is showing improving underlying demand. Sweden (-14%) and Finland (-16%) also declined.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;Following the Q2 report, we expect consensus to leave '26e-'28e adj. EBIT estimates broadly unchanged. The new organisation is also now fully operational, and we see this as positive and expect to see a meaningful impact in the coming quarters. T&lt;font color="#000000"&gt;here will be a conference call at 09.00 CET,&lt;/font&gt; &lt;a data-bm-trackable="false" href="https://www.youtube.com/live/wOWzI2zaj9s" target="_blank"&gt;link.&lt;/a&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-03107de8-0f75-4bf0-b68c-703839093dbb" name="bm-comp-03107de8-0f75-4bf0-b68c-703839093dbb" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="03107de8-0f75-4bf0-b68c-703839093dbb" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-d87ec6e6-1ef4-4cbb-91db-cf805f39464b" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ework/Equity-research/2026/7/ework-group---order-intake-turns-the-corner/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 21 Jul 2026 06:45:12 GMT</pubDate>
      <isin>SE0002402701</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Embellence Group - Sales miss, margins resilient</title>
      <description>&lt;a id="bm-comp-c5a74dca-d095-470a-bc5b-754a6b7d6167" name="bm-comp-c5a74dca-d095-470a-bc5b-754a6b7d6167" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c5a74dca-d095-470a-bc5b-754a6b7d6167" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Net sales SEK 181m, -5% vs ABGSCe&lt;/li&gt;&lt;li&gt;EBITA SEK 23m vs ABGSCe SEK 24m&lt;/li&gt;&lt;li&gt;The share is trading at 7.2-5.9x '26e EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ba207d91-19f8-4b75-b8cb-a0a92957c20e" name="bm-comp-ba207d91-19f8-4b75-b8cb-a0a92957c20e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ba207d91-19f8-4b75-b8cb-a0a92957c20e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 in brief: Softer growth, margins in line with forecasts&lt;/h3&gt;&lt;p&gt;Overall, we believe Embellence Group's Q2 report is softer than our expectations on growth, but with margins in line. Net sales of SEK 181m was -5% vs ABGSCe and corresponded to organic growth of -5%. The shortfall was concentrated in two brands: Bor&amp;#229;stapeter SEK 61m (-7% y-o-y, -10% vs ABGSCe) on weak Swedish traditional retail, and Wall&amp;amp;dec&amp;#242; SEK 19m (-14% y-o-y, -14% vs e), where management explicitly conceded its own commercial execution was not strong enough. Gross margins were 62.3%, +60bp y-o-y driven by the move to DTC, which coupled with a higher opex ratio owing to initiatives to drive future growth, e.g. the replacement of Cole &amp;amp; Son management, resulted in a 12.6% EBITA margin, -90bp y-o-y. EBITA of SEK 23m was -5% vs ABGSCe SEK 24 and corresponded to y-o-y growth of -12%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook: CEO says Cole &amp;amp; Son will weigh less in H2&lt;/h3&gt;&lt;p&gt;Embellence Group gives little in terms of outlook commentary. Management reiterated the DTC/international/hospitality diversification strategy and flagged that the last 2026 platform rollout (Bor&amp;#229;stapeter) went live in April, with conversion and data-driven-traffic work now beginning; all brands grew DTC in H1, Pappelina delivered the strongest (+130% y-o-y). On trajectory, Cole &amp;amp; Son's self-inflicted commercial-decision drag (net sales of SEK 30m, -12% y-o-y) is expected to be "more limited" in H2 than H1, and group resources have been reallocated to fix Wall&amp;amp;dec&amp;#242; execution.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Conclusion: The Q2 report moves our '26e EBITA by -1%&lt;/h3&gt;&lt;p style="text-align:left;"&gt;Using yesterday's closing price and unrevised estimates, Embellence Group is trading at 7.2x-5.9x our '26e-'27e EV/EBITA vs a historical trading range of 7x-8x NTM. L3M, the share has returned -3%. The Q2 report alone moves our '26e EBITA by -1%.&lt;/p&gt;&lt;p style="text-align:left;"&gt;The company hosts a conference call today at 10:00 CET. Call-in det&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/embellence-group/Equity-research/2026/7/embellence-group---sales-miss-margins-resilient/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 21 Jul 2026 06:30:06 GMT</pubDate>
      <isin>SE0013888831</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Qliro - NCI miss, but TPV growth still healthy</title>
      <description>&lt;a id="bm-comp-b3e1344b-8476-4c40-be09-b0802bf1ea43" name="bm-comp-b3e1344b-8476-4c40-be09-b0802bf1ea43" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b3e1344b-8476-4c40-be09-b0802bf1ea43" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Net commission income miss&lt;/li&gt;&lt;li&gt;Negative TPV revisions result in lower earnings&lt;/li&gt;&lt;li&gt;Merchant base still growing, supporting growth&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f6b0bb79-fdb9-4cf7-bdfc-2a57f0dc010f" name="bm-comp-f6b0bb79-fdb9-4cf7-bdfc-2a57f0dc010f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f6b0bb79-fdb9-4cf7-bdfc-2a57f0dc010f" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Net commission income miss&lt;/h3&gt;&lt;p&gt;Qliro reported a 91% operating profit miss versus FactSet consensus and a 92% miss versus ABGSCe, mainly driven by weaker-than-expected net commission income (SEK 16.7m vs. ABGSCe SEK 23.2m and consensus SEK 21.5m) despite TPV growing 28.1% y-o-y. BNPL volumes grew faster than expected (46.7% vs. ABGSCe 41.3%), supporting stronger net interest income (SEK 104.5m vs. ABGSCe 102.9m). Credit losses were also better than expected at SEK -23.7m (vs. ABGSCe SEK -27.0m and consensus SEK -29.5m), suggesting investments in the new credit model are starting to bear fruit. We believe the shorter loan durations are starting to have an impact, resulting in a faster run-off of the existing loan book while BNPL volumes continue to grow. Management is still guiding for a profitable FY26.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Negative TPV revisions&lt;/h3&gt;&lt;p&gt;We still believe Qliro is in continuous growth. However, management highlights that TPV growth will not accelerate as it has before. Therefore, we lower our TPV estimates for '26e, '27e and '28e to 34%, 29% and 27% y-o-y from 40%, 35% and 30%, resulting in a decrease in net income to SEK 11.4m, 19.2m and 39m (after non-controlling interest) respectively. Our main reason for the negative revisions in net income comes from the slower TPV growth in our forecast years, as Qliro is still in a break-even phase.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Merchant base reaches 812 (120% y-o-y)&lt;/h3&gt;&lt;p&gt;We remain positive about Qliro improving its BNPL penetration and credit quality, driven by improved underwriting. As Qliro now has a total merchant base of 812 (120% y-o-y), we still expect larger volumes to materialise as future earnings. We also note that total costs are beginning to level off, suggesting that investments in the new platform, including Gen Checkout 4, are starting to scale without requiring a corresponding increase in the cost base.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/qliro/Equity-research/2026/7/qliro---nci-miss-but-tpv-growth-still-healthy/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 20 Jul 2026 18:30:05 GMT</pubDate>
      <isin>SE0013719077</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ferronordic - Positioning itself for a strong H2</title>
      <description>&lt;a id="bm-comp-c8de167e-fd66-4002-9508-5b4e8e74a985" name="bm-comp-c8de167e-fd66-4002-9508-5b4e8e74a985" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c8de167e-fd66-4002-9508-5b4e8e74a985" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2e: Sales of SEK 1,159m &amp;amp; adj. EBIT of SEK 41m&lt;/li&gt;&lt;li&gt;&lt;font style="background-color:#ffffff;"&gt;FX raises '26e-'28e adj. EBIT &lt;font style="background-color:#ffffff;"&gt;0%/3%/3%&lt;/font&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font style="background-color:#ffffff;"&gt;Trading at 14-9x 26e-'27e EV/EBIT (peers at 18-16x)&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-4524ecb4-580a-421a-bc4e-7c8a7a8f5129" name="bm-comp-4524ecb4-580a-421a-bc4e-7c8a7a8f5129" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4524ecb4-580a-421a-bc4e-7c8a7a8f5129" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Undemanding Q2 comps&lt;/h3&gt;&lt;p&gt;We expect Ferronordic to deliver Q2 sales of SEK 1,159m (vs. SEK 1,088m in Q2'25, +7% y-o-y, +3% q-o-q), with the previous adverse FX effects easing sequentially (-3% in Q2e vs -6% in Q1). We forecast adj. EBIT of SEK 41m (break-even in Q2'25), for a margin of 3.6%. We note that the earnings comps are undemanding, with Q2'25 adj. EBIT soft across all segments. We estimate leverage to decline to 3.2x EBITDA in the quarter, partly on a NWC release from German inventory, as the German truck orders postponed in Q1 are delivered.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font style="background-color:#ffffff;"&gt;Estimates raised on FX&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;We make minimal estimate changes, with '26e-'28e sales upgraded 1%/2%/2% and adj. EBIT upgraded 0%/3%/3% on FX. On July 17, Volvo announced production ramp-ups in conjunction with its Q2 report. Importantly, it also upgraded its full-year guidance for the European heavy-duty registrations for the third consecutive quarter, from 310,000 to 315,000. Volvo's commentary on solid European order intake supports our German estimates into H2'26. Additionally, Volvo &amp;amp; Renault heavy-duty registrations in Germany rose 7% y-o-y in the quarter, with total heavy-duty registrations up 10%. During the quarter, we saw continued strength in US ISM PMIs (53.3 in June) and management continues to see solid demand among underlying drivers such as infrastructure and data centres within its territories.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 14-9x EV/EBIT&lt;/h3&gt;&lt;p&gt;We expect a positive operational development for Ferronordic during the rest of '26e, with continued momentum in the US alongside an emerging recovery in Germany. We also find the possibility of further bolt-on M&amp;amp;A attractive. The share is up +39% YTD, compared with +7% for OMXSGI. &lt;font style="background-color:#ffffff;"&gt;The valuation presently sits at 14-9x '26e-'27e EV/EBIT, which can be compared to our heavy equipment distributor peer group at 18-16x.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ferronordic/Equity-research/2026/7/ferronordic---positioning-itself-for-a-strong-h2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 20 Jul 2026 13:30:06 GMT</pubDate>
      <isin>SE0005468717</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Prevas - Organic recovery delayed further </title>
      <description>&lt;a id="bm-comp-ff7c592d-c802-4494-9a40-c0cf7d4514ac" name="bm-comp-ff7c592d-c802-4494-9a40-c0cf7d4514ac" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ff7c592d-c802-4494-9a40-c0cf7d4514ac" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Organic decline of 2%, weighed down by Finland&lt;/li&gt;&lt;li&gt;Adj. EBITA margin of 5.6%, below the 6.9% expected&lt;/li&gt;&lt;li&gt;Trading at 6x adj. EV/EBITA on '27e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ae6e2c28-dd1f-4583-a726-115752c28285" name="bm-comp-ae6e2c28-dd1f-4583-a726-115752c28285" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ae6e2c28-dd1f-4583-a726-115752c28285" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Changes in Finland will likely take time&lt;/h3&gt;&lt;p&gt;The report came in softer than expected, with an organic decline of 2% continuing to weigh on growth. Most important here is adj. EBITA, which came in SEK 5m below our estimate, at a margin of 5.6% (vs. 6.9% expected). This was mainly due to weaker demand in Finland, driven by a customer that has made major layoffs, directly affecting Prevas. Postponed deliveries also weighed on the quarter, though we expect these to materialise as early as Q3. To address demand in Finland, the company took SEK 8m of restructuring costs, which we view as necessary to build a stronger foundation and improve margins.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Organic growth taking longer to turn around&lt;/h3&gt;&lt;p&gt;We therefore lower our '26 sales estimate by 2% and adj. EBITA by 14%. Worth noting for consulting firms, organic growth is driven primarily by three things. 1) The calendar effect, i.e. working days compared to last year, 2) price increases and utilisation, and 3) whether FTEs are growing or decreasing. On price and utilisation, the company is able to raise prices despite competition and improve utilisation. FTEs are where it gets tough, as consulting firms have to lay off personnel to align with lower demand, which directly cuts organic growth through fewer billable hours. So what matters most here is the adj. EBITA margin, which we expect to gradually improve as changes take effect.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Increasing margins in focus&lt;/h3&gt;&lt;p&gt;A return to positive organic growth will take longer than anticipated. Focus remains on restructuring to lift margins, with benefits expected to become more visible through H2. At current levels, Prevas is trading at 6x adj. EV/EBITA on '27e, well below its historical median and around 30% below peers.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/prevas/Equity-research/2026/7/prevas---organic-recovery-delayed-further-/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 19 Jul 2026 18:45:03 GMT</pubDate>
      <isin>SE0000356008</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ovzon - Ramping costs now for bigger wins later</title>
      <description>&lt;a id="bm-comp-93a24e1e-b258-4376-a8c0-7f72b90527af" name="bm-comp-93a24e1e-b258-4376-a8c0-7f72b90527af" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="93a24e1e-b258-4376-a8c0-7f72b90527af" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Strong sales figure, but EBIT shortfall on rising opex&lt;/li&gt;&lt;li&gt;We cut '26e/'27e/'28e EBIT by 9%/2%/1% due to higher costs&lt;/li&gt;&lt;li&gt;Order activity has recently increased, 15x '26e EV/EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c4f61484-7541-4162-9733-ad060550db38" name="bm-comp-c4f61484-7541-4162-9733-ad060550db38" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c4f61484-7541-4162-9733-ad060550db38" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 sales in line, but higher costs than expected&lt;/h3&gt;&lt;p&gt;Q2 sales broadly met our top line (-1%), growing 48% y-o-y on recent contract wins. Margins were weaker than expected, with EBIT -31% vs. our forecast and -28% vs. Modular Finance consensus. The deviation was from 1) SEK 6m NRIs tied to COGS periodisation from Q1, and 2) a ramp-up in growth-related costs, with FTEs up 5 q-o-q, to 49. We were positively surprised by Q1's strong margins and had extrapolated that level; smoothing the SEK 6m across both quarters shows a more stable picture. The FTE growth is short-term negative, but we remain positive about demand and view it as the right investment.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We lower our margin assumptions&lt;/h3&gt;&lt;p&gt;SATCOM demand remains high, though Ovzon's order activity was slow through H1. More recently, however, activity has picked up, which bodes well for H2e. One might ask why Ovzon keeps signing leased-capacity orders while holding spare capacity on its proprietary satellite Ovzon-3 (~90% gross margin vs. ~65% for leased), but this reflects the company pursuing even more accretive wins, which we think it will land. Visibility into large wins remains limited, though we argue that progress is being made. We increase our terminal sales assumptions on recent contracts, while raising opex assumptions due to the reasons above. Net, we cut '26e by 9%, '27e by 2% and '28e by 1%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;15x-12x 2026e-2027e EV/EBIT&lt;/h3&gt;&lt;p&gt;Modern warfare increasingly spans domains where satellite connectivity is mission-critical, driving a structural, multi-year uplift in space investment. Ovzon is well-positioned to capture this demand given its specialisation in high-resilience, high-throughput SATCOM solutions. The stock is trading at 15x-12x '26e-'27e EV/EBIT.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ovzon/equity-research/2026/7/ovzon---ramping-costs-now-for-bigger-wins-later/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 19 Jul 2026 17:15:02 GMT</pubDate>
      <isin>SE0010948711</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Alligo - Finland again ahead of plan in a solid Q2</title>
      <description>&lt;a id="bm-comp-3774dbb5-1e7f-46f6-8198-278707819de7" name="bm-comp-3774dbb5-1e7f-46f6-8198-278707819de7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3774dbb5-1e7f-46f6-8198-278707819de7" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Solid Q2: adj. EBITA 1% above us, 2% above consensus&lt;/li&gt;&lt;li&gt;Raise '26e-'28e adj. EBITA 1-2%: stronger Finland, weaker Norway&lt;/li&gt;&lt;li&gt;Trading at 13-10x '26e-'28e P/E; margin-recovery story intact&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-52fbd2cd-bfc9-4620-828f-0e5b61b81e78" name="bm-comp-52fbd2cd-bfc9-4620-828f-0e5b61b81e78" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="52fbd2cd-bfc9-4620-828f-0e5b61b81e78" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Alligo delivered a solid Q2, with adj. EBITA of SEK 187m, 1% above our estimate (2% above FactSet consensus), on sales 2% above us. Organic growth was +3%, with FX and acquisitions taking the headline to +6%, while the gross margin rose to 40.7% (40.1%) on a higher own-brand share, better mix and lower USD costs. Finland was again the standout, its adj. EBITA margin recovering to 7.0% (4.6%) as the turnaround, industrial sales recovery and defence sales more than offset two phased-out customers; Sweden improved to 8.8% (7.2%), while Norway stayed the drag, its margin easing to 3.2% (3.4%) on continued oil &amp;amp; gas weakness. The result was, however, somewhat flattered by a SEK 9m (4m) contingent-consideration reversal not adjusted for by the company.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We raise our '26e-'28e adj. EBITA by 1-2%, as a much stronger Finland more than offsets a somewhat weaker Norway, with Sweden broadly unchanged. The Finland upgrade reflects a margin recovery ahead of plan and the lost volumes now largely replaced, although we do not fully extrapolate the 7.0% Q2 margin yet. Management still calls the market stable but uneven and cautious; we think organic growth is trending in the right direction and will continue to do so.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;We believe the margin-recovery story remains intact, supported by encouraging organic growth figures and better than expected progress on the Finnish turnaround. We forecast the adj. EBITA margin moving up to 8.8% from last year's 6.5% by '28e, steadily approaching the 10% target. The share is trading at 13-10x '26e-'28e P/E. The next catalyst is likely to be some kind of strategy update from the new CEO Samuel Alteborg once he has landed in his new role.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/Alligo/Equity-research/2026/7/alligo---finland-again-ahead-of-plan-in-a-solid-q2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 19 Jul 2026 17:00:02 GMT</pubDate>
      <isin>SE0009922305</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Midsona - Looking due North as South comps ease in H2</title>
      <description>&lt;a id="bm-comp-69186446-ca89-4be2-879f-a94222e74c17" name="bm-comp-69186446-ca89-4be2-879f-a94222e74c17" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="69186446-ca89-4be2-879f-a94222e74c17" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2'26: Profitable but not yet growing into the story&lt;/li&gt;&lt;li&gt;H2'26e: One tailwind balanced with a few open cost questions&lt;/li&gt;&lt;li&gt;Trading at NTM EV/EBITA of 9x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-e2d070e3-a76d-45c0-8ee3-f770610ebb65" name="bm-comp-e2d070e3-a76d-45c0-8ee3-f770610ebb65" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e2d070e3-a76d-45c0-8ee3-f770610ebb65" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;North Europe is the underlying culprit&lt;/h3&gt;&lt;p style="text-align:left;"&gt;Q2 missed the mark on both sales and adj. EBIT, although not by a lot (-2% on sales, -7% on adj. EBIT, i.e. SEK 1m). The gross margin was in line with expectations at 29%, but elevated opex caused the EBIT miss. Management flags that it has stepped up the marketing behind priority brands. The Nordics impressed (adj. EBIT 15% above ABGSCe), while North Europe stayed flat at SEK 5m adj. EBIT on a further -4% organic sales decline. South Europe, meanwhile, improved to SEK 2m from break-even despite a -7% organic drag from the Spanish fire aftermath.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;The Spain comp fades, but input cost risk doesn't&lt;/h3&gt;&lt;p style="text-align:left;"&gt;The clearest structural tailwind heading into H2 2026 is the phasing out of the Spain fire base effect in Q3, which should remove a significant drag on contract manufacturing comparisons. Cost savings are fully embedded in the run rate, but marketing spend will remain elevated as a strategic choice. Raw material and energy cost trends for H2 remain uncertain, with some risk to input costs from Middle East disruptions and fertiliser price increases. The outlook comments in the report are fairly in line with our previous understanding, with nothing in the report warranting a material change to our estimates or long-term view.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;We cut '26e adj. EBITA by 2%&lt;/h3&gt;&lt;p&gt;We make slight cuts to our sales and adj. EBITA estimates, lowering '26e-'27e sales by ~1% p.a. and adj. EBITA by 2-1%, respectively. We slightly lower our H2'26 estimates to reflect a somewhat elevated opex base. Our EPS estimates are up on lower-than-expected net financials and taxes. Based on our revised estimates, the company is trading at ~9x NTM EV/EBITA, which is ~15% below current peer multiples. We note that peers are in turn trading ~20% below their 10-year historical median of ~14x NTM EV/EBITA.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/midsona/Equity-research/2026/7/midsona---looking-due-north-as-south-comps-ease-in-h2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 19 Jul 2026 11:00:04 GMT</pubDate>
      <isin>SE0000565228</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nolato - Not so bad when breaking it down</title>
      <description>&lt;a id="bm-comp-b9f349ac-54f0-4ca0-ba57-87fd67058d68" name="bm-comp-b9f349ac-54f0-4ca0-ba57-87fd67058d68" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b9f349ac-54f0-4ca0-ba57-87fd67058d68" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 below expectations, largely due to temporary effects&lt;/li&gt;&lt;li&gt;We cut our EBITA estimates by 3% for '26e, 1% for '27e-'28e&lt;/li&gt;&lt;li&gt;Organic growth to accelerate in H2e, and M&amp;amp;A potential on top&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-15a9412f-a542-4b3f-9176-a0565f74293f" name="bm-comp-15a9412f-a542-4b3f-9176-a0565f74293f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="15a9412f-a542-4b3f-9176-a0565f74293f" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Miss in Q2 driven mainly by temporary effects&lt;/h3&gt;&lt;p&gt;Nolato reported Q2 adj. EBITA 3% below MFN consensus and an adj. EBITA margin 0.4pp below. However, both operating segments were either in line or above expectations on EBITA (Medical in line, Engineered +4%), while the miss was driven by above-average group costs that are expected to come down somewhat. Moreover, temporary effects from higher raw material costs weighed SEK -20m on EBITA (-0.8pp on the margin), and the effect is expected to be roughly half of this in Q3, and none at all in Q4.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Limited EBITA downgrades of 3% for '26e, 1% for '27e-'28e&lt;/h3&gt;&lt;p&gt;Given the largely temporary nature of the factors that drove the miss, and in our view clear indications that margins should improve into Q3, we do not extrapolate the earnings miss. As such, our EBITA downgrades are limited to 3% for '26e and 1% per year for '27e-'28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Organic acceleration ahead with an M&amp;amp;A optionality&lt;/h3&gt;&lt;p&gt;The company confirmed that commercial GLP-1 volumes have started from its new site in Hungary, and these will gradually ramp up to ~SEK 700m in sales over the coming few years, which we estimate will drive a ~3pp lift in organic growth. Meanwhile, management sounds more optimistic now regarding potential M&amp;amp;A, which would make sense considering the strong balance sheet, with r12m ND/EBITDA now at 0.7x. The share is currently trading at 13-11x '26e-'27e EV/EBITA, and offers FCF yields of 3%/6%/7% for '26e/'27e/'28e.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nolato/Equity-research/2026/7/nolato---not-so-bad-when-breaking-it-down/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 17 Jul 2026 09:30:10 GMT</pubDate>
      <isin>SE0015962477</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Prevas - Finland weighs on the quarter</title>
      <description>&lt;a id="bm-comp-41d5efd7-2d3b-4832-b8bc-530779450be1" name="bm-comp-41d5efd7-2d3b-4832-b8bc-530779450be1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="41d5efd7-2d3b-4832-b8bc-530779450be1" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales of SEK 405m, organic decline of ~2%&lt;/li&gt;&lt;li&gt;Adj. EBITA of SEK 23m, and a margin of 5.7%&lt;/li&gt;&lt;li&gt;Restructuring costs weigh on the quarter&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c5a262e9-855a-4214-9f59-48cf0705f181" name="bm-comp-c5a262e9-855a-4214-9f59-48cf0705f181" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c5a262e9-855a-4214-9f59-48cf0705f181" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Adj. EBITA softer than expected&lt;/h3&gt;&lt;p&gt;Prevas reports Q2'26 net sales of SEK 405m (in line with ABGSCe SEK 407m), down slightly y-o-y with a negative organic growth of 2%. Adj. EBITA, which excludes SEK 8.0m of restructuring costs taken during the quarter, came in at SEK 23m (vs. ABGSCe SEK 28m), corresponding to a margin of 5.7% (vs. ABGSCe 6.9%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Finland the swing factor&lt;/h3&gt;&lt;p&gt;The quarter was shaped almost entirely by Finland, where cutbacks at large customers and postponed investment decisions weighed on results. We see this as a temporary setback rather than a sign of deeper structural issues, and view management's response as a necessary step given the weaker market backdrop. On another note, ~SEK 55m of new business was signed in June, including new Defence customers, pointing to a segment that remains fundamentally strong. Defence itself kept growing, with sales up 8% y-o-y to SEK 68m, and LTM defence revenue now ~SEK 280m (~17% of group sales).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation and outlook&lt;/h3&gt;&lt;p&gt;On our unrevised estimates, Prevas is trading at 8x adj. EV/EBITA, around 25% below the peer group, despite offering higher margins and stronger long-term growth prospects, in our view. The company is slowly but steadily heading toward a better cost structure and, on that front, signed orders which are likely to improve results in the coming quarters. Management will hold a presentation at CET 09.30 (&lt;a data-bm-trackable="false" href="https://www.finwire.tv/webcast/prevas/q2-2026/" target="_blank"&gt;link&lt;/a&gt;).&lt;/p&gt;&lt;table id="bm-img-50a58b62-f2c1-41bf-bdae-588946546b54" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/prevas/Equity-research/2026/7/prevas---finland-weighs-on-the-quarter/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 17 Jul 2026 07:15:11 GMT</pubDate>
      <isin>SE0000356008</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Alligo - Slight beat driven by Finland</title>
      <description>&lt;a id="bm-comp-381847f9-7e6a-4ffe-9c26-96c894538b66" name="bm-comp-381847f9-7e6a-4ffe-9c26-96c894538b66" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="381847f9-7e6a-4ffe-9c26-96c894538b66" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales +1%, adj. EBITA +2% vs. FactSet consensus&lt;/li&gt;&lt;li&gt;Slight beat driven by Finland improving faster again&lt;/li&gt;&lt;li&gt;Expect consensus adj. EBITA to come up 1-2%&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-15db0070-66e2-40f8-b64a-10aeff8be0a6" name="bm-comp-15db0070-66e2-40f8-b64a-10aeff8be0a6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="15db0070-66e2-40f8-b64a-10aeff8be0a6" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Sales grew 6% y-o-y (+3% org.) and were 2% above our estimate (1% above FactSet consensus). With a margin of 7.2%, 0.1pp below our estimate (0.1pp above consensus), EBITA adj. was 1% above our estimate (2% above consensus). The slight beat vs our estimates was driven by Finland once again improving more than we expected. EBITA included non-recurring items with a negative margin impact of 0.4pp. There is a conference call at 11:00 CET: &lt;a data-bm-trackable="false" href="https://www.alligo.com/en/report/q2-2026/" target="_blank"&gt;webcast&lt;/a&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We expect consensus EBITA adj. to come up 1-2% on the slight beat.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Company valuation&lt;/h3&gt;&lt;p&gt;Over the past three months, the share has returned +4%, compared to the +1% of the OMX Stockholm Allshare. The share is currently trading at 13x-10x '26e-'28e P/E, compared to its 10-year historical median of 14x-9.5x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-984758f4-850c-41f6-8609-c3bff81f96e0" name="bm-comp-984758f4-850c-41f6-8609-c3bff81f96e0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="984758f4-850c-41f6-8609-c3bff81f96e0" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-118cf132-c7fd-4c5d-b8dd-9dde671150a6" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. estimates Q2'26&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company Data, FactSet&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/Alligo/Equity-research/2026/7/alligo---slight-beat-driven-by-finland/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 17 Jul 2026 07:01:19 GMT</pubDate>
      <isin>SE0009922305</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ovzon - Good topline, but weaker margins</title>
      <description>&lt;a id="bm-comp-9f56f65a-e42b-4560-a531-dbba42b61030" name="bm-comp-9f56f65a-e42b-4560-a531-dbba42b61030" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9f56f65a-e42b-4560-a531-dbba42b61030" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales +48% y-o-y, in line with cons&lt;/li&gt;&lt;li&gt;EBIT 28% below, partly due to SEK 6m one-offs (adj. -18%)&lt;/li&gt;&lt;li&gt;Cons to cut '26e EBIT by ~5% on lower GMs, share down similarly&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-56beaa9d-6113-4706-a933-2dbee37d5c98" name="bm-comp-56beaa9d-6113-4706-a933-2dbee37d5c98" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="56beaa9d-6113-4706-a933-2dbee37d5c98" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Sales SEK 245m (-1% vs ABGSCe 246m and 0% vs cons 246m), EBIT 47m (-31% vs ABG 68m and -28% vs cons 65m). Note that Q2 EBIT was impacted by a cost periodisation of SEK 6m that should have been allocated to Q1. Adjusting for this, EBIT would have been SEK 53m, or 18% below consensus. Furthermore, FCF was solid at SEK 76m (SEK 93m in Q2'25), resulting in a NIBD of SEK 112m, down from 191m in Q1'26.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Q2 thoughts&lt;/h3&gt;&lt;p&gt;Terminal sales were in line with last quarter, which was expected. Meanwhile, SATCOM was only slightly below our estimate, but down 9% q-o-q because some previous orders have not yet been renewed (including SSC). The gross margin impacted by aforementioned item. If we adjust for that, it was ~62%, which was in line with Q1 (though the stronger-than-expected Q1 figure had previously made us extrapolate that number). Order activity during the quarter was slow, but has improved after the end of the quarter, which bodes well for better figures in H2. We are especially encouraged by the SEK 74m renewal order from a EU NATO country as it represents the start of an initiative to add more countries to a satellite communication coalition.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;At a first glance, we expect consensus to lower '26e EBIT by ~5%, with lower gross margin assumptions offset by improved order activity (including yesterday's SEK 36m terminal order). Although there were some one-offs, we expect the stock to underperform the market today, down in line with revisions. The valuation is sitting at 15x '26e EV/EBIT on our unrevised estimates. There is a webcast at 14.00 CET &lt;a data-bm-trackable="false" href="https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.youtube.com%2Flive%2FcbaNZSLTt88%3Fis%3Db5Bg7oXji8pT0vW9&amp;amp;data=05%7C02%7Ccatharina%40vero.se%7C4b46acf15d7f4266a96d08dedb59cb1f%7C6db0294c5d8b4633a3082c9d3ca44097%7C0%7C0%7C639189375901277265%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;amp;sdata=qBchQ01XhqtjzdnAnpRQclfizLwuUqzA21Yfh7u4vcQ%3D&amp;amp;reserved=0" target="_blank"&gt;(link)&lt;/a&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-8dfe929b-ecc4-4521-8ed5-806b5e4e4417" name="bm-comp-8dfe929b-ecc4-4521-8ed5-806b5e4e4417" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8dfe929b-ecc4-4521-8ed5-806b5e4e4417" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-699170bf-52ca-4baf-8fd0-9cc783231ebf" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data, Modular Finance for cons&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ovzon/equity-research/2026/7/ovzon---good-topline-but-weaker-margins/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 17 Jul 2026 07:00:11 GMT</pubDate>
      <isin>SE0010948711</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Midsona - Another quarter of margin over momentum</title>
      <description>&lt;a id="bm-comp-84d3dc90-9299-4406-a848-238a9137b353" name="bm-comp-84d3dc90-9299-4406-a848-238a9137b353" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="84d3dc90-9299-4406-a848-238a9137b353" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Adj. EBIT SEK 20m, 7% below ABGSCe SEK 21m&lt;/li&gt;&lt;li&gt;Continued sales drag from contract manufacturing&lt;/li&gt;&lt;li&gt;Consensus adj. EBIT revisions likely down low-single-digits&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-be2f4dc0-4798-427e-be66-3e036ad0e7a7" name="bm-comp-be2f4dc0-4798-427e-be66-3e036ad0e7a7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="be2f4dc0-4798-427e-be66-3e036ad0e7a7" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Growth recovery a story for H2, not Q2&lt;/h3&gt;&lt;p&gt;The Q2 report was softer than expected on both sales and adj. EBIT. Net sales came in at SEK 870m, 2% below ABGSCe SEK 885m and only 0.6% above last year's SEK 865m. Organic growth was -1.2%, missing ABGSCe's +0.9% by a chunky 2.1pp and only marginally better than the -2.0% comp from Q2'25. Gross margin was the bright spot, in line with ABGSCe at 28.7% reported and 29.3% adjusted, driven by a richer own-brand mix and tight production cost control. However, that didn't carry through to adj. EBIT, which landed at SEK 20m which missed ABGSCe SEK 21m by 7%, with the adj. EBIT margin of 2.3% 0.1pp light of the 2.4% estimate. Opex was a bit elevated as management stepped up marketing behind priority brands. Segment-wise, Nordics was the standout, adj. EBIT of SEK 38m vs. SEK 25m a year ago on 0.5% organic growth. PTP and net profit both beat on lower net financial expenses and 0m in taxes.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Spain clarity and Risenta integration are the next checkpoints&lt;/h3&gt;&lt;p&gt;On Risenta, it was consolidated on 1 June and contributed to growth by 1.3%.The Risenta production equipment handover is scheduled for autumn 2026, when the brand is meant to be folded into Midsona's own manufacturing base; until then, only the brand and finished-goods inventory sit on the balance sheet. Midsona has yet to reach an official decision on the long-term plan for operations in Spain, but noted that clarification will be provided during Q3. Marketing investment behind priority own brands is described as "gradually" delivering sales gains and is expected to continue at an elevated sequential level, meaning opex is unlikely to snap back down in H2. On costs, management notes raw material and packaging input prices have been relatively stable but sees no clear picture into year-end, flagging that recent fertiliser price rises could fee&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/midsona/Equity-research/2026/7/midsona---another-quarter-of-margin-over-momentum/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 17 Jul 2026 06:45:10 GMT</pubDate>
      <isin>SE0000565228</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nolato - Slight miss vs. cons on higher group costs</title>
      <description>&lt;a id="bm-comp-7593bf3d-f6d4-4cbe-9982-0040743baa28" name="bm-comp-7593bf3d-f6d4-4cbe-9982-0040743baa28" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7593bf3d-f6d4-4cbe-9982-0040743baa28" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Adj. EBITA SEK 253m (-7% vs. ABG, -3% vs. MFN cons)&lt;/li&gt;&lt;li&gt;We expect cons EBITA to come down by 2-3%&lt;/li&gt;&lt;li&gt;Share trading at 13-11x '26e-'27e EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-3f67eb6d-3502-42ec-bb22-8ece0dbad4a8" name="bm-comp-3f67eb6d-3502-42ec-bb22-8ece0dbad4a8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3f67eb6d-3502-42ec-bb22-8ece0dbad4a8" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 outcome&lt;/h3&gt;&lt;p&gt;Sales came in at SEK 2,454m (-1% vs. ABG 2,467m, 0% vs. Modular Finance cons 2,453m), up 2% y-o-y, of which +4% was organic (ABG +4%, no cons). Adj. EBITA was SEK 253m (-7% vs ABG 271m, -3% vs. cons 262m), for an adj. EBITA margin of 10.3% (ABG 11.0%, cons 10.7%), and this excludes one-off severnce pay costs of SEK -6m reported under group costs. Even adjusted for these, group costs were higher than usual, which drove the miss, while both segments were in line with or above consensus expectations on EBITA (Medical in line, Engineered +4%). FCF amounted to SEK 154 (ABG 186m), for a cash conversion of 91%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and estimate changes&lt;/h3&gt;&lt;p&gt;The company does not issue formal guidance. However, it mentions 1) GLP-1 commercial deliveries from the new Hungary site started in Q2, and will continue to ramp upp according to plan, and 2) Q2 saw temporary margin effects from higher input costs, while prices to customers will be raised in coming quarters, i.e. margin should improve ahead. All in all, we expect fairly minor downgrades to cons EBITA of 2-3%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation and conference call details&lt;/h3&gt;&lt;p&gt;The report was on the softer side, but nothing too dramatic, with a slight margin-driven miss vs. cons on an adjusted basis, but some indications in the management commentary that margins should improve ahead. On our pre-Q2 estimates, the share trades at 13-11x '26e-'27e EV/EBITA, compared to its historical average fwd. multiple of 15x. Finally, the company will host a conference call at 08:45 CEST, &lt;a data-bm-trackable="false" href="https://storage.mfn.se/c1cfbed5-a90c-4086-9d3c-8b503fb50b37/webcast-conference-call-on-july-17-about-nolatos-interim-report-for-q2-2026.pdf" target="_blank"&gt;register here&lt;/a&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c7836e2f-dbb4-47f2-b6d3-fee87f37a49f" name="bm-comp-c7836e2f-dbb4-47f2-b6d3-fee87f37a49f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c7836e2f-dbb4-47f2-b6d3-fee87f37a49f" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-18301212-3daf-417c-a531-26c13b748030" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier estimates, Modular Finance IR consensus&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nolato/Equity-research/2026/7/nolato---slight-miss-vs.-cons-on-higher-group-costs/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 17 Jul 2026 06:15:10 GMT</pubDate>
      <isin>SE0015962477</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Proact - Favourable market conditions in Q3e as well</title>
      <description>&lt;a id="bm-comp-b6365feb-df62-4651-90c4-c359b68f7da7" name="bm-comp-b6365feb-df62-4651-90c4-c359b68f7da7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b6365feb-df62-4651-90c4-c359b68f7da7" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;A combination of growth and cost reductions...&lt;/li&gt;&lt;li&gt;.. and a balance between pricing tailwinds &amp;amp; extended lead times&lt;/li&gt;&lt;li&gt;Small revisions to estimates, adj. EBITA +0-2%&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-3372be1d-208d-471c-a4d3-a25fc0b96877" name="bm-comp-3372be1d-208d-471c-a4d3-a25fc0b96877" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3372be1d-208d-471c-a4d3-a25fc0b96877" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Combining top-line growth with lower costs&lt;/h3&gt;&lt;p&gt;Q2 adj. EBITA was 7% better than we expected, growing 39% y-o-y on a combination of 10% revenue growth and 1% lower opex. The system sales market remains volatile, however, due to the sharp increase in memory prices. While serving as a tailwind to growth, it is also a headwind on volumes, as it extends delivery times in the market. We therefore expect the 12% organic growth in system sales to rise further to 15% in Q3e before coming down to 2% in Q4e, which we view as relatively in line with Proact's comments about a favourable set-up in Q3 and more uncertainty in Q4. The uncertainty in Q4 is mostly related to the longer delivery times and whether some deliveries will be pushed into 2027. The cost programme in 2025 is bearing fruit and the lower cost base should prove sustainable ahead.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Small estimate revisions&lt;/h3&gt;&lt;p&gt;As the report was broadly in line with our estimates, we make only minor revisions. System sales are slightly higher while service sales are slightly lower, leaving our group sales forecast almost unchanged. On adj. EBITA, we raise 2026e by 2% while leaving 2027-28e unchanged, but we acknowledge relatively high estimate uncertainty ahead.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Share at 7.6x 2026e EV/adj. EBITA&lt;/h3&gt;&lt;p&gt;On our updated estimates, the share is trading at 7.6x 2026e EV/adj. EBITA, and we currently expect -4% adj. EBITA growth in 2027e driven by a normalisation in the market and somewhat higher costs. Near-term, we expect earnings growth to be strong, with adj. EBITA +33% y-o-y in Q3e. Proact will hold a CMD in H2'26, and given the current LTM adj. EBITA margin of 7.9% vs. its target of &amp;gt;8% it will be interesting to see if it raises its margin target or intensifies growth plans.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/proact/Equity-research/2026/7/proact---favourable-market-conditions-in-q3e-as-well/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 16 Jul 2026 15:15:09 GMT</pubDate>
      <isin>SE0015961222</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Proact - Solid Q2 execution in a volatile market</title>
      <description>&lt;a id="bm-comp-271aaeeb-827a-4cfe-8fe3-cee24f10ec91" name="bm-comp-271aaeeb-827a-4cfe-8fe3-cee24f10ec91" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="271aaeeb-827a-4cfe-8fe3-cee24f10ec91" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;8% organic growth, sales +3% vs ABGe, adj. EBITA +7%&lt;/li&gt;&lt;li&gt;High memory prices into 2027, extended lead times but favourable Q3e set-up&lt;/li&gt;&lt;li&gt;Estimates +2-4%, stock to slightly outperform&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7f54f6cc-77d1-4c4b-a281-413fe23f2103" name="bm-comp-7f54f6cc-77d1-4c4b-a281-413fe23f2103" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7f54f6cc-77d1-4c4b-a281-413fe23f2103" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 details&lt;/h3&gt;&lt;p&gt;Sales SEK 1,286m (3% vs ABG 1,247m, no cons). Adj. EBITA 105m (7% vs ABG 98m), Adj. EBITA margin 8.2% (ABG 7.9%). Organic growth 8% (vs ABG 5%), of which system sales 12% (ABG 8%) and services 3% (ABG 0%). Adj. EBITA +39% y-o-y (ABG +30%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Volatile markets, but good execution&lt;/h3&gt;&lt;p&gt;Proact operates in a volatile market with higher prices and extended lead times for memory components. System sales impacted positively from higher prices, but negatively from extended lead times pushing some deliveries into Q3. Full effect realised from cost program driving earnings growth y-o-y. OCF at SEK 107m (127m Q2&amp;#8217;25) is Ok. Gross margin normalised to 23.3% (ABGe 22.6%), down from 25.2% in Q1 and more in line with 2025 levels. High memory prices to persist well into 2027. 54% y-o-y growth in cloud order intake will lead to higher recurring revenue towards end of 2026, driven by UK. Proact mentions favourable market conditions for Q3, while uncertain dynamics for Q4.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Slight positive estimate revisions and share reaction&lt;/h3&gt;&lt;p&gt;We expect consensus to make relatively small estimate revisions on 2026 (+2-4%) and share likely to outperform the market slightly today. Conf call at CET 14.00.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-751cde94-59e2-4b7b-8f3b-6beae4f25d4c" name="bm-comp-751cde94-59e2-4b7b-8f3b-6beae4f25d4c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="751cde94-59e2-4b7b-8f3b-6beae4f25d4c" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-af50d0f9-0323-48c1-b378-a636dc53b363" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/proact/Equity-research/2026/7/proact---solid-q2-execution-in-a-volatile-market/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 16 Jul 2026 11:45:09 GMT</pubDate>
      <isin>SE0015961222</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Impact Coatings - Eyes on the pipeline in Q2</title>
      <description>&lt;a id="bm-comp-4967e1ad-4f5d-4e4a-9abc-3549637c1a9b" name="bm-comp-4967e1ad-4f5d-4e4a-9abc-3549637c1a9b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4967e1ad-4f5d-4e4a-9abc-3549637c1a9b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2e sales SEK 16m (6m), EBIT SEK -8m (-16m)&lt;/li&gt;&lt;li&gt;No machine deliveries in Q2, but two machine orders de-risk '26e&lt;/li&gt;&lt;li&gt;Announced repeat order from LINDEBERG worth EUR 1-1.5m&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-2ed4d3aa-4950-4339-a534-3196adbfea7e" name="bm-comp-2ed4d3aa-4950-4339-a534-3196adbfea7e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2ed4d3aa-4950-4339-a534-3196adbfea7e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 expectations&lt;/h3&gt;&lt;p&gt;We expect Q2 sales of SEK 16m (6.5m), driven by Coating Services (SEK 14m) and Aftermarket (SEK 2m), with no machine deliveries scheduled in the quarter (HJWAVE's IC500 is to be delivered in Q3'26). Following the customer-specific delays in Coating Services in Q1, which management attributed to supply chain timing rather than weaker underlying demand, we look for a normalisation in service activity. On adj. EBIT, we forecast SEK -8m (-16m). We expect the company to end Q2 with a cash position of SEK 14m (SEK 18m at end-Q1).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;We lower '26e sales by 8%, mainly as we had modelled an IC2000 delivery in our estimates, while the Lindberg order announced in May was for an IC500, which carries a lower price tag. That said, our two forecast machine deliveries for '26e are now both backed by firm orders following the HJWAVE IC500 order in April (~EUR 1.5m) and the Lindberg order (EUR 1-1.5m). At its capital market update in November, the company guided for orders within all four business areas in '26. The two orders received cover two of these areas (electronics and decorative), and we await commentary on momentum and pipeline in the remaining areas in the Q2 report before revisiting our estimates.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Waiting for order conversion&lt;/h3&gt;&lt;p&gt;At Q1, management noted a clear pickup in customer dialogue following China's hydrogen pilot programme announcement in March, though not yet in production volumes. Q2 is the first full quarter under the new programme, and we will be listening for whether the increased dialogue is translating into concrete orders, on both PVD systems and Coating Services. On SOFC, progress continues via the Ceres collaboration, where the timing of a first system order remains uncertain. The company is currently trading at 4.1x-2.8 '26e-'28e EV/sales vs. peers at 3.0-0.9x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/impact_coatings/Equity-research/2026/7/impact-coatings---eyes-on-the-pipeline-in-q2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 16 Jul 2026 11:15:09 GMT</pubDate>
      <isin>SE0001279142</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>I-tech - Smooth sailing into easy comps</title>
      <description>&lt;a id="bm-comp-79173fd5-648b-4792-9196-baf62dcaa5a3" name="bm-comp-79173fd5-648b-4792-9196-baf62dcaa5a3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="79173fd5-648b-4792-9196-baf62dcaa5a3" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2e: +58% organic growth, EBIT SEK 13m (5m)&lt;/li&gt;&lt;li&gt;Easy comps: customer with financial constraints not in Q2'25 base&lt;/li&gt;&lt;li&gt;Trading at '26e-'28e EV/EBIT 11x-5x, ~40-60% below peers&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c9d2db8b-8c60-4d4d-a850-2c2c6845c293" name="bm-comp-c9d2db8b-8c60-4d4d-a850-2c2c6845c293" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c9d2db8b-8c60-4d4d-a850-2c2c6845c293" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 expectations&lt;/h3&gt;&lt;p&gt;We estimate Q2 sales of SEK 48m, +53% y-o-y (+58% organic, -5% FX). Whereas Q1 faced tough comps, Q2 marks the start of an easier comparison period. This is because the financial constraints at I-Tech's second-largest customer began in Q2'25, meaning that we assume that last year's quarter carried essentially no volumes from this customer. With order patterns having normalised in Q1'26, we expect this to be a meaningful growth driver from Q2 onwards. Moreover, the FX headwind should also begin to ease as we lap last year's SEK appreciation (-14% FX effect in Q1). On EBIT, we forecast SEK 13m (5m) for a margin of 27% (15%), with the gross margin trend (record 60% in Q1) supporting profitability.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;We raise '26e-'28e sales and EBIT by 3% ahead of the report. Looking ahead, we will be listening for commentary on the company's business development initiatives. I-Tech has been hiring in this area and, with SEK 157m in cash at the end of Q1, it has the balance sheet to act.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Remain positive long-term&lt;/h3&gt;&lt;p&gt;Our long-term view on I-Tech is unchanged. Selektope is currently used on around 3,500 of the ~110,000 commercial vessels in the global commercial fleet, leaving plenty of room to grow in both new-build and drydocking. The drydocking market is roughly 10x the size of new-build and represents the larger long-term opportunity, with China a key geography where maintenance-market penetration remains low relative to its fleet size and drydocking activity. The share is trading at '26e-'28e EV/EBIT of 11x-5x and 16x-9x P/E, i.e. ~40-60% below peers.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/i-tech/Equity-research/2026/7/i-tech---smooth-sailing-into-easy-comps/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 16 Jul 2026 09:45:09 GMT</pubDate>
      <isin>SE0011167725</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Coor - Denmark masks underlying improvements</title>
      <description>&lt;a id="bm-comp-2c69e783-9cf0-421b-b042-0ef87fcfc45d" name="bm-comp-2c69e783-9cf0-421b-b042-0ef87fcfc45d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2c69e783-9cf0-421b-b042-0ef87fcfc45d" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We cut '26e-'28e adj. EBITA by 1% on temporary DK weakness&lt;/li&gt;&lt;li&gt;Positive development below surface, should be more visible from Q4&lt;/li&gt;&lt;li&gt;Fair value range maintained at SEK 40-80 per share&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-b9b5cb64-9693-4286-8ebc-a4e925d93664" name="bm-comp-b9b5cb64-9693-4286-8ebc-a4e925d93664" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b9b5cb64-9693-4286-8ebc-a4e925d93664" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Denmark overshadowed underlying improvements&lt;/h3&gt;&lt;p&gt;Coor delivered a stable Q2 report, although margins in Denmark surprised a bit negatively, resulting in adj. EBITA 2% below our expectation (adj. EBITA +3% y-o-y). Denmark earnings were expected to be soft due to the announced contract losses in late 2025, but the margin of 2.8% (vs. 3.7% in Q1) was surprising. Management highlighted that the contract losses have resulted in additional challenges within delivery, which should be of a temporary nature as the Danish business recalibrates. As such, we slightly lower Denmark H2'26 EBITA, but do not extrapolate the weak Q2 margin. Meanwhile, the rest of the business is showing promising signs. Norway is holding up well against unusually high variable volumes last year, and both Sweden and Finland grew organically and improved margins. Management also highlighted promising tendering activity. For this reason, we anticipate accelerated adj. EBITA growth in the coming quarters (6%/14% y-o-y in Q3/Q4).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Limited changes to '26e-'28e adj. EBITA&lt;/h3&gt;&lt;p&gt;We cut sales and adj. EBITA by 1% for '26e-'28e, respectively. The effect on 2026 EBIT and EPS is greater, mainly due to restructuring costs incurred in Q2, as well as an SEK 20m one-off cost in Q3 resulting from an unfavourable ruling in Denmark regarding a customer case from 2022.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;The new strategy to bear fruit from Q4&lt;/h3&gt;&lt;p&gt;While Q3 will likely remain pressured by tough comps and the challenges in Denmark, we think Coor will return to solid earnings growth from Q4, supported by the new strategy presented at the CMD, which we find convincing. By returning to organic growth, and reaching margins &amp;gt;5.5% over the coming year, we see strong adj. EPS growth, cash generation and a solid gearing of 2.2x in 2027. The share is trading at 10x adj. P/E and P/FCF on 2027e, with 5% dividend y&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/coor/Equity-research/2026/7/coor---denmark-masks-underlying-improvements/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 16 Jul 2026 04:45:08 GMT</pubDate>
      <isin>SE0007158829</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Infrea - Paving it forward</title>
      <description>&lt;a id="bm-comp-f154187f-3da9-4b80-ba84-58f20480a174" name="bm-comp-f154187f-3da9-4b80-ba84-58f20480a174" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f154187f-3da9-4b80-ba84-58f20480a174" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Different stories depending on segment...&lt;/li&gt;&lt;li&gt;...overall better than we expected...&lt;/li&gt;&lt;li&gt;... but share price is pegged to Netel&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-59c91b3e-87a1-401c-8593-62da8ff3ac79" name="bm-comp-59c91b3e-87a1-401c-8593-62da8ff3ac79" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="59c91b3e-87a1-401c-8593-62da8ff3ac79" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Diverging segments with Paving carrying the beat&lt;/h3&gt;&lt;p&gt;Note, Infrea sold its Water &amp;amp; Sewage segment during Q4'25, and we have the segment in the comparable numbers for 2025. Infrea's Q2 was slightly better than expected at group level with sales +1% vs ABGSCe and EBITA +11% vs. ABGSCe but with sharply diverging segment performance. The beat was driven entirely by Paving Services (PS), where sales rose +29% y&amp;#8209;o&amp;#8209;y to SEK 239m, while Land &amp;amp; Construction (L&amp;amp;C) fell &amp;#8209;9% to SEK 376m on the absence of larger contracts and tougher comps. EBITA in PS rose to SEK 33m (+SEK 11m / +47% y-o-y) on the momentum but was held back by ~SEK 4m of one-off remediation costs at Duo Asfalt. L&amp;amp;C EBITA fell ~SEK 5m to SEK &amp;#8209;5m on distorted comps (Q2'25 included Mikaels Gr&amp;#228;vtj&amp;#228;nst at &amp;#8209;SEK 3m and unusually high volumes).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Now in the high production season&lt;/h3&gt;&lt;p&gt;We raise '26e-'28e EBITA by 10-15% on the reported beat and solid momentum in PS on both order intake and delivery. Bitumen was volatile in the quarter, but Infrea managed the pass-through well, which we view as a strength. Duo Asfalt is commissioning a new plant in Aug/Sep, which affected Q2, but should improve in H2. In L&amp;amp;C we expect the north to remain a headwind, but believe most write-downs are behind us as Infrea focuses on catching issues earlier and there have been fewer write-downs in recent years. On that basis, gradually improving margins support SEK 58m EBITA in '26e and a 19% EBITA CAGR over '25-'28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Infrea is pegged to Netel&lt;/h3&gt;&lt;p&gt;For now, Infrea's share price is pegged to Netel's, and we have removed our fair value range. The merger's exchange ratio is 17 new Netel shares for every 4 Infrea shares, i.e., 4.25 Netel shares per Infrea share. Netel closed today at SEK 3.1 per share, implying a value of SEK 13.2 per Infrea share. Netel reported on 10 July and the share is dow&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/infrea/Equity-research/2026/7/infrea---paving-it-forward/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 15 Jul 2026 18:30:08 GMT</pubDate>
      <isin>SE0010600106</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Svedbergs Group - Logistics drag persists into H2</title>
      <description>&lt;p&gt;&lt;a id="bm-comp-38a2b545-b53f-44df-842d-7b24f557267e" class="BMCustomAnchor" name="bm-comp-38a2b545-b53f-44df-842d-7b24f557267e"&gt;&lt;/a&gt;&lt;span style="color: #ff0000;"&gt;An earlier version of this report included incorrect numbers, due to a&lt;/span&gt;&lt;br /&gt;&lt;span style="color: #ff0000;"&gt;modelling error.&lt;/span&gt;&lt;/p&gt;
&lt;table&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; width: 100.000000%;"&gt;
&lt;ul&gt;
&lt;li&gt;EBITA margin -90bp y-o-y driven by well-flagged UK logistics...&lt;/li&gt;
&lt;li&gt;...which are likely to weigh on Q3-Q4 as well before move is done&lt;/li&gt;
&lt;li&gt;We reiterate our fair value range of SEK 57-77&lt;/li&gt;
&lt;/ul&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;a id="bm-comp-dd5021f4-188e-43dc-8ca9-0029676ac2a8" class="BMCustomAnchor" name="bm-comp-dd5021f4-188e-43dc-8ca9-0029676ac2a8"&gt;&lt;/a&gt;&lt;/p&gt;
&lt;table&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td style="vertical-align: top; width: 100.000000%;"&gt;
&lt;h3 class="bm-h3"&gt;Undramatic Q2, Thebalux was strong&lt;/h3&gt;
&lt;p&gt;UK growth slowed driven by softer end-markets, as previously flagged. The 2% reported UK org. growth is consistent with continued market share gains, however. In the Nordics, the consumer market was described as soft, but the project arm of the business kept growing. All in all, we consider the Q2 report rather undramatic - growth slowed slightly vs Q1 to +2% org., a deceleration that can be explained by tougher comps, and UK logistics kept weighing on profitability, as it did in Q1. From here, we expect a gradual recovery in Nordics, for Central Europe to keep performing well (Thebalux grew 4.5% org. y-o-y in Q2 and we assess its margin expanded ~1pp), but also for the UK market to remain soft throughout '26e.&lt;/p&gt;
&lt;h3 class="bm-h3"&gt;We await Roper Rhodes warehouse move in Q4&lt;/h3&gt;
&lt;p&gt;During the conference call, Svedbergs Group's CEO stated that UK logistics difficulties accounted for 0.8-1pp of the y-o-y margin decline for the Group. The Group EBITA margin decline was 90bp y-o-y, meaning UK logistics drove the full y-o-y margin contraction. We expect similar negative profitability effects from logistics in Q3, and a smaller effect in Q4 before the new warehouse is fully live. The CEO also said consultant costs weighed on Nordics Q2 profitability by ~SEK 1m, brought in to help turn the margin trend for the better (Nordics EBITA margin declined 20bp y-o-y&lt;br /&gt;in Q2).&lt;/p&gt;
&lt;h3 class="bm-h3"&gt;Svedbergs is trading at 11x/9x '26e/'27e EV/EBITA&lt;/h3&gt;
&lt;p&gt;We make only minor EBITA revisions in this note. Below the EBITA line, one-off M&amp;amp;A costs weighed for a downward revision of 6% on '26e net profit, mostly related to Q2 revisions. We raise our EPS forecasts due to a different UBC-related accounting than we had expected - it&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/svedbergs/Equity-research/2026/7/svedbergs-group---logistics-drag-persists-into-h2/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 15 Jul 2026 15:45:08 GMT</pubDate>
      <isin>SE0000407991</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Infrea - Strong quarter but pegged to Netel</title>
      <description>&lt;a id="bm-comp-9c411dd0-e543-482f-ad78-01f09cff16e5" name="bm-comp-9c411dd0-e543-482f-ad78-01f09cff16e5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9c411dd0-e543-482f-ad78-01f09cff16e5" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales +1%, EBITA +11% vs. ABGSCe, 3% org. growth&lt;/li&gt;&lt;li&gt;'26e-'28e EBITA estimates likely up 3-7%&lt;/li&gt;&lt;li&gt;Share to focus on good performance in Paving services&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-5bfbbd85-ea21-4f4b-aec1-b056dd697484" name="bm-comp-5bfbbd85-ea21-4f4b-aec1-b056dd697484" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5bfbbd85-ea21-4f4b-aec1-b056dd697484" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 details&lt;/h3&gt;&lt;p&gt;Infrea delivered a strong report. Organic sales was +3% y-o-y, and EBITA margin at 4.4% vs Q2'25 at 3.6%. However, the beat is purely driven by Paving services while Land &amp;amp; Construction was weaker than we expected. In Q4'25, Infrea sold the Water &amp;amp; Sewage segment. We included the segment in the comparable numbers for '25. Sales came in at SEK 611m (+1% vs. ABGSCe), +3% organic (-15% Q1'26), driven by Paving services. Adj. EBITA decined SEK -5m to SEK -5m in Land &amp;amp; Construction (vs ABGSC at 4m, Q2'25 at 0m) while EBITA grew in Paving Services to SEK 33m (SEK 13m above ABGSCe at 20m, Q2'25 at 23m). EBITA margin came in at 4.4% (ABGSCe 4.0%) driven by Paving services.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;Looking ahead, management is not providing a formal outlook. In the report, management comments that prices for fuel and plastic materials are volatile, and that they see continued high activity linked to data centres and discussions about Swedish power supply, but also a potentially brightening outlook for residential construction. We expect estimates for '26e-'28e adj. EBITA to come up by 3-7%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;A strong report with sales in line and EBITA above our expectations. Infrea and Netel intend to merge in Q4'26. Until then, Infrea's share price is pegged to Netel's, so we do not expect a stock-specific reaction. &lt;font style="background-color:#ffffff;"&gt;We believe that the market will focus on the continued positive margin development resulting from Infrea's hard internal work.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-cc361487-3a62-407d-b467-ec90fc88c1b7" name="bm-comp-cc361487-3a62-407d-b467-ec90fc88c1b7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cc361487-3a62-407d-b467-ec90fc88c1b7" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-29aac66c-d2e8-4350-a1c2-3c8e0027798d" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. expectations&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/infrea/Equity-research/2026/7/infrea---strong-quarter-but-pegged-to-netel/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 15 Jul 2026 07:15:09 GMT</pubDate>
      <isin>SE0010600106</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Coor - Solid earnings despite softer sales</title>
      <description>&lt;a id="bm-comp-072b58a6-0d69-4a02-b58f-44f386432b6f" name="bm-comp-072b58a6-0d69-4a02-b58f-44f386432b6f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="072b58a6-0d69-4a02-b58f-44f386432b6f" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Adj. EBITA 1% vs cons, -2% vs ABGSCe, up 3% y-o-y&lt;/li&gt;&lt;li&gt;Continued margin increase, and org. growth to improve in Q4-Q1&lt;/li&gt;&lt;li&gt;Estimates likely largely unchanged; CC at 10:00 CET&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-78d88940-f9c2-4483-aecd-90ddbfee4969" name="bm-comp-78d88940-f9c2-4483-aecd-90ddbfee4969" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="78d88940-f9c2-4483-aecd-90ddbfee4969" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Sales were stable but slightly below expectations (-2% vs ABGSCe and Infront consensus), driven by Norway and Denmark (6% and 3% below cons). Sales declined 3% y-o-y, whereof organic growth was -3% (positive in Sweden/Finland, and negative in Norway/Denmark). Adj. EBITA was SEK 170m, +3% y-o-y (-2% vs ABGSC and 1% vs cons), holding up better due to efficiency gains driving margin expansion (5.5% vs 5.2% last year). EBIT and net profit were in line with cons. FCF was weak due to seasonality and in line with last year (SEK -8m vs -9m last year) and the LTM cash conversion of 47% was in line with last quarter. Gearing of 2.5x was up slightly from 2.3x in Q1 due to the dividend and seasonal cash flow but down vs 2.9x last year.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and estimate changes&lt;/h3&gt;&lt;p&gt;Management said it looks forward to the rest of 2026 with confidence and expect that its initiatives to boost add-on sales will bear fruit. Near-term, comps remain tough on organic growth due to the contract losses in Denmark and high variable volumes in Norway in Q3 last year. But as these effects fade from Q4-Q1, we think Coor is well-positioned to come back to solid organic growth, while margins should continue to improve. We do not expect any material estimate changes on the back of the Q2 numbers.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;Overall, it was a solid report. The share has been weak into number, -14% L3M vs OMXSGI +3% and closest peer ISS +17%, and now trades at 10x adj. P/E and 10x EV/adj. EBITA on our 2027e vs its five-year average of 12x (NTM).&lt;/p&gt;&lt;p&gt;Management will host a presentation of the report at 10:00 CET, you can use this &lt;a data-bm-trackable="false" href="https://coor.events.inderes.com/q2-report-2026/register" target="_blank"&gt;link&lt;/a&gt; to participate.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-20182c8e-c4f3-4b1e-98c7-cb403065bc0d" name="bm-comp-20182c8e-c4f3-4b1e-98c7-cb403065bc0d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="20182c8e-c4f3-4b1e-98c7-cb403065bc0d" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-26e3e910-f54d-4549-bc33-0c08a282c07e" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviations&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data, Infront consensus&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/coor/Equity-research/2026/7/coor---solid-earnings-despite-softer-sales/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 15 Jul 2026 06:30:09 GMT</pubDate>
      <isin>SE0007158829</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Svedbergs Group - Nordics and one-offs weigh</title>
      <description>&lt;a id="bm-comp-ea867e0a-1372-4d8f-9242-8ddf8e81677c" name="bm-comp-ea867e0a-1372-4d8f-9242-8ddf8e81677c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ea867e0a-1372-4d8f-9242-8ddf8e81677c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Net sales SEK 592m, 0% vs ABGSCe, -1% vs Factset cons.&lt;/li&gt;&lt;li&gt;EBITA SEK 81m, -3% vs ABGSCe, -7% vs cons&lt;/li&gt;&lt;li&gt;Nordic markets remain soft&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c8cc5714-29f3-42a5-8ee0-07b65a916cad" name="bm-comp-c8cc5714-29f3-42a5-8ee0-07b65a916cad" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c8cc5714-29f3-42a5-8ee0-07b65a916cad" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 in brief: muted growth, Nordics and UBC dilute the margin&lt;/h3&gt;&lt;p&gt;Our overall impression is a soft quarter vs consensus, but broadly in line with our more cautious estimates on the top line and segment level. Net sales grew ~4% y-o-y to SEK 592m, -1% vs Factset cons (SEK 601m) and in line with ABGSCe (SEK 590m). Organic growth was 1.8% (cons 3%, ABGSCe 1.2%), and UBC (consolidated from 8 June) added 4%. Gross margins were 47.7%, +70bp y-o-y but ~20-30bp below forecasts. By segment (vs ABGSCe): UK EBITA was SEK 49m vs SEK 48m expected, with the margin down ~180bp y-o-y to 16.7% on logistics costs from running five parallel warehouses ahead of the DC move, this was well-flagged; Central Europe EBITA was SEK 30m, in line with our forecast, with UBC diluting the margin; the EBITA miss was Nordics at SEK 14m vs ABGSCe SEK 17m, with Sweden and Finland still weak. Group EBITA was SEK 81m (SEK 83m), -4% vs ABGSCe and -7% vs cons, for a margin margin 13.7%. Below EBITA, SEK 9m of UBC acquisition costs (not in forecasts) plus higher interest costs took EPS to SEK 0.78, -22% vs cons. Adjusted for UBC costs, we assess the miss is 6% on net profit.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook: Demand decent despite geopolitical uncertainty&lt;/h3&gt;&lt;p&gt;Management describes underlying demand as decent despite geopolitical uncertainty. The key operational catalysts flagged are the UK distribution centre move-in during late Q4 (seasonally low volumes), which replaces the five current warehouses and should materially improve cost efficiency, and UBC integration with purchasing and product synergies. Nordic commentary is unchanged in tone from Q1: Denmark strong, Finland challenging, Sweden slightly weaker.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Conclusion: the report moves consensus EBITA by -2%&lt;/h3&gt;&lt;p&gt;The share has returned -4% L3M, which can suggest low expectations into numbers, and is now trading at 11.4x-9.4x our '26e-'27e EV/EBITA vs a historical trading range o&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/svedbergs/Equity-research/2026/7/svedbergs-group---nordics-and-one-offs-weigh/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 15 Jul 2026 06:00:18 GMT</pubDate>
      <isin>SE0000407991</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nexam Chemical - Solid Q2, profitability within reach</title>
      <description>&lt;a id="bm-comp-b9620356-9c42-48ad-84d2-24f2cb6add39" name="bm-comp-b9620356-9c42-48ad-84d2-24f2cb6add39" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b9620356-9c42-48ad-84d2-24f2cb6add39" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales SEK 60m (+9% vs. ABGSCe), first EBIT-positive quarter&lt;/li&gt;&lt;li&gt;We continue to forecast full-year profitability from '27e&lt;/li&gt;&lt;li&gt;Recycling +76% y-o-y, '26 doubling ambition intact&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-742f0b8d-0845-4c2b-b71a-7d9f3205d079" name="bm-comp-742f0b8d-0845-4c2b-b71a-7d9f3205d079" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="742f0b8d-0845-4c2b-b71a-7d9f3205d079" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p style="text-align:left;"&gt;Nexam reported record quarterly sales of SEK 60m (+11% y-o-y, +9% vs. ABGSCe), after a weaker Q1. Recycling was again the highlight at SEK 10.2m (+76% y-o-y), passing SEK 10m in a quarter for the first time, while Performance Chemicals rose 16% and Masterbatch 7%. Lightweighting improved vs. a weak Q1, although management notes quarterly fluctuations remain, and High Temperature is still held back by NA destocking. EBIT came in positive at SEK 0.1m (ABGSCe -1.8m). The profitability came from operating leverage: +11% sales growth on a broadly flat cost base.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We only partially extrapolate the strong Q2 into the rest of '26e, as quarterly sales remain volatile and management flags Q3 as the seasonally weaker holiday quarter. We raise '26e-'28e sales by 1-2% and total EBIT by SEK 3m after the report, and continue to expect Nexam to reach positive full-year EBIT in '27e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Recycling becoming an earnings driver&lt;/h3&gt;&lt;p&gt;At ~17% of sales and growing 76%, Recycling is transitioning from option value to earnings driver, supported by the virgin-price surge (PET/PE +40% in June per management) that shifts recycling from sustainability choice to cost necessity, consistent with the thesis in our Q1 note. The concentration point cuts both ways: growth so far is driven by a few large accounts ramping up, and the pipeline's conversion to serial production is the key swing factor for the doubling ambition in 2026. The share has returned +39% L3M (vs. peers +5%, OMXSALLS +3%) and is trading at 1.7x-1.3x '26e-'28e EV/Sales vs. the peer median of 1.3x-0.7x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nexam-chemical/Equity-research/2026/7/nexam-chemical---solid-q2-profitability-within-reach/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 14 Jul 2026 17:30:07 GMT</pubDate>
      <isin>SE0005101003</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nexam Chemical - Record sales and first positive EBIT</title>
      <description>&lt;a id="bm-comp-afcc84d6-0317-453c-99b7-81f5a072e63c" name="bm-comp-afcc84d6-0317-453c-99b7-81f5a072e63c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="afcc84d6-0317-453c-99b7-81f5a072e63c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Record quarterly sales: SEK 60m (+11% y-o-y), +9% vs. ABGSCe&lt;/li&gt;&lt;li&gt;EBIT positive at SEK 0.14m (vs. ABGSCe -1.8m)&lt;/li&gt;&lt;li&gt;Recycling now ~17% of sales (+76% growth y-o-y)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-77daa949-3f18-4351-9959-7e662935623d" name="bm-comp-77daa949-3f18-4351-9959-7e662935623d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="77daa949-3f18-4351-9959-7e662935623d" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 results&lt;/h3&gt;&lt;p&gt;Nexam reported record high quarterly sales at SEK 60m (+9% vs. ABGSCe 55m), +11% y-o-y. Growth was driven by Recycling (SEK 10.2m, +76% y-o-y, first quarter above SEK 10m), with Performance Chemicals up 16% and Performance Masterbatch up 7%, while High Temperature remained soft on North American destocking. EBIT turned positive for the first time in the company's history at SEK 0.14m (vs. ABGSCe -1.8m), for a margin of +0% (ABGSCe -3%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates and outlook&lt;/h3&gt;&lt;p&gt;On numbers alone, '26e-'28e sales change by +2%, and EBIT adj. changes by SEK +1.9m. Management sees "favourable conditions" for continued strong Recycling growth in H2, supported by a growing pipeline and new distributors in France and Turkey, but flags Q3 as the seasonally weaker holiday quarter.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;The share has returned +19% L3M (vs. peer median +5% and OMX Stockholm Allshare +3%), and is currently trading at 1.5x-1.2x '26e-'28e EV/Sales on our pre-report estimates vs. the peer median of 1.3x-0.7x. The company will host a &lt;a data-bm-trackable="false" href="https://www.youtube.com/live/qO9DpV1dwdY" target="_blank"&gt;presentation&lt;/a&gt; of the Q2 results at 09:30 CEST.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f8710733-3989-4f44-a929-404310a45102" name="bm-comp-f8710733-3989-4f44-a929-404310a45102" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f8710733-3989-4f44-a929-404310a45102" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-cf51513a-0d0d-43bd-a925-552b4b3d74df" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nexam-chemical/Equity-research/2026/7/nexam-chemical---record-sales-and-first-positive-ebit/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 14 Jul 2026 07:00:05 GMT</pubDate>
      <isin>SE0005101003</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Eastnine - Warsaw to become the largest market</title>
      <description>&lt;a id="bm-comp-e307d273-173c-4066-8ea1-2313dfd9ceb1" name="bm-comp-e307d273-173c-4066-8ea1-2313dfd9ceb1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e307d273-173c-4066-8ea1-2313dfd9ceb1" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 report broadly in line with expectations&lt;/li&gt;&lt;li&gt;The Bridge deal is the largest incremental news&lt;/li&gt;&lt;li&gt;Significant earnings growth in 2027/2028e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-0cfcae45-df46-4b7e-997d-f50937743d21" name="bm-comp-0cfcae45-df46-4b7e-997d-f50937743d21" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0cfcae45-df46-4b7e-997d-f50937743d21" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 report wrap&lt;/h3&gt;&lt;p&gt;Eastnine's Q2 report saw rental income and NOI in line with expectations, while rec PTP was burdened by the large cash position and costs related to build-up of the organisation in Poland. The occupancy rate surprised positively and came in at 96.5% (+0.9pp q-o-q) while earnings capacity contracted sequentially on the Riga divestments, as expected.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;The Bridge drives estimate revisions&lt;/h3&gt;&lt;p&gt;As we highlighted in our &lt;a data-bm-trackable="false" href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fabgsc.bluematrix.com%2Flinks2%2Fdoc%2Fpdf%2F35f38c46-7d8e-4763-a391-2cd73c5cfcf3&amp;amp;data=05%7C02%7Cfredrik.stensved%40abgsc.se%7C7eba573468474e9f5a8608dedbeda725%7C853e8b8340544eb98b26ec6513dd213d%7C0%7C0%7C639190010926899145%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;amp;sdata=dbXatOAAmONSKK32WNiEVqhbMY0bZNl5gBzH9XCWPkI%3D&amp;amp;reserved=0" target="_blank"&gt;fast comment&lt;/a&gt; last Tuesday, Eastnine has acquired The Bridge in central Warsaw with a rental value of EUR 18.2m at an underlying property value of EUR 300m. The occupancy rate is 92% and the deal will be financed with existing cash, new debt, and refinancings of the existing portfolio. We understand that the purchase price of EUR 260m is lower than the property value of EUR 300m due to remaining tenant adaptations (~EUR 15m), deductions for initial vacancies (e.g. Visa will move in during 2027) and rental discounts. Management sounds confident that the letting ratio will surpass the current 92% at completion (Q4'26e), but tenants will move in gradually, meaning that the reported occupancy will come down initially while the full effect from the acquisition will only start to show in 2028e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Prime assets but with high yields&lt;/h3&gt;&lt;p&gt;Unlike the Swedish office market, Eastnine's core markets are seeing strong GDP growth, low office vacancies and positive rent reversion. Supply growth is falling and demand remains solid. We expect this to fuel stronger like-for-like rental income growth than Swedish peers, and significantly better cash flow, especially after maintenance capex. At a normalised cash ROE (CEPS/EPRA NRV) of ~6.7%, the returns are more comparable to Swedish industrial companies (Catena/Sagax/SLP at ~7%) than office companies (Atrium Ljungberg, Fabege, Hufvudstaden at ~3%), but with prime CBD assets.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/eastnine/Equity-research/2026/7/eastnine---warsaw-to-become-the-largest-market/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 14 Jul 2026 06:45:06 GMT</pubDate>
      <isin>SE0002158568</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ascelia Pharma - CRL update</title>
      <description>&lt;a id="bm-comp-7a3c88de-014a-40f9-915c-63235e23d84c" name="bm-comp-7a3c88de-014a-40f9-915c-63235e23d84c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7a3c88de-014a-40f9-915c-63235e23d84c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;CRL questions SPARKLE endpoint analysis; re-read rejected&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Ascelia disputes both points; &lt;font color="#000000"&gt;expresses confidence&lt;/font&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Type A meeting next; outcomes range widely&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-2b4dfe49-b6f6-4bc6-a192-6cac685a32b8" name="bm-comp-2b4dfe49-b6f6-4bc6-a192-6cac685a32b8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2b4dfe49-b6f6-4bc6-a192-6cac685a32b8" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;The CRL's stated grounds&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;In the CRL (Complete Response Letter), the FDA states that SPARKLE failed its co-primary endpoints on the initial read, and rejects the subsequent re-evaluation on two grounds: i.) a risk that new readers were influenced by prior knowledge of the images/results; and ii) a scoring scope limited to T1-weighted images, which the FDA says cannot show added value over standard-of-care imaging (which includes non-T1 sequences).&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Ascelia's response&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;The company disputes both points. It states the second reade&lt;font color="#000000"&gt;rs had no prior knowledge of the images or earlier results, directly countering the FDA's bias concern. On imaging scope, the FDA's comment concerns what was &lt;em&gt;scored&lt;/em&gt; in the re-read, while Ascelia's statement concerns what was &lt;em&gt;acquired&lt;/em&gt; in the trial (confirming T1, T2 and DWI sequences were all collected), a distinction the company appears confident resolves the concern once clarified with the FDA. Ascelia also states its re-read approach was discussed with the FDA pre-submission, though the CRL itself does not address this either way. On product documentation, management seems confident and expects resolution in the near term.&lt;/font&gt; Overall, Ascelia maintains that SPARKLE was an adequate and well-controlled pivotal study providing a robust basis for evaluating Orviglance, while remaining confident the product documentation issues can be resolved in the near term.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;What's next?&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Ascelia maintains that it will submit a briefing package and request an expedited FDA Type A meeting, which, if granted, is typically held within 30 days of the request. Outcomes could range from a relatively quick resolution based on clarification alone, to a further re-read scoring the full set of acquired sequences rather than T1 only, or, in the worst case, a ne&lt;font color="#000000"&gt;w pivotal trial with fresh patient data, a materially tougher and likely unfe&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/ascelia-pharma/Equity-research/2026/7/ascelia-pharma---crl-update/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 13 Jul 2026 18:00:04 GMT</pubDate>
      <isin>SE0010573113</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Medicover - Steady as she goes</title>
      <description>&lt;a id="bm-comp-81ce4423-30f4-4d58-9f8d-ed8ad029bfcc" name="bm-comp-81ce4423-30f4-4d58-9f8d-ed8ad029bfcc" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="81ce4423-30f4-4d58-9f8d-ed8ad029bfcc" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2'26 numbers due on 22 July at 07:45 CET&lt;/li&gt;&lt;li&gt;Minor estimate changes, margins unchanged&lt;/li&gt;&lt;li&gt;Fair value range kept at SEK 190-270&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7b1117e1-e789-43c2-8c08-8e33e0ee415c" name="bm-comp-7b1117e1-e789-43c2-8c08-8e33e0ee415c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7b1117e1-e789-43c2-8c08-8e33e0ee415c" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2'26 expectations&lt;/h3&gt;&lt;p&gt;For Q2, we expect Medicover to perform broadly in line with Q1'26. In Poland and Romania, government funding pressures are creating a near-term headwind in the publicly funded segment. However, we expect volumes to recover over time through a higher FFS mix. For HS, we forecast org. growth of 10.5% and an EBITDAaL margin of 13.0%. In Germany, we expect the lab business to remain stable despite tighter public funding reimbursement. For DS, we forecast org. growth of 9% and an EBITDAaL margin of 13.8%. We expect India to keep building momentum as new hospital capacity ramps up, although growth should moderate from a very strong Q1'26. In June, Medicover confirmed discussions with KKR regarding a potential sale of its 66.9% stake in the Indian business (USD 1bn+), while continuing to pursue an IPO in parallel. No transaction is certain. In total, we forecast sales of EUR 641m, driven by ~10% org. growth, and adj. EBITDA of EUR 111m (17.3% margin).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Minor estimate changes&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;We make minor downward revisions to our estimates into the Q2 results, reflecting a slightly more cautious near-term view on the publicly funded segment in Poland and Romania. Margins are left unchanged across both divisions and at the group level, and our long-term assumptions remain intact. We believe the ongoing FFS mix shift across both HS and DS supports continued margin improvement and operational leverage as the network matures.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range unchanged at SEK 190-270&lt;/h3&gt;&lt;p&gt;We leave our fair value range unchanged at SEK 190-270. The range is derived from the trading multiples of two peer groups &amp;#8211; one with healthcare providers in developing countries and one in developed countries &amp;#8211; alongside a DCF. The range corresponds to a '26e EV/EBITDA of 9x-12x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/medicover/Equity-research/2026/7/medicover---steady-as-she-goes/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 13 Jul 2026 17:00:04 GMT</pubDate>
      <isin>SE0009778848</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Arctic Paper - Pulp beats paper</title>
      <description>&lt;a id="bm-comp-b870c38a-0eaa-402e-95b4-6f14e79f98e8" name="bm-comp-b870c38a-0eaa-402e-95b4-6f14e79f98e8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b870c38a-0eaa-402e-95b4-6f14e79f98e8" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2e: we expect Paper EBIT of ~PLN -20m&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Pulp costs up following Suzano hikes&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range of SEK 15-50&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9860a1b8-82d4-4419-8002-00ead719ef0d" name="bm-comp-9860a1b8-82d4-4419-8002-00ead719ef0d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9860a1b8-82d4-4419-8002-00ead719ef0d" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2e Paper EBIT of ~PLN -20m&lt;/h3&gt;&lt;p&gt;We expect Q2 to be another challenging quarter, with negative volume effects and higher costs q-o-q. Arctic Paper announced price hikes in April and June of 8-10% and 4-8% respectively. We estimate that the somewhat strong Q1 volumes were driven by short-term effects ahead of the price hikes, and that Q2 will see a reversal of the positive effects. Furthermore, our trackers indicate that the increases in selling prices were insufficient to offset higher pulp costs. Coupled with headwinds from the Middle East conflict &amp;#8211; i.e. higher logistics and chemical costs &amp;#8211; we see pressure on Q2 (note the large sensitivities to input costs, hence the large estimate revisions). Our bridge now points to Q2 Paper EBIT of ~PLN -20m, down from PLN -2m in Q1 and FY Paper EBITDA of ~74m. Q3 should remain difficult, with slow demand and still high input costs. Q4 should be helped by energy compensation.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Pulp costs up following Suzano hikes&lt;/h3&gt;&lt;p&gt;Paper markets remain structurally oversupplied at ~75% utilisation, and while the ~4% supply cuts for '26 help, the market still needs ~3mt of capacity cuts to reach historical utilisation. The pulp market faced headwinds in '25, but key drivers are now moving in the right direction. Hardwood prices are up ~20% (40% in EU) following Suzano&amp;#8217;s +30% hikes. This is a headwind for Arctic but a tailwind for Rottneros. We note, however, that Rottneros' exposure is mainly to softwood and CTMP, which have lagged hardwood. Softwood is slightly up, and with lower wood costs, Rottneros could improve q-o-q.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of SEK 15-50&lt;/h3&gt;&lt;p&gt;The company is trading at an EV/CE multiple of ~0.45x, which is ~40% below its historical average. We have applied three valuation methodologies and arrive at a fair value range of SEK 15-50.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/arctic-paper/Equity-research/2026/7/arctic-paper---pulp-beats-paper/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 13 Jul 2026 16:15:04 GMT</pubDate>
      <isin>PLARTPR00012</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>StrongPoint - The American dream</title>
      <description>&lt;a id="bm-comp-689f5fdf-9fbf-4915-a015-512268218f28" name="bm-comp-689f5fdf-9fbf-4915-a015-512268218f28" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="689f5fdf-9fbf-4915-a015-512268218f28" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;A stable quarter with solid EBITDA&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#1B2634"&gt;&lt;font color="#000000"&gt;One step back at Sainsbury's, a leap into the US&lt;/font&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range of NOK 8-18 per share&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-710b8663-47e8-42e6-8605-c5cb02e37d05" name="bm-comp-710b8663-47e8-42e6-8605-c5cb02e37d05" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="710b8663-47e8-42e6-8605-c5cb02e37d05" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#000000"&gt;A stable quarter with solid EBITDA&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Q2 delivered revenues of NOK 342m, -2% y-o-y (ABGSCe NOK 343m). Growth was s&lt;font color="#000000"&gt;trong&lt;/font&gt; in UK &amp;amp; Ireland (+25% y-o-y) and Spain (+35%), while the Nordics fell 22% on the ESL partner transition. GM came in at 42.7% vs. our 44%, yielding gross profit ~3% below us. EBITDA landed at NOK 5m (ABGSCe NOK 3m), but note that this includes a NOK 4m one-off, i.e adj. EBITDA was NOK 9m and the adj. margin 2.6% (vs. ABGSCe 0.9%). Clean opex was ~7% better than forecast, which we view as impressive. Disposable funds increased to NOK 98m on stronger cash flows and net debt fell to NOK 57m (NOK 91m in Q1).&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#000000"&gt;One step back at Sainsbury's, a leap into the US&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Order Picking performance remains mixed: Sainsbury's is rolling out slower than planned, and the two sides have agreed a temporary cut to the volume commitment, which weighs on near-term licence revenue. Against this, StrongPoint has got its first taste of the American dream with its first US Order Picking customer, marking a breakthrough into the largest Western grocery market. Focus lies on cost savings initiatives and converting signed Order Picking agreements into recurring revenue. The Pricer recurring run-off will remain a headwind through '26: the rolling 12-month ESL licence and service base will fall from NOK 52m at end-2025 to zero by end-2026, with the Vusion offset building over time.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;Fair value range of NOK 8-18 per share&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Q2 was a stable quarter, with flattish revenue and an EBITDA beat on lower opex. The pipeline is building - Meijer, Coop Estonia, AutoStore contracts and a new CashGuard Connect pilot in Spain. The path to sustained profitability will have ups and downs, but the overall direction is positive. Our DCF indicates an equity value of ~NOK 650m, and we see a fair value range of NOK 8-18.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/StrongPoint/Equity-research/2026/7/strongpoint---the-american-dream/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 10 Jul 2026 16:00:43 GMT</pubDate>
      <isin>NO0010098247</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Careium - The pressure valve starting to open</title>
      <description>&lt;a id="bm-comp-032d82c1-486c-4830-b794-097a739c5b7a" name="bm-comp-032d82c1-486c-4830-b794-097a739c5b7a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="032d82c1-486c-4830-b794-097a739c5b7a" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Strong growth, margin squeeze softer than expected&lt;/li&gt;&lt;li&gt;We raise our '26-'28 EBIT estimates by 3-4%&lt;/li&gt;&lt;li&gt;Share is trading at 13x-8x '26e-'28e EV/EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f96e885f-5523-406d-a022-75c348814675" name="bm-comp-f96e885f-5523-406d-a022-75c348814675" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f96e885f-5523-406d-a022-75c348814675" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;A beat on all accounts&lt;/h3&gt;&lt;p&gt;Q2 was a strong quarter in terms of growth, with SEK 251m in sales, representing 26% organic growth. This was ~10% above our expectations. Careium also delivered an EBIT margin of 6%, which was 1.5pp above our estimated 4.5% and resulted in an EBIT beat of ~50% (SEK 15m vs. estimated 10m). Q2'25 supplied a light comp (sales -9% y-o-y), but we are impressed by the cost control. All regions showed strong growth, with the Nordics being the weakest link at 14%. The gross margin was weighed down by the phasing in of a new, large, Norwegian contract and a 5.5m installation project in the UK, connected to the A2D transformation. Opex grew 18% in the quarter, mainly on SD&amp;amp;M as well as continued high R&amp;amp;D costs.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;H1 held the line, H2 should push forward&lt;/h3&gt;&lt;p style="text-align:left;"&gt;Careium had previously guided for margin pressure in H1, and hinted towards a normalisation in H2. We do not believe the company will report H2 EBIT margins in line with e.g. 2024 (10%), but as the margin pressure from the onboarding of the Norwegian contract should be mostly over and Careium has taken steps to improve its underlying profitability, we believe it can deliver an H2 EBIT margin of 9%. For reference, the H2 margin in 2025 was 6%, mainly due to a very soft Q4'25.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Solid outlook - we raise EBIT&lt;/h3&gt;&lt;p&gt;&lt;font color="#212529"&gt;We raise&lt;/font&gt; &lt;font color="#212529"&gt;'26e-'28e sales by 3-4%&lt;/font&gt; on the back of the report and &lt;font color="#212529"&gt;u&lt;/font&gt;pdated FX movements. Our '26e-'28e EBIT estimates are also up 3-4%, as we do not make significant changes to our margin assumptions. Our EPS estimates are, however, lifted by 11-5% due to lower than expected interest payments in recent quarters. Our estimates imply '26e-'28e sales and adj. EBIT CAGRs of 9% and 25%. On our updated estimates, the share is trading at 13x-8x '26e-'28e EV/EBIT. We reiterate o&lt;font color="#212529"&gt;ur fair value range of SEK 20-34.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/careium/Equity-research/2026/7/careium---the-pressure-valve-starting-to-open/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 10 Jul 2026 16:00:09 GMT</pubDate>
      <isin>SE0017131824</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>StrongPoint - Solid Q2 performance</title>
      <description>&lt;a id="bm-comp-888e73e6-4606-46b9-b726-cca405c88990" name="bm-comp-888e73e6-4606-46b9-b726-cca405c88990" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="888e73e6-4606-46b9-b726-cca405c88990" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q2 reported EBITDA NOK 5m vs ABGSCe NOK 3m&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;One step back at Sainsbury's, a leap into the US&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Pricer transition temporary drag, offset by Vusion momentum&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-e17832a9-1176-4c05-879e-8dd43ba680aa" name="bm-comp-e17832a9-1176-4c05-879e-8dd43ba680aa" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e17832a9-1176-4c05-879e-8dd43ba680aa" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;Q2: Reported EBITDA of NOK 5m vs ABGSCe NOK 3m&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Sales were down ~2% y-o-y, with strong performance in Ireland &amp;amp; UK (+25% y-o-y) and Spain &amp;amp; the Baltics (+35% and +8%, respectively), offset by the Nordics declining 22% y-o-y driven by loss of recurring revenues from former ESL partner.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font color="#000000"&gt;Total revenues came in at NOK 342m, vs our NOK 343m. GP was -3% vs. our estimate, driven by a gross margin of 42,7% (ABG 44.0%). EBITDA came in at NOK 5m but included a NOK 4m one-off, i.e. adj. EBITDA 9m vs. ABGSCe NOK 3m, on weaker gross margin offset by lower opex. EBITDA margin landed at 1.4% and adj. EBITDA at 2.6% (vs. ABGSCe 0.9%). EPS came in at NOK -0.19 vs. ABGSCe NOK -0.18. Net debt came in at NOK 57m (NOK 91m in Q1).&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font color="#000000"&gt;StrongPoint sees scope for continued improvement in both EBITDA and recurring revenue. It points to identified cost initiatives (admin and IT, plus productivity in support and development) to lift EBITDA, and to delivery of the signed Order Picking agreements as the route to projected recurring revenue. Quarterly fluctuations are expected given variable project timing, but the long-term ambitions are unchanged: healthy revenue growth and a &amp;gt;10% EBITDA margin.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#000000"&gt;&lt;strong&gt;One step back at Sainsbury's, a leap into the US&lt;/strong&gt;&lt;/font&gt;&lt;/h3&gt;&lt;p style="text-align:left;"&gt;&lt;font color="#000000"&gt;Order Picking delivered one setback and one breakthrough in the quarter. Sainsbury's is live in a double-digit number of stores, fewer than first anticipated, and the two sides have agreed a temporary cut to the volume commitment, which weighs on near-term license and recurring revenue. Management frames it as a complex integration needing more work from both parties, with the rollout continuing into Q3 and the original volume commitment expected to be restored thereafter. The offset landed on 3 July: Meijer, StrongPoint's first US Order Picking customer and a USD 22bn regional grocer with 500+ supercenters&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/StrongPoint/Equity-research/2026/7/strongpoint---solid-q2-performance/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 10 Jul 2026 06:15:07 GMT</pubDate>
      <isin>NO0010098247</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Careium - Growth's comeback tour continues </title>
      <description>&lt;a id="bm-comp-bbbc50ea-2b16-409a-82e3-40a642beb6c1" name="bm-comp-bbbc50ea-2b16-409a-82e3-40a642beb6c1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bbbc50ea-2b16-409a-82e3-40a642beb6c1" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2 sales 10% above our ests. at SEK 251m, for 26% org. growth&lt;/li&gt;&lt;li&gt;Adj. EBIT SEK 15m vs. ABGSCe 10m&lt;/li&gt;&lt;li&gt;Trading at 12x-9x '26e-'27e EV/EBITA adj.&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-cb213a97-709d-4609-98fe-2ab04f0b2888" name="bm-comp-cb213a97-709d-4609-98fe-2ab04f0b2888" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cb213a97-709d-4609-98fe-2ab04f0b2888" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;An exceptional growth quarter on a forgiving comp&lt;/h3&gt;&lt;p&gt;Q2 came in better than expected on all accounts. Careium delivered sales of SEK 251m (10% vs ABGSCe 228m), corresponding to y-o-y organic growth ex. FX of 25.6% (12.6pp vs ABGSCe 13.0%). Segment wise, service sales was SEK 179m, and product sales was SEK 72m. The gross margin decreased by 0.8pp to 42.5% (0.3pp vs ABGSCe 42.2%). Opex came in at SEK -92m (7% vs ABGSCe -86m). EBIT amounted to SEK 15m (48% vs ABGSCe 10m), for a margin of 6.0% (1.5pp vs ABGSCe 4.5%), vs. 4.9% Q2'25. The Nordics grew by 14%, and all remanding regions reported growth above 30%, which is impressive. The only sub-segment that was down was product sales in the Nordics. However, keep in mind that Q2'25 posted -12% growth, providing light comps. FCF was positive in the quarter and came in at SEK 4.7m (vs. 1m Q2'25), driven by the strong earnings but somewhat dragged down by working capital build-up. H1'26 FCF is still negative, at SEK -9m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Well on its way but not quite there yet&lt;/h3&gt;&lt;p&gt;We are encouraged by the better-than-expected earnings, and believe that Careium still has room to increase its margins going forward. While the EBIT margin improved y-o-y, earnings are still being weighed down by product development, partly driven by a lower capitalisation ratio, and growth initiatives. The gross margin was also negatively affected by an installation project of SEK 5.5m with a "limited margin", in connection with the A2D transformation in the UK. Moreover, the previously mentioned onboarding of a large contract in Norway continued to add margin pressure through upfront costs. The technical integration is described as complete, which could be read as the margin drag from onboarding starting to roll off, but management doesn't say this explicitly for guidance purposes.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Hybrid loan settled, creating a possibility of dividends&lt;/h3&gt;&lt;p&gt;We &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/careium/Equity-research/2026/7/careium---growths-comeback-tour-continues-/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 10 Jul 2026 06:00:17 GMT</pubDate>
      <isin>SE0017131824</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Infrea - Road tripping with Netel</title>
      <description>&lt;a id="bm-comp-21cda861-04f2-409c-9f28-a4192b459740" name="bm-comp-21cda861-04f2-409c-9f28-a4192b459740" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="21cda861-04f2-409c-9f28-a4192b459740" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;The merger in focus for now&lt;/li&gt;&lt;li&gt;Three announced orders in the quarter&lt;/li&gt;&lt;li&gt;Infrea's share price pegged to Netel's&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-5252dfd9-ed09-4a25-a273-494022589da2" name="bm-comp-5252dfd9-ed09-4a25-a273-494022589da2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5252dfd9-ed09-4a25-a273-494022589da2" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Merger with Netel&lt;/h3&gt;&lt;p&gt;The main event in the quarter is the merger between Infrea and Netel, as we wrote about in our Fast Comment (&lt;a data-bm-trackable="false" href="https://abg-portal.bluematrix.com/report/d6dfc35f-eb52-45c6-94f7-0b5e7643d86d" target="_blank"&gt;Infrea and Netel to merger&lt;/a&gt;). Completion is conditional on approval at extraordinary general meetings in August '26, competition clearance, and Netel's rights issue of ~SEK 127m, with registration at the Swedish Companies Registration Office expected in Q4'26. A prospectus with more detail on the combined company will be published in July '26. The combined entity will have revenues of ~SEK 5bn and is expected to generate annual cost synergies of ~SEK 50m within 12&amp;#8211;24 months, with Infrea's CEO Martin Reinholdsson as new CEO. The merger diversifies the portfolio, lowers the risk, and lets the company leverage its greater scale. Infrea's management has a proven track record of turning around infrastructure companies, from Infrea in '23, key for Netel given its current state.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Focus in the quarter&lt;/h3&gt;&lt;p&gt;During the quarter, Infrea has announced three order wins, one of which contains several contracts, for an amount of SEK 360m. It is positive to see Infrea being able to take on larger contracts, leveraging the scale of the group. For estimates, we lower '26e sales by 1% and '26e EBITA by SEK 3m as we believe Q2'26 will have a tough comp in Paving Services. We now forecast '26 adj. EBITA of SEK 53m (SEK 49m '25), accelerating to SEK 65m in 2027e, as margins rise from 2.2% in '25 to 3.0% in '27e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Infrea is pegged to Netel&lt;/h3&gt;&lt;p&gt;For now, Infrea's share price is pegged to Netel's, and we have therefore removed our fair value range. The merger's exchange ratio is 17 new Netel shares for every 4 Infrea shares, i.e., 4.25 Netel shares per Infrea share. Netel closed today at SEK 3.31 per share, implying a value of SEK 14.07 per Infrea share. Netel reports on 10 July and currently has no analyst consensus.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/infrea/Equity-research/2026/7/infrea---road-tripping-with-netel/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 09 Jul 2026 15:45:07 GMT</pubDate>
      <isin>SE0010600106</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Alligo - Softer growth, but margin recovery continues</title>
      <description>&lt;a id="bm-comp-c76f3c12-7b3f-416f-a26c-8bc9ee4720bf" name="bm-comp-c76f3c12-7b3f-416f-a26c-8bc9ee4720bf" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c76f3c12-7b3f-416f-a26c-8bc9ee4720bf" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We see 1% organic growth in Q2 as the winter weather boost fades&lt;/li&gt;&lt;li&gt;Cost savings and FX lift adj. EBITA margin 1.4pp y-o-y to 7.2%&lt;/li&gt;&lt;li&gt;New CEO Samuel Alteborg took over the helm on 1 June&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7550d20c-0897-4176-909c-33d8cdcacaf0" name="bm-comp-7550d20c-0897-4176-909c-33d8cdcacaf0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7550d20c-0897-4176-909c-33d8cdcacaf0" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 expectations&lt;/h3&gt;&lt;p&gt;The strong Q1 organic growth of 5% was boosted by cold winter weather, which naturally did not recur in Q2. With underlying demand stable q-o-q, we forecast organic growth of 1%, with FX and bolt-on M&amp;amp;A lifting total growth to around 4%. The positive gross margin trend should persist, driven by own-brand sales and favourable FX, and we forecast 41.5% (40.1%). Together with the final quarter of benefit from the H2'25 cost savings, this takes the adj. EBITA margin to 7.2% (5.8%). We expect the Finland restructuring to continue, but at a lower one-off cost than in Q1, at around SEK -4m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We make only very minor changes, leaving our '26e-'28e estimates broadly unchanged. Sweden continues to develop well, while the Finland restructuring keeps weighing somewhat on the near-term results, albeit with lower one-off costs in Q2 than in Q1.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;Samuel Alteborg took over as CEO on 1 June, having previously led rental company Cramo, and we look forward to hearing his strategy for Alligo after the summer. Our early impression is that his experience is highly relevant and that near-term continuity is intact. Our overall view is unchanged: Alligo should reap the rewards of an improving market over the coming years, with organic growth driving further margin recovery and, in turn, substantial adj. EPS growth of around 25% in '26e. The share is trading at a '26e-'28e P/E of 12-9x, and we reiterate our fair value range of SEK 120-190.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/Alligo/Equity-research/2026/7/alligo---softer-growth-but-margin-recovery-continues/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 08 Jul 2026 16:00:04 GMT</pubDate>
      <isin>SE0009922305</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Qliro - Key earnings drivers intact</title>
      <description>&lt;a id="bm-comp-5e282c0c-22db-4c6a-9c15-32a88bb2d816" name="bm-comp-5e282c0c-22db-4c6a-9c15-32a88bb2d816" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5e282c0c-22db-4c6a-9c15-32a88bb2d816" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Merchant onboarding and TPV remain key Q2 watch points&lt;/li&gt;&lt;li&gt;Forecasts unchanged ahead of Q2&lt;/li&gt;&lt;li&gt;Key earnings drivers intact&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-6cb70fc3-c110-40d0-9d11-40433ee1f0cb" name="bm-comp-6cb70fc3-c110-40d0-9d11-40433ee1f0cb" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="6cb70fc3-c110-40d0-9d11-40433ee1f0cb" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Merchant growth to remain the key driver&lt;/h3&gt;&lt;p&gt;Following Q1&amp;#8217;s return to profitability, we expect Qliro to remain profitable in Q2, forecasting operating profit rising to SEK 8.6m (5% above FactSet consensus). We expect TPV to increase by 28% q-o-q and 40% y-o-y to SEK 5.8bn, supported by stronger seasonal consumer spending ahead of the summer period and continued merchant ramp-up. At the same time, the completed ~SEK 100m equity raise (SEK 60m rights issue and ~SEK 40m over-allotment) should strengthen the CET1 ratio and support continued loan book expansion. We forecast a CET1 ratio of 18% (vs. consensus at 17.2%), supported by the equity raise and retained earnings. We view TPV development, merchant onboarding and capital generation as the key indicators to watch in Q2.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Forecasts intact ahead of Q2&lt;/h3&gt;&lt;p&gt;Ahead of Q2, we leave our estimates unchanged following &lt;a data-bm-trackable="false" href="https://abg-portal.bluematrix.com/report/3be659ab-ba00-4a2f-ae45-e1fb9a029e7e" target="_blank"&gt;our recent initiation&lt;/a&gt;. We continue to forecast total income of SEK 126.8m (+31.4% y-o-y), driven primarily by net interest income of SEK 102.9m and a continued loan book expansion at SEK 2,050m. At the same time, we expect total costs of SEK 91.2m (vs. consensus at SEK 93.5m).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Key long-term earnings drivers intact&lt;/h3&gt;&lt;p&gt;Increasing merchant onboarding, higher BNPL penetration and continued loan book expansion should remain the key long-term earnings drivers. As profitability improves, we forecast operating profit to increase from SEK 37m in 2026e to SEK 116m in 2028e, while the company trades at 31x, 13x and 8x P/E and 1.0x, 0.9x and 0.8x P/BV for '26e, '27e and '28e, respectively. Lastly, Qliro appointed Evelin Kaup as Deputy CEO during Q2 as part of a broader organisational restructuring. We view the updated management structure as an area to monitor as the company continues to scale its operations.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/qliro/Equity-research/2026/7/qliro---key-earnings-drivers-intact/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 08 Jul 2026 06:00:14 GMT</pubDate>
      <isin>SE0013719077</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nexam Chemical - We expect a firmer sequential quarter</title>
      <description>&lt;a id="bm-comp-c72e98b6-95d8-4e5a-b2ab-89ea577313ca" name="bm-comp-c72e98b6-95d8-4e5a-b2ab-89ea577313ca" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c72e98b6-95d8-4e5a-b2ab-89ea577313ca" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Report out on 14 July&lt;/li&gt;&lt;li&gt;Q2e sales of SEK 55m (+1% y-o-y), EBIT SEK -1.8m (-2.8m)&lt;/li&gt;&lt;li&gt;Cost economics increasingly favour recycled content&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-bf9b6d5a-286e-4bb8-875d-78cf8a1edec1" name="bm-comp-bf9b6d5a-286e-4bb8-875d-78cf8a1edec1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bf9b6d5a-286e-4bb8-875d-78cf8a1edec1" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 expectations&lt;/h3&gt;&lt;p style="text-align:left;"&gt;We estimate Q2 sales of SEK 55m, up 1% y-o-y despite tough comps in the quarter. We estimate sales of SEK 23m (+2% y-o-y) for Performance Chemicals, driven by continued growth in Recycling (~15% of sales in Q1), where a US recycling customer is stepping up its use of Nexam's additives in rigid food packaging to an ~SEK 11m annual run-rate from Q2. In addition, we expect High Temperature to normalise after the Q1 destocking. Moreover, we look for Masterbatch to hold up and estimate SEK 32m (+11% q-o-q, +2% y-o-y). On EBIT, we estimate SEK -1.8m (-2.8m).&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We leave '26 sales and EBIT broadly unchanged but lower '27e-'28e EBIT by SEK 5m. We continue to forecast Nexam reaching positive EBIT in '27e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Elevated virgin plastic prices favour recycled content&lt;/h3&gt;&lt;p&gt;Our long-term view is unchanged. Virgin plastic prices remain well above 2025 levels, and although they have been easing from their crisis peaks since mid-June, the economic case for recycled content has strengthened. Commercial traction is broadening, as well, with the US food-packaging ramp underway, a new Canadian customer approaching commercialisation, and the Palmer Holland agreement plus new distributors in France and Turkey extending the pipeline. At the Q1 report, management reiterated its ambition to double Recycling sales in '26 vs. '25. The stock is trading at '26e-'28e EV/Sales of 1.5x-1.2x on our estimates.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nexam-chemical/Equity-research/2026/7/nexam-chemical---we-expect-a-firmer-sequential-quarter/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 07 Jul 2026 08:00:04 GMT</pubDate>
      <isin>SE0005101003</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Eastnine - Adding in Warsaw</title>
      <description>&lt;a id="bm-comp-b61a45d2-5d58-404a-bdaa-ef3d933ffac6" name="bm-comp-b61a45d2-5d58-404a-bdaa-ef3d933ffac6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b61a45d2-5d58-404a-bdaa-ef3d933ffac6" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Acquiring "The Bridge" in Warsaw for EUR 300m&lt;/li&gt;&lt;li&gt;92% let, newly built, no new equity needed&lt;/li&gt;&lt;li&gt;20% IFPM accretion, clearly positive&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-6a303472-5b42-4095-9332-2103d18fc867" name="bm-comp-6a303472-5b42-4095-9332-2103d18fc867" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="6a303472-5b42-4095-9332-2103d18fc867" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Doing what they say&lt;/h3&gt;&lt;p&gt;Eastnine this morning announced that is has agreed with "Ghelamco" to acquire the property "The Bridge" in Warsaw for EUR 300m. Eastnine has acquired from Ghelamco before, and has for a long time been clear in its intentions to continue to grow in Warsaw through M&amp;amp;A. Just recently, Stena acquired a large building from Skanska, which we understand that investors have been speculating about Eastnine acquiring. The Bridge comprise 55,000 sqm, is 92% occupied, the two largest tenants (Erste Bank Polska and Visa) together lease 76% of the property, and other tenants include e.g. Grant Thornton. The rental value is EUR 18.2m and leases are generally triple-net.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;No equity needed&lt;/h3&gt;&lt;p&gt;The transaction will be financed with existing cash, adding additional debt to the existing property portfolio, and a EUR 180m secured bank debt on a 5Y-term. The company specifically states that no equity raise is needed. All else equal, we believe the transaction will push LTV by ~14pp (we forecast year-end 2026 LTV of 43%, this deal would increase that figure to 56%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Larger than expected&lt;/h3&gt;&lt;p&gt;Given the company's clear communication on its plans to continue to acquire assets in Warsaw, we argue that investors have been expecting a deal. Any deal would basically add to both leverage and earnings. However, this one is larger than we have anticipated, EUR 300m. The company states that IFPMps will increase by 20%, compared to the Q1'26 earnings capacity. In summary, we argue that the deal makes much sense, Eastnine is acquiring in Warsaw as it has said, from a developer it has done business with before. The deal is larger than we expected, is financed without raising equity, and adds 20% to earnings. We expect a positive reaction today.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/eastnine/Equity-research/2026/7/eastnine---adding-in-warsaw/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 07 Jul 2026 06:15:04 GMT</pubDate>
      <isin>SE0002158568</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ovzon - No Q2 fireworks, but plenty of fuel</title>
      <description>&lt;a id="bm-comp-fdb354a8-1047-4aa6-9796-2d85e2680d8d" name="bm-comp-fdb354a8-1047-4aa6-9796-2d85e2680d8d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fdb354a8-1047-4aa6-9796-2d85e2680d8d" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Strong Q2e, but more orders are needed...&lt;/li&gt;&lt;li&gt;...and we expect them to come&lt;/li&gt;&lt;li&gt;15x '26e EV/EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-480366ae-8c95-4317-baf3-ee8874497ce1" name="bm-comp-480366ae-8c95-4317-baf3-ee8874497ce1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="480366ae-8c95-4317-baf3-ee8874497ce1" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2e largely similar to Q1&lt;/h3&gt;&lt;p&gt;We expect Q2 to be broadly similar to Q1, with the main difference being an increased contribution from the EU NATO customer (which was utilised in the middle of Q1), while the still-not-renewed SSC contract is a headwind. This leads us to estimate SATCOM sales of SEK 176m, down from SEK 188m in Q1. The backlog of terminals remains strong&lt;font color="#28AD20"&gt;&lt;span style="white-space-collapse:preserve;"&gt;,&lt;/span&gt;&lt;/font&gt; and we anticipate linear deliveries throughout 2026, with SEK 70m in Q2e (SEK 72m in Q1). In total, we forecast Q2 net sales of SEK 246m, +48% y-o-y. Regarding margins, the product mix remains favourable, while opex continue to grow gradually. We see EBIT of SEK 69m, for a margin of 28%. Given the payment plans previously announced with the company's largest customer &amp;#8211; the Swedish FMV &amp;#8211; we see strong FCF of SEK 113m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Small estimate revisions&lt;/h3&gt;&lt;p&gt;Although general demand for SATCOM continues to grow, there been little activity in terms of orders since December. Recently, Ovzon signed a &lt;a data-bm-trackable="false" href="http://cr.abgsc.com/link/f8d1e7e7215e4f728ba91273cf7f47f3.aspx" target="_blank"&gt;SEK 74m renewal contract with an EU NATO customer&lt;/a&gt;, but more orders are needed for the company to meet our SEK 1,034m sales estimate for 2026 (although ~SEK 800m of this is already in the backlog). Due to its high customer concentration, lead times are long. Therefore, we are not concerned and expect more orders ahead. Still, we cut '26e EBIT by 4% due to slightly lower sales assumptions.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Still more Ovzon-3-related headroom&lt;/h3&gt;&lt;p&gt;Modern warfare is increasingly fought across domains where satellite connectivity has become mission-critical, driving a structural, multi-year uplift in space investments. Ovzon is well-positioned to capture this demand given its specialisation in high-resilience, high-throughput SATCOM solutions. With Ovzon-3 still at ~50% utilisation, it still has meaningful capacity headroom. The stock is trading at 15x '26e EV/EBIT on our current estimates.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ovzon/equity-research/2026/7/ovzon---no-q2-fireworks-but-plenty-of-fuel/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 06 Jul 2026 13:45:04 GMT</pubDate>
      <isin>SE0010948711</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>StrongPoint - Steady through the transition</title>
      <description>&lt;a id="bm-comp-fb7b29db-39f2-4f0c-87c9-9ea365c8d26f" name="bm-comp-fb7b29db-39f2-4f0c-87c9-9ea365c8d26f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fb7b29db-39f2-4f0c-87c9-9ea365c8d26f" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q2e top line &lt;font color="#000000"&gt;flat&lt;/font&gt; q-o-q, EBITDA of NOK 3m&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Pricer transition a temporary drag, offset by Vusion momentum&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range of NOK 8-18 per share&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-22fa8d6f-6a69-4c96-907e-ddae868f068e" name="bm-comp-22fa8d6f-6a69-4c96-907e-ddae868f068e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="22fa8d6f-6a69-4c96-907e-ddae868f068e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Q2e EBITDA of NOK 3m&lt;/h3&gt;&lt;p&gt;Q1'26 delivered revenues of NOK 342m, with strong growth in UK &amp;amp; Ireland (+93%) and Spain (+13%) offset by weakness in Norway and Sweden (lower ESL deliveries and the Pricer/Vusion transition). We expect more of the same for Q2, and pencil in revenues of NOK 343m. We pencil in a gross margin of ~44%, which compares to ~45% in Q1'26. This yields EBITDA of NOK 3m. The key focus in '26 is the new partnership with Vusion, and we like that StrongPoint and Vusion have landed a contract to &lt;a data-bm-trackable="false" href="https://newsweb.oslobors.no/message/672348" target="_blank"&gt;digitalise Coop Estonia&lt;/a&gt; (EUR 8m contract, set to start H2'26). We view this as a validation of the partnership.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Pricer transition temporary drag, offset by Vusion momentum&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;The Pricer recurring run-off will remain a headwind through '26: the rolling 12-month ESL licence and service base falls from NOK 52m at end-2025 to zero by end-2026, with a NOK 10m y-o-y hit already in Q1. The offset is coming but will take time. Vusion is a far broader platform than ESL alone, spanning EdgeSense, the Captana shelf-edge camera and retail media, and the Coop Estonia win is early proof. We expect recurring revenue to trough in '26, with the Vusion base scaling from H2.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Pipeline building; fair value range of NOK 8-18 per share&lt;/h3&gt;&lt;p&gt;Q2 will not be a step-change quarter, but likely a stable one. The pipeline is building, with new contracts announced in '26 (Coop Estonia, Iceland Foods, NorgesGruppen, AutoStore projects, and &lt;a data-bm-trackable="false" href="https://newsweb.oslobors.no/message/677616" target="_blank"&gt;a US order picking&lt;/a&gt; project). The path to sustained profitability will have ups and downs, and the Sainsbury's rollout moving slower than expected is a reminder that large projects carry execution risk. That said, things seem to be slowly moving in the right direction for StrongPoint. Our DCF indicates an equity value of ~NOK 650m, and we see a fair value range of NOK 8-18 per share.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/StrongPoint/Equity-research/2026/7/strongpoint---steady-through-the-transition/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 05 Jul 2026 18:15:02 GMT</pubDate>
      <isin>NO0010098247</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ascelia Pharma - Complete Response Letter for Orviglance NDA</title>
      <description>&lt;a id="bm-comp-f813df2d-6d66-4edb-9fef-cd48eb5ee074" name="bm-comp-f813df2d-6d66-4edb-9fef-cd48eb5ee074" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f813df2d-6d66-4edb-9fef-cd48eb5ee074" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Additional clinical data and product documentation requested&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Urgent FDA meeting to discuss next steps&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Very low visibility: Valuation suspended until more clarity&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-4ce92958-33e7-4f06-b454-af5e6f7982dd" name="bm-comp-4ce92958-33e7-4f06-b454-af5e6f7982dd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4ce92958-33e7-4f06-b454-af5e6f7982dd" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Additional clinical data and product documentation requested&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Ascelia Pharma announced today that it has received a Complete Response Letter (CRL) from the FDA regarding the NDA for Orviglance. The FDA has stated that it cannot approve the application in its present form and has requested additional clinical data and product documentation. It remains unclear at this stage whether the FDA's request amounts to a relatively modest data addition, which could potentially result in a delay of only around six months, or whether a new pivotal clinical trial will be required. The latter would represent a significantly longer and more costly development path and raises serious questions about its financial and operational feasibility. The company has confirmed a cash runway into 2027 and will assess potential cost-saving initiatives.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Urgent FDA meeting to discuss next steps&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Ascelia intends to request a Type A meeting with the FDA as soon as possible to clarify the requirements and discuss a path forward. Given the urgency associated with Type A meetings, the FDA aims to respond to such requests within 14 days and, if granted, schedule the meeting within 30 days. The FDA's negative response came as a surprise given that the pivotal Phase 3 trial successfully met its primary endpoint, demonstrating that the &lt;font color="#000000"&gt;company's MRI contrast agent Orviglance significantly (p &amp;lt; 0.001) improved the visualisation of metastatic liver lesions compared with un-enhanced MRI, with the secondary endpoints further supporting these results. Reflecting this surprise,&lt;/font&gt; the stock is down ~75%.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Very low visibility: Valuation suspended until more clarity&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Given the wide range of possible outcomes, from a limited data request to a full new trial, and no disclosure yet on the specific deficiencies cited by the FDA, visibility on the path forward is too low&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/ascelia-pharma/Equity-research/2026/7/ascelia-pharma---complete-response-letter-for-orviglance-nda/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 03 Jul 2026 14:45:05 GMT</pubDate>
      <isin>SE0010573113</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Fastpartner - Positive development on IFPM guidance NTM</title>
      <description>&lt;a id="bm-comp-8ae945b7-2b51-4a4a-a11d-20bf78929a3e" name="bm-comp-8ae945b7-2b51-4a4a-a11d-20bf78929a3e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8ae945b7-2b51-4a4a-a11d-20bf78929a3e" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Solid letting activity, but timing/impact uncertain&lt;/li&gt;&lt;li&gt;Lower interest rate assumptions and SBBs drive estimates&lt;/li&gt;&lt;li&gt;2026e P/CEPS of 11x vs coverage average of 14x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-50d27faf-2649-45aa-8cf4-fa05566284f9" name="bm-comp-50d27faf-2649-45aa-8cf4-fa05566284f9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="50d27faf-2649-45aa-8cf4-fa05566284f9" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Softer top-line, lower operating costs&lt;/h3&gt;&lt;p&gt;Fastpartner delivered Q2 NOI largely in line with us and Factset cons., where a slightly softer top-line was mitigated by lower costs. Central admin costs were in line with our estimate, while net financials were markedly higher, despite average paid interest compressing 10bp to 3.8% q-o-q. The result was rec. PTP 5% below our forecast. NAV (ABGSC definition) was 1.5% below our forecast, driven by negative value changes of SEK 220m, where property values in Kista dropped by 12% q-o-q. We make CEPS revisions of 0-4%, driven by lower assumed rates, SBBs during the quarter and timing of lettings.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Solid activity but low insight on actual impact&lt;/h3&gt;&lt;p&gt;Q2 was active in terms of lettings, the largest was the 15k sqm letting to MagasinX in Frihamnen, another was HM Studios which expanded its lease by 3k sqm. So letting activity looks solid, but data points on rent levels, investment volumes, etc. is scarce, making it very difficult to assess the financial impact. And, as the company does not report net letting, visibility on top-line progression is low. Guidance on IFPM NTM was +1% q-o-q to SEK 790m, with market rates down sequentially we expect this explains the bulk of the positive development. On another note, following the appointment of a new CEO, the company is reviewing the portfolio with divestment likely to follow, no volume indicated. The CEO also announced a 100MW pipeline of potential of data center projects, but no indication of timeline or investment volumes.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;'26e P/CEPS of 11x, coverage average of 14x&lt;/h3&gt;&lt;p&gt;The share is trading at '26e P/CEPS of 11x, below the average in our coverage of 14x and the average for office peers in our coverage at 14x. On '26e P/EPRA NRV, the share is trading at 0.4x compared to office peers at 0.6x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/fastpartner/Equity-research/2026/7/fastpartner---positive-development-on-ifpm-guidance-ntm/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 03 Jul 2026 05:15:06 GMT</pubDate>
      <isin>SE0013512506</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Fastpartner - Q2 on the soft side but positive guidance</title>
      <description>&lt;a id="bm-comp-5abfae58-3e39-4f3c-bd00-5f79bbf8fccd" name="bm-comp-5abfae58-3e39-4f3c-bd00-5f79bbf8fccd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5abfae58-3e39-4f3c-bd00-5f79bbf8fccd" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;NOI -2% y-o-y, 0.6% vs ABGSCe, -0.4% vs cons.&lt;/li&gt;&lt;li&gt;Value changes of -0.64% vs ABGSCe of 0.28%&lt;/li&gt;&lt;li&gt;Share to trade in-line with the sector on the back of this report&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-83f2295d-32e3-47da-abd1-e6edb333b38d" name="bm-comp-83f2295d-32e3-47da-abd1-e6edb333b38d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="83f2295d-32e3-47da-abd1-e6edb333b38d" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Rec. PTP -5.2% vs ABGSCe, -7.2% y-o-y&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Fastpartner delivered Q2 results with rental income of SEK 546m (-1.4% vs ABGSCe, -0.9% vs cons.), with an NOI margin of 74.6% (0.2pp y-o-y) driving NOI of SEK 407m (0.6% vs ABGSCe, -0.4% vs cons.), rec. PTP of SEK 209m (-5.2% vs ABGSCe, -7.2% y-o-y), adj. EPRA NRV p.s. of SEK 93 (-1.5% vs ABGSCe, 2.6% y-o-y). The economic occupancy was up 0.1pp q-o-q to 89.3% (91.3%), occupancy adj. for projects was down -0.2pp q-o-q to 89.5% (91.8%).&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;adj. EPRA NRV p.s. of SEK 93 (-1.5% vs ABGSCe, 2.6% y-o-y.)&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Realised and unrealised value changes amounted to SEK -220m or -0.64%, we expected SEK 95m or 0.28%, and the average valuation yield amounted to 5.20%, 0.1pp q-o-q. Property values in Kista were down 12% q-o-q, following Ericssons decision to move from the area. Net LTV (ABGSC definition) amounted to 48.4% (47.5%), 0.8pp q-o-q, vs ABGSCe at 47.4%. The average paid interest rate decreased by -0.1pp q-o-q to 3.80%.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Conclusion&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Guidance for IFPM NTM of SEK 790m, vs SEK 780m in Q1'26, compared to our estimate NTM of SEK 771m. The year-end '28 target of a run-rate IFPM was flat q-o-q at SEK1,200m. The CEO flags for divestments ahead, we believe a likely use of proceeds is SBBs. Despite softer than expected results the guidance NTM is positive, we expect cons. to keep estimates (rec. PTP) fairly flat on the back of this report. In summary we expect the share to trade in-line with the sector today.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1803311a-27e6-40f4-81d2-c2b5d5564d07" name="bm-comp-1803311a-27e6-40f4-81d2-c2b5d5564d07" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1803311a-27e6-40f4-81d2-c2b5d5564d07" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-2d11d570-94ae-4f22-b7e9-94362fbd3f41" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data, Factset&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/fastpartner/Equity-research/2026/7/fastpartner---q2-on-the-soft-side-but-positive-guidance/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 02 Jul 2026 12:00:06 GMT</pubDate>
      <isin>SE0013512506</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Prevas - Waiting for volumes to follow</title>
      <description>&lt;a id="bm-comp-72d6c5fd-d021-45bb-878f-ed9279fe97f9" name="bm-comp-72d6c5fd-d021-45bb-878f-ed9279fe97f9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="72d6c5fd-d021-45bb-878f-ed9279fe97f9" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Signs of stabilisation but pricing remains pressured&lt;/li&gt;&lt;li&gt;We leave our estimates broadly unchanged&lt;/li&gt;&lt;li&gt;Trading ~25% below Nordic peers&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-e07a4a8d-363d-4f32-8c16-2f09f352b24a" name="bm-comp-e07a4a8d-363d-4f32-8c16-2f09f352b24a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e07a4a8d-363d-4f32-8c16-2f09f352b24a" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;A stabilising market, but pricing remains the challenge&lt;/h3&gt;&lt;p&gt;The technical consulting market has been weaker for longer than most expected. We believe conditions are gradually stabilising, although a meaningful recovery in volumes will likely take time. As reflected in recent market KPIs, Sweden is showing tentative signs of improvement, while Denmark remains challenging following large layoffs at major corporates. We therefore expect Denmark to remain a headwind despite Prevas' continued capacity adjustments. We estimate Q2 sales of SEK 407m, corresponding to flat y-o-y growth, driven primarily by acquisitions, while organic growth is likely to remain slightly negative. We estimate adj. EBITA of SEK 28m, corresponding to a 6.9% margin (6.5% in Q2'25), as continued cost discipline should partly offset persistent pricing pressure and higher salary costs following the annual wage revisions.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Limited changes to estimates&lt;/h3&gt;&lt;p&gt;We make only limited changes to our estimates. Defence demand remains strong, supported by long project durations and high barriers to entry, while the company's EAM offering continues to gain traction through long-term customer relationships.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading 25% below its peers&lt;/h3&gt;&lt;p&gt;Prevas is trading at 8x EV/EBITA on our '26 estimates, around 25% below the Nordic engineering consultancy peer group, despite offering higher margins and stronger long-term growth prospects, in our view. Near-term visibility remains limited, and pricing pressure is likely to persist until demand improves more meaningfully. However, we continue to believe that Prevas' niche positioning, high degree of specialisation and exposure to structurally growing end-markets should allow the company to outperform peers once the consulting cycle turns.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/prevas/Equity-research/2026/7/prevas---waiting-for-volumes-to-follow/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 01 Jul 2026 19:00:06 GMT</pubDate>
      <isin>SE0000356008</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Midsona - Top-line recovery around the corner </title>
      <description>&lt;a id="bm-comp-c7725b1e-2190-41a4-83d2-a89b70aea75a" name="bm-comp-c7725b1e-2190-41a4-83d2-a89b70aea75a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c7725b1e-2190-41a4-83d2-a89b70aea75a" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2e: 1% organic growth and 4% EBITA margin&lt;/li&gt;&lt;li&gt;Limited estimate changes&lt;/li&gt;&lt;li&gt;Trading at NTM EV/EBITA of 10x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-56574a24-f33d-40b1-a799-8e6af2bd33ec" name="bm-comp-56574a24-f33d-40b1-a799-8e6af2bd33ec" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="56574a24-f33d-40b1-a799-8e6af2bd33ec" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2e: back to growth&lt;/h3&gt;&lt;p style="text-align:left;"&gt;We anticipate organic growth of 1% in Q2'26e, implying sales of SEK 885m and EBIT of SEK 33m, for a margin of 3.8%. The organic growth, coupled with a 1.3% M&amp;amp;A contribution and a 0.2% FX effect, puts top-line growth at 2.3%. This would imply the first quarter with positive growth since Q1'25, and we highlight that comps are relatively light but that this also stems from sequential underlying improvements. We expect a slightly lower GM q-o-q (28.7% vs. 29.8%), on assumed higher COGS on raw material prices. The Q1 report commented on a shift in the Nordics, where management expected some volumes that typically land in Q1, to land in Q2, which we also believe will slightly support the quarter.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;What to look for in the Q2 report&lt;/h3&gt;&lt;p style="text-align:left;"&gt;We make limited revisions to our Q2 estimates, increasing '26e-'28e sales and adj. EBIT by ~1% and ~2% p.a., respectively. The majority of changes stem from updated FX movements. We are excited to see the first quarter with Risenta in the figures, and hope for more colour on how physically moving the production will affect earnings. We also expect a decision on the long-term plan for Spain, as this was communicated in the Q1 report. In terms of growth, we look for updates regarding B2B sales in the Nordics, as the termination of unprofitable contracts has weighed on growth for several quarters.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Implied valuation and new LTIP&lt;/h3&gt;&lt;p&gt;Based on our revised estimates, the company is trading at ~10x-9x '26e-'27e adj. EV/EBITA, which is ~55-45% below current peer multiples at 15x-14x. We note that peers are in turn trading ~4% above the 10-year historical median of ~14x NTM EV/EBITA. We also note that Midsona has launched a LTIP, with payouts geared 90% to EPS growth ('26-'28) and 10% to emissions reduction, capped at ~1.8% dilution and an estimated P&amp;amp;L cost of SEK 16-50m depending on outcome.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/midsona/Equity-research/2026/7/midsona---top-line-recovery-around-the-corner-/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 01 Jul 2026 16:15:06 GMT</pubDate>
      <isin>SE0000565228</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nolato - Nearing organic growth acceleration</title>
      <description>&lt;a id="bm-comp-5f9244f1-a27b-4213-ae54-10847b81b832" name="bm-comp-5f9244f1-a27b-4213-ae54-10847b81b832" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5f9244f1-a27b-4213-ae54-10847b81b832" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2e: some GLP-1 ramp-up, more to come in H2e&lt;/li&gt;&lt;li&gt;Estimates up on FX and higher growth in Engineered&lt;/li&gt;&lt;li&gt;Trading at 13x '26e EV/EBITA vs. historical average of 15x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-228a7739-77c0-4df0-b7ba-5e0475da17c0" name="bm-comp-228a7739-77c0-4df0-b7ba-5e0475da17c0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="228a7739-77c0-4df0-b7ba-5e0475da17c0" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2e: slight organic acceleration, more to come in H2e&lt;/h3&gt;&lt;p&gt;We expect Nolato to report Q2 net sales of SEK 2,467m, up 3% y-o-y (+4% organic, -1% FX). This marks a slight uptick in organic growth compared to Q1, which stems from the ramp-up of GLP-1 sales from the new facility in Hungary, although we note that commercial volumes are set to start towards the end of the quarter. As such, the impact on organic growth should be more visible in H2e as the site gradually ramps up to ~7% of group sales (we estimate full utilisation by Q4'27e). We estimate Q2 EBITA of SEK 271m, for a margin of 11.0% (11.6%). We see some potential temporary gross margin pressure in Q2e and Q3e as a result of rising input costs for petrochemicals, but these should be fairly marginal. In its Q1 conference call, Nolato flagged that ~SEK 1.6-1.7bn of its cost base was subject to 5-10% cost increases on current prices, and oil prices have since fallen significantly.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate revisions&lt;/h3&gt;&lt;p&gt;Ahead of the report, we make several smaller adjustments to our estimates, raising growth estimates for Engineered Solutions, increasing net financial expenses, and updating FX assumptions. All in all, this results in 2% EBITA upgrades for '26e and 3% for '27e-'28e, while EPS comes up ~1pp less per year.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Potential to accelerate both organic and M&amp;amp;A growth&lt;/h3&gt;&lt;p&gt;The aforementioned ramp-up of the new Hungarian site should add ~3pp to organic growth for both '26e and '27e, providing a much-needed acceleration in organic growth, which has been somewhat lacklustre in recent years. On top of this, we think there is room to pick up the M&amp;amp;A pace given the strong balance sheet. The stock is trading at 13x '26e EV/EBITA, compared to its historical fwd. multiple of 15x, and offers 4-7% lease-adj. FCF yields for '26e-'28e.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nolato/Equity-research/2026/7/nolato---nearing-organic-growth-acceleration/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 01 Jul 2026 11:45:50 GMT</pubDate>
      <isin>SE0015962477</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Eltel - New services improving the financial profile</title>
      <description>&lt;a id="bm-comp-0db3b61a-f83a-40bc-9f81-e4c098b0705c" name="bm-comp-0db3b61a-f83a-40bc-9f81-e4c098b0705c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0db3b61a-f83a-40bc-9f81-e4c098b0705c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2e: big y-o-y earnings improvement&lt;/li&gt;&lt;li&gt;Raised EBITA driven by increasing emerging service sales&lt;/li&gt;&lt;li&gt;Share trading at 10x '26e EV/EBITA, goes to 7x in '28e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-210550c9-f654-466c-b60c-2750ce883305" name="bm-comp-210550c9-f654-466c-b60c-2750ce883305" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="210550c9-f654-466c-b60c-2750ce883305" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2e: significant y-o-y EBITA improvement&lt;/h3&gt;&lt;p&gt;We expect Eltel to report Q2 net sales of EUR 211m, up 5% y-o-y, (4% organic, 1% FX). Although not as strong as the Q1 organic growth of 11%, which was boosted by completion of a larger Finnish project, we expect organic growth figures in Q2 and ahead to improve due to so-called emerging services reaching a sizeable share of sales (23% in Q1'26 vs. 6% in Q1'25), as well as the contract pipeline (53% in Q1'26 vs. 38% in Q1'25). Moreover, these new sales typically carry higher margins than Eltel's legacy business, and thus we model a significant y-o-y profitability increase, with Q2 EBITA of EUR 8.4m (2.5m in Q2'25) for a margin of 4.0% (1.2%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Raised organic growth and margin assumptions&lt;/h3&gt;&lt;p&gt;We raise our estimates for both organic growth and margins, and both for the same reason &amp;#8211; the aforementioned increasing share of emerging service revenues. This results in our '26e-'27e EBITA coming up by 3%, and 4% for '28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Strategic shift now clearly improving the financials&lt;/h3&gt;&lt;p&gt;The strategic shift away from a largely telecom-focused business model towards more diversified and faster-growing markets is now starting to show more clearly in the financials. There is still much room left to reach the EBITA margin target of 5% (compared to 2.7% on a r12m basis), and our estimates remain somewhat short of the target at 4.2% for '27e and 4.6% for '28e. Still, we model a substantial '26e-'28e adj. EBITA CAGR of 17%. On our estimates, the share is trading at 10x '26e EV/EBITA, which falls to 7x by '28e.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/eltel/Equity-research/2026/7/eltel---new-services-improving-the-financial-profile/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 01 Jul 2026 11:45:05 GMT</pubDate>
      <isin>SE0006509949</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ework Group - Stabilising but volumes still await</title>
      <description>&lt;a id="bm-comp-060790d0-1aeb-4ee9-8a4e-02ef15b94533" name="bm-comp-060790d0-1aeb-4ee9-8a4e-02ef15b94533" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="060790d0-1aeb-4ee9-8a4e-02ef15b94533" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Market conditions remain soft&lt;/li&gt;&lt;li&gt;We lower '26e-'27e adj. EBIT by 1-4%&lt;/li&gt;&lt;li&gt;11x-9x '26e-'27e EV/EBIT adj.&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-8156821e-5883-4b29-9a24-66ef543e5773" name="bm-comp-8156821e-5883-4b29-9a24-66ef543e5773" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8156821e-5883-4b29-9a24-66ef543e5773" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Positive signals in Sweden, but volumes await&lt;/h3&gt;&lt;p&gt;The Nordic consultancy downturn has lasted longer than most anticipated, and while early signs of stabilisation are emerging, a meaningful recovery is unlikely in the near term. We believe the market is broadly flat, with pricing pressure persisting across most geographies. Sweden, representing ~72% of group sales, is showing early signs of improvement, although volume growth will likely remain muted in Q2. Denmark remains a drag, as large layoffs at major corporates such as Novo Nordisk have led to a significant oversupply of consultants. We believe Norway will likely be the relative outperformer, driven by continued telecom investments. We expect Q2 sales of SEK 3.1bn, a decline of 14% y-o-y. On costs, we expect continued discipline following the reorganisation, although adj. EBIT is likely to decrease to SEK 34m (vs. SEK 45m in Q2'25) given the lower volumes.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Uncertainty remains&lt;/h3&gt;&lt;p&gt;With the reorganisation now fully implemented and SEK 18m in annualised cost savings being gradually realised through '26, we think Ework is better equipped to handle the current environment. Q2 will likely be the first quarter with an improved cost base, but the volume issue remains a key uncertainty. KPIs (from the Swedish National Institute of Economic Research) show some improvement but remain muted, leaving us cautious on the pace of recovery. As a result, we lower our adj. EBIT for '26e by 1% and '27e by 4%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 11x-9x '26e-'27e EV/EBIT adj.&lt;/h3&gt;&lt;p&gt;The share is trading at 11x/9x '26e/'27e EV/EBIT adj. (vs. peers at 12x/9x), which is largely in line with its 10Y avg. of ~12x. The overall market remains subdued and visibility into the timing and trajectory of the recovery remains blurred. We continue to expect earnings to pick up once demand returns, but anticipate subdued growth in the near term.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ework/Equity-research/2026/6/ework-group---stabilising-but-volumes-still-await/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 30 Jun 2026 19:30:04 GMT</pubDate>
      <isin>SE0002402701</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ovzon - Renewed order with EU NATO customer</title>
      <description>&lt;a id="bm-comp-97cbb755-e0d7-4eee-8e29-e2b221aed899" name="bm-comp-97cbb755-e0d7-4eee-8e29-e2b221aed899" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="97cbb755-e0d7-4eee-8e29-e2b221aed899" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Renewed SEK 74m order with EU NATO customer (Ovzon-3 related)&lt;/li&gt;&lt;li&gt;100% SATCOM (5-months); deliveries start 1 Aug'26&lt;/li&gt;&lt;li&gt;Supports our estimates; potential for more orders&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-fecad052-4ccc-4528-be4b-55f236a113a8" name="bm-comp-fecad052-4ccc-4528-be4b-55f236a113a8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fecad052-4ccc-4528-be4b-55f236a113a8" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;A welcomed order announcement&lt;/h3&gt;&lt;p&gt;Ovzon has signed a SEK 74m renewal order from the defence organisation of a European NATO country relating to the company's full SATCOM solution on Ovzon-3. Order intake has been quiet for a while, so today's news is welcome. The order will run for five months from 1 Aug'26. This order is a renewal of one received on 19 Dec'25, but, unlike that one, it only includes SATCOM. There is also potential for further expansion and extension, and the company views this as the beginning of a broader initiative to establish a shared satellite communication coalition with additional European NATO countries.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Supports 2026e estimates&lt;/h3&gt;&lt;p&gt;The order is roughly the same size as the previous contract (SEK 96m SATCOM order for ~6 months) and continues to utilise the spare capacity we have identified on Ovzon-3 (~50% utilisation, according to our estimates). The fact that this renewal is SATCOM-only, rather than including terminals, suggests that the customer is renewing because of the capacity itself - i.e. "high-quality" revenue. As the contract begins on 1 August, the majority of the value will be realised in H2 2026. The 'coalition' language is worth keeping an eye on; if it leads to more European NATO countries signing up, it would be a good way to expand the customer base further. Overall, a positive order that breaks a quiet period and supports our 2026 estimates. Stock is trading at 14x '26e EV/EBIT on our current estimates.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a1d88d6a-2129-4cfd-b4a3-726192112ecc" name="bm-comp-a1d88d6a-2129-4cfd-b4a3-726192112ecc" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a1d88d6a-2129-4cfd-b4a3-726192112ecc" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-9f447eb1-bdc2-4953-b3cd-098750706ec6" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Sales, quarterly (SEKm)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-19b7d00b-091e-477b-be39-bb6cd52a8050" name="bm-comp-19b7d00b-091e-477b-be39-bb6cd52a8050" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="19b7d00b-091e-477b-be39-bb6cd52a8050" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-4a0803bf-566d-4320-a7c0-584810705cdf" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Sales breakdown (SEKm)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d652aaf2-b7ce-42db-a5a5-95e75685ba56" name="bm-comp-d652aaf2-b7ce-42db-a5a5-95e75685ba56" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d652aaf2-b7ce-42db-a5a5-95e75685ba56" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-16f67ffc-80c6-4fee-806a-d32e38de4c42" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Net sales (SEKm) and EBIT margins&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ovzon/equity-research/2026/6/ovzon---renewed-order-with-eu-nato-customer/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 30 Jun 2026 15:30:05 GMT</pubDate>
      <isin>SE0010948711</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Petrolia Noco - Q1 solid, May shut-in trims '26e production</title>
      <description>&lt;a id="bm-comp-24105f31-b514-4217-a75f-dd4a11d7debc" name="bm-comp-24105f31-b514-4217-a75f-dd4a11d7debc" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="24105f31-b514-4217-a75f-dd4a11d7debc" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 EBITDA NOK 167m, 14% above ABGSCe&lt;/li&gt;&lt;li&gt;'26e production down 3%, '27e-'28e unchanged&lt;/li&gt;&lt;li&gt;Fair value range NOK 1.0-4.5&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-60fdb25e-8b3d-4bb0-a351-4077f2177d0b" name="bm-comp-60fdb25e-8b3d-4bb0-a351-4077f2177d0b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="60fdb25e-8b3d-4bb0-a351-4077f2177d0b" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 production 3.34 kboe/d, in line with ABGSCe&lt;/h3&gt;&lt;p&gt;Q1'26 production was 3.34 kboe/d, 1% above ABGSCe of 3.30 kboe/d. Revenue of NOK 244m was 7% above ABGSCe of NOK 229m due to higher realised prices. Production costs of NOK 50m were in line with our expectations, with only a minor over-/underlift effect during the quarter. Exploration expenses amounted to NOK 13m, below ABGSCe of NOK 17m, although this remains a lumpy line item. Overall, Q1 EBITDA came in at NOK 167m, 14% above ABGSCe of NOK 146m, although the underlying operating performance was broadly in line with our expectations. Petrolia exited Q1 with a cash position of NOK 98m, and we estimate this increased to NOK 121m by the end of Q2.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;'26e production down 3% due to Brage shut-in in May&lt;/h3&gt;&lt;p&gt;Based on monthly production updates from Lime Petroleum (34% interest in Brage), we know that April production was slightly lower than we had expected. More importantly, Lime also reported that production at Brage was shut in throughout May due to maintenance, which lasted longer than initially scheduled. However, production fully restarted on 3 June, and we expect output to return to pre-shut-in levels. We also anticipate somewhat higher production for the remainder of the year than we had previously estimated. Nevertheless, this prompts us to lower '26e production by 3%, while we keep '27e-'28e unchanged. With a higher realised oil price in Q2 than we had forecast, we make only minor estimate changes, lowering '26e EBITDA by 1%. We make no changes to our oil price deck and reiterate USD 75/bbl from '27e, as stated in our &lt;a data-bm-trackable="false" href="https://abg-portal.bluematrix.com/links2/pdf/4af36cf4-1b08-476a-92a6-85c200e40832?firmId=45691" target="_blank"&gt;Crude Quarterly&lt;/a&gt; sector report.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of NOK 1.0-4.5/sh&lt;/h3&gt;&lt;p&gt;Assuming a long-term Brent price of USD 50-100/bbl, we estimate a NAV of NOK 1.0-5.2/sh for Petrolia. Using a 13% WACC, the current share price implies a discounted oil price of USD 55/bbl on ABGSCe.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/petrolia-noco/Equity-research/2026/6/petrolia-noco---q1-solid-may-shut-in-trims-26e-production/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 26 Jun 2026 15:45:07 GMT</pubDate>
      <isin>CY0102630916</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Embellence Group - Comps dictate Q2 performance</title>
      <description>&lt;a id="bm-comp-a3052b06-34c5-4d9e-a596-42e049b03152" name="bm-comp-a3052b06-34c5-4d9e-a596-42e049b03152" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a3052b06-34c5-4d9e-a596-42e049b03152" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We forecast net sales of SEK 191m in Q2'26e&lt;/li&gt;&lt;li&gt;DTC could weigh on Q2 EBITA, -7% y-o-y at SEK 24m&lt;/li&gt;&lt;li&gt;We reiterate our SEK 36-43 fair value range&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c16d4910-d240-4f9a-b4df-ca2a983517db" name="bm-comp-c16d4910-d240-4f9a-b4df-ca2a983517db" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c16d4910-d240-4f9a-b4df-ca2a983517db" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;We forecast EBITA -6% y-o-y in Q2 on elevated DTC efforts&lt;/h3&gt;&lt;p&gt;We expect sequentially tougher comps to lead to a deceleration for Embellence Group. Compared to 3.5% organic growth in Q1, we expect deceleration to flat growth in Q2 for net sales of SEK 191m. By segment, we expect the soft spell in Cole &amp;amp; Son to continue from Q1, following changes to the distribut&amp;#237;on setup, and we forecast -6% organic growth for this segment. We also forecast a clear organic decline, -19%, for Artscape, versus the same quarter last year in which it launched a product line with a large customer. On the other hand, we expect Pappelina to continue to perform well after the DTC platform update (+20% org. growth) and its External Manufacturing segment to remain at the net sales level it reached in Q1, suggesting 16% growth. We expect stable gross margins to continue from Q1, and a slightly lower absolute opex level as Q1 contained more costs for trade fairs than is typical in Q2. All in all, we forecast adj. EBITA of SEK 24m, -7% y-o-y, as the group ramps up its DTC efforts.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Shift to DTC weighs on '26e EBITA growth&lt;/h3&gt;&lt;p&gt;The transition to DTC is likely to keep weighing on profitability through a higher opex ratio: we forecast a 45% opex ratio for 2026 compared to 44% for 2025 and 42% for 2024. As such, we believe Embellence Group's EBITA growth for '26e could be muted at 1%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We reiterate our fair value range of SEK 36-43&lt;/h3&gt;&lt;p&gt;As we make only minor estimate revisions, we reiterate our fair value range of SEK 36-43. The share is currently trading at 7.5/5.2x EV/EBITA '26e/'28e, compared to a historical trading range of 7x-8x NTM and a Swedish peer group of home improvement companies at a median 11x/6.5x '26e/'28e. We estimate a 11-14% FCF yield '26e-'28e, and a dividend yield of 5-5.7% for the same years.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/embellence-group/Equity-research/2026/6/embellence-group---comps-dictate-q2-performance/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 25 Jun 2026 06:30:04 GMT</pubDate>
      <isin>SE0013888831</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Cavotec - Quiet quarter, small tweaks</title>
      <description>&lt;a id="bm-comp-bddccf0c-c11e-45d4-b2c8-b9df8e04383e" name="bm-comp-bddccf0c-c11e-45d4-b2c8-b9df8e04383e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bddccf0c-c11e-45d4-b2c8-b9df8e04383e" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2: Sales of EUR ~37m (~36m), adj. EBIT of 3.5m (-0.7m)&lt;/li&gt;&lt;li&gt;Order intake set to ease off a strong Q1&lt;/li&gt;&lt;li&gt;Share is trading at ~24-10x adj. EV/EBIT '26e-'27e.&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-26bfd563-66ca-44cb-ba8d-0c3fbd037e56" name="bm-comp-26bfd563-66ca-44cb-ba8d-0c3fbd037e56" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="26bfd563-66ca-44cb-ba8d-0c3fbd037e56" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2 expectations&lt;/h3&gt;&lt;p&gt;We expect Q2 sales of EUR 37.2m, +4% y-o-y and +13% q-o-q. We expect sales of EUR 21.4m (+1% y-o-y) for Ports &amp;amp; Maritime, and EUR 15.9m (10% y-o-y) for Industry. We estimate Q2 order intake of ~EUR 36m (-18% y-o-y, -39% q-o-q) for an R12M book-to-bill of 1.16. The comps look demanding, particularly for P&amp;amp;M order intake (both year-on-year and sequentially). On adj. EBIT, we forecast a sequential return to positive earnings: EUR 3.5m (vs. -0.7m Q2'25) for a margin of 9.3% (-2.0%). We see further potential for short-cycle orders booked and delivered within 2026 in Industry (e.g. the motorised cable and hose reels order to a shipping customer in India), but remain reluctant to include these given their lumpy nature. Additional upside for the remainder of 2026 should come from gradually rising service penetration across the MoorMaster and shore power offering.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;We make small changes to our revenue estimates, up 2% for '26-'27e and 1% for '28e. P&amp;amp;M sees a 2%/1%/1% top-line increase '26e/'27e/'28e, while Industry a 1%/1%/1% increase for '26e/'27e/'28e. We cut '26e EBIT by ~EUR 0.5m on changed assumptions around the timing and size of the restructuring costs and push '27-'28e slightly higher following upbeat commentary on P&amp;amp;M backlog conversion. These costs total ~EUR 3m across 2026, most of which we expect to land in Q2 due to the timing of implementation (EUR -2m in Q2, EUR -1m in Q3). We also view the recent appointment of incoming CFO Christoffer Robertsson as positive given his relevant experience from Novo Energy and ABB. Robertsson will assume the role in early September.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;The share is currently trading at 49-10x '26e-'27e EV/EBIT on vs. the peer median of 15-12x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/cavotec/Equity-research/2026/6/cavotec---quiet-quarter-small-tweaks/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 24 Jun 2026 15:45:04 GMT</pubDate>
      <isin>CH0136071542</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Svedbergs Group - UBC Group adds 8% to '27e EBITA</title>
      <description>&lt;a id="bm-comp-7afcbf84-f833-4da0-9bfa-fde724926aea" name="bm-comp-7afcbf84-f833-4da0-9bfa-fde724926aea" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7afcbf84-f833-4da0-9bfa-fde724926aea" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;UK RM&amp;amp;I forecast cut to -8% in 2026&lt;/li&gt;&lt;li&gt;We include UBC in our model, '27e EBITA +8%&lt;/li&gt;&lt;li&gt;We raise our fair value range to SEK 57-77 (55-75)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a14944f7-6c39-423d-8b94-bfeddb3414eb" name="bm-comp-a14944f7-6c39-423d-8b94-bfeddb3414eb" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a14944f7-6c39-423d-8b94-bfeddb3414eb" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Deceleration on tougher comps, Q2e EBITA +1% y-o-y&lt;/h3&gt;&lt;p&gt;We expect Svedbergs Group to decelerate in Q2: comparable growth figures are harder to meet and UK data (Roper Rhodes makes up 52% of 2025 net sales) looks soft. We forecast organic growth of 1%. We include UBC from June, which adds another 4% to sales in Q2. We expect the Q1 gross margin to have been stronger than should be extrapolated, with higher shipping rates and fuel surcharges weighing in Q2, in addition to a negative mix effect from UBC, but we still expect a 1pp higher GM y-o-y. We expect logistics-related difficulties in the UK segment to continue from Q1, for a 1pp EBITA margin contraction in this segment y-o-y. Overall we forecast a 40bp EBITA margin contraction for the Group in Q2e, EBITA of SEK 84m (for a margin of 14.2%) is +1% y-o-y.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;UBC inclusion lifts '27e EBITA by 8%&lt;/h3&gt;&lt;p&gt;The inclusion of UBC in our model brings our '26e-'28e net sales and EBITA up by 7-14% and 4-10% respectively. The acquisition further diversifies Svedbergs Group's geographical exposure, as it adds presence in East Europe (from June Czech Republic will be ~8% of net sales). The acquisition is margin-dilutive initially, which means we cut our '27e EBITA margin by 80bp. In addition to the UBC inclusion, we are becoming even more cautious on UK organic growth seeing another forecast cut by CPA, this time of a larger magnitude than previously.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We raise our fair value range to SEK 57-77 (55-75)&lt;/h3&gt;&lt;p&gt;Svedbergs Group is currently trading at 11.5-9.5x our '26e EBITA or 14-12x our '26e P/E. This compares to its L5Y average multiples of 9x and 11x NTM, respectively, or a Nordic peer group P/E median of 13x '26e (arguably, FM Mattsson is the closest peer at 17.6x). We raise our fair value range to SEK 57-77 (55-75) on our higher estimates, corresponding to 9-11x '27e EV/EBITA, 11-14x P/E.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/svedbergs/Equity-research/2026/6/svedbergs-group---ubc-group-adds-8-to-27e-ebita/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 24 Jun 2026 07:00:03 GMT</pubDate>
      <isin>SE0000407991</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Proact - Navigating volatile market conditions</title>
      <description>&lt;a id="bm-comp-8528c330-520d-4699-923f-471052a47978" name="bm-comp-8528c330-520d-4699-923f-471052a47978" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8528c330-520d-4699-923f-471052a47978" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Server prices surge amid memory shortage, causing pricing tailwind...&lt;/li&gt;&lt;li&gt;...but also volume setback and potentially increased price competition&lt;/li&gt;&lt;li&gt;'26e-'27e adj. EBITA -3%, 30% EBITA growth y-o-y in Q2e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-74a80c98-c6f6-4641-89b2-a76dc86c4a88" name="bm-comp-74a80c98-c6f6-4641-89b2-a76dc86c4a88" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="74a80c98-c6f6-4641-89b2-a76dc86c4a88" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Volatile market conditions create estimate uncertainty&lt;/h3&gt;&lt;p&gt;The global shortage of memory components due to data centre expansion is creating large price increases on servers and storage disks that Proact re-sells in its system offering (from partners Dell and NetApp). Both Dell and NetApp reported accelerated growth rates and better-than-expected sales in &lt;a data-bm-trackable="false" href="https://abg-portal.bluematrix.com/links2/pdf/a2c918ad-a4f0-4c5e-8b02-dccf2f950e65?firmId=45691" target="_blank"&gt;their recent quarters&lt;/a&gt; (expected to accelerate further ahead), supporting our thesis of good momentum and a pricing tailwind for Proact. However, we also understand that current market conditions are affecting delivery times negatively, i.e. &lt;a data-bm-trackable="false" href="https://covenco.com/insights/article/enterprise-hardware-lead-times-2026/" target="_blank"&gt;increasing them&lt;/a&gt;, which means that even though orders may be strong (which Proact does not report), sales recognition may become more spread out over Q2e-Q4e. The higher prices likely also create tougher price competition among re-sellers in the market as customers are looking for as low prices as possible, to a larger extent than under normal market conditions, as well as having a small negative effect on other IT spending (like service sales for Proact) due to less headroom in IT budgets. For Q2 we estimate 8% organic growth in system sales and 0% in service sales, resulting in a group organic growth rate of 5%. As a result of cost actions made, we estimate an adj. EBITA of SEK 98m, up 30% y-o-y, for another good earnings growth quarter.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Small negative estimate changes&lt;/h3&gt;&lt;p&gt;We leave our sales estimates unchanged but decrease '26e-'27e adj. EBITA by 3% due to somewhat delayed delivery times and increased competition in the market.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Share at 8.1x 2026e EV/EBITA&lt;/h3&gt;&lt;p&gt;On our updated estimates and post a strong share price increase (+42% L3M), the share currently trades at 8.1x 2026e EV/EBITA.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/proact/Equity-research/2026/6/proact---navigating-volatile-market-conditions/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 23 Jun 2026 11:45:04 GMT</pubDate>
      <isin>SE0015961222</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Careium - Growth's necessary trade-off</title>
      <description>&lt;a id="bm-comp-4f3a1ce5-5e93-4496-aec9-718f301343e3" name="bm-comp-4f3a1ce5-5e93-4496-aec9-718f301343e3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4f3a1ce5-5e93-4496-aec9-718f301343e3" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q2e: 13% organic sales growth, 4.5% EBITA margin&lt;/li&gt;&lt;li&gt;We raise opex on increased competition&lt;/li&gt;&lt;li&gt;Trading at 11.5x '26e EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-057e5d44-665d-40e0-ba07-d4204c904b12" name="bm-comp-057e5d44-665d-40e0-ba07-d4204c904b12" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="057e5d44-665d-40e0-ba07-d4204c904b12" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q2e will likely mirror Q1&lt;/h3&gt;&lt;p&gt;We expect another strong quarter from Careium in terms of organic growth y-o-y due to the easy comps that do not include financial lease agreements. However, we also expect Q2 to mirror Q1'26 in the context of a soft margin. As previously discussed, we believe that the investments in organic growth and a slower development in product sales will affect margins. We expect Q2 sales and EBITA of SEK 228m and SEK 10m, respectively, corresponding to y-o-y organic sales growth of 13% and a margin of 4.5%. This implies a margin contraction of 0.6pp y-o-y, compared to the 2.7pp drop y-o-y in Q1'26.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;FX tailwinds offset by increased competition&lt;/h3&gt;&lt;p&gt;We make limited organic revisions to our sales estimates, but updated FX movements cause a positive change of ~1% p.a. to '26e-'28e sales. However, the new ADDA framework has now been signed, and we are closing in on the A2D deadline in the UK. We believe that the new ADDA framework includes more competitors than before. Moreover, the UK &amp;amp; Ireland segment has been lumpy in terms of gross margins, and we assess that this is likely because of price competition, especially leading up to the A2D deadline. As such, we expect that Careium will have increased its admin and SD&amp;amp;M costs to prepare for this competitive period in two key markets. Moreover, Careium commented in the Q1 report that the onboarding of the new Norwegian client would weigh on margins in both Q1 and Q2. We raise our COGS and opex assumptions, leading to negative EBITA estimate revisions of 3-4%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 11.5x '26e EBITA&lt;/h3&gt;&lt;p&gt;On our updated estimates, Careium is trading at '26e-'27e multiples of 11.5x-9x EV/EBITA and 14x-10x P/E, and we highlight '25-'28e sales and EBITA CAGRs of 7% and 23%, respectively. Careium has historically traded at an average of 8x EBITA and 11x P/E, NTM.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/careium/Equity-research/2026/6/careium---growths-necessary-trade-off/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 16 Jun 2026 06:00:13 GMT</pubDate>
      <isin>SE0017131824</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Infrea - Infrea and Netel to merger</title>
      <description>&lt;a id="bm-comp-96ccac0e-8734-42d3-9c3c-59dde4e7786b" name="bm-comp-96ccac0e-8734-42d3-9c3c-59dde4e7786b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="96ccac0e-8734-42d3-9c3c-59dde4e7786b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Infrea and Netel to merger&lt;/li&gt;&lt;li&gt;The combined company to have ~SEK 5bn in revenue&lt;/li&gt;&lt;li&gt;Stynnergies of ~SEK 50m yearly&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-fbf28a96-84c3-4002-bdc7-abc3775e7279" name="bm-comp-fbf28a96-84c3-4002-bdc7-abc3775e7279" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fbf28a96-84c3-4002-bdc7-abc3775e7279" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;A 12% premie to close, an 8% discount to 90 days average&lt;/h3&gt;&lt;p&gt;Netel and Infrea intend to carry out a merger between the companies where Netel absorbs Infrea. The combined platform will generate revenues of approximately SEK 5bn and is expected to deliver annual synergies of around SEK 50m. The transaction is strategically compelling as the two companies complement each other across service offering, customer exposure and geography, operating in partly different markets while sharing a common infrastructure focus. Infrea's shareholders will receive 17 new Netel shares for every 4 shares held. Netel's board intends to carry out a fully secured rights issue of approximately SEK 127m ahead of closing, with an over-allotment issue of up to SEK 75m also proposed. The theoretical ex-rights price represents a 12% premium to the last closing price, is flat to the 30-day average and reflects an 8% discount to the 90-day average. Martin Reinholdsson, currently CEO of Infrea, will serve as CEO of the combined company, and Alireza Etemad, Chairman of Netel, will continue as Chairman of the board.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;About Netel&lt;/h3&gt;&lt;p&gt;Netel is a provider of critical infrastructure services spanning design, installation, maintenance and upgrades, with a particular emphasis on reliable energy systems and resilient communications networks. The company operates across Sweden, Norway and Germany, organised into three business segments: Infraservices, Power and Telecom. 2026 Netel had reported sales of SEK 2.9bn and EBITA of -5m. Netel employs ~800 people and has been listed on Nasdaq Stockholm since 2021.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Timeline of the merger&lt;/h3&gt;&lt;p&gt;Both companies' boards have recommended their respective shareholders to approve the merger. Extraordinary general meetings will be held in August, with the prospectus expected to be published in July. The merger is planned to be registered with the Swedish Companies Registration Office in Q4'2&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/infrea/Equity-research/2026/6/infrea---infrea-and-netel-to-merger/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 15 Jun 2026 07:00:03 GMT</pubDate>
      <isin>SE0010600106</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Qliro - From checkout volumes to recurring earnings</title>
      <description>&lt;a id="bm-comp-2fffcda2-c920-4b6b-a5a9-839adc82e36d" name="bm-comp-2fffcda2-c920-4b6b-a5a9-839adc82e36d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2fffcda2-c920-4b6b-a5a9-839adc82e36d" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Merchant-first platform in a fragmented Nordic market&lt;/li&gt;&lt;li&gt;Loan book growth transforms volumes into recurring earnings&lt;/li&gt;&lt;li&gt;Fair value range of SEK 15-35&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-08aed0e1-5189-430d-870f-f5c72682ae65" name="bm-comp-08aed0e1-5189-430d-870f-f5c72682ae65" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="08aed0e1-5189-430d-870f-f5c72682ae65" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Merchant-led growth supports long-term TPV expansion&lt;/h3&gt;&lt;p&gt;Qliro operates a merchant-first Nordic checkout platform combining Pay Now and Pay Later products within a single offering. The company benefits from structural growth in Nordic e-commerce, increasing merchant onboarding and growing Pay Later adoption. We forecast total payment volume (TPV) to increase from SEK 17.9bn in 2025 to SEK 43.2bn in 2028e, driven by continued merchant additions and increasing penetration within existing customers. Qliro&amp;#8217;s estimated market share is currently only ~4%, indicating significant room for continued expansion.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Recurring lending revenues drive earnings inflection&lt;/h3&gt;&lt;p&gt;Qliro&amp;#8217;s business model benefits from a structural lag between transaction growth and earnings generation. As Buy Now Pay Later (BNPL) volumes increase, the loan book expands, supporting higher recurring lending revenues over time. We forecast net interest income to increase from SEK 353m in 2025 to SEK 568m in 2028e, while operating profit improves from SEK -103m to SEK 116m, supported by operating leverage, loan book growth and improving credit quality.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of SEK 15-35 highlights execution potential&lt;/h3&gt;&lt;p&gt;We value Qliro using a Gordon growth framework complemented by peer analysis. Given the company&amp;#8217;s current growth phase, valuation outcomes remain highly sensitive to assumptions regarding TPV growth, BNPL penetration, operating leverage and credit performance. Across our scenarios, the implied valuation range spans SEK 15&amp;#8211;35 per share, which we use as our fair value range. Based on our forecast, Qliro is trading at 7.7x P/E 2028e.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/qliro/Equity-research/2026/6/qliro---from-checkout-volumes-to-recurring-earnings/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 09 Jun 2026 09:51:44 GMT</pubDate>
      <isin>SE0013719077</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Qben Infra - Increasing focus on Power</title>
      <description>&lt;a id="bm-comp-7df1387a-9d42-40c0-97d7-6f90d39c69b7" name="bm-comp-7df1387a-9d42-40c0-97d7-6f90d39c69b7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7df1387a-9d42-40c0-97d7-6f90d39c69b7" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Focus now on the Power segment&lt;/li&gt;&lt;li&gt;Strategically important acquisition in Norway&lt;/li&gt;&lt;li&gt;Divestment of Inspekt expected to close in Q2&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-61646bc7-67be-4d39-85b4-257e4ac6db17" name="bm-comp-61646bc7-67be-4d39-85b4-257e4ac6db17" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="61646bc7-67be-4d39-85b4-257e4ac6db17" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 highlights&lt;/h3&gt;&lt;p&gt;Qben Infra reported Q1 sales of SEK 169m and EBITA of SEK -44m. The Construction segment had a slow quarter, with SEK 12m in sales and EBITA of SEK -14m, due to lower activity and fewer handovers during the quarter, this is expected by the company to improve from Q3. The most interesting segment, Power, also had a slow start to the year, with sales of SEK 156m (-7% y-o-y) and EBITA of SEK -17m (vs. SEK 1m in Q1'25), driven by smaller projects pressuring margins, seasonality, and cold weather delaying some work. The Inspekt segment grew sales by 32% y-o-y, to SEK 47m, but EBITA declined to SEK -6m (vs. SEK -4m in Q1'25). However, this segment is slated for divestment, with the company expecting the transaction to close in Q2'26.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and estimate changes&lt;/h3&gt;&lt;p&gt;The remaining segments of Qben Infra, Power and Construction (Team Bygg), continue to see good demand. During the quarter, Qben announced the acquisition of B45 Anlegg (B45), a Norwegian contractor specialising in concrete works for critical infrastructure, including power plants, dams, transmission lines, and other structures requiring solid concrete foundations. Demand in the energy sector is strong across the Nordic countries, and Qben is increasingly focused on becoming a power-focused company. Q1 is a seasonally small quarter, and there will be catch-up effects. EBITA '26e is down mechanically due to the SEK 15m one-off charge taken in the quarter, while we leave adj. EBITA untouched.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Looking ahead&lt;/h3&gt;&lt;p&gt;Qben should be viewed as a Power-focused company. Management states that the divestments of Rail, Kvalitetsbygg, and the upcoming Inspekt divestment will free up resources for redeployment into faster-growing infrastructure segments (Power), which benefit from strong market conditions and a solid order backlog.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/qben-infra/Equity-research/2026/6/qben-infra---increasing-focus-on-power/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 02 Jun 2026 07:30:04 GMT</pubDate>
      <isin>SE0023114012</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Proact - Dell and NetApp better-than-expected</title>
      <description>&lt;a id="bm-comp-2baa9374-f3cb-4918-b441-4f141ee33044" name="bm-comp-2baa9374-f3cb-4918-b441-4f141ee33044" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2baa9374-f3cb-4918-b441-4f141ee33044" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Dell group sales +24% vs cons, NetApp +4%, stocks +27% and +15% in aft-mkt&lt;/li&gt;&lt;li&gt;Accelerated revenue growth in Dell Storage sales and NetApp group revenue&lt;/li&gt;&lt;li&gt;Positive read-across to Proact System sales, share at 8.3x EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f2ef76c1-3b01-4724-bc46-a77e81c560b6" name="bm-comp-f2ef76c1-3b01-4724-bc46-a77e81c560b6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f2ef76c1-3b01-4724-bc46-a77e81c560b6" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Dell beat mainly driven by AI servers, but storage also solid&lt;/h3&gt;&lt;p&gt;Dell delivered a strong beat vs expectations in its Q1'27 report due tonight after market close, with group sales growing 88% y-o-y and beat consensus by 24%. Share was up 27% in after market trading, and it was the segment AI-Optimized Servers within ISG that drove the beat, growing 757% y-o-y reaching USD 16bn in sales. Looking at the relevant segment for Proact, it is mainly the Storage part that grew 8% y-o-y and came in 8% above consensus.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;NetApp accelerating sales growth&lt;/h3&gt;&lt;p&gt;NetApp reported its Q4'26 report after market close tonight as well, with sales growing 12% y-o-y coming in 4% above consensus expectations. It also provided a FY 2027 sales guidance 3% above consensus expectations and representing a growth of 8%. Both Dell and NetApp have likely seen price tailwinds from recent price hikes due to increased memory prices which is an important component in storage products, and both reported its highest growth rates since 2023 for respective relevant segment for Proact.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Positive read-across to Proact&lt;/h3&gt;&lt;p&gt;Proact is a value added re-seller of both Dell and NetApp storage products in its System sales segment (55% of group sales). We expect accelerated organic growth rates in the coming quarters due to both positive price effects and potential pre-buying from customers wanting to secure availability before even larger possible price increases. This strength will likely continue for at least a few quarters. The share trades at 8.3x NTM EV/EBITA and we forecast 33% EBITA growth in 2026e. We expect the share to outperform the market tomorrow.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-23cb1244-030a-4894-8df3-74c2b3b06eee" name="bm-comp-23cb1244-030a-4894-8df3-74c2b3b06eee" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="23cb1244-030a-4894-8df3-74c2b3b06eee" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-755256ee-8797-46be-b238-622e425f0f2a" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Dell Storage sales growth&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Dell&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f7ff1a86-d6e6-4cc1-a6e1-f4d885258d7b" name="bm-comp-f7ff1a86-d6e6-4cc1-a6e1-f4d885258d7b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f7ff1a86-d6e6-4cc1-a6e1-f4d885258d7b" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-954e506e-b288-4030-bc2d-3f73c46626ce" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;NetApp sales growth&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, NetApp&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-2146c1bf-28c4-4248-8f35-71c3a44da0ed" name="bm-comp-2146c1bf-28c4-4248-8f35-71c3a44da0ed" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2146c1bf-28c4-4248-8f35-71c3a44da0ed" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-67ecc8f1-190c-4c9f-8dc9-3d9b72b9d9d6" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Proact System sales organic growth&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Coll&lt;/td&gt;&lt;/tr&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/proact/Equity-research/2026/5/proact---dell-and-netapp-better-than-expected/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 28 May 2026 22:15:03 GMT</pubDate>
      <isin>SE0015961222</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Xplora Technologies - Stronger signal ahead </title>
      <description>&lt;a id="bm-comp-b23f5820-9baf-4543-8e4a-00bc4ca77f94" name="bm-comp-b23f5820-9baf-4543-8e4a-00bc4ca77f94" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b23f5820-9baf-4543-8e4a-00bc4ca77f94" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We cut '26e EBITA by 15%, but lift '27e/'28e EBITA by 9%/8%&lt;/li&gt;&lt;li&gt;We forecast a ~50% EBITA CAGR from '26e to '28e...&lt;/li&gt;&lt;li&gt;... leading EV/EBITA to drop from 13.6x in '26e to 4.7x in '28e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-83dacb0a-b250-49bf-a318-59307bc1eb30" name="bm-comp-83dacb0a-b250-49bf-a318-59307bc1eb30" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="83dacb0a-b250-49bf-a318-59307bc1eb30" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;'27e/'28e EBITA +9%/8% on raised synergy target...&lt;/h3&gt;&lt;p&gt;At first glance Xplora delivered a soft Q1 report with EBITDA 35% below FactSet consensus on lower ARPU (down 7% y-o-y) and Kids device sales. But, a large part of the miss came from NOK 10m lower R&amp;amp;D capitalisation vs. Q1'25. If it hadn't been for this, EBITDA would have been NOK 38m, up 30% y-o-y. Still below expectations, but not a disaster given that Q1 only tends to be 2-7% of full-year EBITDA. Also, Xplora lifted the Doro cost synergy target from NOK 30m to NOK 50m. We cut '26e-'28e revenues by 3-4% on lower ARPU and lower device ASP due to a stronger NOK vs. EUR. But we also cut our opex estimates on higher synergies. This reduces '26e EBITA by 15%, but lifts '27e/'28e EBITA by 9%/8%.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Xplora has the tools it needs to succeed with Doro Connect&lt;/h3&gt;&lt;p&gt;With ~1.2m senior phones sold annually, converting senior customers to recurring subscribers is the key value driver. Doro Connect is soon live on its own web stores across all markets, after which a retail rollout will follow. We have looked at the ROI of giving a free feature phone in exchange for a subscription and found that as long as the GM is 60% or higher, the LTV/CAC is above 3.5x which means a very attractive ROI. Hence, Xplora has the tools it needs to drive a high conversion rate in the senior segment. Keep in mind that we have assumed some CAC in our estimates which is directly expensed over the P&amp;amp;L, underestimating the underlying earnings. If we instead were to capitalise it and depreciate it over five years, '27e/'28e EBITA would increase by ~NOK 30m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of NOK 40-130/share&lt;/h3&gt;&lt;p&gt;Xplora is now trading at 13.6x '26e EV/EBITA, but due to the full effect of senior subscriptions not really having an impact before '27e this drops to 7.7x in '27e and further to 4.7x in '28e. Our DCF&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/xplora_technologies/Equity-research/2026/5/xplora-technologies---stronger-signal-ahead-/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 28 May 2026 05:00:06 GMT</pubDate>
      <isin>NO0010895782</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Prevas - Feedback from ABGSC's Investor Days</title>
      <description>&lt;a id="bm-comp-18122a67-6fab-4747-acf2-a93f40ff5b0d" name="bm-comp-18122a67-6fab-4747-acf2-a93f40ff5b0d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="18122a67-6fab-4747-acf2-a93f40ff5b0d" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Prioritising profitability, targeting 12% EBITA margin&lt;/li&gt;&lt;li&gt;Building on the 15+ years of defence expertise&lt;/li&gt;&lt;li&gt;Disciplined M&amp;amp;A approach, waiting for the right fit&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9091a886-846a-4c2a-a61a-5943ce2a19a9" name="bm-comp-9091a886-846a-4c2a-a61a-5943ce2a19a9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9091a886-846a-4c2a-a61a-5943ce2a19a9" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;A Nordic technical consulting firm&lt;/h3&gt;&lt;p&gt;Last week, we hosted Prevas CEO Magnus Wel&amp;#233;n at ABGSC's Investor Days. The company is a technical consultancy focused on product and production development, specialised in engineering, defence, life science and energy. Founded in 1985 and listed since 1998, Prevas operates across three main markets: Sweden (~81% of total sales, including Norway and other operations), Finland (~12%) and Denmark (~8%). Defence in particular is the fastest growing segment, up 22% in Q1'26 and now representing ~17% of total sales.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Takeaways from the presentation&lt;/h3&gt;&lt;p&gt;We took away three key points from the presentation. 1) The current main priority is not rapid growth but rather restoring profitability towards the 12% EBITA margin target, with the adj. EBITA margin having improved for three consecutive quarters. To get there, the company is continuing to adjust the business towards the demand picture seen today, and more specifically, putting extra focus on higher-margin niches such as EAM. 2) Defence was highlighted as a structurally attractive area, where Prevas has built up security systems, processes and customer understanding over 15 years. We also asked about concentration risk, and management said they are comfortable with the current ~17% exposure of total sales, viewing defence as a structural growth area that is here to stay. 3) On M&amp;amp;A, the tone was disciplined, with management noting that new technologies, customer value and cultural fit all need to be right, so we expect M&amp;amp;A activity to remain limited near-term.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Gradual margin recovery underway&lt;/h3&gt;&lt;p&gt;As is well known in the consultancy sector, margins have been weighed down by lower demand, leading to increased competition and pricing pressure. Over time, Prevas has undergone several organisational and structural changes to meet demand, as Mr&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/prevas/Equity-research/2026/5/prevas---feedback-from-abgscs-investor-days/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 25 May 2026 16:30:03 GMT</pubDate>
      <isin>SE0000356008</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>BTS Group - North America behind improved sentiment</title>
      <description>&lt;a id="bm-comp-3c8b526c-dd95-46a7-b63a-e57e0af6f1a7" name="bm-comp-3c8b526c-dd95-46a7-b63a-e57e0af6f1a7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3c8b526c-dd95-46a7-b63a-e57e0af6f1a7" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Adj. EBITA -3%/-2%/+1% in '26e/'27e/'28e; North America delivers&lt;/li&gt;&lt;li&gt;We estimate positive EBITA growth in 2026e, in line with guidance&lt;/li&gt;&lt;li&gt;11.2x '26e EV/EBITA, sentiment still under pressure for consultants&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-18e0b7ec-439b-4565-b59a-7c74b6502087" name="bm-comp-18e0b7ec-439b-4565-b59a-7c74b6502087" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="18e0b7ec-439b-4565-b59a-7c74b6502087" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Improvements and setbacks in Q1&lt;/h3&gt;&lt;p&gt;We are encouraged by the turnaround in North America, which is back to organic growth again (4% in Q1) after three negative quarters. This also means that comps now get easier, and combined with positive outlook comments about the region, we expect to see solid growth momentum in the coming quarters. Europe stood out with its 17% organic growth in Q1, but we note a tougher comp in Q2 (31% organic growth last year). which makes us somewhat more cautious in Q2e (although the business momentum sounds solid, with highlights across Germany, France and the defence sector generally). The setback in south-east Asia (Other markets segment) was a surprise for us: although we expect improvements in H2'26e, we make some estimate cuts here.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Small estimate changes&lt;/h3&gt;&lt;p&gt;On the back of a solid Q1 report, unchanged FY guidance and small movements from FX, we cut '26e-'27e adj. EBITA by 3%/2% but increase '28e by 1%. Segment-wise, we increase EBITA in North America and Europe, but decrease in Other markets due to the weakness in Q1.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Sentiment remains under pressure, but could improve&lt;/h3&gt;&lt;p&gt;On our revised estimates, the share trades at 11.2x 2026e EV/EBITA. The sentiment towards consulting firms (both management consulting and IT services) remains under pressure, with Accenture's share -41% L12M trading at 8.3x NTM EV/EBITA. Moreover, the average organic growth rates for Swedish IT services declined to -6% in Q1 and Knowit's share is -27% L12M. The effects from AI remain uncertain for consulting companies, where the bulls argue for increased demand and improved internal efficiency, while the bears argue for lower demand (as companies will do more themselves). We think there will be opportunities for companies capturing the AI opportunity, and BTS' recent comments around AI sou&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/bts-group/Equity-research/2026/5/bts-group---north-america-behind-improved-sentiment/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 25 May 2026 12:15:02 GMT</pubDate>
      <isin>SE0000805426</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Qben Infra - Feedback from ABGSC's Investor Days</title>
      <description>&lt;a id="bm-comp-0a48d203-78af-41d9-95a6-ebf04d230149" name="bm-comp-0a48d203-78af-41d9-95a6-ebf04d230149" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0a48d203-78af-41d9-95a6-ebf04d230149" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Streamlining the group with a clean balance sheet&lt;/li&gt;&lt;li&gt;Power as the core focus area&lt;/li&gt;&lt;li&gt;Targeting NOK 2bn in revenue by '27-'28&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1a82b81d-ee98-49fb-b74f-60470df9f1c3" name="bm-comp-1a82b81d-ee98-49fb-b74f-60470df9f1c3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1a82b81d-ee98-49fb-b74f-60470df9f1c3" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Overview of Qben Infra&lt;/h3&gt;&lt;p&gt;Last week, we hosted Qben Infra's interim CFO Patrik Sj&amp;#246;lund at ABGSC's Investor Days. Founded in 2001, Qben Infra is a Nordic infrastructure services group focused on acquiring and developing companies that build, maintain, and future-proof socially critical infrastructure. It operates across three niches currently: construction, power, and testing, inspection &amp;amp; certification (TIC). Qben combines organic growth with strategic acquisitions and group-driven synergies, serving customers across both public (~90% in the Power segment) and private sector.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Streamlined into Power and Construction with a clean balance sheet&lt;/h3&gt;&lt;p&gt;During the presentation, Mr Sj&amp;#246;lund discussed how to think about Qben Infra's strategic transformation and margin trajectory going forward. Following the divestments of Rail in early 2026 and Kvalitetsbygg, together with the signed LOI to sell Inspect, expected to close in Q2'26, Qben has streamlined the group into two segments: Power as the core focus area and Construction through Teambygg. The Rail divestment enabled the redemption of the SEK 500m bond, cleaning up the balance sheet and creating room for further acquisitions. The core focus, Power, is supported by a stronger order book underpinned by public investments such as Svenska kraftn&amp;#228;t's announced SEK 210bn programme (10y) and planned Norwegian grid investments of NOK 150-200bn (10-20y). Management targets an EBITA margin of 10% in Power, higher than peers (Bravida &amp;amp; Instalco according to management), and by '27-'28 they are targeting revenue of NOK 2bn (group).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Looking ahead&lt;/h3&gt;&lt;p&gt;Qben Infra should be viewed as an investment company. Management states that the transactions will free up resources for redeployment into the faster-growing infrastructure segments (Inspect and Power), which benefit from solid market conditions and a strong order back&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/qben-infra/Equity-research/2026/5/qben-infra---feedback-from-abgscs-investor-days/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 25 May 2026 09:45:04 GMT</pubDate>
      <isin>SE0023114012</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nolato - Announces Anders Björklund as new CEO</title>
      <description>&lt;a id="bm-comp-805311b7-d147-4de2-9f32-45e67940901c" name="bm-comp-805311b7-d147-4de2-9f32-45e67940901c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="805311b7-d147-4de2-9f32-45e67940901c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Christer Wahlquist stepping down, Anders Bj&amp;#246;rklund new CEO&lt;/li&gt;&lt;li&gt;Pre-planned, internal recruitment should make for a smooth transition&lt;/li&gt;&lt;li&gt;A loss for the company, but still plenty of experience in the mgmt. team&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-4281f8ce-f1ff-4410-bbc1-c184e914b48e" name="bm-comp-4281f8ce-f1ff-4410-bbc1-c184e914b48e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4281f8ce-f1ff-4410-bbc1-c184e914b48e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Anders Bj&amp;#246;rklund appointed new CEO&lt;/h3&gt;&lt;p&gt;Nolato announced yesterday evening that CEO Christer Wahlquist will step down on July 17, while staying on in an advisory role until year-end. Anders Bj&amp;#246;rklund, Head of the Engineered Solutions segment since 2023, has been appointed as his successor. Prior to joining Nolato, Mr. Bj&amp;#246;rklund held the position of Managing Director of Kanthal (at the time a division within Sandvik Materials Technology), as well as various positions within Gunnebo, Volvo Construction Equipment, and Ericsson before that. The now outgoing CEO Mr. Wahlquist has been at Nolato for over 30 years, of which 10 as CEO and previously as Head of the Medical Solutions segment. He has been a key part of developing both the group as a whole, and in particular the Medical segment from a small business into now accounting for a majority of the company's earnings, and he has also been widely appreciated by the investor community.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Our thoughts&lt;/h3&gt;&lt;p&gt;This came a bit out of the blue for us, and given Mr. Wahlquist's long tenure and success as CEO it is certainly a loss for the company. However, we highlight that there is still plenty of experience in the management team, with CFO Per-Ola Holmstr&amp;#246;m for example having held his position since 1995. Also, the transition seems smooth and thought out given there is a pre-planned internal recruitment already in place, as well as Mr. Wahlquist staying on as an advisor. Finally, as Head of one of Nolato's two segments currently, and with plenty of prior experience, Mr Bj&amp;#246;rklund seems a logical choice as new CEO.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nolato/Equity-research/2026/5/nolato---announces-anders-bjorklund-as-new-ceo/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 25 May 2026 06:15:01 GMT</pubDate>
      <isin>SE0015962477</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Gentoo Media - Continues to deleverage</title>
      <description>&lt;a id="bm-comp-7d892120-4c74-43f6-9e77-0606f3e1397c" name="bm-comp-7d892120-4c74-43f6-9e77-0606f3e1397c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7d892120-4c74-43f6-9e77-0606f3e1397c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sports margin weak in Feb'26&lt;/li&gt;&lt;li&gt;Minor estimate revisions&lt;/li&gt;&lt;li&gt;Trading below peers at 4.0x '26e EV/EBITDA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ab4bf31c-1057-490e-b653-70c7c2970fe6" name="bm-comp-ab4bf31c-1057-490e-b653-70c7c2970fe6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ab4bf31c-1057-490e-b653-70c7c2970fe6" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Sports margin held back the quarter&lt;/h3&gt;&lt;p&gt;Q1 was a bit softer than we had expected with respect to adj. EBITDA, which was 6% below our expectation but in line with FactSet consensus. Given that revenue was in line with our expectations, we also deem the maintained guidance range credible (even though it is rather wide). Going forward, we expect revenue growth to accelerate to 16% in Q2e, and to then gradually normalise down to 5% in a few quarters. The company continues to deleverage, and the leverage ratio is now closer to 2.7x net debt/EBITDA.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate revisions&lt;/h3&gt;&lt;p&gt;We only make minor estimate changes, cutting '26e EBITDA by 3% after the report. We remain in line with the lower end of Gentoo's '26e guidance for revenue and EBITDA. Encouragingly, the Q1 operating cash flow was strong and de-risks the guidance for operating cash flow, which is important for the deleveraging journey ahead. Notably, this performance should be considered against the backdrop of a weak sports margin in Feb'26 that should not be extrapolated. The reason is that the sports margin is often mostly contingent on sports outcomes, and these can vary significantly from quarter to quarter. We continue to believe that Gentoo can return to growth in the coming years as some of the old headwinds abate.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 4.0x '26e EV/EBITDA&lt;/h3&gt;&lt;p&gt;Gentoo is trading at 4.0x '26e EV/EBITDA, well below Better Collective (7.5x) and Gambling.com (4.3x). This means that Gentoo is trading 35% below the average of Better Collective and Gambling.com. Moreover, we highlight that Gentoo is trading at a '26e lease-adj. FCF yield excl. M&amp;amp;A of nearly 25%, as it should be noted that the company is largely focused on deleveraging.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/gentoo-media/Equity-research/2026/5/gentoo-media---continues-to-deleverage/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 24 May 2026 20:30:02 GMT</pubDate>
      <isin>US36467X2062</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Tempest Security - Feedback from ABGSC's Investor Days</title>
      <description>&lt;a id="bm-comp-2997ded6-49c5-44fc-b425-0dcdc8a77cda" name="bm-comp-2997ded6-49c5-44fc-b425-0dcdc8a77cda" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2997ded6-49c5-44fc-b425-0dcdc8a77cda" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Benefiting from becoming a larger company&lt;/li&gt;&lt;li&gt;Eyeing a Nordic expansion&lt;/li&gt;&lt;li&gt;Potential in the SOC business&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-db5a9766-9069-4a55-8caa-27949b591648" name="bm-comp-db5a9766-9069-4a55-8caa-27949b591648" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="db5a9766-9069-4a55-8caa-27949b591648" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Focusing on the Guarding&lt;/h3&gt;&lt;p&gt;This Friday, we hosted Tempest Security CEO Andrew Spry at ABGSC's Investor Days. Tempest Security released its Q1'26 report on Thursday, delivering a solid set of numbers with earnings exceeding ABGSC's expectations. Mr. Spry's presentation focused on the future of the Guarding segment, which accounts for roughly 90% of group revenue and is therefore central to the investment case. The segment has undergone significant changes over the past few years and is now in a stronger, more focused position. Performance has improved and Tempest is now exploring a Nordic expansion. The CEO was clear that this will be pursued with care and discipline, establishing operations only in countries where existing clients have a demonstrated need for Tempest's services.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Growing revenue and lifting margins&lt;/h3&gt;&lt;p&gt;Additionally, Mr Spry discussed how to think about volumes and margins in the Guarding segment going forward. Following the termination of the Scania contract in 2024, the short-term focus was on replacing the lost volume, which Tempest managed well without seeing a drop in revenue. However, raising profitability on the new contracts has taken time, driven by a substantial recruitment need in new regions that led to elevated overtime costs and weighed on margins. The level of maturity has now improved, and profitability has followed. Historically, the Guarding segment has delivered margins around 9%, and we argue that margins of 12&amp;#8211;13% should be achievable ahead.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Cleaned and set for 2026&lt;/h3&gt;&lt;p&gt;We believe the company has taken important steps throughout 2025 with the divestment of the US business and the turnaround in Denmark. There are further efficiencies to be gained from the recently signed contracts in Guarding, as profitability typically improves gradually after the initial start-up period. The SOC is an interesting part of the group given its 100% scalability, and&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/tempest-security/Equity-research/2026/5/tempest-security---feedback-from-abgscs-investor-days/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 22 May 2026 16:45:07 GMT</pubDate>
      <isin>SE0010469221</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Coeli Private Equity - Feedback from ABGSC's Investor Days</title>
      <description>&lt;a id="bm-comp-36137eb3-bb26-4e96-ab9d-08dd0380368e" name="bm-comp-36137eb3-bb26-4e96-ab9d-08dd0380368e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="36137eb3-bb26-4e96-ab9d-08dd0380368e" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Listed exposure to Nordic private equity (~28% current NAV discount)&lt;/li&gt;&lt;li&gt;Historical outperformance in small- and mid-cap, Nordic buyouts&lt;/li&gt;&lt;li&gt;Closing the NAV discount 'largely a matter of awareness': CEO&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d9698267-e3e6-46ea-b797-5e3f00ac82e6" name="bm-comp-d9698267-e3e6-46ea-b797-5e3f00ac82e6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d9698267-e3e6-46ea-b797-5e3f00ac82e6" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Accessible private equity exposure&lt;/h3&gt;&lt;p&gt;We hosted Coeli Private Equity AB at ABGSC's Investor Days today, where CEO and fund manager Henrik Arfvidsson discussed the investment case for Nordic unlisted small- and mid-cap investing. Coeli PE offers listed exposure to an otherwise hard-to-reach asset class with a share price of SEK 122 and a NAV of SEK 174, indicating a NAV discount of ~28%. Arfvidsson emphasised that gaining direct exposure to Nordic private equity is far from straightforward for private investors, and that the listed structure offers a rare and accessible entry point into an asset class typically reserved for institutional capital.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Understanding the asset class&lt;/h3&gt;&lt;p&gt;Arfvidsson spent time explaining how private equity actually works, from fund structure and the GP/LP dynamic to how value is created over a typical 5-7 year holding period. Key takeaways included the freedom from quarterly reporting pressure, which allows management teams and owners to focus on long-term value creation. Data were also provided to show that this has historically translated into returns well above public market equivalents. The European PE index has outperformed Eurostoxx 50 by roughly 9-10 percentage points per year over both 5- and 10-year periods.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Why Nordic, and why small-/mid-cap&lt;/h3&gt;&lt;p&gt;Furthermore, Arfvidsson explained the rationale behind the geographic and size focus. Nordic buyouts have delivered a realised multiple of 2.7x since 2003, ahead of both North America (2.4x) and the rest of Europe (2.3x). The region also stands out with a lower share of loss-making investments at 14%, compared to 16% in North America and 18% in the rest of Europe. Within that, Arfvidsson pointed out that the small and mid-cap segment offers lower entry multiples (~6.5x EV/EBITDA vs. ~12x for large cap), less competitio&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/company-name2/Equity-research/2026/5/coeli-private-equity---feedback-from-abgscs-investor-days/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 22 May 2026 16:30:06 GMT</pubDate>
      <isin>SE0012012268</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ogunsen - Holding margins through a soft market</title>
      <description>&lt;a id="bm-comp-c0873435-d8c7-4663-b9fb-bc5270a364dc" name="bm-comp-c0873435-d8c7-4663-b9fb-bc5270a364dc" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c0873435-d8c7-4663-b9fb-bc5270a364dc" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Soft quarter, brighter outlook&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;We raise our EBIT estimates by 3-2% for '26e-'27e&lt;/font&gt;&lt;/li&gt;&lt;li&gt;Early signs of a better market environment&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-b38b0c1b-7963-4529-8b7f-931dafcf6e2a" name="bm-comp-b38b0c1b-7963-4529-8b7f-931dafcf6e2a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b38b0c1b-7963-4529-8b7f-931dafcf6e2a" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1'26 report&lt;/h3&gt;&lt;p&gt;Ogunsen reported Q1&amp;#8217;26 sales of SEK 115m, down 2% y-o-y, reflecting lower hourly rates in the consulting segment and weaker demand in the recruitment segment. Sales were flat in the consulting segment at SEK 106m, and now correspond to 93% of total sales. The recruiting segment has historically been affected by weaker demand, and Q1 sales decreased by 18% to SEK 8m. Even if the top-line remains soft due to weaker demand in the market, Ogunsen kept adj. EBIT flat at SEK 6m (SEK 6m in Q1&amp;#8217;25) and came in above our expectations at SEK 5m, with a margin of 5.3% (5.2% in Q1'25 adjusted for one-off costs last year), supported by a leaner organisation and AI-driven efficiency, which we expect to support margins going forward.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Slightly increased EBIT estimates&lt;/h3&gt;&lt;p&gt;After years of a declining consulting market alongside headwinds from lower demand and pricing pressure, we think that market conditions are slowly showing early signs of easing. As such, we slightly raise our '26e-'27e EBIT estimates by 3-2%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 10x/8x EV/EBIT for '26e/'27e&lt;/h3&gt;&lt;p&gt;Ogunsen is trading at 10x/8x EV/EBIT for &amp;#8217;26e/&amp;#8217;27e and is well-positioned to benefit from improving market conditions in H2&amp;#8217;26. Consulting volumes are slightly rising and should support sales as pricing recovers, while early signs of somewhat stronger recruitment demand could add upside in the longer term given the segment&amp;#8217;s high margins, driving earnings into next year.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ogunsen/Equity-research/2026/5/ogunsen---holding-margins-through-a-soft-market/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 22 May 2026 15:30:07 GMT</pubDate>
      <isin>SE0008406151</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>BTS Group - Feedback from ABGSC's Investor Days</title>
      <description>&lt;a id="bm-comp-3c19f473-2db7-4482-bc98-81a6445225e3" name="bm-comp-3c19f473-2db7-4482-bc98-81a6445225e3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3c19f473-2db7-4482-bc98-81a6445225e3" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;CEO highlighted AI as a "big friend to our firm at the moment"&lt;/li&gt;&lt;li&gt;Anthropic customer case sounds attractive, while software clients slow&lt;/li&gt;&lt;li&gt;On track to deliver on FY guidance, share now at 10.2x NTM EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-df6ad9e7-0240-4bee-b54c-f005667bb23b" name="bm-comp-df6ad9e7-0240-4bee-b54c-f005667bb23b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="df6ad9e7-0240-4bee-b54c-f005667bb23b" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;More clarity on the AI opportunity&lt;/h3&gt;&lt;p&gt;We hosted BTS' CEO Jessica Skon today at ABGSC's Investor Days, where she framed the current business momentum as "AI is a big friend to our firm at the moment". What she refers to is both increased demand from customers on implementing AI use cases as well as customer wins from AI companies, combined with internal productivity gains through AI workflows. This combination is well needed to improve sentiment for the share, given recent challenging market and AI uncertainties to the consulting sector. BTS reported that direct AI bookings in Q1 increased 35% y-o-y and that AI product bookings (within license revenues) increased 3x y-o-y. It has reached SEK 74m in 2026 annual cost savings due to AI workflow and product innovations in 2025, that will boost profits ahead. Mrs Skon mentioned that Anthropic is a client since 9 months ago, and that BTS will help Anthropic with leadership development in the new management team as well as assignments for the Chief Revenue Officer in forming a global sales force with the decided go-to-market model and scale it over time, from for example 500 to 2,000 sales people aligning with the strategy. On the contrary to this tailwind, the software sector is not doing great in North America at the moment due to delayed projects and hesistance about the future path.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;North America set to grow, Other markets recovery in H2&lt;/h3&gt;&lt;p&gt;Mrs Skon was clear that the turnaround in North America is completed, and the region is back to positive organic growth again (after three negative quarters). With a continued solid momentum in Europe, BTS' internal actions will be concentrated to turn Other markets (and particularly southeast Asia) into growth again. This should be managable during H2'26e, as BTS has historically solved internal &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/bts-group/Equity-research/2026/5/bts-group---feedback-from-abgscs-investor-days/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 22 May 2026 12:30:07 GMT</pubDate>
      <isin>SE0000805426</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Infrea - Feedback from ABGSC's Investor Days</title>
      <description>&lt;a id="bm-comp-17f23eba-bcde-4761-a79e-272528a6db5b" name="bm-comp-17f23eba-bcde-4761-a79e-272528a6db5b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="17f23eba-bcde-4761-a79e-272528a6db5b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We expect Civil Engineering spending to rise&lt;/li&gt;&lt;li&gt;Taking advantages from being part of a group&lt;/li&gt;&lt;li&gt;7-4x EBITA '26e-'28e, 17-13% FCF yields&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d57a00f8-9f3b-4308-82fe-8e33ae0bda27" name="bm-comp-d57a00f8-9f3b-4308-82fe-8e33ae0bda27" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d57a00f8-9f3b-4308-82fe-8e33ae0bda27" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Civil engineering on the rise&lt;/h3&gt;&lt;p&gt;On Thursday we hosted Infrea's CEO, Martin Reinholdsson, at ABGSC's Investor Days. Mr. Reinholdsson opened by placing Infrea in the context of the infrastructure investment surge currently taking place in Sweden. Interestingly, it has been talked about for years but has not really materialised. However, according to Veidekke's half-yearly market report, 2026 is the year it will take off. Infrea appears well positioned to capture growth from increased defence spending in roads and civil engineering, as well as from increasing demand for energy, water and sewerage infrastructure.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;The benefits of being part of a group&lt;/h3&gt;&lt;p&gt;Infrea has also made meaningful progress on internal efficiency. A key part of its journey in recent years has been improving knowledge sharing across the group companies, including best practices and practical tips. This is an effort that Infrea's management has been undertaking for some time, and the benefits are now becoming visible. For example, with the Middle East situation pushing fuel prices higher, Infrea can share approaches to indexation across the group to offset the impact, something standalone small companies would find harder to do on their own. AI is another area where the group is increasingly benefiting from its scale.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Margins to improve and FCF to stabilise&lt;/h3&gt;&lt;p&gt;We believe that Infrea is well positioned to grow organically and improve margins, given its exposure to underlying demand and to public customers (~55%), as well as support from M&amp;amp;A (13% sales CAGR in '21-'24). For '25-'28e, we expect Infrea to deliver profitability growth and FCF above peers, but with slightly lower margins and sales growth. The share is trading at 7-4x adj. EBITA on '26e-'28e with a 17-13% lease-adj. FCF yield, while peers are trading at 7-6x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;pagebreak &lt;a id="bm-comp-2bbf581e-71b7-41ea-9be7-219c91347828" name="bm-comp-2bbf581e-71b7-41ea-9be7-219c91347828" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;a id="bm-comp-8c3a2bf4-1f09-49ff-aade-a50f8a7b0509" name="bm-comp-8c3a2bf4-1f09-49ff-aade-a50f8a7b0509" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2bbf581e-71b7-41ea-9be7-219c91347828" style="vertical-align: top; width:50.000000%;"&gt;&lt;table id="bm-img-24586ce9-3e7a-452f-9899-15811e79ec80" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Sweden civil engineering market&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, &lt;/td&gt;&lt;/tr&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/infrea/Equity-research/2026/5/infrea---feedback-from-abgscs-investor-days/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 22 May 2026 05:00:06 GMT</pubDate>
      <isin>SE0010600106</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Tempest Security - Securing a strong start</title>
      <description>&lt;a id="bm-comp-2ecee68c-ee47-4017-bade-4b03c7849c68" name="bm-comp-2ecee68c-ee47-4017-bade-4b03c7849c68" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2ecee68c-ee47-4017-bade-4b03c7849c68" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1: +11% sales growth, 3.2% EBITDA margin&lt;/li&gt;&lt;li&gt;'26e EBITDA up 2%&lt;/li&gt;&lt;li&gt;Guarding continues to take steps forward&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-608f2370-3a41-4b27-887d-160c16f2f4ce" name="bm-comp-608f2370-3a41-4b27-887d-160c16f2f4ce" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="608f2370-3a41-4b27-887d-160c16f2f4ce" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Starting the year on a positive note&lt;/h3&gt;&lt;p&gt;Tempest continues to deliver improvements, with Q1 EBITDA coming in 6% above ABGSCe. Guarding grew sales by ~13% (adjusted for the transfer of personal protection into the segment), while EBITDA improved from SEK 8m to SEK 10m. This marks a solid step forward, with focus on stable volume growth and management noting healthy demand within the SOC, a highly scalable area that is interesting for the future. Risk Solutions saw top-line sales decline by SEK 0.5m (adj.) but improved EBITDA from a loss in Q1'25 to a SEK 0.6m profit in Q1'26, driven by Denmark and Sweden. Looking at the broader market, pricing has been a challenge in the security space, but with growing demand for security services, market pricing is improving. As Tempest has scaled, it has established itself as a credible player, which in turn makes bidding for new contracts easier.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;'26e EBITDA up 2%&lt;/h3&gt;&lt;p&gt;We leave '26e-'28e sales fairly flat and lift '26e EBITDA by 2% due to the good performance and momentum in Guarding. We expect the performance to continue as Tempest maintains its core business focus and continues its efficiency improvements, while Denmark and the UK are delivering better results. Q1 is a seasonally weaker quarter, and now we are entering high season (Q2 and Q3) where we think Tempest can keep the positive momentum.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Focus on core operations&lt;/h3&gt;&lt;p&gt;We believe the company took important steps throughout '25, with the divestment of the US and the turnaround in Denmark. There are further efficiencies to be gained from the newly signed contracts in Guarding, as profitability typically increases gradually after the initial start-up period. This is because the additional costs associated with extra hiring decrease, planning and efficiency improve and Tempest can sell additional services that improve profitability.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/tempest-security/Equity-research/2026/5/tempest-security---securing-a-strong-start/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 22 May 2026 04:45:07 GMT</pubDate>
      <isin>SE0010469221</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Midsona - Feedback from ABGSC Investor Days</title>
      <description>&lt;a id="bm-comp-21c746f7-2fe8-496b-936a-265906088b1b" name="bm-comp-21c746f7-2fe8-496b-936a-265906088b1b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="21c746f7-2fe8-496b-936a-265906088b1b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Health food sales need a healthier consumer climate&lt;/li&gt;&lt;li&gt;Margins prioritised over volume in a downside scenario&lt;/li&gt;&lt;li&gt;Both mix and volume needed to reach 8% margin target&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-2fcfb1bc-4f99-4570-80d4-4ab381327e4f" name="bm-comp-2fcfb1bc-4f99-4570-80d4-4ab381327e4f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2fcfb1bc-4f99-4570-80d4-4ab381327e4f" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Moving down in Maslow's Hierarchy of Needs&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Today, we welcomed Midsona's new CEO, Henrik Hjalmarsson, to &lt;a data-bm-trackable="false" href="https://www.youtube.com/live/viQQZNevUFI" target="_blank"&gt;ABGSC Investor Days&lt;/a&gt;. During his presentation, Mr Hjalmarsson discussed Midsona's strategy to drive profitable growth, and five pillars that create shareholder value: 1) Clear position in long-term healthy food choices. 2) European scale with strong local presence. 3) Unique portfolio of strong market leading brands. 4) Robust platform that realises synergies. 5) Proven ability to acquire and refine. The underlying long-term demand driver was attributed to consumers caring more and more about both the contents and longevity of the products they consume, moving Midsona's products down in Maslow's Hierarchy of Needs, as the CEO put it. It has been evident that a tough consumer climate has weighed on Midsona's growth over the past few years, as consumers have not prioritised health and/or organic foods. Hopefully, a healthier consumer climate will enable customers to trade up again.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Optimistic, but prepared in case of a downside scenario&lt;/h3&gt;&lt;p&gt;Moreover, Mr Hjalmarsson was later interviewed by &lt;a data-bm-trackable="false" href="https://efn.se/play/borslunch-tar-pulsen-pa-marknaden-live-fran-abg-investor-days" target="_blank"&gt;EFN B&amp;#246;rslunch&lt;/a&gt; on site, where he implied that he, while cautiously optimistic, believes that consumers may be ready to trade up again in terms of e.g. grocery products. When asked about any potential concern for inflation, he stated that he is always prepared for the worst, but that he is not worried about any short term effects on Midsona. However, if inflation rises and consumers face prolonged tough times, he noted that this could potentially lead to consumers trading down further. Hjalmarsson continued to note that Midsona has started to create action plans to prepare for a downside scenario that could require powerful actions. It was made clear in the interview that in the event that Midsona would face elevated COGS, it would&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/midsona/Equity-research/2026/5/midsona---feedback-from-abgsc-investor-days/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 21 May 2026 14:15:07 GMT</pubDate>
      <isin>SE0000565228</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Tempest Security - Guarding leading the way</title>
      <description>&lt;a id="bm-comp-c3adb5c3-9ecc-4d37-bf44-d45483e293a4" name="bm-comp-c3adb5c3-9ecc-4d37-bf44-d45483e293a4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c3adb5c3-9ecc-4d37-bf44-d45483e293a4" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales -SEK 9m, EBITDA +SEK 0.3m vs. ABGSCe&lt;/li&gt;&lt;li&gt;'26e-'28e EBITDA estimates likely up&lt;/li&gt;&lt;li&gt;Share to focus on the margin improvements&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7b8b9b55-b5f5-456e-be85-9b302110df19" name="bm-comp-7b8b9b55-b5f5-456e-be85-9b302110df19" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7b8b9b55-b5f5-456e-be85-9b302110df19" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 details&lt;/h3&gt;&lt;p&gt;Tempest delivered a Q1 report with both sales and EBITDA y-o-y growth. Sales came in at SEK 146m (-9% vs. ABGSCe at SEK 155m), +11% y-o-y, driven by Guarding, and partly offset by Risk Solutions. EBITDA grew by SEK 3m y-o-y to SEK 4.6m (+0.3m, vs. ABGSCe at SEK 4.3m), for a margin of 3.2% (ABGSCe 2.8%, 1.2% Q1'25) driven by both Guarding and Risk Solutions. Looking at y-o-y development, we see positive progress in both Guarding and Risk Solutions. Guarding, the largest segment, continued to show improvements as a result of the internal work done in 2025, with management noting good momentum in the SOC business.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;Looking ahead, management is not providing a formal outlook. However, they acknowledge that the focus remains on increasing internal efficiency and cost control following a period of organisational streamlining. We consider Tempest's positive internal development to be a sign that the company is taking important steps in the right direction. We expect estimates for '26e-'28e adj. EBITDA to come up.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;A report in the right direction with sales and profitability growth. The share has outperformed the broader market into numbers (+1% YTD vs. OMXSGI -2%). We believe that the market will recognise stabilisation of the business and the margin improvements resulting from Tempest's hard internal work.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;pagebreak &lt;a id="bm-comp-37a11514-51c2-462d-9f17-9da3ff97df23" name="bm-comp-37a11514-51c2-462d-9f17-9da3ff97df23" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="37a11514-51c2-462d-9f17-9da3ff97df23" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-463fad0d-a740-472f-851f-f344c07fcd87" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. expectations&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/tempest-security/Equity-research/2026/5/tempest-security---guarding-leading-the-way/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 21 May 2026 07:00:42 GMT</pubDate>
      <isin>SE0010469221</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Gentoo Media - Stable quarter despite sports margin headwind</title>
      <description>&lt;a id="bm-comp-0f574480-d96b-4e01-bd32-d870eb8ad00b" name="bm-comp-0f574480-d96b-4e01-bd32-d870eb8ad00b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0f574480-d96b-4e01-bd32-d870eb8ad00b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 adj. EBITDA in line with FactSet consensus&lt;/li&gt;&lt;li&gt;Expect limited consensus estimate revisions&lt;/li&gt;&lt;li&gt;Value of deposits stable around EUR 200m&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-181f3dba-32e4-423a-affb-74426e09a015" name="bm-comp-181f3dba-32e4-423a-affb-74426e09a015" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="181f3dba-32e4-423a-affb-74426e09a015" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Q1 outcome&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Gentoo reported Q1 sales of EUR 24.0m, corresponding to a 5% y-o-y decline, in line with both ABGSCe and Factset consensus. Moreover, adj. EBITDA of EUR 10.5m was 6% below ABGSCe but in line with consensus. The sports margin was soft during February, in line with commentary from both Better Collective and various operators. That said, player deposit volumes continue to be stable around EUR 200m, suggesting that the underlying trend is stable despite quarterly fluctuations in the sports margin.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;No changes to guidance&lt;/h3&gt;&lt;p&gt;The Q1 report was unsurprising, and Gentoo has therefore maintained its guidance ('26e revenue of EUR 105-115m, adj. EBITDA of EUR 49-54m and operating cash flow of EUR 37-41m). Operating cash flow was roughly EUR 7m, up approx. 60% y-o-y, de-risking the cash flow guidance a bit. This is encouraging to see given Gentoo's leverage ratio of close to 2.7x LTM EBITDA (down 0.2x sequentially).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Mechanical estimate revisions flat&lt;/h3&gt;&lt;p&gt;The Gentoo share is down 4% YTD, compared to OMXSGI, which is up 6% YTD. Based on our unrevised estimates, Gentoo is trading at 3.4x '26e EV/EBITDA. Following the report, which was in line with consensus' expectations, we anticipate consensus to maintain its revenue and EBITDA estimates. More details are likely to be presented on the conference call at 10.00 CET. Link to the webcast &lt;a data-bm-trackable="false" href="https://www.redeye.se/events/1144484/live-q-gentoo-media-6" target="_blank"&gt;here&lt;/a&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7c6e5e06-23e8-43d8-91ae-58f7c5146383" name="bm-comp-7c6e5e06-23e8-43d8-91ae-58f7c5146383" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7c6e5e06-23e8-43d8-91ae-58f7c5146383" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-549b9407-83b7-46e1-ac10-2a17a021df68" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data, FactSet.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/gentoo-media/Equity-research/2026/5/gentoo-media---stable-quarter-despite-sports-margin-headwind/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 21 May 2026 07:00:06 GMT</pubDate>
      <isin>US36467X2062</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Xplora Technologies - Soft ARPU, good cost control</title>
      <description>&lt;a id="bm-comp-ea702e66-a4f8-467a-9092-53753b132e8c" name="bm-comp-ea702e66-a4f8-467a-9092-53753b132e8c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ea702e66-a4f8-467a-9092-53753b132e8c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 EBITDA -35% vs cons on lower ARPU and Kids device sales&lt;/li&gt;&lt;li&gt;Doro Connect and XploraOne progressing well&lt;/li&gt;&lt;li&gt;Expect cons to cut '26 EBITDA by 5-7%, share to follow&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-4418778f-ed15-4295-880e-59d5d151bf99" name="bm-comp-4418778f-ed15-4295-880e-59d5d151bf99" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4418778f-ed15-4295-880e-59d5d151bf99" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;EBITDA NOK 28m, -35% vs cons&lt;/h3&gt;&lt;p&gt;Revenue was NOK 376m, -3% below FactSet cons of NOK 387m (+2% vs. ABGSCe NOK 370m). Gross margin was 54.3%, -2.6pp vs ABGSCe of 56.9% and -2.3pp vs cons at 56.6%. Opex was NOK 176m, +5% above ABGSCe of NOK 168m and in line with cons of NOK 176m. This is an increase of only 8% y-o-y which shows good cost control in our view. This gave an EBITDA of NOK 28m, 35% below cons and ABGSCe of NOK 43m, corresponding to an EBITDA margin of 7.4% vs. 5.2% in Q1'25. The miss was primarily driven by lower ARPU and lower device revenue in Kids &amp;amp; Youth. Capex was NOK -9m (ABGSCe NOK -12m), resulting in adj. EBITDA-capex of NOK 19m, -39% below ABGSCe of NOK 31m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Service revenue soft, -5% below ABGSCe&lt;/h3&gt;&lt;p&gt;Total device revenue was NOK 284m, 4% above ABGSCe of NOK 273m. Kids &amp;amp; Youth device sales of NOK 40m was -24% below ABGSCe, and Senior device sales (Doro) of NOK 244m was +11% above ABGSCe. Watch activations was 93k in the quarter, which is higher than the units sales indicating that distributor inventories declined in the quarter. Kids &amp;amp; Youth service revenue was NOK 92m, -5% below ABGSCe of NOK 97m, corresponding to a growth of +15% y-o-y. Number of Kids subscriptions ended at 474k as pre-announced, of which 299k were Connectivity (ABGSCe 296k), 125k were Premium (ABGSCe 117k), 32k were B2B (ABGSCe 33k), and 18k were Service fee (ABGSCe 16k). However, the ARPU continued to decline and this quarter came in at NOK 65/month vs. ABGSCe at NOK 69, which is a 7% decline compared to NOK 74 in Q1'25. Some of this decline is due to FX and part of the decline is due to strong subscription growth in Germany where ARPU is lower.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Solid progress on Doro Connect and good launch for XploraOne&lt;/h3&gt;&lt;p&gt;As of Q1 Doro Connect was live in Xplora's own webstores in 7 of Xplora's core markets, with the last two (Germany and Denm&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/xplora_technologies/Equity-research/2026/5/xplora-technologies---soft-arpu-good-cost-control/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 21 May 2026 06:30:07 GMT</pubDate>
      <isin>NO0010895782</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>BTS Group - North American recovery, guidance unchanged</title>
      <description>&lt;a id="bm-comp-bb2447af-e94c-4b16-82ee-050026ae7d77" name="bm-comp-bb2447af-e94c-4b16-82ee-050026ae7d77" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bb2447af-e94c-4b16-82ee-050026ae7d77" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales 0% vs cons (2% organic growth), adj. EBITA +1% vs cons&lt;/li&gt;&lt;li&gt;North America and Europe better, Other markets (southeast Asia) weaker&lt;/li&gt;&lt;li&gt;FY guidance unchanged, estimates +1-3%, share +2-4% on good mix&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-301cb6d4-3075-454e-b7e2-c90ae9640db4" name="bm-comp-301cb6d4-3075-454e-b7e2-c90ae9640db4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="301cb6d4-3075-454e-b7e2-c90ae9640db4" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 details&lt;/h3&gt;&lt;p&gt;Sales SEK 602m (2% vs ABG 590m, 0% vs cons 601m), adj. EBITA 62m (-2% vs ABG 63m, 1% vs cons 61m), adj. EBITA margin 10.3% (ABG 10.7%, cons 10.1%). Adj. EBITA -3% y-o-y (ABG -1%, cons -4%). Organic growth 2% (ABG 5%, cons 1%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;North American recovery as planned&lt;/h3&gt;&lt;p&gt;Positive organic growth in both North America (4%) and Europe (17%), while negative in Other markets (-7%). EBITA beats in North America (+12% vs cons) and Europe (+54% vs cons), see strengthening client demand in North America among energy, healthcare and AI companies. Other markets miss vs cons related to Southeast Asia, but grew double-digit in Middle East. Good mix in returning North America to growth again. Unchanged guidance of &amp;#8220;higher EBITA in 2026 vs 2025&amp;#8221; as expected (cons +13% y-o-y), and says that actions taken in Other markets will show effects in H2.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Unchanged guidance, small positive estimate changes&lt;/h3&gt;&lt;p&gt;We expect consensus to make small changes to 2026 EBITA due to the in-line report and unchanged guidance (+1-3% likely), while the mix is positive with North America and Europe better than expected, which should support the share today (+2-4%). Conf call CET 8.00.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d96801a1-2504-4cd3-85e8-42a1324197bf" name="bm-comp-d96801a1-2504-4cd3-85e8-42a1324197bf" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d96801a1-2504-4cd3-85e8-42a1324197bf" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-94c3e7a7-462c-41ac-9f3c-529992fd5f78" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, FactSet, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/bts-group/Equity-research/2026/5/bts-group---north-american-recovery-guidance-unchanged/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 21 May 2026 05:30:05 GMT</pubDate>
      <isin>SE0000805426</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Generic - Broadening verticals lift the mix</title>
      <description>&lt;a id="bm-comp-9b2796a1-ea63-46bc-97d5-51066930159a" name="bm-comp-9b2796a1-ea63-46bc-97d5-51066930159a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9b2796a1-ea63-46bc-97d5-51066930159a" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Volume growth in coming quarters&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Growing verticals will likely add some costs&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;EV/EBIT of 10x '26e and 9x '27e&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c27059be-b3ad-4249-9166-9fad6a390297" name="bm-comp-c27059be-b3ad-4249-9166-9fad6a390297" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c27059be-b3ad-4249-9166-9fad6a390297" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Likely past the bottom of the cycle&lt;/h3&gt;&lt;p&gt;Volumes came in above our expectations. The Messaging segment (SMS, RCS, SenderID), Generic's largest at 73% of sales, grew 9% y-o-y to SEK 36m. While volumes are recovering, parts of the market, such as logistics, will likely remain cautious near term. However, Generic continues to win customers in less cyclical verticals such as e-health, which we expect to gradually shift the revenue mix towards more stable growth. Taken together, we think the bottom of the cycle is now behind us. Looking further out, we see Digital products (DOCS, fax) as the most important growth driver. Digital products has already penetrated over 30% of Swedish municipalities, and the division is now broadening into regions, authorities, and private companies, which we expect to lift both recurring revenues and gross margins.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Expecting some added costs from expansion&lt;/h3&gt;&lt;p&gt;We trim EBIT by 2-4% for '26e-'28e on the back of the report. As Generic grows and expands its product mix, we expect some added costs from recruitment and other growth investments. We expect 8% sales growth in '26e, resulting in an EBIT of SEK 41m, a margin of 21%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading 60% below peers&lt;/h3&gt;&lt;p&gt;The sector has been affected over the past few years by increased pricing from telecom operators, which has hurt gross margins. Despite this, the company is gradually increasing gross margin by broadening its product mix, and has delivered a 95% cash conversion over the past five years. Generic still operates with only 22 employees, corresponding to ~SEK 9m in revenue per employee, one of the highest rates in the Swedish tech sector. The stock is currently trading at 10x EV/EBIT on '26e, and 9x on '27e, ~60% below peers.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/generic/Equity-research/2026/5/generic---broadening-verticals-lift-the-mix/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 19 May 2026 20:45:05 GMT</pubDate>
      <isin>SE0001790791</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Isofol Medical - Taking action on recruitment </title>
      <description>&lt;a id="bm-comp-8cc68be2-424f-49c3-b709-37e07c752171" name="bm-comp-8cc68be2-424f-49c3-b709-37e07c752171" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8cc68be2-424f-49c3-b709-37e07c752171" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Solid cost control&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#1B2634"&gt;&lt;font color="#000000"&gt;Slower-than-expected patient recruitment&lt;/font&gt;&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Negative share price reaction expected&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-71cf0a4d-81bb-4f9b-b77d-61c5fa3b876d" name="bm-comp-71cf0a4d-81bb-4f9b-b77d-61c5fa3b876d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="71cf0a4d-81bb-4f9b-b77d-61c5fa3b876d" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#1B2634"&gt;&lt;font color="#000000"&gt;Solid cost control&lt;/font&gt;&lt;/font&gt;&lt;/h3&gt;&lt;p style="text-align:left;"&gt;&lt;font color="#000000"&gt;Net income came in fairly in line with expectations at SEK -15m (vs. ABGSCe at SEX -14m and SEK -13m in Q4'25), with CF from operating activities at SEK -16m (vs. ABGSCe at SEK -14m and SEK -13m in Q4'25). Before the addition of the recent SEK 19m in gross proceeds from exercise of the TO1 warrants, cash and cash equivalents came in at SEK 111m (SEK 127m in Q4'25). With the TO1 proceeds and exercise of the TO2 warrants due in November 2026, we continue to estimate a financial runway into 2028e.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#1B2634"&gt;&lt;font color="#000000"&gt;Slower-than-expected patient recruitment&lt;/font&gt;&lt;/font&gt;&lt;/h3&gt;&lt;p style="text-align:left;"&gt;&lt;font color="#000000"&gt;Isofol today reported slower-than-expected recruitment in its ongoing Phase 1b/2 trial of arfolitixorin in RAS-mutated metastatic colorectal cancer, resulting in the study remaining in the ongoi&lt;font color="#000000"&gt;ng 300 mg dose cohort for longer than anticipated.&lt;/font&gt; However, the protocol optimisation approved by Germany&amp;#8217;s federal regulatory authority BfArM&lt;/font&gt; &lt;font color="#000000"&gt;in April, including broader inclusion criteria, a direct comparison with leucovorin, and the addition of one further study centre (increasing the number of active sites from one to two), should accelerate enrolment going forward. The recruitment update follo&lt;font color="#000000"&gt;ws encouraging interim data presented in February from the first two dose cohorts, where all six evaluable patients experienced tumour shrinkage of up to ~50%,&lt;/font&gt; half of the patients improved to such a degree that they were removed from the trial for consideration of surgical removal (rare in this hard-to-treat population), and no dose-limiting toxicities were observed.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#1B2634"&gt;&lt;font color="#000000"&gt;Negative&lt;/font&gt; share price reaction expected&lt;/font&gt;&lt;/h3&gt;&lt;p style="text-align:left;"&gt;&lt;font color="#212529"&gt;&lt;font color="#000000"&gt;The opex in line with expectations, combined with slower-than-expected recruitment, leads us to expect a negative share price reaction today.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/isofol-medical/Equity-research/2026/5/isofol-medical---taking-action-on-recruitment-/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 19 May 2026 07:15:04 GMT</pubDate>
      <isin>SE0009581051</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Lumi Gruppen - Accretive acquisition of Bjørknes</title>
      <description>&lt;a id="bm-comp-3b8342f7-14b6-4405-a00f-96364bf3f0c7" name="bm-comp-3b8342f7-14b6-4405-a00f-96364bf3f0c7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3b8342f7-14b6-4405-a00f-96364bf3f0c7" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Lumi acquires Bj&amp;#248;rknes at 4.6x EV/EBIT&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Meaningful synergies identified&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Estimates could rise by 6-9%&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d5962eea-62eb-43b7-a49f-2e26d88fb018" name="bm-comp-d5962eea-62eb-43b7-a49f-2e26d88fb018" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d5962eea-62eb-43b7-a49f-2e26d88fb018" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Lumi acquires Bj&amp;#248;rknes at 4.6x EV/EBIT&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Lumi announced this morning that they have acquired the operating business of Bj&amp;#248;rknes Privatskole, an Oslo-based provider of exam preparation courses for private candidates, founded in 1950. The transaction is valued at an enterprise value of NOK 37m, implying an EV/EBIT multiple of 4.6x on '25 adjusted EBIT (vs. Lumi's '26 EV/EBIT of ~12x), with an indicative equity value of ~NOK 39.6m. Bj&amp;#248;rknes generated revenue of NOK 37m in '25 and adjusted EBIT of around NOK 8m in both '24 and '25, with '26 expected to show similar profitability. The acquisition will be financed through existing facilities and available cash, with closing targeted in Q3'26.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Meaningful synergies identified&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Bj&amp;#248;rknes operates from a campus in Nydalen, Oslo, offering full-time, part-time and online instruction, with particular strength in STEM-oriented courses. The business will complement Lumi's existing subsidiary Sonans, broadening the combined offering for private candidates. Management has identified operational synergies related to shared infrastructure, marketing and platform utilisation, with run-rate EBIT improvement expected in the range of 75-100% of Bj&amp;#248;rknes' current adjusted EBIT (EV/EBIT would then be ~2.3-2.6x). The bulk of this improvement is expected to be realised from the start of and during the 2027/28 academic year, with associated one-off integration costs to be reported as non-recurring items. A detailed integration plan is to be communicated at a later stage.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates could rise by 6-9%&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Holding underlying revenue and margins flat, the acquisition could lift group 2027e revenue and EBIT estimates by ~6%. Layering in "only" ~50-75% improvement to Bj&amp;#248;rknes' underlying EBIT by 2028e, 2028e group EBIT could increase by ~8-9%.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;pagebreak &lt;a id="bm-comp-50b4ad1a-b5ee-46e7-89d5-47c04ded97f9" name="bm-comp-50b4ad1a-b5ee-46e7-89d5-47c04ded97f9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="50b4ad1a-b5ee-46e7-89d5-47c04ded97f9" style="vertical-align: top; width:100.000000%;"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/lumi-gruppen/Equity-research/2026/5/lumi-gruppen---accretive-acquisition-of-bjorknes/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 19 May 2026 06:00:13 GMT</pubDate>
      <isin>NO0010927288</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ferronordic - German aftermarket gain drives margin beat</title>
      <description>&lt;a id="bm-comp-88ef9ca1-9eaa-4810-b9cc-7bb1bbbc56db" name="bm-comp-88ef9ca1-9eaa-4810-b9cc-7bb1bbbc56db" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="88ef9ca1-9eaa-4810-b9cc-7bb1bbbc56db" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Accretive aftermarket &amp;amp; cost control behind earnings beat&lt;/li&gt;&lt;li&gt;&lt;font style="background-color:#ffffff;"&gt;EBIT '26e raised &lt;font style="background-color:#ffffff;"&gt;4%&lt;/font&gt; on Germany &amp;amp; updated FX forecasts&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font style="background-color:#ffffff;"&gt;Trading at 11-7x 26e-'27e EV/EBIT (peers at 16-15x)&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a7ff4b0b-3e2a-4b15-9351-b0a0f83670a6" name="bm-comp-a7ff4b0b-3e2a-4b15-9351-b0a0f83670a6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a7ff4b0b-3e2a-4b15-9351-b0a0f83670a6" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Aftermarket drives German beat&lt;/h3&gt;&lt;p&gt;Ferronordic's Q1 sales were SEK 1,128m (-6% y-o-y, -1% vs ABGSCe) with EBIT of SEK 37m (+7% vs. ABGSCe 35m) for a margin of 3.2% (ABGSCe 3.0%). The earnings beats was driven by an improving Germany, where we see a high share of margin-accretive aftermarket sales. The US missed on EBIT (-15% vs. ABGSCe, -2% y-o-y), but displayed positive signs with decreasing opex/sales and organic growth. Proficient control of both corporate cost and German opex also supported margins in the quarter. Net debt increased by 7% y-o-y and 21% sequentially, due to tied-up working capital continuing to weigh on Q1 cash flow. Alongside the sequential earnings decline, ND/EBITDA increased to 3.8x (3.4x in Q4'25). We continue to see the &amp;lt;3.0x ND/EBITDA leverage target as achievable in 2026.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font style="background-color:#ffffff;"&gt;4-1% '26-'27e EBIT raise&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;Estimate changes are modest, reflecting a broadly in-line report (~SEK 15m sales miss, ~SEK 2m EBIT beat). We lower US EBIT by 3% (~SEK 7m) in &amp;#8217;26e on slightly softer equipment sales than previously expected, while raising &amp;#8217;27-&amp;#8217;28e by 1% on updated FX forecasts. We raise our German '26e EBIT estimate by ~SEK 7m, reflecting higher expected volumes in Q2'26 following management's commentary on deliveries postponed during Q1, as well as continued opex discipline and continued aftermarket traction. Encouragingly, continued cost discipline within group functions leads us to extrapolate this development further. On a group level, EBIT is raised 4% '26-'27e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 11-7x EV/EBIT vs. peers at 16-15x&lt;/h3&gt;&lt;p&gt;Ferronordic is enjoying a solid start to the year, led by a favourable German revenue mix and continued cost control. The valuation presently sits at 11-7x '26e-'27e EV/EBIT, which can be compared to our distributor peer group at 16-15x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ferronordic/Equity-research/2026/5/ferronordic---german-aftermarket-gain-drives-margin-beat/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 13 May 2026 14:30:08 GMT</pubDate>
      <isin>SE0005468717</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Catella - Putting the strong balance sheet to use</title>
      <description>&lt;a id="bm-comp-df8be4a4-df37-4b48-80eb-01fec9c50144" name="bm-comp-df8be4a4-df37-4b48-80eb-01fec9c50144" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="df8be4a4-df37-4b48-80eb-01fec9c50144" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q1 lower than expected&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Estimates down given a lower AUM base&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Capital repatriation will help to drive the share&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d1f85224-c63b-4a64-b904-5d73a430b4df" name="bm-comp-d1f85224-c63b-4a64-b904-5d73a430b4df" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d1f85224-c63b-4a64-b904-5d73a430b4df" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 softer than expected&lt;/h3&gt;&lt;p&gt;Catella's Q1 results were below both ABGSC and FactSet consensus expectations, with EBIT at SEK -45m (-43m) compared to ABGSCe of SEK +18m, where both the Corporate Finance and Investment Management segment came in softer than expected, burdened by the sluggish transaction market at the start of 2026. We expect underlying activity to remain soft in the short term, but to gradually improve. As market activity picks up, we foresee variable fees within Investment Management to gradually follow suit, which should drive both improved margins and bottom-line earnings growth in the coming years.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Lower AUM base cuts our 2026&amp;#8211;28 forecasts&lt;/h3&gt;&lt;p&gt;As AUM in Q1 came in 2% below our forecast, we have cut our AUM estimates, which lowers our earnings forecasts within Investment Management. In addition, we have tweaked our assumption of a pick-up in variable fees and pushed it further out in time, given the macro back-drop. The newly announced buyback of SEK 100m offsets part of these negative revisions. In sum, our EPS estimates are reduced by 20% for 2027 and 9% for 2028 following the report. Our 2026e EBIT is cut more given the soft Q1 report.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;2027-28e P/E of 6-8x with cash yield of 6-10% p.a.&lt;/h3&gt;&lt;p&gt;Despite Q1 falling short of our expectations, we think the company has some attractive fundamentals, including a strong balance sheet. It's encouraging to see that the company has already started putting it to good use with both bond buybacks and the newly announced share buybacks of SEK 100m, which we view as very welcome. Given the free-float level of ~50%, this could potentially have a material positive impact on the shares over the coming quarters. When applying our latest revisions, Catella is trading at an P/E of 6-8x for 2027-28e and a cash yield (dividend and buybacks) of ~6-10% p.a. throughout our forecast horizon.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/catella/Equity-research/2026/5/catella---putting-the-strong-balance-sheet-to-use/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 13 May 2026 14:15:09 GMT</pubDate>
      <isin>SE0000188518</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ferronordic - Stronger in Germany</title>
      <description>&lt;a id="bm-comp-32f778cb-62a0-41e2-a511-5bcdabae7098" name="bm-comp-32f778cb-62a0-41e2-a511-5bcdabae7098" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="32f778cb-62a0-41e2-a511-5bcdabae7098" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales SEK 1,128m &amp;amp; EBIT 37m&lt;/li&gt;&lt;li&gt;Adj. EBIT mechanically raises EBIT 1%&lt;/li&gt;&lt;li&gt;Share is currently trading at 11-7x '26e/'27e adj. EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ae789726-cd83-4bed-9d78-feb4ac555c93" name="bm-comp-ae789726-cd83-4bed-9d78-feb4ac555c93" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ae789726-cd83-4bed-9d78-feb4ac555c93" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Sales SEK 1,128m (-1% vs. ABGSCe 1,143m, no cons), adj. EBIT 37m (7% vs. ABGSCe 35m), adj. EBIT margin 3.3% (ABGSCe 3.0%). &lt;font style="background-color:#ffffff;"&gt;EBIT beat vs ABGSCe driven by solid performance in Germany, alongside lower-than-expected group costs. NRIs 0m (ABGSCe 0). Net debt came up slightly to 1,957m&lt;/font&gt; (1,607m in Q4), which is seasonally tied to NWC buildup. We hope to hear more about how management continues to work with reducing leverage during the conference call.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and estimate changes&lt;/h3&gt;&lt;p&gt;Management remains optimistic about US operations and environment ahead. In Germany they expect a recovery as fleet renewal requirements build, although higher fuel prices following the conflict in the Middle East adds uncertainty. The report would mechanically raise EBIT by 1%. Concl: In-line report, good to see positive EBIT results in the historically struggling German market.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;Prior to today's report, the share had returned -22% L3M, compared to the +1% of OMXSGI. The share is currently trading at 11-7x '26e-'27e EV/EBIT. The company will host a conference call at 10.00 CET, link &lt;a data-bm-trackable="false" href="https://ferronordic.events.inderes.com/q1-report-2026" target="_blank"&gt;here&lt;/a&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;pagebreak &lt;a id="bm-comp-66530ff4-bb59-4feb-b75d-4609eae4a44e" name="bm-comp-66530ff4-bb59-4feb-b75d-4609eae4a44e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="66530ff4-bb59-4feb-b75d-4609eae4a44e" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-f769287e-9125-48ea-9fcf-0c7a8ce33c04" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ferronordic/Equity-research/2026/5/ferronordic---stronger-in-germany/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 13 May 2026 06:01:27 GMT</pubDate>
      <isin>SE0005468717</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Generic - Volumes back in business</title>
      <description>&lt;a id="bm-comp-e8ba986f-85d2-4e54-9bb6-44b5e666d7d9" name="bm-comp-e8ba986f-85d2-4e54-9bb6-44b5e666d7d9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e8ba986f-85d2-4e54-9bb6-44b5e666d7d9" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Volumes stronger than expected&lt;/li&gt;&lt;li&gt;Gross margin continues to be steady at ~44%&lt;/li&gt;&lt;li&gt;DOCS now penetrated &amp;gt;30% of municipalities&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-0d3e93da-e974-4835-bb4a-cccafc2fca9a" name="bm-comp-0d3e93da-e974-4835-bb4a-cccafc2fca9a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0d3e93da-e974-4835-bb4a-cccafc2fca9a" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1'26 details&lt;/h3&gt;&lt;p&gt;Generic reported Q1'26 sales of SEK 49m, 9% y-o-y growth (+6% vs ABGSCe 46m), driven by higher volumes in the SMS business, which we view positively after a period of customer cost caution. Gross margin came in broadly in line with last year, at 44%, supported by a favourable mix. Adj. EBITA came in at SEK 10m (+4% vs ABGSCe 10m), corresponding to a margin of 21%, fairly in line with our expectations.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Thoughts&lt;/h3&gt;&lt;p&gt;DOCS continues to be a success story, and Generic keeps taking market share among Swedish municipalities, having now penetrated over 30% of the market. Beyond this, it is worth noting that the company is likely to continue growing within regions and private companies as well, which we see as promising, broadening its vertical exposure over time and supporting higher gross margins. Generic has also disclosed more information in the report and we appreciate the increased transparency.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;The company is valued at 10-9x EV/EBIT on our unrevised numbers. Q1 results were affected by costs related to management changes (former CEO and CFO transition), which we expect to largely fade from Q2 onwards. Generic continues to operate with 22 employees, making it one of the highest sales-per-employee companies in the Swedish tech sector.&lt;/p&gt;&lt;table id="bm-img-f6ce31ad-7eed-4c68-a3b7-79dda25348c1" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/generic/Equity-research/2026/5/generic---volumes-back-in-business/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 13 May 2026 06:00:17 GMT</pubDate>
      <isin>SE0001790791</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Coeli Private Equity - Unlocking new exposure</title>
      <description>&lt;a id="bm-comp-9e65c450-9782-4f19-81ae-d21ecfff3957" name="bm-comp-9e65c450-9782-4f19-81ae-d21ecfff3957" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9e65c450-9782-4f19-81ae-d21ecfff3957" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Diversified Nordic buyout platform with multi-vintage exposure&lt;/li&gt;&lt;li&gt;Documented realisation discipline and resilient NAV progression&lt;/li&gt;&lt;li&gt;Trading above historical NAV discount, driven by private risk premium&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c3302b90-413d-48af-aa44-8d3faa9369d0" name="bm-comp-c3302b90-413d-48af-aa44-8d3faa9369d0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c3302b90-413d-48af-aa44-8d3faa9369d0" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Diversified Nordic buyout platform&lt;/h3&gt;&lt;p&gt;Coeli Private Equity provides listed exposure to ~40 Nordic small- and mid-cap buyout funds, representing over 220 underlying portfolio companies. The multi-vintage structure reduces single-cycle risk and supports continuous capital deployment across market environments. The evergreen format enables reinvestment, distributions or share buybacks as realised proceeds are generated, preserving capital allocation flexibility over time.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Documented value creation and NAV resilience&lt;/h3&gt;&lt;p&gt;Historical exit data (including the platform track record prior to listing) indicates average realised multiples of ~2.7x and IRR of ~20% across more than 170 exits. Realised values have on average exceeded prior carrying values, indicating conservative fund-level valuations. NAV has remained resilient across cycles, with 12-month rolling NAV growth of ~6.5% (including the March 2026 distribution) despite a softer exit environment post-2022. The performance reflects diversified exposure and disciplined manager selection rather than single outlier transactions.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation reflects elevated private market risk premium&lt;/h3&gt;&lt;p&gt;As of April 2026, reported NAV amounts to SEK 174.47 per share, with the stock trading at a ~28.4% discount - above the average of ~21% since 2020. The valuation reflects a continued private market risk premium linked to valuation lag, exit timing and limited near-term distribution visibility. Applying a 20-35% discount range to current NAV implies a fair value range of SEK 113-140 per share, reflecting varying assumptions regarding exit normalisation and structural risk premia. Relative to its peer NAXS, Coeli is trading at a wider discount despite stronger NAV progression and a leaner cost base. This suggests discount dynamics remain closely tied to exit visibil&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/company-name2/Equity-research/2026/5/coeli-private-equity---unlocking-new-exposure/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 13 May 2026 04:45:08 GMT</pubDate>
      <isin>SE0012012268</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ascelia Pharma - Steady quarter</title>
      <description>&lt;a id="bm-comp-7182f964-3484-48b9-b2d0-5184ddfa2300" name="bm-comp-7182f964-3484-48b9-b2d0-5184ddfa2300" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7182f964-3484-48b9-b2d0-5184ddfa2300" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Orviglance data accepted for presentation at high-quality congress&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Cash runway into 2027&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range updated: SEK 2.0-5.4 (2.1-5.8)&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1f3d3500-eec4-420d-95b3-b12ce6c53edb" name="bm-comp-1f3d3500-eec4-420d-95b3-b12ce6c53edb" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1f3d3500-eec4-420d-95b3-b12ce6c53edb" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Orviglance on track for July approval; cash runway into 2027&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Ascelia delivered a quarter largely in line with expectations, with operating CF at SEK -15.9m (SEK -16.9m in Q1'25) and cash and cash equivalents at SEK 33.9m (SEK 49.9m in Q4'25). Opex decreased by 16% y-o-y, but increased by 9% q-o-q. After the quarter, Ascelia completed a directed share issue raising a gross SEK 20m, extending the cash runway into 2027, which is well beyond the expected FDA approval date of Orviglance.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font color="#000000"&gt;The FDA review of the New Drug Application (NDA) for the MRI contrast agent Orviglance is progressing according to plan, with a PDUFA action date (decision date) on 3 July 2026. Ascelia stated that it continues to be in active partner discussions. This comes after the pivotal Ph 3 SPARKLE trial successfully met its primary endpoint, demonstrating that the company's MRI contrast agent Orviglance significantly (p &amp;lt; 0.001) improved the visualisation of metastatic liver lesions compared to unenhanced MRI. Further validating the clinical profile of Orviglance, an abstract with data from the program has been accepted for oral presentation at the high-quality annual radiology congress ESGAR 2026.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;Estimate revisions&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;As before, we model that Orviglance will be commercialised through a partner, which is in line with sustained company guidance. We make the following estimate revisions to our model: i) We update FX; ii) We add the gross SEK 20m equity raise; iii) We slightly increase opex following the 9% q-o-q increase.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;Valuation update &amp;#8211; fair value range of SEK 2.0-5.4 (2.1-5.8)&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;The changes listed above yield a new fair value range of SEK 2.0-5.4 (2.1-5.8). Importantly, Ascelia has funding well beyond the PDUFA action date, which materially improves the company's negotiating position.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ascelia-pharma/Equity-research/2026/5/ascelia-pharma---steady-quarter/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 12 May 2026 19:30:08 GMT</pubDate>
      <isin>SE0010573113</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Arctic Paper - Turning the page on a weak market</title>
      <description>&lt;a id="bm-comp-bebe90eb-2a72-4148-9216-9e9e0dd84cdd" name="bm-comp-bebe90eb-2a72-4148-9216-9e9e0dd84cdd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bebe90eb-2a72-4148-9216-9e9e0dd84cdd" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q1 Paper EBIT of ~PLN -2m&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Still waiting for Rottneros pulp tailwinds&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range of SEK 15-50&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-29db6ced-cbe6-474f-88bb-7e691bccb7d9" name="bm-comp-29db6ced-cbe6-474f-88bb-7e691bccb7d9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="29db6ced-cbe6-474f-88bb-7e691bccb7d9" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;Q1 Paper EBIT of ~PLN -2m&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Paper EBIT was PLN -2m vs. ABGSCe -15m, with the beat driven by stronger-than-expected volumes (137k tonnes vs 125k in Q1'25). Impressively&lt;/font&gt;&lt;font color="#000000"&gt;, Arctic's market share has risen by ~2pp over the past three years. The quarter was again characterised by geopolitical uncertainty, trade barriers and subdued demand. Group EBIT improved sequentially to PLN -36m (-72m in Q4&amp;#8217;25), while EBITDA came in at PLN 2.6m, reflecting a continued weak performance in Rottneros due to FX and weak demand. Looking ahead, announced price increases of 5&amp;#8211;7% from April and 4&amp;#8211;8% from June aim to support margins, alongside ~PLN 6m in cost savings and incremental earnings from the Grycksbo pellet ramp-up (~SEK 40-50m in 2026). However, with demand still soft and visibility limited, we expect only a gradual recovery and forecast Q2 Paper EBIT of PLN 24m (group PLN 16m). Our 2026e estimates are up due to the stronger Q1.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;Still waiting for pulp tailwinds&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Paper markets remain structurally oversupplied at ~75% utilisation, and while ~4-6% supply cuts are underway, the market still needs ~3mt of capacity cuts to reach historical utilisation. The pulp market faced headwinds in 2025, but key drivers are now moving in the right direction. Hardwood prices are up ~22% (38% in EU) following Suzano&amp;#8217;s +30% hikes. However, Rottneros' exposure is mainly to softwood and CTMP, which have lagged hardwood, i.e. we are still waiting for the Rottneros pulp tailwinds. FX does not help either. Overall, management retained a cautious outlook, with 'no indication of a rapid market recovery', and emphasised continued focus on cost savings.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;Fair value range of SEK 15-50&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;The company is trading at an EV/CE multiple of ~0.40x, which is ~48% below its historical average. We have applied three valuation methodologies and arrive at a fair value range of SEK 15-50.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/arctic-paper/Equity-research/2026/5/arctic-paper---turning-the-page-on-a-weak-market/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 12 May 2026 17:00:08 GMT</pubDate>
      <isin>PLARTPR00012</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Svedbergs Group - Expanding footprint further</title>
      <description>&lt;a id="bm-comp-023ec3fe-779c-4bbe-9a5b-1772d62c0133" name="bm-comp-023ec3fe-779c-4bbe-9a5b-1772d62c0133" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="023ec3fe-779c-4bbe-9a5b-1772d62c0133" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Svedbergs Group acquires Czech Group UBC s.r.o.&lt;/li&gt;&lt;li&gt;Acquires 80% initially, remaining 20% planned in the next 3-5y&lt;/li&gt;&lt;li&gt;Adds 16% to net sales, 13% to EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-bbe69dcb-837f-405d-b648-1164d87e9c47" name="bm-comp-bbe69dcb-837f-405d-b648-1164d87e9c47" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bbe69dcb-837f-405d-b648-1164d87e9c47" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Adds 13% to our '26e EBITA&lt;/h3&gt;&lt;p&gt;Svedbergs Group has announced the acquisition of Czech bathroom furniture Group UBC s.r.o.. The Group to be acquired consists of three companies; UBC, Polysan and Sapho Manufactory. We understand the latter two to be small manufacturing companies, while the main UBC banner's business model mirrors Roper Rhodes, i.e. design and sourcing in-house with outsourced production. Together, the UBC Group reported net sales of EUR 34m in 2025 (SEK 365m, i.e. adding 16% to our '26e) with EBITA of SEK 4.2m (SEK 45m, adding 13% to our '26e for Svedbergs Group).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Leverage post-acquisition likely very manageable&lt;/h3&gt;&lt;p&gt;Svedbergs Group does not specify the multiple paid in the press release, however it states that the acquisition is to be paid using own funds and bank debt. The most recent acquisitions have been completed at EV/EBITA multiples of 5-9x. Using the upper end of this range for illustrative purposes, Svedbergs Group's ND/EBITDA post acquisition (i.e. paying ~SEK 400m in Q2'26) could be ~1.5x excluding the effects from IFRS-16 but including earn-outs. The most recent acquisition Thebalux was done at an EV/EBITA multiple of around 6x including earn-outs, for reference.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Continues&lt;/h3&gt;&lt;p&gt;The announced acquisition is slightly margin dilutive, as it reports an EBITA margin of 12% vs the Svedbergs Group average of 15%. We note, however, that Svedbergs Group has a track record of improving acquired companies' earnings over time, &lt;a data-bm-trackable="false" href="https://abg-portal.bluematrix.com/report/31a7914f-dce7-4917-af7c-90eb4548cc67" target="_blank"&gt;as discussed previously&lt;/a&gt;. The acquisition also adds new markets to Svedbergs Group's exposure in Eastern Europe, and thus aligns well with its aspiration of becoming the leading supplier of bathroom products in (Northern) Europe. The acquisition is expected to be completed during Q2 2026 and is not subject to any regulatory approval.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/svedbergs/Equity-research/2026/5/svedbergs-group---expanding-footprint-further/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 12 May 2026 11:30:07 GMT</pubDate>
      <isin>SE0000407991</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Arctic Paper - Still cold, but the ice is cracking </title>
      <description>&lt;a id="bm-comp-b9cc532f-b92c-4118-bec1-e0f0d0218e25" name="bm-comp-b9cc532f-b92c-4118-bec1-e0f0d0218e25" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b9cc532f-b92c-4118-bec1-e0f0d0218e25" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q1e Paper EBIT of ~PLN -15m&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Markets remain challenging, but pulp winds are turning&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range of SEK 15-50&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-b8a3cd4e-ed48-4950-89da-cd517d1c7c1b" name="bm-comp-b8a3cd4e-ed48-4950-89da-cd517d1c7c1b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b8a3cd4e-ed48-4950-89da-cd517d1c7c1b" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;&lt;strong&gt;Q1 Paper EBIT of ~PLN -15m&lt;/strong&gt;&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;We expect Q1 Paper EBIT of ~PLN -15m, up from ~PLN -27m in Q4&amp;#8217;25. Prices are expected to remain broadly in line q-o-q, while seasonally higher volumes should provide some support. However, margins remain under pressure from weak demand, Asian competition, and increasingly higher pulp prices. Looking ahead, the announced paper price increases of +8-10% are expected to take effect from Q2, and we therefore forecast a recovery in Paper EBIT to ~PLN 25m in Q2e. For FY&amp;#8217;26e, we make limited changes to our estimates, with Paper EBITDA of ~135m. The 2026e estimate revisions are related to Rottneros (pulp EBITDA).&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;&lt;strong&gt;Still challenging markets, but pulp winds are turning&lt;/strong&gt;&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Pulpwood prices are down ~25% across Scandinavia as high inventories and low demand pressure the market, which should provide some cost relief. Paper markets are helped by 4-6% supply cuts in '25-'26e, but with (too) low demand, utilisation rates remain at only ~75%, implying that ~3mt (~15%) of additional cuts are needed to reach historical averages. The pulp market has faced short-term headwinds, but key drivers are now moving in the right direction. Hardwood prices are up ~22% following Suzano&amp;#8217;s several hikes (+30%). While Rottneros' exposure is mainly to softwood and CTMP, which have lagged hardwood, these increases signal improving pulp price dynamics and could support pricing in 2026.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;Fair value range of SEK 15-50&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;The company is trading at an EV/CE multiple of ~0.40x, which is ~45% below its historical average. We have applied three valuation methodologies and arrive at a fair value range of SEK 15-50.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/arctic-paper/Equity-research/2026/5/arctic-paper---still-cold-but-the-ice-is-cracking-/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 11 May 2026 17:15:05 GMT</pubDate>
      <isin>PLARTPR00012</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Clavister - The defence story is just starting</title>
      <description>&lt;a id="bm-comp-5d9618ac-affb-4a59-98e8-56b183bc0f0d" name="bm-comp-5d9618ac-affb-4a59-98e8-56b183bc0f0d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5d9618ac-affb-4a59-98e8-56b183bc0f0d" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Gross margins above its target of 80%&lt;/li&gt;&lt;li&gt;Order book at a record and foundation getting stronger&lt;/li&gt;&lt;li&gt;Trading at EV/EBITDA of 18-10x '26e-'27e, ~20% below peers&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ea76f241-6c04-4886-b86e-a701e2618674" name="bm-comp-ea76f241-6c04-4886-b86e-a701e2618674" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ea76f241-6c04-4886-b86e-a701e2618674" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Only getting better from here&lt;/h3&gt;&lt;p&gt;Clavister reported a strong Q1'26 report, with sales up 35% y-o-y and a gross margin of 81%, driven by a favourable mix. EBITDA was SEK 14m, up +110% y-o-y, (19% margin). Adjusting for one-off costs of SEK 1.1m and temporary ramp-up costs of SEK 3.6m related to the Norwegian order, the underlying EBITDA margin was 26%. The civilian business was held back by cautious customers, although the ARR still grew 6% y-o-y - a promising sign that the underlying base is intact.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;42% y-o-y sales growth in '26e&lt;/h3&gt;&lt;p&gt;The Norwegian order will now contribute in full in the coming quarters, as the contract was only signed in late January. We also expect cash from the order to come in later this year. H2'26e will have easier comps, although we lower '26e EBIT by 5%, reflecting somewhat higher costs from larger orders and continued investments in the ongoing business expansion. Also promising is the order book of SEK 640m, of which the company expects SEK 162m to roll out over the next 12 months.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading ~20% below its peers&lt;/h3&gt;&lt;p&gt;We have seen the telecom sector increasing its investments around Europe, and although this has not yet shown up in Clavister's numbers, we think this should be another growth driver going forward. Energy companies and municipalities are also running active evaluations of their cybersecurity set-ups, which today are mostly built around US solutions. Clavister is in these discussions, but lead times are long, so we think it will take time to show in the numbers. The company is trading at an EV/EBITDA of 18-10x for '26e-'27e, ~20% below peers. We remain positive on the expansion of the company across both the civilian business (~70% of group sales) and the defence sector.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/clavister/Equity-research/2026/5/clavister---the-defence-story-is-just-starting/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 10 May 2026 20:45:37 GMT</pubDate>
      <isin>SE0005308558</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Generic - Bottoming before the bounce</title>
      <description>&lt;a id="bm-comp-36599d9a-8e21-4345-a45b-371bd1106eae" name="bm-comp-36599d9a-8e21-4345-a45b-371bd1106eae" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="36599d9a-8e21-4345-a45b-371bd1106eae" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Volumes likely soft in Q1&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Management changes to weigh on earnings&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;EV/EBIT of 10-9x on '26e-'27e, ~60% below its CPaaS peers&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-54c2f210-b2a7-487c-b6a1-4682c029c6e7" name="bm-comp-54c2f210-b2a7-487c-b6a1-4682c029c6e7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="54c2f210-b2a7-487c-b6a1-4682c029c6e7" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Likely at the bottom of the cycle&lt;/h3&gt;&lt;p&gt;The market continues to be weighed by pricing pressure and customers holding back on spending, which we have seen hurting volumes and sales growth across peers. For Generic, we expect Q1'26 sales of SEK 46m, representing 3% y-o-y growth, with SMS volumes being the main factor holding back the top line. What we like about Generic is its growing tilt towards non-cyclical segments, such as e-health, alongside with the continued expansion of its SaaS products (e.g. DOCS) with higher penetration in the Swedish municipalities. We expect this shift to broaden over time, lifting both recurring revenue and gross margins. For now, however, we think we are at the bottom of the cycle and estimate a gross margin of 44% in Q1 and adj. EBIT of SEK 10m, for an EBIT margin of 21% (23% Q1'25), likely held back by management changes.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Management changes to weigh on earnings&lt;/h3&gt;&lt;p&gt;Generic has gone through some management changes in recent months, and we think this will weigh on margins in the near term, and we therefore cut our '26e EBIT by 7%. Looking at H2'26e, the company will have easier comps, and we estimate sales growth of 7% in '26e, an EBIT margin of 21% (21% '25).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at an EV/EBIT of 10-9x '26e-'27e&lt;/h3&gt;&lt;p&gt;We think over time that Generic will reach more customer groups. The company owns its own data centres, and can secure its customers' data, and offers solutions such as DOCS and SenderID. What we like about the company is that it has over time been a quality company, with margins over peers, and a ~95% cash conversion over the last five years. The company is trading at 10x EV/EBIT, ~60% below average CPaaS peers, and ~1.5x better EBIT margins for '26e-'27e.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/generic/Equity-research/2026/5/generic---bottoming-before-the-bounce/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 10 May 2026 20:45:03 GMT</pubDate>
      <isin>SE0001790791</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Prevas - Positioned for a stronger 2026</title>
      <description>&lt;a id="bm-comp-884c5d53-4f60-4bbc-96c5-551d2225f7de" name="bm-comp-884c5d53-4f60-4bbc-96c5-551d2225f7de" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="884c5d53-4f60-4bbc-96c5-551d2225f7de" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;EBITA margins in line with expectations&lt;/li&gt;&lt;li&gt;Cost focus likely to drive margin uplift in H2&lt;/li&gt;&lt;li&gt;Trading at 9-6x EV/EBITA on '26e-'27e, 20% below peers&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d9e10daf-22cc-429f-a61c-5a3b1d152d66" name="bm-comp-d9e10daf-22cc-429f-a61c-5a3b1d152d66" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d9e10daf-22cc-429f-a61c-5a3b1d152d66" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Right steps in a cautious market&lt;/h3&gt;&lt;p&gt;Prevas delivered a stable quarter given the market headwinds the consulting companies are facing. Sales came in at SEK 426m, in line with our expectations, although organic growth remained negative for the 7th consecutive quarter. Defence continues to be the clear standout, with sales up 22% y-o-y in the quarter, and Finland is also showing growth despite cautious customer behaviour and some delayed projects. The EBITA margin landed at 8.4%, which we think is encouraging and a sign that the cost focus initiated last year is starting to show benefits. Worth noting is that this quarter had restructuring costs related to 1) a weak market in Denmark and 2) the restructuring of the business units in southern Sweden; we think Q2 will have some one-offs as well.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Margin uplift on the horizon&lt;/h3&gt;&lt;p&gt;We leave estimates relatively unchanged and expect the company to reach EBITA margins of 9% in '26e (7% '25) with EPS growth of ~40%. Importantly, Prevas also signed an EAM contract together with Hexagon (Octave) worth SEK 80m over 12 years, with material effects from Q2e and adding ~SEK 5m to '26e sales.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading a 9-6x EV/EBITA, ~20% below peers&lt;/h3&gt;&lt;p&gt;The market remains cautious, but management is taking the right actions on costs, and we expect the full margin uplift to materialise in H2'26. With defence as a strong growth engine, a healthy balance sheet supporting potential M&amp;amp;A, and structural improvements working their way through, we continue to view Prevas as a quality consulting firm. The stock is trading at 9-6x EV/EBITA on '26e-'27e, roughly 20% below peers.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/prevas/Equity-research/2026/5/prevas---positioned-for-a-stronger-2026/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 10 May 2026 20:30:42 GMT</pubDate>
      <isin>SE0000356008</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Gentoo Media - Muted expectations for Q1</title>
      <description>&lt;a id="bm-comp-1e88c4ce-2adf-4693-a780-bb3ba21a1606" name="bm-comp-1e88c4ce-2adf-4693-a780-bb3ba21a1606" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1e88c4ce-2adf-4693-a780-bb3ba21a1606" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1e: 3% revenue decline y-o-y&lt;/li&gt;&lt;li&gt;'26e EBITDA toward bottom end of guidance range&lt;/li&gt;&lt;li&gt;Trading ~50% below peers at 3.5x '26e EV/EBITDA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d2342c8b-098c-413b-8bbc-25259f42fd97" name="bm-comp-d2342c8b-098c-413b-8bbc-25259f42fd97" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d2342c8b-098c-413b-8bbc-25259f42fd97" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Challenging sports outcomes &amp;amp; volatile casino data&lt;/h3&gt;&lt;p&gt;We expect Q1 revenue of EUR 24m, implying a 3% y-o-y decline. This means that we expect adj. EBITDA of roughly EUR 11m, corresponding to a 47% margin. North American operators have highlighted sports outcomes that are largely player-friendly (negative for operators from a financial perspective). We believe that this will adversely impact Gentoo's Q1 figures. Moreover, changes in iGaming tax regimes in Europe and volatile markets in casino (primarily due to regulatory action) are likely to be additional headwinds.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate revisions&lt;/h3&gt;&lt;p&gt;Our updated estimates imply relatively minor estimate changes, as we raise '26e and '27e adj. EBITDA by 3% and 2%. Our updated estimates imply that we are in line with the lower end of the company's '26 guidance for revenue and EBITDA. However, on cash flow, we expect an outcome toward the upper end, as there is potential to optimise working capital. We have taken a somewhat more cautious stance on the revenue growth in '26e-'28e, as the company's cash flow is likely to be deployed toward reducing the leverage.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 3.5x '26e EV/EBITDA&lt;/h3&gt;&lt;p&gt;Gentoo is trading below 6x '26e EV/EBITDA, well below Better Collective (8.2x) and Gambling.com (5.2x). This means that Gentoo is trading 10% below the average of Better Collective and Gambling.com. Moreover, we highlight that Gentoo is trading at a '26e lease-adj. FCF yield excl. M&amp;amp;A of over 30%, as it should be noted that the company is largely focused on deleveraging.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/gentoo-media/Equity-research/2026/5/gentoo-media---muted-expectations-for-q1/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 10 May 2026 20:30:02 GMT</pubDate>
      <isin>US36467X2062</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Inission - Momentum to persist throughout 2026</title>
      <description>&lt;a id="bm-comp-cf81ff52-3e2d-450d-8036-0a6343992208" name="bm-comp-cf81ff52-3e2d-450d-8036-0a6343992208" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cf81ff52-3e2d-450d-8036-0a6343992208" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales up 37% y-o-y as adj. EBITA more than doubled&lt;/li&gt;&lt;li&gt;Continued order momentum drives estimate upgrades&lt;/li&gt;&lt;li&gt;Enedo recovering, M&amp;amp;A and Tunis factory to add further growth&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ad68916b-a53c-46eb-9b87-d0f0a809d6c5" name="bm-comp-ad68916b-a53c-46eb-9b87-d0f0a809d6c5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ad68916b-a53c-46eb-9b87-d0f0a809d6c5" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;The earnings-growth trend that started in Q3 accelerated in Q1. Sales were up 37% y-o-y (11% M&amp;amp;A), while the book-to-bill stayed at a very healthy 1.1x. With the adj. EBITA margin expanding to 7.0% (4.8%), earnings more than doubled y-o-y, beating our estimate by 10%. Management attributed the strong growth to increased momentum in the defence, data centre, and quantum computing end markets. Importantly, Inission Power (Enedo) demonstrated strong growth, a great book-to-bill of 1.3x, and decent profitability of 3.1% (-2.8%), which is the first time since Q3'24 that it reached this margin on an unadjusted basis.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;The earnings beat and surprisingly persistent order intake momentum drive us to raise '26e-'28e adj. EBITA by 5%. This puts us above the high end of the company's guidance range for '26 (SEK 2.3-2.5bn sales, &amp;gt;6% EBITA margin), but we think this is warranted given the strong start to the year and management's indication during the earnings call that the guidance is on the conservative side.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;Management said that the raised geopolitical uncertainty does not seem to have curbed the budding macroeconomic recovery; it has, however, impacted the component market, but the company is working with its suppliers to mitigate this. Given the recent order intake, the company sees good chances for the strong start of the year to persist throughout '26, as do we. M&amp;amp;A remains an active part of the strategy, with some processes making progress during the quarter, and we view an acquisition this year as likely, which would boost growth further. The company is also in discussions with several potential customers for the Tunis factory, something that should further help earnings in the medium term. The share is trading at 14-10x the '26e-'28e P/Es, vs. Nordic peer&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/inission/Equity-research/2026/5/inission---momentum-to-persist-throughout-2026/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 10 May 2026 20:15:02 GMT</pubDate>
      <isin>SE0016275069</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Proact - Strong near-term sales growth </title>
      <description>&lt;a id="bm-comp-36323287-183a-422a-a563-066acb769815" name="bm-comp-36323287-183a-422a-a563-066acb769815" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="36323287-183a-422a-a563-066acb769815" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Memory prices boost system sales in Q2-Q3e&lt;/li&gt;&lt;li&gt;Cost initiatives paying off s&lt;font color="#00204E"&gt;imultaneously&lt;/font&gt;, adj. EBITA +8-22%&lt;/li&gt;&lt;li&gt;Share now trading at 6.8x 2026e EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-2553c154-3aa9-453c-bb65-d321dc565d03" name="bm-comp-2553c154-3aa9-453c-bb65-d321dc565d03" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2553c154-3aa9-453c-bb65-d321dc565d03" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Market tailwinds starting to become visible&lt;/h3&gt;&lt;p&gt;Proact had already pre-announced a strong EBITA growth in Q1, and the full report confirmed this. Although organic sales growth did not accelerate meaningfully (3%), we expect to see higher growth rates in the coming quarters, driven by both higher memory prices in the market and pre-buying activities. The main driver for the EBITA beat was, however, cost initiatives in 2025, which should also pave the way for significant earnings growth in 2026e. The margin recovery in the West and Central segments (both positive in Q1) is also encouraging to see, as the turnaround activities are starting to bear fruit.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Adj. EBITA 8-22%&lt;/h3&gt;&lt;p&gt;We have updated our numbers after the positive Q1 PW and the full report released earlier this week. We raise near-term estimates on organic system sales due to rising memory prices, resulting in 1-4% higher sales estimates in 2026-28e. Combined with solid gross margins and a lower cost base, we raise EBITA by 8-22% in 2026-28e. Our EPS revisions are larger due to a lower number of shares post share buybacks.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Share at 6.8x 2026e EV/EBITA&lt;/h3&gt;&lt;p&gt;On our revised estimates, the share is trading at 6.8x 2026e EV/EBITA. We estimate that the 47% adj. EBITA growth in Q1 will continue in the coming quarters (41% in Q2e and 34% in Q3e), driving a strong 2026e.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/proact/Equity-research/2026/5/proact---strong-near-term-sales-growth-/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 08 May 2026 15:15:08 GMT</pubDate>
      <isin>SE0015961222</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>NYAB - Starting the year with a record order backlog</title>
      <description>&lt;a id="bm-comp-34417570-c747-4c97-9610-cd58b61a13c0" name="bm-comp-34417570-c747-4c97-9610-cd58b61a13c0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="34417570-c747-4c97-9610-cd58b61a13c0" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We leave our estimates fairly unchanged (EBIT +1-0%)&lt;/li&gt;&lt;li&gt;But strong order intake in Q1 de-risks 2026 estimates&lt;/li&gt;&lt;li&gt;We reiterate our fair value range of SEK 6-9 per share&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-cb839e80-c360-4877-945c-2557bd677597" name="bm-comp-cb839e80-c360-4877-945c-2557bd677597" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cb839e80-c360-4877-945c-2557bd677597" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 characterised by strong orders&lt;/h3&gt;&lt;p&gt;NYAB performed solidly in a seasonally weaker Q1, with earnings (EUR 1m) fairly in line with our estimates and strong FCF (EUR 5m), despite a bit weaker organic growth (-6%). Due to low absolute levels of earnings in Q1 in general (typically &amp;lt;5% of full-year earnings), we put more emphasis on the order intake, which remained strong. With order growth of 24% and the backlog up 28% y-o-y, we think the company remains well-positioned to deliver on our full-year 2026 expectations.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates relatively unchanged&lt;/h3&gt;&lt;p&gt;We keep our EBIT estimates fairly unchanged (+0.6%/0.3%/0.3% on '26e/'27e/'28e) and expect NYAB to deliver 19% EBIT growth in 2026 and 10% in 2027. These assumptions exclude potential positive impacts from the two large ongoing Phase 1 projects that the company expects to convert to Phase 2 later this year (during Q2-Q3). Together, these projects provide substantial upside potential to the order backlog, with a potential total order value of ~EUR 700m (of which 400m-500m relates to NYAB).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;9x/8x/7x EV/EBITA '26e/'27e/'28e, 15-20% below key peers&lt;/h3&gt;&lt;p&gt;With the share reaction to the report and based on our unchanged estimates, the valuation remains at ~9x/8x/7x EV/EBITA on '26e/'27e/'28e, which is ~15-20% below infrastructure service peers, and ~10-20% below Nordic construction peers, which are expected to deliver fairly similar earnings growth on average. But due to its net cash position and strong cash flow (&amp;gt;100% FCF/EBITA conversion historically), we think NYAB has a better opportunity to scale faster and grow through M&amp;amp;A. And because of the strong orders, we think our 2026 estimates for NYAB have been de-risked, although it still has to execute with good margins, which the company has done historically (6-12% L10Y vs. construction peers at ~3%).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nyab/Equity-research/2026/5/nyab---starting-the-year-with-a-record-order-backlog/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 08 May 2026 08:45:09 GMT</pubDate>
      <isin>SE0022242434</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Catella - Q1 burden by weak transaction market</title>
      <description>&lt;a id="bm-comp-39781eb3-edd5-4e25-8e02-9fd31c4c112a" name="bm-comp-39781eb3-edd5-4e25-8e02-9fd31c4c112a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="39781eb3-edd5-4e25-8e02-9fd31c4c112a" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 EBIT of SEK -45m, vs. ABGSC of SEK +18m and cons. SEK +9m&lt;/li&gt;&lt;li&gt;SEK 100m share buyback announced, positive&lt;/li&gt;&lt;li&gt;Negative consensus revisions to follow, stock slightly down today&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-6c5c081d-b98c-4f86-9a32-bde968bdad9b" name="bm-comp-6c5c081d-b98c-4f86-9a32-bde968bdad9b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="6c5c081d-b98c-4f86-9a32-bde968bdad9b" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Q1 EBIT SEK -45m, vs. ABGSC at +18m &amp;amp; consensus at +9m&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;The Q1&amp;#8217;26 EBIT remained negative y-o-y and came in at SEK -45m (-43m), which was 63m below ABGSC and 54m below FactSet consensus. Looking at underlying development, both the Corporate Finance and Investment Management segment delivered weaker than expected results in Q1, with both lower top-line and EBIT in both segments, than ABGSC forecast.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;AUM of SEK 159.8 bn in Q1, 1% below consensus forecast&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Net sales in Q1 came in at SEK 296m (465m), which was 22% below ABGSC's forecast and 15% below consensus. Reported EBITDA came in at SEK -28m, 67m below ABGSC and 77m below FactSet consensus. The AUM came in at SEK 159.8bn, up 3% q-o-q (SEK +4.5bn), which was 2% below ABGSC forecast and 1% below consensus. The increase of 4.5bn sequentially is mainly driven by a reporting change implemented in 2026, under which assets under development are included in AUM.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Negative cons. revisions to follow, stock slightly down today&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;We expect consensus to cut their 2027-&amp;#8216;28e EBIT by ~1-3% driven by the lower AUM base. However, a positive announcement was that Catella will launch a share buyback program of SEK 100m (5% of mcap). Given the EBIT miss in Q1, we expect the share to come slightly down today, where some off the negative impact is offset by the positive buyback announcement. Conf. Call at 10.00.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;pagebreak &lt;a id="bm-comp-edd80a2d-84f7-4142-8ec2-b952574c6e66" name="bm-comp-edd80a2d-84f7-4142-8ec2-b952574c6e66" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="edd80a2d-84f7-4142-8ec2-b952574c6e66" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-725bacb9-c757-46d9-9c7a-beb4a97c0754" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/catella/Equity-research/2026/5/catella---q1-burden-by-weak-transaction-market/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 08 May 2026 06:30:10 GMT</pubDate>
      <isin>SE0000188518</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>I-tech - 2026 looking better than feared</title>
      <description>&lt;a id="bm-comp-c22accb2-0413-4307-977e-ad3631c808a3" name="bm-comp-c22accb2-0413-4307-977e-ad3631c808a3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c22accb2-0413-4307-977e-ad3631c808a3" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1: Organic growth of +7% despite tough comps (vs. ABGSCe -15%)&lt;/li&gt;&lt;li&gt;Customer with financial constraints back to normal order cadence&lt;/li&gt;&lt;li&gt;We raise organic growth ests. for '26e to +25% (+15% previously)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f3ee01e0-e23b-451b-98f2-fc641ac2dd87" name="bm-comp-f3ee01e0-e23b-451b-98f2-fc641ac2dd87" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f3ee01e0-e23b-451b-98f2-fc641ac2dd87" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p style="text-align:left;"&gt;Q1 sales were much stronger than we expected at SEK 53m (+7% org, -14% FX), +27% vs. ABGSCe. EBIT was also higher at SEK 19m, vs. ABGSCe SEK 9.8m. The company continued its positive gross margin trend, with a record high margin of 60% (56% 2025), which it attributes to ongoing work with producers and a favourable customer mix. A key highlight was that the previously constrained customer appears back to normal order patterns and contributed to Q1 volumes.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We raise '26e/'27e/'28e sales by 6%/5%/5%, mainly on higher organic growth assumptions for '26e (+25% vs. +15% previously), as I-Tech's second-largest customer is back to a normal order cadence, a recovery we had not previously fully incorporated in our '26e. We also expect growth to be supported by rising CMP volumes and ongoing momentum among smaller customers (PPG, Jotun, Kansai Paints). Our raised sales estimate also lift our '26e-'28e EBIT estimates by 10%/5%/9%, partly offset by SEK 10m of costs for the ongoing EOGRT study (split between '26e/'27e).&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Remain positive long term&lt;/h3&gt;&lt;p&gt;Our long-term view on I-Tech is unchanged. Selektope is currently used on around 3,500 of the ~110,000 commercial vessels globally, leaving plenty of room to grow in both new-build and drydocking. The drydocking market is roughly 10x the size of new-build, and is where we see the bigger long-term opportunity. China stands out as a key geography where I-Tech's penetration in the maintenance market is still low relative to the size of the local fleet and the volume of drydocking activity. The company is trading at '26e-'28e EV/EBIT of 11x-4x, and 16x-9x P/E, i.e. ~40-60% below peers.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/i-tech/Equity-research/2026/5/i-tech---2026-looking-better-than-feared/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 08 May 2026 06:01:50 GMT</pubDate>
      <isin>SE0011167725</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Clavister - A new chapter begins</title>
      <description>&lt;a id="bm-comp-1580fb7f-d115-44c9-9db1-35fc76edbd19" name="bm-comp-1580fb7f-d115-44c9-9db1-35fc76edbd19" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1580fb7f-d115-44c9-9db1-35fc76edbd19" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales of SEK 72m (-5% vs. ABGSCe 76), a 35% y-o-y growth&lt;/li&gt;&lt;li&gt;Order book at a record, and ARR up 6%&lt;/li&gt;&lt;li&gt;Now with a solid foundation for the future&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-540bf020-c75e-4de8-8181-16c9992e1b03" name="bm-comp-540bf020-c75e-4de8-8181-16c9992e1b03" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="540bf020-c75e-4de8-8181-16c9992e1b03" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1'26 results&lt;/h3&gt;&lt;p&gt;Clavister reported Q1'26 sales of SEK 72m (-5% vs. ABGSCe 76m), implying 35% y-o-y growth, reflecting strong execution on the defence contracts. Last year's quarter also represented a tough comp due to a temporary boost from hardware deliveries. EBITDA came in at SEK 14m, slightly below our estimates, although the quarter included items affecting comparability of SEK 1.1m, implying an adjusted EBITDA of SEK 15m. We also note non-recurring costs of SEK 3.6m related to the Norwegian order, these are excluded from the company's adjusted EBITDA but, if added back, would imply an underlying EBITDA of ~SEK 19m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Delivery on track and a backlog at record levels&lt;/h3&gt;&lt;p&gt;ARR grew 6% y-o-y to SEK 142m, a stable growth rate, and worth keeping in mind that the recurring base remains a key growth pillar over time. The previously flagged delivery delays from Q4'25 also appear to have been partly resolved, which we view as a positive signal for delivery capacity going forward.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Positive on the company story&lt;/h3&gt;&lt;p&gt;On our unrevised estimates, Clavister is trading at 18-8x EV/EBITDA for '26e-'27e. We remain positive on the company story and see Clavister continuing to deliver on important metrics, a strong order book, scaling profitability, and stable ARR growth. Management will host a presentation of the report CET 09.00 (&lt;a data-bm-trackable="false" href="https://register.gotowebinar.com/register/7424364760654706519" target="_blank"&gt;link&lt;/a&gt;).&lt;/p&gt;&lt;table id="bm-img-19333268-9d10-466a-8000-e78e36b4ee83" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/clavister/Equity-research/2026/5/clavister---a-new-chapter-begins/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 07 May 2026 07:15:12 GMT</pubDate>
      <isin>SE0005308558</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>I-tech - Significant beat across the P&amp;L</title>
      <description>&lt;a id="bm-comp-175ea917-23ba-42e3-a073-340183b907e7" name="bm-comp-175ea917-23ba-42e3-a073-340183b907e7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="175ea917-23ba-42e3-a073-340183b907e7" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales +27&lt;font color="#000000"&gt;% vs. ABGSCe, EBIT SEK 19m vs. ABGSCe 9.8m&lt;/font&gt;&lt;/li&gt;&lt;li&gt;A beat on all line items, despite very tough comps&lt;/li&gt;&lt;li&gt;Gross margin 60% (56% LY), though may soften on raw material prices&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9ef54492-8d7d-4184-997e-1a454b0b1520" name="bm-comp-9ef54492-8d7d-4184-997e-1a454b0b1520" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9ef54492-8d7d-4184-997e-1a454b0b1520" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Much stronger growth than expected&lt;/h3&gt;&lt;p&gt;Sales came in above expectations at SEK 53m (+27% vs. ABGSCe 42m), -7% y-o-y (+7% org.). EBIT was SEK 19m (+89% vs. ABGSCe 9.8m), for a margin of +35% (ABGSCe +24%). EBIT adj. was SEK 19m (+89% vs. ABGSCe 9.8m), for a margin of +35% (ABGSCe +24%). Moreover, the gross margin continued to improve in the quarter to 60% (56% LY), however management flags that it may soften going forward due to cost increases in raw materials. I-Tech writes that all major customers continued to develop positively with offtake in line with or exceeding Q1'25. FCF lease adj. came in at SEK 8.5m (vs. ABGSCe 0.38m).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates and outlook&lt;/h3&gt;&lt;p&gt;On numbers alone, '26e-'28e sales change by +6%, and EBIT adj. changes by +18%. The company notes the global newbuilding orderbook hit a 17y high at the end of Q1, though pace of newbuild ordering slowed slightly in March on the Middle East conflict. Moreover, during the quarter, I-Tech announced it has received an extension of its regulatory approval in the EU until Dec '26, due to the ongoing process not being finalised within timeframe.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;The share has returned +44% L3M (vs. peer median +11% and OMXSSMAC +15%), and is currently trading at 16x-9.1x '26e-'28e P/E on our pre-report estimates vs. the peer median of 28x-16x. &lt;font style="background-color:#ffffff;"&gt;&lt;font style="background-color:#ffffff;"&gt;T&lt;font color="#212529"&gt;he company will host a&lt;/font&gt; &lt;a data-bm-trackable="false" href="https://www.youtube.com/live/QtqRaG69sxk" style="color: rgb(0, 123, 255); box-sizing: border-box; text-decoration: none; font-family: Arial, &amp;quot;Unifont Calibri&amp;quot;, &amp;quot;Unifont Helvetica&amp;quot;, &amp;quot;Unifont Gotham&amp;quot;, &amp;quot;Unifont Arial&amp;quot;, Unifont !important;" target="_blank"&gt;presentation&lt;/a&gt; &lt;font color="#212529"&gt;of the Q1 results at&lt;/font&gt;&lt;/font&gt;&lt;/font&gt; &lt;font color="#000000"&gt;&lt;font style="background-color:#ffffff;"&gt;&lt;font style="background-color:#ffffff;"&gt;&lt;font style="background-color:#ffffff;"&gt;13:00 CET.&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-241d2eae-771c-468c-8f70-2d8e3df9c6e7" name="bm-comp-241d2eae-771c-468c-8f70-2d8e3df9c6e7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="241d2eae-771c-468c-8f70-2d8e3df9c6e7" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-5721570e-e79a-4603-967e-27e56c3a0702" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/i-tech/Equity-research/2026/5/i-tech---significant-beat-across-the-pl/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 07 May 2026 07:00:55 GMT</pubDate>
      <isin>SE0011167725</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>NYAB - Strong orders in low season quarter</title>
      <description>&lt;a id="bm-comp-058ccf9e-519f-4ef0-b870-6ee2be616415" name="bm-comp-058ccf9e-519f-4ef0-b870-6ee2be616415" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="058ccf9e-519f-4ef0-b870-6ee2be616415" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Big deviations in a seasonally smaller quarter&lt;/li&gt;&lt;li&gt;Strong orders de-risks '26e in our view&lt;/li&gt;&lt;li&gt;Estimates should be fairly unchanged&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c0bbdc83-e54d-4663-b78c-3aeb327ab50a" name="bm-comp-c0bbdc83-e54d-4663-b78c-3aeb327ab50a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c0bbdc83-e54d-4663-b78c-3aeb327ab50a" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Sales were a bit weaker in a seasonally weak Q1, 12% below ABGSC and 14% below FactSet consensus with -6% organic growth y-o-y. But more importantly, orders in Civil Engineering were strong, with order intake +24% y-o-y and order backlog +28% y-o-y, supporting solid growth in the seasonally stronger Q2-Q4. EBIT of EUR 1.5m saw big deviations (16% vs ABGSCe 1.3m and -31% vs cons 2.2m), but Q1 constitute a small part of full-year earnings (&amp;lt;5%). Net profit was EUR 1.1m (44% vs ABGSCe 0.8m and 12% vs cons 1.0m). FCF remained solid at EUR 5m in Q1 and 38m LTM (120% EBIT conversion).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Preliminary estimate changes&lt;/h3&gt;&lt;p&gt;Management said market conditions remains favourable, illustrated by the company's strong order book, but also in ongoing Phase 1 projects that could drive even stronger orders if NYAB wins the Phase 2's. Management has indicated before that tenders for two major projects should be completed before the summer (Norrbotten power line and Uppsala tram), but no update on the timelines were provided in the report. We do not expect consensus to extrapolate deviations from the Q1 into '26e-'28e estimates. Instead, we expect estimates to remain fairly unchanged, while the strong order book de-risks 2026e a bit in our view.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thought&lt;/h3&gt;&lt;p&gt;The share has been flat both L1M and YTD and lagged OMXSGI which is +7% in both periods. We think the key trigger will be how the company executes on the strong order book in 2026 while increasing margins in Sweden again. The upcoming major tenders in Uppsala and Norrbotten are also key factors.&lt;/p&gt;&lt;p&gt;Management will host a presentation of the report at 10:00 CET, you can use this &lt;a data-bm-trackable="false" href="https://nyabgroup.events.inderes.com/q1-report-2026" target="_blank"&gt;link&lt;/a&gt; to participate.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1efa3908-c2b2-4d26-90db-899904b8169a" name="bm-comp-1efa3908-c2b2-4d26-90db-899904b8169a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1efa3908-c2b2-4d26-90db-899904b8169a" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-b8d60793-49ba-4b79-8f84-afb8280067d0" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviations&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, FactSet consensus&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nyab/Equity-research/2026/5/nyab---strong-orders-in-low-season-quarter/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 07 May 2026 07:00:12 GMT</pubDate>
      <isin>SE0022242434</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Inission - A very strong start to the year</title>
      <description>&lt;a id="bm-comp-af221990-5e90-4899-bca4-69d79abf55bb" name="bm-comp-af221990-5e90-4899-bca4-69d79abf55bb" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="af221990-5e90-4899-bca4-69d79abf55bb" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Orders +20%, sales +14%, adj. EBITA +10% vs. ABGSCe&lt;/li&gt;&lt;li&gt;Enedo sees strong orders, growth and margin uplift&lt;/li&gt;&lt;li&gt;Growth trend to continue for the rest of the year&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-380bfcea-93f3-4502-8341-c54bf6c332c6" name="bm-comp-380bfcea-93f3-4502-8341-c54bf6c332c6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="380bfcea-93f3-4502-8341-c54bf6c332c6" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Orders were up 17% y-o-y and 20% above our estimate. Sales grew 37% y-o-y and were 14% above our estimate. With a margin of 7.0%, 0.2pp below our estimate, EBITA adj. was 10% above our estimate. Importantly, Enedo, recently renamed Inission Power OEM, reported a book-to bill of 1.3x while sales grew 15% organically and adj. EBITA reached 3.8m (-2.3m), a margin of 3.1% (-2.8%). Lease adj. FCF was 26m, bringing the R12m figure to 115m, i.e. 180% of net income. There is a conference call at 17:00 CET: &lt;a data-bm-trackable="false" href="https://www.inissiongroup.com/sv/webcasts-inission-ab/" target="_blank"&gt;webcast&lt;/a&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;The Q1 numbers in isolation imply EBITA adj. comes up 3%. Management stated that the solid book-to-bill should enable the growth the company is seeing to persist for the rest of the year, something we agree with. Furthermore, the company made progress with some potential acquisition targets in the quarter.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Company valuation&lt;/h3&gt;&lt;p&gt;Over the past three months, the share has returned +37%, compared to the Nordic EMS peer median of +18% and the +2% of the OMX Stockholm Allshare. The share is currently trading at 13x-9.9x '26e-'28e P/E, compared to its 10-year historical median of 13x-8.9x and peers at 17x-14x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-91dcf395-4148-401f-9437-a2d79a475aa1" name="bm-comp-91dcf395-4148-401f-9437-a2d79a475aa1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="91dcf395-4148-401f-9437-a2d79a475aa1" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-fb4a49ce-5d22-4bb1-b57c-12cf12855e34" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. estimates Q1'26&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/inission/Equity-research/2026/5/inission---a-very-strong-start-to-the-year/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 07 May 2026 06:45:11 GMT</pubDate>
      <isin>SE0016275069</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>G5 Entertainment - Savings to restore margins</title>
      <description>&lt;a id="bm-comp-3aa8e3d6-76eb-4929-9c17-5ee5b2f06127" name="bm-comp-3aa8e3d6-76eb-4929-9c17-5ee5b2f06127" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3aa8e3d6-76eb-4929-9c17-5ee5b2f06127" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Significant cuts to '26e on lower sales&lt;/li&gt;&lt;li&gt;...but '27e-'28e fairly unchanged due to cost savings&lt;/li&gt;&lt;li&gt;Trading 6x EV/adj. EBIT 2026e but 2x on 2027e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-05f7ba48-484d-407d-8f6e-996414126acd" name="bm-comp-05f7ba48-484d-407d-8f6e-996414126acd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="05f7ba48-484d-407d-8f6e-996414126acd" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We have assumed ~USD 6m cost savings on an annualised level, with full effect from Q4'26. This means that we expect 2026 to be relatively unaffected by the savings. We therefore cut 2026 adj. EBIT by 39% on 3% lower sales, magnified by a relatively low adj. EBIT figure. For 2027-2028, we expect that the savings will offset 5-8% lower sales, for +2% and -4% adj. EBIT revisions. We now expect USD 7.6m adj. EBIT in both 2027 and 2028 (~SEK 70m) and USD 7.6-7.7m in FCF (~SEK 70m).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Gross margins and cost savings to support earnings&lt;/h3&gt;&lt;p&gt;Continued gross margin improvements (73% in Q1 vs 72% in Q4 and 70% in Q1'25) mean that gross profits remain fairly stable, especially compared to sales and adj. EBIT. Gross profit decreased 8% in 2025, and we expect -4% in 2026e. The main problem we see for earnings is that the company has been over-staffed given its mature portfolio profile. Assuming current portfolio dynamics persist (i.e. no new games to put significant investments behind) we think the organisation could be downsized significantly more. If sales continue to decline, we still think G5 could sustain &amp;gt;10% EBIT margins and &amp;gt;USD 5m EBIT for many years, but if some of its larger games are put in harvest-mode, we think margins could reach 20-30%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;18% FCF yield '27e and ~60% of market cap in net cash&lt;/h3&gt;&lt;p&gt;The main question is how much the company is willing to continue to invest in generating new titles. Success has been sparse, but all it takes is one title. We see management's willingness to right-size as positive because it could support a higher pay-out ratio in the wait for better growth. On our updated estimates, the share is trading at an 18% FCF yield when cost savings are fully visibile in 2027e, while the company also carries ~60% of market cap in net cash.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/g5-entertainment/Equity-research/2026/5/g5-entertainment---savings-to-restore-margins/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 07 May 2026 05:45:11 GMT</pubDate>
      <isin>SE0001824004</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nolato - Stable performance in an unstable world </title>
      <description>&lt;a id="bm-comp-96de8757-d33c-4fa0-96ec-55def1d21979" name="bm-comp-96de8757-d33c-4fa0-96ec-55def1d21979" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="96de8757-d33c-4fa0-96ec-55def1d21979" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Company confident about parrying input cost pressure&lt;/li&gt;&lt;li&gt;We make only minor estimate revisions&lt;/li&gt;&lt;li&gt;Accelerating organic growth ahead, and room for M&amp;amp;A&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c3d93d6b-693d-4e3a-8353-85a2daa923b4" name="bm-comp-c3d93d6b-693d-4e3a-8353-85a2daa923b4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c3d93d6b-693d-4e3a-8353-85a2daa923b4" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Company confident about parrying input cost pressure&lt;/h3&gt;&lt;p&gt;Going into the report, our key concern was related to rising input costs, as Nolato is reliant on the purchasing of petrochemicals, but the company expects only limited timing impacts from this, which we found reassuring. According to the company, it has roughly SEK 1.6-1.7bn in material costs that are, to varying degrees, linked to oil prices. On these costs, it has seen average inflation of ~5-10%, i.e. the mid-point implies ~SEK 120m higher costs on an annualised basis. However, keep in mind that it roughly takes only one quarter to pass these costs on to customers, meaning we calculate the actual EBITA impact to be only SEK -30m (3% of '26e EBITA), split roughly 50/50 between Q2 and Q3.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We make only minor estimate revisions&lt;/h3&gt;&lt;p&gt;The Q1 numbers were undramatic, with EBITA 1% above Modular Finance IR consensus. We make no major revisions, updating FX assumptions and, as mentioned above, factoring in some slight margin pressure for Q2 and Q3 (although note we already downgraded margins a bit on this theme ahead of the report). At the group level we make EBITA downgrades of 2% for '26e and 1% each for '27e and '28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Accelerating organic growth ahead, and room for M&amp;amp;A&lt;/h3&gt;&lt;p&gt;The stock is trading at 14x '26e EV/EBITA, compared to its historical fwd. multiple of 15x, and offers ~4-6% lease-adj. FCF yields for '26e-'28e. We see organic growth accelerating ahead, slightly in Q2e, but more so in Q3e and beyond, driven by the ramp-up of GLP-1 volumes at the new Hungarian site. We also see good opportunities for an accelerated pace of M&amp;amp;A given the strong balance sheet, with r12m ND/EBITDA (ex. pensions and leasing) at 0.5x, and we note the company&amp;#8217;s communication on M&amp;amp;A opportunities has become more forward-leaning in recent quarters.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nolato/Equity-research/2026/5/nolato---stable-performance-in-an-unstable-world-/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 06 May 2026 19:45:09 GMT</pubDate>
      <isin>SE0015962477</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nolato - An in-line report with no surprises</title>
      <description>&lt;a id="bm-comp-1e12b0b6-2c50-4a9f-8505-f2ce036a5acd" name="bm-comp-1e12b0b6-2c50-4a9f-8505-f2ce036a5acd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1e12b0b6-2c50-4a9f-8505-f2ce036a5acd" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;EBITA SEK 260m (-2% vs. ABG, 0% vs. IR consensus)&lt;/li&gt;&lt;li&gt;We expect no material revisions to cons EBITA&lt;/li&gt;&lt;li&gt;Share trading at 13x '26e EV/EBITA on our pre-Q1 estimates&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7b92ff44-6397-4af3-a50d-d7b68bb278e9" name="bm-comp-7b92ff44-6397-4af3-a50d-d7b68bb278e9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7b92ff44-6397-4af3-a50d-d7b68bb278e9" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 outcome&lt;/h3&gt;&lt;p&gt;Sales came in at SEK 2,357m (-2% vs. ABG 2,394m, 0% vs. IR cons 2,358m), down 4% y-o-y, of which organic growth was +3% (ABG +3%). EBITA was SEK 260m (-1% vs ABG 262m, +1% vs. cons 258m), for an EBITA margin of 11.0% (ABG 11.0%, cons 10.9%). At the segment-level, Medical came in 2% below cons on EBITA, while Engineered was 4% above. FCF was SEK +32m, for a low cash conversion of 18%, yet this is due to typical seasonal working capital tie-up in Q1.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and estimate changes&lt;/h3&gt;&lt;p&gt;The company does not give guidance or much outlook commentary in the report. However, it does mention that higher input costs risk having temporary effects (on margins), although over time are moved on to customers, and in our experience this typically takes 3-6 months. Also, the company reiterates that commercial deliveries from the new Hungarian site will commence towards the end of Q2. All in all, we expect no material revisions to cons EBITA following an in-line report.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation and conference call details&lt;/h3&gt;&lt;p&gt;In our view, the report did not contain any major surprises, with in-line numbers and reassuring commentary on moving higher input costs on to customers (as expected). On our pre-Q1 estimates (and on yesterday's closing price) the share trades at 13x '26e EV/EBITA, compared to its historical average fwd. multiple of 15. Finally, the company will host a conference call at 13:30 CEST, &lt;a data-bm-trackable="false" href="https://storage.mfn.se/c6d7190f-adda-4495-b544-a88e1d4d07b9/webcast-conference-call-on-may-6-about-nolatos-interim-report-for-q1-2026.pdf" target="_blank"&gt;register here&lt;/a&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-b04bcbc3-959a-4f7c-922c-dfc8f962a836" name="bm-comp-b04bcbc3-959a-4f7c-922c-dfc8f962a836" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b04bcbc3-959a-4f7c-922c-dfc8f962a836" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-b17c9cb0-7026-41b8-8e2d-b3d1e78f8bc9" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier estimates, Modular Finance IR consensus&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nolato/Equity-research/2026/5/nolato---an-in-line-report-with-no-surprises/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 06 May 2026 11:30:09 GMT</pubDate>
      <isin>SE0015962477</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ework Group - Costs in check as volume focus builds</title>
      <description>&lt;a id="bm-comp-c79ab7d4-b31e-478e-880e-e991ee91c215" name="bm-comp-c79ab7d4-b31e-478e-880e-e991ee91c215" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c79ab7d4-b31e-478e-880e-e991ee91c215" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Market remains soft, but Ework is taking decisive actions on costs&lt;/li&gt;&lt;li&gt;We raise '26e-'28e adj. EBIT by 4-2% on 1% higher sales&lt;/li&gt;&lt;li&gt;11x/9x '26e/'27e EV/EBIT adj. &amp;#8211; in line with peers&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7864143a-e1f2-4e60-b2ba-f537a57431bd" name="bm-comp-7864143a-e1f2-4e60-b2ba-f537a57431bd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7864143a-e1f2-4e60-b2ba-f537a57431bd" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;No signs of recovery yet, but Ework is taking actions on costs&lt;/h3&gt;&lt;p&gt;The Nordic consultancy market has yet to recover from its protracted slump, resulting in Ework reported sales -14% y-o-y (vs. -12% y-o-y in Q4'25). Peers have also reported negative org. growth, with Knowit, B3, and Prevas averaging -7% y-o-y. That said, amid better-than-expected cost control, adj. EBIT of SEK 23m (-33% y-o-y) was above our SEK 17m forecast. Here, Ework reported NRIs of SEK 9m relating to the previously communicated reorganisation. While Sweden showed a similar trend to recent quarters, Norway is improving (+19% y-o-y), supported by telecom, the public sector and energy. Denmark had a notably weak quarter (sales -29% y-o-y), albeit this was not too surprising given recent industry news of layoffs at companies such as Novo Nordisk.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Improved cost base&lt;/h3&gt;&lt;p&gt;The reorganisation is now fully implemented. As part of the new CEO's strategic shift, Ework is becoming more customer-centric, which includes reducing the management team by around 50%. In light of the recent drop in sales volumes, we believe this move is sensible and will better equip Ework to handle the current dynamic environment. Also, and unlike under the previous management, the company is now prioritising volume growth over improving gross margins. Nonetheless, we lift our '26e-'28e adj. EBIT figures by 4-2% on slightly higher sales assumptions.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;11x/9x '26e/'27e EV/EBIT adj.&lt;/h3&gt;&lt;p&gt;The overall market remains subdued and visibility into the timing and trajectory of the recovery remains blurred. With that said, we argue that Ework's market-leading position and strong balance sheet mean it is comparatively better at handling the lower volumes. The stock is currently at 11x/9x '26e/'27e EV/EBIT adj., in line with peers.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ework/Equity-research/2026/5/ework-group---costs-in-check-as-volume-focus-builds/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 06 May 2026 07:30:08 GMT</pubDate>
      <isin>SE0002402701</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>G5 Entertainment - Weak Q1 but layoffs should lift estimates</title>
      <description>&lt;a id="bm-comp-92226524-5008-412e-b22b-0094b3c1d698" name="bm-comp-92226524-5008-412e-b22b-0094b3c1d698" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="92226524-5008-412e-b22b-0094b3c1d698" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Adjusted EBIT turned negative on sales miss&lt;/li&gt;&lt;li&gt;But a major layoffs could lift cons '27e-'28e EBIT (~5-10%)&lt;/li&gt;&lt;li&gt;FCF positive and significant net cash position&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-cf759a8f-64fc-4f31-929f-4a86bb471e33" name="bm-comp-cf759a8f-64fc-4f31-929f-4a86bb471e33" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cf759a8f-64fc-4f31-929f-4a86bb471e33" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;First, G5 has changed reporting currency from SEK to USD. Sales were USD 21.7m, -11% y-o-y and 6% below ABGSC and FactSet consensus. Reported earnings were better than expected, but boosted by FX revaluations. Adjusted EBIT was USD -0.2m (2.9m), vs ABGSC 0.8m and cons 0.8m. Net profit was relatively in line due to the boost from FX revaluations, 0.8m vs ABGSC 0.7m and cons 0.8m. Despite negative underlying EBIT, FCF remained strong at 3.7m. Adjusted for working capital swings, FCF was 0.3m in Q1.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Preliminary estimate changes&lt;/h3&gt;&lt;p&gt;We expect consensus to cut underlying 2027-2028 estimates by 20% based on the weaker Q1 numbers. However, G5 also announced a cost savings programme, with planned savings of USD 6.2m (SEK 57m) on an annualised basis. Part of these savings will be reinvested in higher user acquisition to stabilise and grow its existing games and potentially new releases. We still expect the net effect of this to be positive, while also offset the negative underlying revisions from the Q1 miss. Our base case is that consensus EBIT for 2027-2028 will be raised slightly, by ~5-10%. But we could also see estimates revised up by ~20% if the higher user acquisition helps stabilise sales. Management also sounded open to further right-sizing if the growth trend of some of its titles (mainly the Jewel series) does not improve coming quarters.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;The share has underperformed both the market and mobile peers like MTG and Stillfront YTD. While the growth trend remains challenging, we think it is positive that management is acting by right-sizing the organisation, which should lift earnings from the current levels. On the conference call today, management also sounded positive on continued use of dividend and buybacks. The FCF remains positive, while G5 sits on a net cash position of ~SEK 240m in Q1 compared to i&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/g5-entertainment/Equity-research/2026/5/g5-entertainment---weak-q1-but-layoffs-should-lift-estimates/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 06 May 2026 07:00:09 GMT</pubDate>
      <isin>SE0001824004</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Fastpartner - Lettings mitigate vacancy concerns</title>
      <description>&lt;a id="bm-comp-cd305b82-591b-4fff-91c8-fd3fba0fc6b8" name="bm-comp-cd305b82-591b-4fff-91c8-fd3fba0fc6b8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cd305b82-591b-4fff-91c8-fd3fba0fc6b8" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Solid lettings in the wake of Nasdaq, but timing uncertain&lt;/li&gt;&lt;li&gt;Estimates hit by higher interest rate assumptions&lt;/li&gt;&lt;li&gt;2026e P/CEPS of 12x vs coverage average of 14x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-85d477ee-b7c1-45e2-9d51-07d026d145a5" name="bm-comp-85d477ee-b7c1-45e2-9d51-07d026d145a5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="85d477ee-b7c1-45e2-9d51-07d026d145a5" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results very much in line with our expectations&lt;/h3&gt;&lt;p&gt;FastPartner delivered rental income, NOI and rec. PTP in line with our forecasts, while NOI was 3% below FactSet consensus. Occupancy deteriorated by 2.1pp q-o-q to 89.2% (89.7% adjusted for projects), driven by Nasdaq vacating its premises in Frihamnen. The NOI margin deteriorated by 0.9pp y-o-y to 64.5%, primarily driven by a softer top-line, where cost reductions have been counteracted by an increase in property taxation. We make negative CEPS revisions of 1-4%, driven primarily by higher rates in our forecast.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;A chunk of the Nasdaq vacancy is already off the market&lt;/h3&gt;&lt;p&gt;The 23,000 sqm let to Nasdaq in Frihamnen expired as of year-end 2025, which was the key driver behind the 2.1pp vacancy increase in Q1. In conjunction with the report, the company announced a 10-year lease of 15,000 sqm to MagasinX, i.e. ~60% of the lettable area, while a number of existing tenants in the property have also extended and expanded their leases. However, we have no information on move-in timing, capex or rental levels, which makes it difficult to access the impact; we have assumed the same rental level as for Nasdaq starting Q1'27e. We are ~1% below IFPM NTM guidance of SEK 780, likely pertaining to letting timing and our revised interest rate assumptions. Management highlights a continued challenging rental market, fuelled by both a weak economic cycle and AI reducing demand for office premises, and targets earnings returning to 'normalised' levels in 2027e.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;2026e P/CEPS of 12x, coverage average of 14x&lt;/h3&gt;&lt;p&gt;The share is trading at 2026e P/CEPS of 12x, below the average in our coverage of 14x and the average for office peers in our coverage at 15x. On 2026e P/EPRA NRV, the share is trading at 0.4x compared to office peers at 0.6x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/fastpartner/Equity-research/2026/5/fastpartner---lettings-mitigate-vacancy-concerns/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 06 May 2026 06:45:07 GMT</pubDate>
      <isin>SE0013512506</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Embellence Group - Going through changes</title>
      <description>&lt;a id="bm-comp-9493b3ac-18c2-4e26-aad1-114d248046c8" name="bm-comp-9493b3ac-18c2-4e26-aad1-114d248046c8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9493b3ac-18c2-4e26-aad1-114d248046c8" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Cole &amp;amp; Son management changes weigh on Q1 EBITA&lt;/li&gt;&lt;li&gt;We expect Cole &amp;amp; Son to move toward hospitality&lt;/li&gt;&lt;li&gt;We reiterate our fair value range of SEK 36-43&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-87dc9540-c9c1-4760-a680-8c5364cc3f64" name="bm-comp-87dc9540-c9c1-4760-a680-8c5364cc3f64" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="87dc9540-c9c1-4760-a680-8c5364cc3f64" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Nordics performed better, DTC changes the P&amp;amp;L&lt;/h3&gt;&lt;p&gt;In Q1, Embellence Group accelerated to 3% organic growth vs. broadly flat growth in Q4. As in Q4, Nordic brands were accretive for growth, with Bor&amp;#229;stapeter growing 5% organically while External manufacturing grew by 20%. Pappelina, which recently received a major online platform overhaul, took significant strides as well, which is a positive signal for the ongoing DTC transformation. Cole &amp;amp; Son, which was undergoing management changes, declined 19%. The DTC transformation is making a clear mark in Embellence Group's P&amp;amp;L structure: gross margins improved 1.3pp y-o-y, but the SG&amp;amp;A ratio also rose 2.7pp. The result was a ~2pp margin contraction for an EBITA margin of 13.9% and EBITA of SEK 28m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We expect near-term softness in Cole &amp;amp; Son&lt;/h3&gt;&lt;p&gt;Yelena Ford joined Cole &amp;amp; Son as Managing Director in April, succeeding the Group CEO, who had held the role on an interim basis. We expect the new management to have a greater focus on hospitality sales going forward, thereby joining Wall &amp;amp; Dec&amp;#242; in this end-market. Cole &amp;amp; Son&amp;#8217;s new DTC platform performed well, but near-term distribution optimisation is likely to weigh on sales and margins into Q2. Cole &amp;amp; Son margins were also impacted by management changes in Q1, though the magnitude is unclear.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We reiterate our fair value range of SEK 36-43&lt;/h3&gt;&lt;p&gt;As we make only very minor estimate revisions, we reiterate our fair value range of SEK 36-43. The share is currently trading at 7.7-5.4x EV/EBITA '26e-'28e, which can be compared to a historical trading range of 7x-8x NTM and a Swedish peer group of home improvement companies at a median 10.8x-8.1x '26e-'28e. We estimate a 10-13% FCF yield '26e-'28e, and a dividend yield of 5-5.7% for the same years.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/embellence-group/Equity-research/2026/5/embellence-group---going-through-changes/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 05 May 2026 19:15:08 GMT</pubDate>
      <isin>SE0013888831</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Infrea - Bumpy Q1 but road intact</title>
      <description>&lt;a id="bm-comp-7f918c03-163d-4f63-a1ad-f748a7d7e586" name="bm-comp-7f918c03-163d-4f63-a1ad-f748a7d7e586" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7f918c03-163d-4f63-a1ad-f748a7d7e586" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Normalisation in a small quarter&lt;/li&gt;&lt;li&gt;Better cash flow, low net debt and buybacks&lt;/li&gt;&lt;li&gt;M&amp;amp;A on the way and infrastructure spending to rise&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1afe343f-8b9c-4cb3-bff4-c846f03ce835" name="bm-comp-1afe343f-8b9c-4cb3-bff4-c846f03ce835" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1afe343f-8b9c-4cb3-bff4-c846f03ce835" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Sales and earnings miss driven by normalisation&lt;/h3&gt;&lt;p&gt;Infrea sold its Water &amp;amp; Sewage segment during Q4'25, and we have included the segment in the comparable numbers for 2025. Infrea's Q1 was softer than expected, mainly because Q1'25 was stronger than we had realised in both segments, driven by a different project mix and milder weather last year. This caused sales in both segments to decline, with Land &amp;amp; Construction (L&amp;amp;C) -13% y-o-y and Paving Services (PS) -28%. Organic sales growth was -15% y-o-y (+3% Q4'25), while total sales were down -22% due to the divestment. EBITA was stable in PS at SEK -35m, while EBITA in L&amp;amp;C declined by SEK 6m to SEK -11m on tough comps, although it is now reverting to a normalised level. FCF was better y-o-y at SEK -32m (Q1'25 at -45m) despite high capex and a seasonally weak cash flow quarter.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Seasonally, Q1 is the smallest quarter&lt;/h3&gt;&lt;p&gt;We lower '26e-'28e EBITA by 10-6% on the miss and the normalisation of the Q1 numbers into '27-'28. Q1 is a small quarter, and we argue the weaker numbers should not be extrapolated into further quarters in '26e. Infrea continues to focus on internal efficiency and margins over volumes. We think improving margins should support SEK 56m EBITA in '26e and a 9% CAGR '25-'28e. The low net debt at 0.8x makes us more confident that Infrea could add growth through M&amp;amp;A.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Margins to improve and FCF to stabilise&lt;/h3&gt;&lt;p&gt;We believe that Infrea is well-positioned to grow organically and improve its margins given its exposure to underlying demand and to public customers (~55%), as well as support from M&amp;amp;A (13% sales CAGR in '21-'24). For '25-'28e, we expect Infrea to deliver profitability growth and FCF above peers but with slightly lower margins and sales growth. The share is trading at 7-4x adj. EBITA on '26e-'28e with a 17-13% lease-adj. FCF yield, while peers are trading at 7-6x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/infrea/Equity-research/2026/5/infrea---bumpy-q1-but-road-intact/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 05 May 2026 16:30:08 GMT</pubDate>
      <isin>SE0010600106</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>OssDsign - Reset underway ahead of H2'26</title>
      <description>&lt;a id="bm-comp-3ed83e70-4317-4c15-810c-f306d8abeae6" name="bm-comp-3ed83e70-4317-4c15-810c-f306d8abeae6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3ed83e70-4317-4c15-810c-f306d8abeae6" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 in line with pre-announced numbers&lt;/li&gt;&lt;li&gt;Minor estimate revisions, H2'26 the key catalyst&lt;/li&gt;&lt;li&gt;Fair value range unchanged at SEK 4.0-6.2&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d1ba47b8-423d-4ae0-b867-33d0ef372838" name="bm-comp-d1ba47b8-423d-4ae0-b867-33d0ef372838" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d1ba47b8-423d-4ae0-b867-33d0ef372838" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Weak GM in Q1, opex offset&lt;/h3&gt;&lt;p&gt;Q1 sales confirmed the pre-announced number of SEK 36.9m (0% vs. ABGSCe) with an organic decline of 3.6%, and -17.1% y-o-y growth in SEK. Adj. EBIT of SEK -13.4m (-2% vs. ABGSCe) was within the range provided on 10 April, yet with a gross margin of 91.6% (ABGSCe 95.5%) surprising on the negative side. Management highlighted that the gross margin decline reflected an unfavourable product/customer mix, negative COGS scale effects on the lower volumes, and an FX-related lag between production and consumption. Opex was below our forecast at SEK -47.2m (ABGSCe SEK -48.3m), with sales commissions and fees coming in in-line with ABGSCe, down 220bp y-o-y, to 47.1%. FCF in the quarter came in at SEK -20.9m (ABGSCe -12.1m), negatively impacted by capitalisation of R&amp;amp;D. At the end of Q1, the cash position remained solid at SEK 170.5m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Execution issues being addressed&lt;/h3&gt;&lt;p&gt;The new US-based CEO attributes the Q1 shortfall to a slowdown in sales rep hiring in late 2025, departures of underperforming reps, and contract renegotiations at certain key accounts, which all materialised in the same quarter. Hiring is said to have accelerated in Q1, key account discussions are progressing, and the CEO's US presence should shorten decision loops with KOLs and hospital systems. Catalyst's clinical profile (88.4% fusion rate in PROPEL) remains the core pillar of the company's prospects. We trim adj. EBIT by -1.1% for '26e and by 5.4%-5.8% for '27e-'28e after Q1. We now assume a similar sales level in Q2 as in Q1, at around USD 4m, before returning to growth in H2'26e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range unchanged at SEK 4.0-6.2&lt;/h3&gt;&lt;p&gt;With relatively limited estimate changes, we leave our DCF-based fair value range unchanged at SEK 4.0-6.2. Evidence of a return to commercial momentum in H2'26 remains the key catalyst going forward.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ossdsign/Equity-research/2026/5/ossdsign---reset-underway-ahead-of-h226/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 05 May 2026 11:45:08 GMT</pubDate>
      <isin>SE0012570448</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>I-tech - Announce extension of Selektope until Dec '26</title>
      <description>&lt;a id="bm-comp-1c14c7b8-ba10-46de-a09c-42aa04324055" name="bm-comp-1c14c7b8-ba10-46de-a09c-42aa04324055" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1c14c7b8-ba10-46de-a09c-42aa04324055" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Approval for Selektope extended again, now until Dec '26&lt;/li&gt;&lt;li&gt;Ongoing process could not be finalised within timeframe&lt;/li&gt;&lt;li&gt;I-Tech views this as positive; invests in new EOGRT study&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-bca34ce4-ffd8-4683-a847-7755fb78799c" name="bm-comp-bca34ce4-ffd8-4683-a847-7755fb78799c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bca34ce4-ffd8-4683-a847-7755fb78799c" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Approval extended again, until Dec '26&lt;/h3&gt;&lt;p&gt;The European Commission and the Standing Committee on Biocidal Products (SCBP) have decided to extend the current approval for Selektope (medetomidine) in antifouling coatings (PT-21) until 31 December '26. This is a second extension following the one-year extension granted in May '25 (previously through June '26). The Commission cites that the ongoing re-approval assessment could not be finalised within the remaining timeframe, for reasons outside the Company's control.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;I-Tech reads the decision as positive; new study underway&lt;/h3&gt;&lt;p&gt;I-Tech views the extension as confirmation that the case is receiving significant attention at EU Member State level, and that authorities consider it appropriate to maintain approval while the assessment continues. In parallel, the Company is investing in a new Extended One-Generation Reproductive Toxicity (EOGRT) study aimed at clarifying remaining scientific uncertainties around possible endocrine effects. The study is predominantly intended for use outside the EU, but I-Tech expects the results to also be relevant in a European regulatory context.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Remain positive on long-term prospects&lt;/h3&gt;&lt;p&gt;Although we still deem it likely that Selektope (medetomidine) will not receive a non-renewal in the EU, we remain positive on the company's long-term outlook given its small exposure to the EU market.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/i-tech/Equity-research/2026/5/i-tech---announce-extension-of-selektope-until-dec-26/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 05 May 2026 10:30:07 GMT</pubDate>
      <isin>SE0011167725</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Prevas - Stable underlying margins</title>
      <description>&lt;a id="bm-comp-2a44af01-47ca-4973-b147-bcd67a68fc78" name="bm-comp-2a44af01-47ca-4973-b147-bcd67a68fc78" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2a44af01-47ca-4973-b147-bcd67a68fc78" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Sales of SEK 426m, organic decline of 3%&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Adj. EBITA of SEK 40m, and a margin of 9%&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Continued growth within defence, up 22% y-o-y&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-246bd8bc-69f2-48da-91c8-240b02d80189" name="bm-comp-246bd8bc-69f2-48da-91c8-240b02d80189" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="246bd8bc-69f2-48da-91c8-240b02d80189" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1'26 details&lt;/h3&gt;&lt;p&gt;Prevas reports Q1'26 sales of SEK 426m (-3% vs. ABGSCe 440m), down 1% y-o-y with an organic decline of ~3%. EBITA was in line with our expectations at SEK 36m, (vs. ABGSCe 37m), with a margin of 8.4% (vs. ABGSCe 8.4%). However, adj. EBITA came in stronger than we expected, which was affected by SEK 3.8m of restructuring costs related to Denmark and Sk&amp;#229;ne, resulting in an adj. EBITA margin of 9.3%. Net FTEs declined, reflecting continued adjustments to market conditions.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;A stable start to the year&lt;/h3&gt;&lt;p&gt;Defence continues to grow, and this quarter was no exception, with sales up 22% y-o-y, representing ~17% of group sales in Q1. Telecom also showed strong momentum, sales up 35% y-o-y, which we attribute to increased investments in the segment. Finland also continues to grow, although customers are increasingly postponing investment decisions, the region increased its sales by ~6% y-o-y.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Prevas is trading 8-7x on '26e-'27e EV/EBITA on our unrevised estimates. Conference call at CET 09.30 (&lt;a data-bm-trackable="false" href="https://www.finwire.tv/webcast/prevas/q1-2026/" target="_blank"&gt;link&lt;/a&gt;).&lt;/font&gt;&lt;/p&gt;&lt;table id="bm-img-eb26f645-3094-4e20-a500-fdbc148f45d8" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/prevas/Equity-research/2026/5/prevas---stable-underlying-margins/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 05 May 2026 07:45:06 GMT</pubDate>
      <isin>SE0000356008</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Infrea - Weak numbers but with positive signals</title>
      <description>&lt;a id="bm-comp-79a59bc3-9684-4ef2-ab4e-00e7c243aa39" name="bm-comp-79a59bc3-9684-4ef2-ab4e-00e7c243aa39" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="79a59bc3-9684-4ef2-ab4e-00e7c243aa39" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales -15%, adj. EBITA -15% vs. ABGSCe, -15% org. growth&lt;/li&gt;&lt;li&gt;'26e-'28e adj. EBITA estimates likely down 5-10%&lt;/li&gt;&lt;li&gt;Share to focus on cash flow and market activity&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-db7a37b9-b895-4c5e-9e40-00a557aad037" name="bm-comp-db7a37b9-b895-4c5e-9e40-00a557aad037" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="db7a37b9-b895-4c5e-9e40-00a557aad037" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 details&lt;/h3&gt;&lt;p&gt;Infrea delivered a slightly soft report in a small quarter. Organic sales was -15% y-o-y, and EBITA margin a bit weak driven by project mix and investments in machinery and people. In Q4'25, Infrea sold the Water &amp;amp; Sewage segment. We included the segment in the comparable numbers for '25. Sales came in at SEK 319m (-15% vs. ABGSCe), -15% organic (+3% Q4'25), driven by both Land &amp;amp; Construction and Paving services. Adj. EBITA declined SEK 6m to SEK -11m in Land &amp;amp; Construction (vs ABGSC at -7m, Q1'25 at -5m) while EBITA was flat in Paving Services at SEK -35m (+2% vs. ABGSCe at -36m). EBITA margin came in at -15.2% (ABGSCe -11.3%) driven by project mix and a colder winter vs. 2025.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;Looking ahead, management is not providing a formal outlook. However, we know the market is tough in some regions. Nevertheless, we consider Infrea's positive internal development in terms of good cash flow and comments about tenter activity to be signs that it is navigating the market well. We expect estimates for '26e-'28e adj. EBITA to come down 5-10%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;A slightly soft report with in a small quarter with sales and adj. EBITA below with our expectations. The share has underperformed the broader market into numbers (L1M) and is trading at 7-5x EBITA '2&lt;font style="background-color:#ffffff;"&gt;6e-'28e. We believe that the market will focus on the continued positive margin development resulting from Infrea's hard internal work.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-cc1c1b95-bb94-4d13-b6bb-7cbf7342788d" name="bm-comp-cc1c1b95-bb94-4d13-b6bb-7cbf7342788d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cc1c1b95-bb94-4d13-b6bb-7cbf7342788d" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-a7d49d32-0d38-45b2-a29b-7fbde468a218" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. expectations&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/infrea/Equity-research/2026/5/infrea---weak-numbers-but-with-positive-signals/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 05 May 2026 07:15:07 GMT</pubDate>
      <isin>SE0010600106</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Embellence Group - Main e-commerce platform upgraded in April</title>
      <description>&lt;a id="bm-comp-de248ec8-50b7-4b41-a6eb-936914ea3698" name="bm-comp-de248ec8-50b7-4b41-a6eb-936914ea3698" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="de248ec8-50b7-4b41-a6eb-936914ea3698" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Net sales SEK 201m, +1% vs ABGSCe&lt;/li&gt;&lt;li&gt;EBITA SEK 28m vs ABGSCe SEK 27m&lt;/li&gt;&lt;li&gt;The share is trading at 7-6x '26e EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7f9183fc-fbe5-4f79-9ea7-171aba71a301" name="bm-comp-7f9183fc-fbe5-4f79-9ea7-171aba71a301" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7f9183fc-fbe5-4f79-9ea7-171aba71a301" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1: In line, transformation weighed on margins&lt;/h3&gt;&lt;p&gt;Overall, we believe Embellence Group's Q1 report is in line with our expectations. Net sales of SEK 201m was +1% vs ABGSCe and corresponded to organic growth of 3%. Growth was driven by the Bor&amp;#229;stapeter, Pappelina and External manufacturing segments, which grew 5%, 18% and 21% respectively. We had expected Bor&amp;#229;stapeter to grow 2%, Pappelina to grow 3% and External manufacturing to grow 20%, for reference. Gross margins were 62.8%, +80bp y-o-y driven partly by a higher share of DTC sales, which coupled with a higher opex ratio owing to initiatives to drive future growth, e.g. the replacement of Cole &amp;amp; Son management, resulted in a 14.0% EBITA margin, -180bp y-o-y. EBITA of SEK 28m was +3% vs ABGSCe SEK 27 and corresponded to y-o-y growth of -13%. Embellence Group's tendency not to adjust for costs that could be considered one-offs (such as management severance costs in Cole &amp;amp; Son) means the -13% y-o-y figure is larger than the underlying development would suggest, but we do not know the magnitude of these costs.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook: Bor&amp;#229;stapeter has been upgraded in April&lt;/h3&gt;&lt;p&gt;In its Q4 report, Embellence Group said that it expects to upgrade the Bor&amp;#229;stapeter platform during H1'26. Bor&amp;#229;stapeter is the largest brand in the Group, which suggests that this could be the most impactful upgrade. In Q1, we get an update about the work, as the CEO says that it went live in the end of April. In the Q4 report, the CEO also noted that recent organisational changes means the Group is now stable enough to resume looking for M&amp;amp;A targets. This sentiment is repeated in the Q1 report in which it also reports leverage of 0.5x ND/EBITDA. It also says that it expects a working capital release of SEK 7m during H2, having tied up the same amount in conjunction with the replacement of a major raw materials supplier.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Ths sha&lt;/h3&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/embellence-group/Equity-research/2026/5/embellence-group---main-e-commerce-platform-upgraded-in-april/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 05 May 2026 06:45:06 GMT</pubDate>
      <isin>SE0013888831</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>OssDsign - Weak gross margin</title>
      <description>&lt;a id="bm-comp-598de07d-0b7b-402f-83cf-46af9d95aaa1" name="bm-comp-598de07d-0b7b-402f-83cf-46af9d95aaa1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="598de07d-0b7b-402f-83cf-46af9d95aaa1" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;In line with pre-announced numbers&lt;/li&gt;&lt;li&gt;Adj. EBIT -2% vs ABGSCe&lt;/li&gt;&lt;li&gt;No change in outlook, cautious near-term&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-0bd090cc-637a-4afa-9708-f5a14b9a018d" name="bm-comp-0bd090cc-637a-4afa-9708-f5a14b9a018d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0bd090cc-637a-4afa-9708-f5a14b9a018d" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;font style="background-color:#ffffff;"&gt;Q1 results&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font style="background-color:#ffffff;"&gt;OssDs&lt;/font&gt;ign pre-announced preliminary Q1 sales and an EBIT range on 10 April. The reported &lt;font style="background-color:#ffffff;"&gt;figures are in line with the preliminary figures with Q1 sales coming in at SEK 36&lt;/font&gt;.9m (0% vs pre-announced SEK 36.9m, 0% ABGSCe SEK 36.9m, no consensus) and adj. EBIT of SEK -13.4m (pre-announced SEK -12 to -14m, -2% vs ABGSCe of -13.1m). The miss on EBIT is mainly attributable to a lower than expected gross margin as sales came in line and opex came in slightly lower. Reported gross margin in Q1 was 91.6% (vs ABGSCe 95.5%). The 'sales and commission and fees' as percentage of sales came in at 47.1%, very close to our forecast (47.0%). The organic sales growth in Q1 amounted to -3.6%, in line with the pre-announced figure. (ABGSCe -3.6%).&lt;/p&gt;&lt;p&gt;Webcast at 11.00 CET today, link: &lt;a data-bm-trackable="false" href="https://qcnl.tv/p/J21zZyaq3hj3uEnQwRNXOg" style="color:#0c6389; text-decoration:none;" target="_blank"&gt;&lt;u&gt;https://qcnl.tv/p/J21zZyaq3hj3uEnQwRNXOg&lt;/u&gt;&lt;/a&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates&lt;/h3&gt;&lt;p&gt;Company is not providing any outlook for 2026 or changing its mid-term financial targets of reaching sales of SEK &amp;gt;400m by 2028 and to become cash flow and EBIT positive in the second half of its 'Strategy Period' (2025-2028). However, management talk about an expected improved commercial momentum in H2'26. We have assumed 0% organic sales growth in Q2'26, up from -3.6% in Q1, and then an acceleration to 10-15% in H2'26. Based on the deviation on adj. EBIT in Q1, we expect FY'26e EBIT to be revised down by mid-single digit.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Share price view&lt;/h3&gt;&lt;p&gt;The stock has been soft into Q1, -10% (-5d), down 30% since pre-announcement (10 April) and down 65% YTD. Based on the small miss on the adj EBIT and cautious near-term outlook, we expect to see a small negative share price reaction today.&lt;/p&gt;&lt;br /&gt;&lt;br /&gt;&lt;table id="bm-img-38cb4b26-98d0-4f96-86e1-f1f6c2c83039" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Q1 deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ossdsign/Equity-research/2026/5/ossdsign---weak-gross-margin/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 05 May 2026 05:45:06 GMT</pubDate>
      <isin>SE0012570448</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Eastnine - Likely to leave Riga in 2027</title>
      <description>&lt;a id="bm-comp-44518c4e-bc37-43a9-9e89-4453b2aa15f5" name="bm-comp-44518c4e-bc37-43a9-9e89-4453b2aa15f5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="44518c4e-bc37-43a9-9e89-4453b2aa15f5" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 earnings capacity +2% q-o-q&lt;/li&gt;&lt;li&gt;Riga divestment impacts estimates negatively short-term...&lt;/li&gt;&lt;li&gt;...but we are confident in the cash being re-invested&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a0adb143-7476-4e34-980e-7d661bc71e2d" name="bm-comp-a0adb143-7476-4e34-980e-7d661bc71e2d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a0adb143-7476-4e34-980e-7d661bc71e2d" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Cold Q1, but improved earnings capacity&lt;/h3&gt;&lt;p&gt;Eastnine delivered a Q1 report with rental income broadly in line with our estimates, while NOI and rec PTP were lower due to an unusually cold Q1. The occupancy rate was basically flat q-o-q (-0.2pp to 95.6%) and net letting was positive. The earnings capacity IFPM increased by 2% sequentially, driven by rental income. We understand that Rockwool is expected to enter new premises in June, adding to Q2 occupancy earnings capacity rental income.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Riga divestment and estimate revisions&lt;/h3&gt;&lt;p&gt;Eastnine has announced that it will sell two of its properties in Riga for ~EUR 38m. Eastnine will obviously pay off debt related to these assets, and will thereafter get ~EUR 12m of liquidity and a ~EUR 6m investment in the fund acquiring the properties (we expect Eastnine to divest this holding). We estimate that this will shave off some ~EUR 2.6m in rental income on an annual basis. Eastnine will still own an 8,800 sqm property in Riga, but with limited earnings given the occupancy rate. We would not be surprised if this also turned out to be divested in 2027, following some refurbishment and letting. In terms of estimate revisions, we now include the divestment, and even though this is expected to drive liquidity, and we know the company aims to re-invest the funds in Poland, we never include template M&amp;amp;A in our estimates. This way, our CEPS revisions look negative, but we expect acquisitions to more than make up for the difference.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Stronger office fundamentals&lt;/h3&gt;&lt;p&gt;Contrary to the Swedish office market, vacancies in Eastnine's markets (especially after leaving Riga) are lower, GDP growth is stronger, and we expect some positive rent reversion in Poland. The share is trading at a 2026e P/CEPS of ~14x, and we see upside potential to estimates, driving earnings growth and lower multiples.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/eastnine/Equity-research/2026/5/eastnine---likely-to-leave-riga-in-2027/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 04 May 2026 05:00:04 GMT</pubDate>
      <isin>SE0002158568</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nolato - Cyclical risk on the rise</title>
      <description>&lt;a id="bm-comp-6ac23d23-4c99-43aa-b0f9-ed461bf804a0" name="bm-comp-6ac23d23-4c99-43aa-b0f9-ed461bf804a0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="6ac23d23-4c99-43aa-b0f9-ed461bf804a0" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Risk of temporary GM pressure from rising oil prices&lt;/li&gt;&lt;li&gt;EBITA lowered by 4% for '26e, 3% for '27e-'28e&lt;/li&gt;&lt;li&gt;Q1e: precious metal headwinds should persist&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-5ec3a652-80bb-4183-829e-123604684884" name="bm-comp-5ec3a652-80bb-4183-829e-123604684884" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5ec3a652-80bb-4183-829e-123604684884" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Risk of temporary GM pressure from rising oil prices&lt;/h3&gt;&lt;p&gt;Rising oil prices (from March) will likely have an impact on Nolato's input costs; material costs were 36% of '25 sales, and management has previously stated that roughly 60% of material costs are linked to oil prices (plastics and silicones). Part of Nolato's business model is to move rising input costs on to customers, but given normal lag effects of ~3-6 months, there could be a risk of temporary gross margin pressure ahead. One big difference compared to the last oil price spike (in 2022) is that the Medical Solutions segment, where end-market demand is less sensitive to pricing, now accounts for 62% of our '26e sales compared to 45% in '22, so we assess that the company is now in a better position to raise prices without too much impact on demand.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;EBITA lowered by 4% for '26e, 3% for '27e-'28e&lt;/h3&gt;&lt;p&gt;Given the aforementioned risk of temporary margin pressure alongside heightened cyclical risk in general, we make some negative revisions to our organic growth and margin estimates. The changes are fairly minor, however, as we consider Nolato to be resilient. Overall, we lower our EBITA estimates by 4% for '26e, followed by 3% for '27e-'28e, of which +1pp per year stems from updated FX assumptions.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Q1e: precious metal headwinds should persist&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;For Q1e, we expect Nolato to report net sales of SEK 2,394m, down 2% y-o-y, and of which +3% is organic growth. We expect EBITA of SEK 262m for a margin of 11.0% (11.0% in Q1'25, 10.4% in Q4'25). It is too early to see any concrete impact from higher oil prices, but rising precious metals prices impacted Nolato's Q4 margins negatively, and given that the price trend has continued into Q1, this margin headwind should persist. Finally, the share is trading at 13x '26e EV/EBITA compared to its historical average fwd. multiple of 15x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nolato/Equity-research/2026/5/nolato---cyclical-risk-on-the-rise/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 03 May 2026 17:30:34 GMT</pubDate>
      <isin>SE0015962477</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Eltel - Impressive given negative seasonality</title>
      <description>&lt;a id="bm-comp-af556112-d830-41f3-bead-2cfbf4ef7519" name="bm-comp-af556112-d830-41f3-bead-2cfbf4ef7519" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="af556112-d830-41f3-bead-2cfbf4ef7519" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Strong growth and continued margin improvement&lt;/li&gt;&lt;li&gt;We raise '26e EBITA by 9%, '27e-'28e by 6% each&lt;/li&gt;&lt;li&gt;9x '26e EV/EBITA, 6-11% '26e-'27e lease-adj. FCF yields&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-e706da83-3d27-40e1-8254-c942152e4948" name="bm-comp-e706da83-3d27-40e1-8254-c942152e4948" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e706da83-3d27-40e1-8254-c942152e4948" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;An impressive showing given negative seasonality&lt;/h3&gt;&lt;p&gt;Eltel reported Q1 net sales of EUR 191m (+7% vs. ABGSCe), up 13% y-o-y, of which +11% was organic growth (ABGSCe +3%). Q1 EBITA was EUR 3.1m (ABGSCe 2.0m) for a margin of 1.6% (ABGSCe 1.2%). The strong organic growth was driven by larger projects in Finland, and as such, we do not see it as replicable in future quarters. Most importantly, though, profitability was impressive given that Q1 is seasonally the weakest quarter for Eltel. The EBITA deviation versus our expectations was driven mainly by Norway, which has long seen weak market conditions. As such, it is good to see that the company's internal efficiency measures in the region are taking effect. Heading into Q2, we model organic growth of +2% and EBITA of EUR 8.2m for a margin of 3.9%, up from 1.2% in Q2'25. We expect continued margin accretion in the coming quarters, driven by an increasing share of new, more profitable end-markets, along with improved commercial terms on contracts in the company's legacy business areas.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We raise '26e EBITA by 9%, and 6% for '27e-'28e&lt;/h3&gt;&lt;p&gt;We raise our top-line estimates, but do not extrapolate the strong organic growth, which was supported by larger projects in the quarter. We also raise margin assumptions, led by Norway, where cost cuts and improving demand suggest the business is past the trough.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;9x '26e EV/EBITA, 6-11% '26e-'27e lease-adj. FCF yields&lt;/h3&gt;&lt;p&gt;We model EBITA margin expansion to 3.6% in '26e, 4.1% in '27e, and 4.6% in '28e, building on what is now an 11-quarter streak of y-o-y margin improvement. On our estimates, the share is now trading at 9x '26e EV/EBITA and offers a 6-11% '26e-'27e lease adj. FCF yield.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/eltel/Equity-research/2026/5/eltel---impressive-given-negative-seasonality/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 03 May 2026 17:30:03 GMT</pubDate>
      <isin>SE0006509949</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Skolon - Expect growth to accelerate</title>
      <description>&lt;a id="bm-comp-fe0d3c36-5629-48c8-bb51-efe45d4eec84" name="bm-comp-fe0d3c36-5629-48c8-bb51-efe45d4eec84" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fe0d3c36-5629-48c8-bb51-efe45d4eec84" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Expect Q2 sales growth of 29%, driven by paying users&lt;/li&gt;&lt;li&gt;Positive gross margin trend is encouraging&lt;/li&gt;&lt;li&gt;'26e EV/Gross profit of ~5x, fair value range of SEK 25-40&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-915d47dd-f375-40d5-82d9-959c12c83a11" name="bm-comp-915d47dd-f375-40d5-82d9-959c12c83a11" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="915d47dd-f375-40d5-82d9-959c12c83a11" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Somewhat lower paying user intake&lt;/h3&gt;&lt;p&gt;While Q1 came in somewhat softer than we expected on the top-line, primarily driven by a slower paying user intake, we take comfort in the continued gross margin expansion. We view this as evidence that the company is tilting towards a more favourable mix. Looking into Q2, we expect Skolon to grow the top-line by 29% y-o-y, driven primarily by a growing paying user base from the international markets, which tend to close deals slightly later than Sweden. This gives us comfort in an accelerating top-line growth from here. Moreover, the NE partnership adds a meaningful growth option for Skolon, as we expect revenues from the deal to start contributing within a few quarters.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Adjusting the base of paying users slightly&lt;/h3&gt;&lt;p&gt;We cut '26e-'28e sales by 5-3%, as we incorporate a slightly lower base of paying users and a slightly lower ARPPU. It is important to remember that businesses such as Skolon tend to experience lumpy user growth, and the outcome of a single quarter should not be fully extrapolated. That said, Skolon's growth is at times contingent on it winning certain large and medium-sized deals, and when such deals are delayed, the revenue base is reset somewhat. On an R12m basis, however, the trend is meaningfully less lumpy, and that is how this business should be evaluated.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Implied valuation&lt;/h3&gt;&lt;p&gt;Based on our revised estimates, the company is trading at '26e-'27e 5-3x EV/Gross profit (GP less capitalised work). Even though the financials may be lumpy from quarter to quarter, the trend is moving in the right direction. The scalability in the business is unchanged, and we believe that the earnings power is significant over a longer time horizon. We revise our fair value range to SEK 25-40 due to our estimate changes.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/company-name/Equity-research/2026/4/skolon---expect-growth-to-accelerate/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 30 Apr 2026 14:00:16 GMT</pubDate>
      <isin>SE0017615784</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Clavister - Norwegian order showing benefits</title>
      <description>&lt;a id="bm-comp-90a6d927-be88-4121-a1be-f18dc9de02b1" name="bm-comp-90a6d927-be88-4121-a1be-f18dc9de02b1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="90a6d927-be88-4121-a1be-f18dc9de02b1" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Defence order lifts Q1e sales to SEK 76m, +42% y-o-y&lt;/li&gt;&lt;li&gt;Entering the new year with stronger financial fundamentals&lt;/li&gt;&lt;li&gt;Expecting an average FCF yield 7% p.a. '26e-'28e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-4a593201-0c8c-4221-895f-1378d2718c68" name="bm-comp-4a593201-0c8c-4221-895f-1378d2718c68" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4a593201-0c8c-4221-895f-1378d2718c68" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong quarter thanks to Norwegian order&lt;/h3&gt;&lt;p&gt;This is the first quarter with the Norwegian order in place, a complete software implementation, resulting in our Q1 estimated sales of SEK 76m, or 42% y-o-y growth. While the defence order boosts the quarter, we think underlying growth will be held back by a soft civilian business. On top of this, we think ~SEK 10m in deliveries that were postponed from Q4'25 will largely land in Q1, although we expect these to carry a lower gross margin. With this, we estimate a Q1 gross margin of 77% and EBITDA of SEK 18m, for a 23% margin. Also worth noting is that we expect net financials to be much lower following the refinancing and removal of the EIB loan.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Some additional costs&lt;/h3&gt;&lt;p&gt;Following a change of analyst, we slightly lower sales estimates for '26, but we increase sales and EBIT for '27e and '28e. The reason for our cut to EBIT for '26e is that we think the company will likely have some additional costs for the Norwegian order. We think this is natural given that the order we estimate as ~26% of group sales for this year. We have previously highlighted the scaling potential, and while this thesis remains intact, we believe growing and gaining market share is the more important priority for Clavister at this stage of its journey.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Exciting times ahead&lt;/h3&gt;&lt;p&gt;Clavister has undergone exciting changes, refinancing its loan, winning a meaningful defence order and gaining market share in the civilian market. Looking ahead, the company now has much stronger finances for growing the business on entirely different terms, and with the growth intact, we estimate an avg. of ~7% FCF yield in our forecast period. The company is trading at EV/EBITDA of 17x/10x/7x for '26e/'27e/'28e, which is ~15% below peers.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/clavister/Equity-research/2026/4/clavister---norwegian-order-showing-benefits/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 21:30:14 GMT</pubDate>
      <isin>SE0005308558</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>OssDsign - No drama expected</title>
      <description>&lt;a id="bm-comp-db5930bb-7b9c-4bbe-987d-202b8418f2d3" name="bm-comp-db5930bb-7b9c-4bbe-987d-202b8418f2d3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="db5930bb-7b9c-4bbe-987d-202b8418f2d3" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Has already pre-announced sales and EBIT for Q1&lt;/li&gt;&lt;li&gt;We assume a recovery in sales growth in H2'26e&lt;/li&gt;&lt;li&gt;Q1'26 resu&lt;font style="background-color:#ffffff;"&gt;lts due 5 May&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-078fcfaf-9edb-4816-9016-390213532f51" name="bm-comp-078fcfaf-9edb-4816-9016-390213532f51" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="078fcfaf-9edb-4816-9016-390213532f51" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1'26 expectations&lt;/h3&gt;&lt;p&gt;OssDsign pre-announced preliminary Q1 sales of SEK 36.9m and an expected EBIT range of SEK -12m to -14m for Q1 on 10 April (see &lt;a data-bm-trackable="false" href="https://abg-portal.bluematrix.com/report/9f3fa0c0-3cbf-48b7-9e3e-892f6fc94a1a" target="_blank"&gt;Declining sales in Q1&lt;/a&gt;), removing much of the uncertainty ahead of the full Q1 release on 5 May. Q1 sales of SEK 36.9m implies an organic decline of 3.6%, or -17.1% in SEK. We have revised our forecast to reflect Q1 sales of SEK 36.9m and EBIT of SEK -13.1m, in the middle of the pre-announced EBIT range, with a gross margin of 95.5% and opex of SEK 48.3m. Management have stated that they have remedied the execution shortcomings that resulted in the weak sales in Q1, and have hired new sales people in the US. We have assumed sales growth to gradually improve over the coming quarters, but from a lower base.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;Ahead of Q1, we cut our sales forecasts by 17-19% for '26e-'28e on the back of the weak sales performance in Q1. We have cut our organic sales growth forecast for '26 to +5.3% from 30%, assuming flat organic growth in Q2'26e and a recovery back to growth in H2'26e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range down to SEK 4.0-6.2 (7-14)&lt;/h3&gt;&lt;p&gt;We cut our fair value range, based on our updated forecasts, to SEK 4.0-6.2 (7-14) ahead of the Q1 results. Our fair value range is derived from a DCF model, applying a terminal growth rate of 3% and a WACC of 10%. While near-term sales and earnings remain soft, impacted by a lack of sales channel expansion and turnover of certain sales reps, we continue to see meaningful long-term potential, supported by improved adoption of Catalyst in the US, high gross margins, and increasing operating leverage as the sales base scales. We expect the share price performance to remain muted until the company shows clear signs of improvements in the ramp-up of sales after three quarters of relatively flat sales before the disappointing decline in Q1.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ossdsign/Equity-research/2026/4/ossdsign---no-drama-expected/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 19:15:14 GMT</pubDate>
      <isin>SE0012570448</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>StrongPoint - The story remains the same</title>
      <description>&lt;a id="bm-comp-6af645b7-8bd1-4258-974a-31b4a3828b03" name="bm-comp-6af645b7-8bd1-4258-974a-31b4a3828b03" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="6af645b7-8bd1-4258-974a-31b4a3828b03" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q1 surprised on gross margin: 45% vs. our 42%&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Pricer transition a temporary drag, offset by Vusion momentum&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range of NOK 8-18 per share&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-395b9bf2-7363-4091-a1c0-8c630d0e159f" name="bm-comp-395b9bf2-7363-4091-a1c0-8c630d0e159f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="395b9bf2-7363-4091-a1c0-8c630d0e159f" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Strong gross margin and a decent quarter&lt;/h3&gt;&lt;p&gt;Q1'26 delivered revenues of NOK 342m, below our NOK 356m estimate, with strong growth in UK &amp;amp; Ireland (+93%) and Spain (+13%) offset by weakness in Norway and Sweden. The gross margin came in at 45% vs. our 42% assumption, yielding gross profit ~3% above our estimate despite the softer top line. Clean opex was ~1% better than our forecast. This brought EBITDA to NOK 10m vs. our NOK 4m estimate, with the margin landing at 2.9%&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Pricer transition temporary drag, offset by Vusion momentum&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;The phase-out of Pricer-related recurring revenue will remain a headwind through 2026, with the rolling 12-month ESL licence and service base declining from NOK 52m at end-2025 to zero by end-2026; a NOK 10m hit already visible in Q1. The offset is coming, but is taking time. UK &amp;amp; Ireland grew 93% in Q1, driven by Vusion ESL installation work alongside AutoStore, and the gross margin expanded from 42% to 45% as lower-margin ESL hardware rollouts gave way to higher-value service revenue. Management remains positive on the Vusion partnership as it offers a broader platform opportunity with products such as EdgeSense, shelf-edge cameras and retail media.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of NOK 8-18 per share&lt;/h3&gt;&lt;p&gt;Q1 was not a step-change quarter, but it was a stable one, with flattish revenue and EBITDA in line with last year. The pipeline is building, with Iceland Foods, NorgesGruppen and three new AutoStore contracts all signed in the quarter. The path to sustained profitability will have ups and downs, as the CEO acknowledged, and the Sainsbury's rollout moving slower than expected is a reminder that large projects carry execution risk. That said, things seem to be moving in the right direction for StrongPoint. Our DCF indicates an equity value of ~NOK 650m, and we see a fair value range of NOK 8-18 per share.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/StrongPoint/Equity-research/2026/4/strongpoint---the-story-remains-the-same/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 17:15:13 GMT</pubDate>
      <isin>NO0010098247</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Donkey Republic - Ready to pedal in the high season</title>
      <description>&lt;a id="bm-comp-088b08b7-38ae-4bcd-a095-8a91908dba74" name="bm-comp-088b08b7-38ae-4bcd-a095-8a91908dba74" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="088b08b7-38ae-4bcd-a095-8a91908dba74" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Strong profitability in weather-harsh Q1&lt;/li&gt;&lt;li&gt;German roll-outs on track; we remain in upper end of guidance&lt;/li&gt;&lt;li&gt;FVR raised to DKK 7.5-11.0 (7.0-10.0)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-966825e7-8f93-450d-a66b-6d79d0bc47d2" name="bm-comp-966825e7-8f93-450d-a66b-6d79d0bc47d2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="966825e7-8f93-450d-a66b-6d79d0bc47d2" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Solid Q1 performance despite weather hit&lt;/h3&gt;&lt;p&gt;DONKEY delivered solid +10% revenue growth in Q1'26, driven by +10% fleet growth and a modest +1% improvement in revenue/bike. Despite a harsh weather impact in January and February, albeit normalising in March, the company delivered a strong improvement in profitability, with the EBITDA loss reducing to DKK -1.2m (from DKK -6.3m in Q1'25) on cost-saving initiatives carried out in Q3 and Q4'25.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;'26e/'27e/'28e EBITDA raised by 4%/2%/2%&lt;/h3&gt;&lt;p&gt;We extrapolate the stronger-than-expected profitability in Q1, raising '26e/'27e/'28e EBITDA by 4%/2%/2%. At the beginning of April, DONKEY started, in line with initial plans, the roll-out to the Ruhr region, and early indicators suggest the D&amp;#252;sseldorf roll-out is also tracking well. This leaves us expecting FY'26 figures in the upper end of guidance, forecasting revenues of DKK 191m (guidance DKK 179m-194m), EBITDA of DKK 42m (guidance 34m-45m) and EBIT of DKK 8m (guidance DKK 1m-9m).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;FVR of DKK raised to DKK 7.5-11.0 (7.0-10.0)&lt;/h3&gt;&lt;p&gt;Europe's bike-sharing fleet, part of the broader shared micromobility market, is projected to grow at a +15% CAGR until '30e, and we see DONKEY's competitive edge centred around its high-quality fleet (especially after the roll-out of its Gen4 bike), its lower prices (price/cost is 50% of scoring in EU tenders), and stronger relations with the cities it serves, coupled with solid positions in the Tier 2 and Tier 3 segments. Considering market tailwinds and DONKEY's pipeline and commercial momentum, including two recent large-scale wins in Germany, we forecast a revenue CAGR of +20% in '25-'28e (vs. +35% in '18-'25). With improving operating leverage, we model adj. EBITDA increasing from DKK 30m in '25 to DKK 85m in '28e and adj. EBIT reaching DKK 40m. We raise our fair value range to DKK 7.5-11.0/share (7.0-10.0).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/donkey-republic/Equity-research/2026/4/donkey-republic---ready-to-pedal-in-the-high-season/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 17:00:14 GMT</pubDate>
      <isin>DK0061540770</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Medicover - Stronger than the weather</title>
      <description>&lt;a id="bm-comp-56b1978b-cd50-45b1-9113-e07ed4ffeb49" name="bm-comp-56b1978b-cd50-45b1-9113-e07ed4ffeb49" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="56b1978b-cd50-45b1-9113-e07ed4ffeb49" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Strong Q1 beat with 110bps margin expansion on adj. EBITDA&lt;/li&gt;&lt;li&gt;Adj. EBITDA up 1% for '26e-'28e on Q1 beat&lt;/li&gt;&lt;li&gt;FVR unchanged at SEK 190-270 on minor estimate revisions&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1b5d0383-8e4c-48d9-914e-695cd391cfcb" name="bm-comp-1b5d0383-8e4c-48d9-914e-695cd391cfcb" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1b5d0383-8e4c-48d9-914e-695cd391cfcb" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;A solid start to '26 despite weather drag&lt;/h3&gt;&lt;p&gt;Q1 was 8%/6% above ABGSCe/Infront consensus, with sales of EUR 624m, adj. EBITDA of EUR 105m and a margin of 16.8% (up 110bps y-o-y). Management quantified the weather drag at a few pp on growth, less than feared, with January and February most affected before normalisation in March. The ability to protect and expand margins despite the volume drop in the first two months underlines the resilience of the model. HS posted organic growth of 12% and an EBITDAaL margin of 11.3% (9.9% Q1'25), driven by Polish sports/wellness and the Indian and Romanian hospitals, with India revenue up 34% (local currency) on the opening of the new Hyderabad hospital. DS delivered organic growth of 7% and an EBITDAaL margin of 16.7% (15.7%), with continued German FFS momentum and SYNLAB supporting the mix despite weather and Ukraine power outages. The slightly soft OCF was flagged as timing-related and is expected to normalise in Q2. Leverage declined to 2.9x (R12).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We raise '26e-'28e adj. EBITDA by 1% on the Q1 beat, while sales are broadly unchanged. Management noted that around half of the margin improvement over the last quarter relates to the previous acquisitions and that margin tailwinds from prior acquisitions will moderate going forward. Against that backdrop, we find our adj. EBITDA margin improvements of ~40/20/50bps for Q2/Q3/Q4'26e to be reasonable. The 2028 targets (sales &amp;gt;EUR 3.25bn, adj. EBITDA &amp;gt;EUR 600m) appear within reach.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;FVR unchanged at SEK 190-270&lt;/h3&gt;&lt;p&gt;We leave our FVR at SEK 190-270 on the minor estimate revisions. We derive our range from the multiples of two peer groups, one with healthcare providers in developing countries and one in developed countries, alongside a DCF. The range corresponds to a '26e EV/EBITDA of 9x-12x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/medicover/Equity-research/2026/4/medicover---stronger-than-the-weather/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 15:45:51 GMT</pubDate>
      <isin>SE0009778848</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>SinterCast - A turning point</title>
      <description>&lt;a id="bm-comp-31b67c73-67d2-4b44-b72c-fe129c1b2e2b" name="bm-comp-31b67c73-67d2-4b44-b72c-fe129c1b2e2b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="31b67c73-67d2-4b44-b72c-fe129c1b2e2b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 exceeded our expectations, but limited estimate revisions&lt;/li&gt;&lt;li&gt;Confirms that Q4 was likely the series production trough&lt;/li&gt;&lt;li&gt;Programme ramp-up and stabilising market support recovery&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-46381bc4-bac5-4784-9c2b-db4d8d397cf1" name="bm-comp-46381bc4-bac5-4784-9c2b-db4d8d397cf1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="46381bc4-bac5-4784-9c2b-db4d8d397cf1" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;SinterCast delivered a reassuring Q1 as Engine Equivalent production returned to y-o-y growth for the first time in 15 months in March, driving quarterly EEs to 3.0m (3.1m), above our 2.8m. This in turn drove sales of SEK 25m, down 8% y-o-y but 8% above our estimate, which, coupled with less unfavourable FX hedge revaluations than we expected, enabled the EBIT margin to reach 25% (37%), 7pp above our estimate.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;While Q1 exceeded our expectations, we had already pencilled in a fairly substantial Engine Equivalent production recovery throughout the year, supported by ramp-up of new production programmes and a stabilising automotive market, and we therefore only make limited revisions to our estimates, raising adj. EBIT by 4%/1%/1% in '26e/'27e/'28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;We believe Q1 marks a turning point for series production after the Q4 trough, which is in line with the company's guidance. Longer-term, the company reiterated its target of reaching the 8m Engine Equivalent milestone in '31, supported by four commercial vehicle programmes scheduled to start production in '26-'27 and '30, and specified that this should result in revenues well in excess of SEK 200m. While the long lead times of these types of programmes give the company good visibility on future volumes, they do come with significant timing uncertainty, which is why we, for now, keep a somewhat more conservative expectation of around SEK 200m in sales by '31. Meanwhile, we believe the company's case that the internal combustion engine will still dominate SinterCast's end markets by 2050 is gaining traction as several OEMs have scaled back their electrification plans and investments over the past year. The share is now trading at 21x-14x '26e-'28e P/E, vs. its historical median of 22x-15x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/sintercast/Equity-research/2026/4/sintercast---a-turning-point/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 15:45:13 GMT</pubDate>
      <isin>SE0000950982</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Byggmästaren - Private momentum tempered by lower P/NAV</title>
      <description>&lt;a id="bm-comp-24ec140f-334a-443b-9622-1c05fdd18594" name="bm-comp-24ec140f-334a-443b-9622-1c05fdd18594" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="24ec140f-334a-443b-9622-1c05fdd18594" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 NAV beat&lt;/li&gt;&lt;li&gt;Strong performance, higher valuations in private assets&lt;/li&gt;&lt;li&gt;P/NAV dislocation persists, well below historical levels&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1d8c3489-06f2-4b6b-b1ce-fee8cc801543" name="bm-comp-1d8c3489-06f2-4b6b-b1ce-fee8cc801543" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1d8c3489-06f2-4b6b-b1ce-fee8cc801543" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1: NAV outperformance, discount widened sharply&lt;/h3&gt;&lt;p&gt;Byggm&amp;#228;staren reported Q1 NAVPS of SEK 67.58, 4% above our estimate. NAV increased by 2% q-o-q (SIXRX -1%), supported by valuation gains in private assets. Green Landscaping weighed on NAV (and is down further following its Q1 report), while Infrea continued to perform well. Despite this, total shareholder return was -14%, as the NAV discount broadened from 8% to 22%, highlighting continued market scepticism. During the quarter, Byggm&amp;#228;staren acquired the remaining shares in Fasticon, taking ownership to 100%. The balance sheet remains strong, with SEK 465m in available liquidity, and management reiterates its ambition to add another core unlisted holding.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;DPP stood out with stellar quarter&lt;/h3&gt;&lt;p&gt;Performance in the private portfolio was highly encouraging. DP Patterning (DPP) delivered an exceptional quarter, with sales of SEK 51m (vs. SEK 8m in Q1&amp;#8217;25) and an EBITDA margin of 26%, driven by a large international customer, resulting in a SEK 51m valuation uplift. We see significant long-term potential in this asset. Safe Life continued to show strong growth and completed three acquisitions during the quarter. Fasticon improved margins y-o-y despite a challenging market and secured a multi-year agreement with a major customer. Team Olivia delivered a solid development, and we continue to see scope for future distributions. In total, private asset valuations increased by SEK 46m, largely driven by DPP.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Discount at 21% vs. 9% historical average&lt;/h3&gt;&lt;p&gt;The shares trade at a 21% NAV discount &amp;#8211; compared to a five-year average of 9% &amp;#8211; despite the strong underlying performance and track record. We update our fair value range to SEK 53&amp;#8211;64 (56&amp;#8211;67), reflecting NAV changes since our last update.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/byggmastaren/Equity-research/2026/4/byggmastaren---private-momentum-tempered-by-lower-pnav/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 13:15:14 GMT</pubDate>
      <isin>SE0006510491</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Impact Coatings - Quiet Q1, system order lifts outlook</title>
      <description>&lt;a id="bm-comp-98e98ad1-9fa7-4e86-9889-5a46c6e4ca20" name="bm-comp-98e98ad1-9fa7-4e86-9889-5a46c6e4ca20" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="98e98ad1-9fa7-4e86-9889-5a46c6e4ca20" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 sales SEK 13m, adj. EBIT SEK -16m (vs. ABGSCe 8m &amp;amp; -12m)&lt;/li&gt;&lt;li&gt;Softer quarter; no machine deliveries &amp;amp; delayed orders in Services&lt;/li&gt;&lt;li&gt;HJWAVE order post-Q1 (~EUR 1.5m); Lindberg LOI still in pipeline&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1fb64e5e-16ed-4506-ab82-b9a45f936fa5" name="bm-comp-1fb64e5e-16ed-4506-ab82-b9a45f936fa5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1fb64e5e-16ed-4506-ab82-b9a45f936fa5" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Q1 sales were SEK 13m (vs. ABGSCe 8m), boosted by a positive one-off of SEK 4.8m associated with the sale of metals from Impact's inventory. Adjusted for this, sales were in line with our estimate of SEK 8m. However, adj. EBIT was lower at SEK -16m (vs. ABGSCe -12m). Q1 was a softer quarter due to the absence of machine deliveries alongside delayed activity in Coating Services. Management clarified in the earnings call that the delay in Coating Services was customer-specific and driven by supply chain timing rather than weaker underlying demand. IC ended Q1 with a cash position of SEK 18m vs. the R12m lease adj. FCF of SEK -56m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;We lower '26e sales by -2% and raise 28e by 2%. Moreover, we lower total '26e-'28e adj. EBIT by SEK 11m. We acknowledge the IC500 order from HJWAVE after the quarter (~EUR 1.5m), with delivery scheduled for Q3'26, which de-risks our '26e. However, we had previously modelled an IC2000 order at a somewhat higher price tag. We continue to estimate two machine deliveries for '26e. Due to market uncertainty, however, we stress downside risk to estimates. Looking ahead, management flagged the Lindberg LOI from Dec '25 as still in the pipeline, which we expect to convert to an order during '26e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;China's new hydrogen push positive for IC&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;We expect the newly launched Chinese hydrogen pilot programme to support investment appetite in the Chinese market. Management noted a clear pickup in customer dialogue since the announcement in March, though not yet in production volumes. On SOFC, progress continues via the Ceres collaboration, which provides access to Ceres' publicly disclosed licensees, although the timing of the first system order remains uncertain. The company is currently trading at 2.2x-1.8x '26e-'28e EV/sales vs. &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/impact_coatings/Equity-research/2026/4/impact-coatings---quiet-q1-system-order-lifts-outlook/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 10:45:12 GMT</pubDate>
      <isin>SE0001279142</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Donkey Republic - Solid start to the year despite harsh weather</title>
      <description>&lt;a id="bm-comp-3f6ac524-d2ba-4436-9bff-4c8d405e6df9" name="bm-comp-3f6ac524-d2ba-4436-9bff-4c8d405e6df9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3f6ac524-d2ba-4436-9bff-4c8d405e6df9" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 EBITDA of DKK -1.2m above ABG DKK -3.2m&lt;/li&gt;&lt;li&gt;FY'26 guidance unchanged&lt;/li&gt;&lt;li&gt;Expect mid-single-digit positive consensus EBITDA revisions&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-b399c29a-7d07-442c-ab85-541f7717bed1" name="bm-comp-b399c29a-7d07-442c-ab85-541f7717bed1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b399c29a-7d07-442c-ab85-541f7717bed1" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 numbers vs. ABGSCe&lt;/h3&gt;&lt;p&gt;DONKEY reported a strong Q1, delivering +10% y-o-y growth and reporting revenues of DKK 29.0m (0% vs. ABGSCe DKK 28.9m). Revenue/bike was DKK 413, +1% y-o-y (ABGSCe DKK 407), while the fleet grew to 23.4k bikes (ABGSCe 23.7k). Q1 EBITDA of DKK -1.2m came in better than ABGSCe at DKK -3.2m. The company experienced harsh weather conditions in key Nordic cities, but we note that activity levels normalised towards the end of the quarter (with March performing in line with expectations). The positive development in EBITDA is primarily driven by full implementation of cost-saving initiatives following the reorganisation carried out in Q3&amp;#8217;25 and Q4&amp;#8217;25.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;FY'26 guidance and outlook&lt;/h3&gt;&lt;p&gt;DONKEY reiterates its FY'26 guidance of revenues DKK 179m-194m (ABGSCe 192m), EBITDA of DKK 34-45m (ABGSCe 40m), EBIT DKK 1-9m (ABGSCe 7m). The company's pipeline appears unchanged compared to the Q4'25 report. We get the impression that the roll-outs in D&amp;#252;sseldorf and the Ruhr Region are progressing well and in line with the company's expectations.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Consensus estimate revisions and share price reaction&lt;/h3&gt;&lt;p&gt;Q1 is a small quarter, but we still expect consensus to make mid-single-digit positive EBITDA revisions for FY'26e.&lt;/p&gt;&lt;table id="bm-img-b5a60386-ca53-4e8d-baab-54cead0ab7d6" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;ABGSCe vs. FY'26 guidance&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table id="bm-img-2088ad48-a245-4906-a8c9-29ae63903f81" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/donkey-republic/Equity-research/2026/4/donkey-republic---solid-start-to-the-year-despite-harsh-weather/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 09:00:13 GMT</pubDate>
      <isin>DK0061540770</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>CTT Systems - Remain seated for another quarter</title>
      <description>&lt;a id="bm-comp-2f498c4d-27b4-4946-a009-36987e984722" name="bm-comp-2f498c4d-27b4-4946-a009-36987e984722" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2f498c4d-27b4-4946-a009-36987e984722" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;2026 now also clouded by uncertainty&lt;/li&gt;&lt;li&gt;'26e-'27e EBIT down 12-4%; ~60% EBIT CAGR '25-'28e&lt;/li&gt;&lt;li&gt;20-11x EBIT '26e-'27e, ~25-40% ROCE, net cash&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-fed0cb9b-83e8-4fe7-8b6f-13710050a5cf" name="bm-comp-fed0cb9b-83e8-4fe7-8b6f-13710050a5cf" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fed0cb9b-83e8-4fe7-8b6f-13710050a5cf" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Better OEM activity, uncertain flight traffic&lt;/h3&gt;&lt;p&gt;2026 started well for CTT, with 41% organic growth (ABGSCe +29%), sequential growth in both OEM and aftermarket (AM) sales, and normalised inventories among distributors. Key drivers for CTT are the increase in aircraft production rates and higher content per aircraft. Both of these factors are now materialising, which should drive &amp;gt;70% organic growth y-o-y in OEM sales for the upcoming quarters, and ~55% growth FY'26. However, flight cancellations due to the Middle Eastern conflict will likely hurt AM sales . Global traffic remained stable y-o-y in April, and CTT's products are mainly on the most fuel efficient and profitable (long-haul) aircraft, but CTT still views this as a risk, which is why we forecast declining earnings again in Q2, before a return to &amp;gt;40% growth from Q3. Our view for 2027-2028 remains largely intact on the back of 1) higher production rates, 2) increased penetration and 3) growth in the installed base.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Return to earnings growth in Q3'26e&lt;/h3&gt;&lt;p&gt;We lower '26e EBIT by 12% to factor in an AM business that is affected by flight cancellations, and a slower OEM ramp-up. Our '27e EBIT is down only 4% though, as we believe the visibility from increased production rates, a rebound in air travel and postponed VIP sales should still support solid earnings. This should in turn drive a ~35% organic sales CAGR and a ~60% EBIT CAGR in '25-'28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Multi-year double-digit growth potential&lt;/h3&gt;&lt;p&gt;Despite seeing tougher headwinds than we had previously anticipated, CTT's core strengths remain: the company benefits from a near-monopolistic position, strong demand, and its margin-accretive AM business. This should drive long-term double-digit earnings growth, while the share is now trading at 20-11x EBIT '26e-'27e (23x L10Y), offering 3-6% dividend yields and ~25-40% ROCE.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ctt-systems/Equity-research/2026/4/ctt-systems---remain-seated-for-another-quarter/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 08:00:12 GMT</pubDate>
      <isin>SE0000418923</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Skolon - A little bit below expectations</title>
      <description>&lt;a id="bm-comp-79689b5b-bd3a-4160-966e-0bfbc08acaba" name="bm-comp-79689b5b-bd3a-4160-966e-0bfbc08acaba" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="79689b5b-bd3a-4160-966e-0bfbc08acaba" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 sales 11% lower than ABGSCe SEK 43m&lt;/li&gt;&lt;li&gt;Improved gross profit, likely due to favourable mix&lt;/li&gt;&lt;li&gt;Likely modestly negative consensus estimate revisions&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-79201a2e-2d31-46d1-b8ea-f491801a2de1" name="bm-comp-79201a2e-2d31-46d1-b8ea-f491801a2de1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="79201a2e-2d31-46d1-b8ea-f491801a2de1" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1'26 report&lt;/h3&gt;&lt;p&gt;Skolon reported net sales of SEK 38m (-11% vs ABGSCe 43m), corresponding to a 19% y-o-y organic growth (-16pp vs ABGSCe 35%). However, the gross margin increased slightly to 36%, in line with our expectations and likely driven by a more favourable mix. ARPPU was SEK 196, which was in line with what we expected. The number of paying users, however, was 1,038k, slightly below our expectation of 1,061k.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Thoughts and outlook&lt;/h3&gt;&lt;p&gt;Q1 is usually the smallest quarter with lower activity but Skolon continues to increase its gross margin and the ARPPU, which we see as strong signs of the underlying business. Worth noting is that EBITDA turned slightly positive in the quarter, compared to last year's period. Sweden remains the main contributor for Skolon and continues to drive profitability, while international markets are still in an investment phase. Interestingly, the company announced its partnership with NE, a leading content provider on the Swedish market, which we see a meaningful addition to the platform.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Consensus estimate revisions and valuation&lt;/h3&gt;&lt;p&gt;The share is down roughly 30% YTD and is trading at 5-4x '26e-'27e EV/Gross profit on our unrevised estimates. Following the report, we believe that consensus could lower sales estimates by mid single-digits.&lt;/p&gt;&lt;table id="bm-img-81169632-d059-4a0e-9384-3d99faebcd5e" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/company-name/Equity-research/2026/4/skolon---a-little-bit-below-expectations/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 07:00:58 GMT</pubDate>
      <isin>SE0017615784</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Impact Coatings - Soft Q1 due to absence of machine deliveries</title>
      <description>&lt;a id="bm-comp-5304f63a-0c70-469e-ad18-ea021c8596d6" name="bm-comp-5304f63a-0c70-469e-ad18-ea021c8596d6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5304f63a-0c70-469e-ad18-ea021c8596d6" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales SEK 12.7m (vs. ABGSCe 7.8m), positive one-off effect of 4.8m&lt;/li&gt;&lt;li&gt;Adj. EBIT SEK -16m (vs. ABGSCe -12m)&lt;/li&gt;&lt;li&gt;Machine order (IC500) placed after Q1, order value ~EUR 1.5m&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-034ea18c-dabc-4984-a167-d7d7619948e4" name="bm-comp-034ea18c-dabc-4984-a167-d7d7619948e4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="034ea18c-dabc-4984-a167-d7d7619948e4" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Sales came in at SEK 12.7m (vs. ABGSCe 7.8m), with no machines delivered in the quarter (in line with estimates). Q1 included a positive one-off of SEK 4.8m from the sale of metals from Impact's inventory to accelerate the transition to a new metal management agreement. Adjusted for this, sales were SEK 7.9m (in line with ABGSCe SEK 7.8m). However, adj. EBIT was lower at SEK -16m (vs. ABGSCe -12m). FCF was SEK -14m (vs. ABGSCe -10m) and the company ended the quarter with a cash balance of SEK 18.3m (26.3m LY). Management writes that the quarter was temporarily affected by Chinese New Year, which reduced activity. Moreover, Coating Services experienced some delay during the quarter, which impacted net sales in the segment.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates and outlook&lt;/h3&gt;&lt;p&gt;On numbers alone, '26e-'28e sales change by +5% and adj. EBIT changes by SEK -4m. After the quarter, Impact received an order for an INLINECOATER IC500 from HJWAVE (Korean vehicle radar antennas), valued at ~EUR 1.5m with delivery scheduled for Q3'26. Discussions with LINDBERG in the luxury segment also remain active. Within energy, Q1 saw continued test orders in electrolysis and fuel cell applications, and after the quarter two larger customers within SOFC and PEM electrolysis placed test orders.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;The share has returned +41% L3M (vs. peer median +8% and OMX Stockholm Allshare +1%), and is currently trading at 2.1x-2.0x '26e-'28e EV/Sales on our pre-report estimates vs. the peer median of 2.0x-0.8x. The company will be hosting a presentation in connection with its Q1 report at 09:00 CEST. Link &lt;a data-bm-trackable="false" href="https://www.finwire.tv/webcast/impact-coatings/q1-2026/" target="_blank"&gt;here&lt;/a&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-fdce18a2-e821-418e-9720-a2adaf692ab1" name="bm-comp-fdce18a2-e821-418e-9720-a2adaf692ab1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fdce18a2-e821-418e-9720-a2adaf692ab1" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-66cc0d19-b704-4eab-a2dc-034f6a63eec9" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/impact_coatings/Equity-research/2026/4/impact-coatings---soft-q1-due-to-absence-of-machine-deliveries/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 06:46:00 GMT</pubDate>
      <isin>SE0001279142</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>SinterCast - Production returning to growth</title>
      <description>&lt;a id="bm-comp-ac5207fe-5e36-49f4-b7df-b83e2afec7da" name="bm-comp-ac5207fe-5e36-49f4-b7df-b83e2afec7da" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ac5207fe-5e36-49f4-b7df-b83e2afec7da" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;EEs +7%, sales +8%, adj. EBIT +53% vs. ABGSCe&lt;/li&gt;&lt;li&gt;Stronger EBIT driven by series production and milder FX&lt;/li&gt;&lt;li&gt;March marked first y-o-y production increase in 15 months&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-0baeb849-2252-4979-89ac-84721fdd57c5" name="bm-comp-0baeb849-2252-4979-89ac-84721fdd57c5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0baeb849-2252-4979-89ac-84721fdd57c5" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Sales fell 7% y-o-y but were 8% above our estimate. Annualised engine equivalents produced were 3.0m, falling 3% y-o-y, and were thereby 7% above our estimate. Importantly, March marked the first y-o-y production increase in 15 months. Sampling cups sold increased 2% y-o-y, and were 9% above our estimate. With a margin of 25.2%, 7.3pp above our estimate, EBIT adj. was 53% above our estimate, driven by the higher than expected series production revenues and a milder negative FX hedge revaluation effect than we had forecast.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;The Q1 numbers in isolation imply EBIT adj. comes up 5%. The return to production growth in March lends welcome support to the company's outlook for recovery and growth this year. The company continues to view upcoming new production programmes favourably, reiterating its ambition for 8m EEs in '31, and specifying that this should correspond to revenue well in excess of SEK 200m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Company valuation&lt;/h3&gt;&lt;p&gt;Over the past three months, the share has returned -4%, compared to the +1% of the OMX Stockholm Allshare. The share is currently trading at 20x-13x '26e-'28e P/E, compared to its 10-year historical median of 22x-15x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7de2ad7a-9a8d-47a6-9cf2-a30e90fa375f" name="bm-comp-7de2ad7a-9a8d-47a6-9cf2-a30e90fa375f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7de2ad7a-9a8d-47a6-9cf2-a30e90fa375f" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-e810cf68-5866-4103-81af-fcca51120364" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. estimates Q1'26&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/sintercast/Equity-research/2026/4/sintercast---production-returning-to-growth/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 06:45:09 GMT</pubDate>
      <isin>SE0000950982</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Medicover - Model proves itself in Q1</title>
      <description>&lt;a id="bm-comp-8434937d-0e77-44a6-b99c-dcfd06a6e653" name="bm-comp-8434937d-0e77-44a6-b99c-dcfd06a6e653" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8434937d-0e77-44a6-b99c-dcfd06a6e653" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;8%/6% adj. EBITDA vs ABGSCe/Infront cons in Q1&lt;/li&gt;&lt;li&gt;Cons estimates likely up 1-3% on adj. EBITDA '26e&lt;/li&gt;&lt;li&gt;Model proved itself despite the weather headwind we flagged&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ab15aab0-90ef-4b3b-8064-342cfa4a2266" name="bm-comp-ab15aab0-90ef-4b3b-8064-342cfa4a2266" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ab15aab0-90ef-4b3b-8064-342cfa4a2266" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Medicover reported a strong start to '26 with sales in-line vs cons and a clear beat on adj. EBITDA vs cons (8%/6% vs. ABGSCe/Infront cons). Q1 sales came in at EUR 624m (3% vs ABGSCe, 0% vs cons). Total organic sales growth in the quarter was +10% (ABGSCe +7%). Adj. EBITDA was 105m (8% vs. ABGSCe, 6% vs. cons), for a margin of 16.8% (ABGSCe 16.0%, cons 15.9%), up 110bps y-o-y. Total NRI in Q1 was EUR -3m (ABGSCe EUR -4m, cons EUR -4m). HS delivers a strong result, with organic growth of 12% driven by Polish sports/wellness and supported by the Indian and Romanian hospitals, lifting the EBITDA margin to 17.2% (15.6% Q1'25). The company highlights that India shows strong double-digit growth, with local currency revenue up 34%, supported by a new hospital opening in Hyderabad during the quarter. DS looks solid, with organic growth of 7% and an EBITDA margin of 20.8% (19.7% Q1'25), supported by continued German FFS momentum and the SYNLAB acquisition, despite weather headwinds in key markets. Overall, a strong report with margin expansion across both segments, demonstrating that the model continues to prove itself despite the weather drag we flagged ahead of Q1.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Outlook and estimate changes&lt;/h3&gt;&lt;p style="text-align:left;"&gt;Management does not provide a specific outlook for 2026. Going forward, the company highlights confidence in continuing the trends of organic growth, margin expansion and good operating cash flow as it works towards its mid-term targets, supported by improving capacity utilisation, pricing and cost management. Based on the Q1 deviation, consensus FY'26 estimates are likely to be revised up by 1-3% on adj. EBITDA.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Share view&lt;/h3&gt;&lt;p&gt;The stock has been down 4% into the report, and we expect it to trade up 3-5% today given the beat and strength in India. Conference call at 09.30 CET today. Link for audiocast: &lt;font color="#201F1E"&gt;&lt;a data-bm-trackable="false" href="https://medicover.events.inderes.com/q1-report-2026/register" target="_blank"&gt;&lt;/a&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/medicover/Equity-research/2026/4/medicover---model-proves-itself-in-q1/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 06:15:08 GMT</pubDate>
      <isin>SE0009778848</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>StrongPoint - EBITDA beat on stronger gross margin</title>
      <description>&lt;a id="bm-comp-6ecfbccd-67df-4de1-91b6-9197414418fb" name="bm-comp-6ecfbccd-67df-4de1-91b6-9197414418fb" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="6ecfbccd-67df-4de1-91b6-9197414418fb" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q1 EBITDA NOK 10m vs ABGSCe NOK 4m&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Pricer transition temporary drag, offset by Vusion momentum&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Stronger gross margin to lift estimates somewhat&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-e3b3c528-124f-432c-900d-0a1b871bc824" name="bm-comp-e3b3c528-124f-432c-900d-0a1b871bc824" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e3b3c528-124f-432c-900d-0a1b871bc824" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;Q1: EBITDA of NOK 10m vs ABGSCe NOK 4m&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Sales were mostly flattish y-o-y, driven by strong growth in the UK &amp;amp; Ireland and Span, which grew 93% and 13%, respectivley. Other markets were generally down. Total revenues came in at NOK 342m, vs our NOK 356m. GP was +3% vs. our estimate, driven by a very strong gross margin of 45% (ABG 42.0%). EBITDA came in at NOK 10m vs. ABGSCe NOK 4m, on higher gross margin and 1% lower opex. The EBITDA margin landed at 2.9% (vs. ABGSCe 1.2%). This is flat y-o-y (Q1'25 2.9%). EPS came in at NOK -0.19 vs. ABGSCe NOK -0.16. Net debt came in at NOK 91m. No changes on outlook: StrongPoint states that they see continued improvement in both EBITDA and recurring revenue. The long term ambitions are healthy revenue growth and an EBITDA margin &amp;gt;10%.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#000000"&gt;&lt;strong&gt;Pricer transition temporary drag, offset by Vusion momentum&lt;/strong&gt;&lt;/font&gt;&lt;/h3&gt;&lt;p style="text-align:left;"&gt;&lt;font color="#000000"&gt;The phase-out of Pricer-related recurring revenue (NOK 52m in 2025) will weigh on near-term financials through 2026. However, the Vusion partnership has already delivered NOK 90m in installation revenue and NOK 19m gross profit in 2025, partially offsetting the ~NOK 26m gross profit lost from Pricer. Management views the transition as strategically positive, expanding the addressable market beyond traditional ESLs to include battery-less labels, shelf-edge cameras and retail media infrastructure, while enabling cross-selling and integrated picking solutions leveraging Vusion's capabilities.&lt;/font&gt;&lt;/p&gt;&lt;p style="text-align:left;"&gt;&lt;font color="#000000"&gt;Below we provide some recent highlights from the new partnership:&lt;/font&gt;&lt;/p&gt;&lt;ul&gt;&lt;li style="text-align:left;"&gt;&lt;font color="#000000"&gt;Installation services growth in UK: Vusion ESL installation services in the UK grew +186% y-o-y in Q1, which was a driver of the 93% revenue growth in UK &amp;amp; Ireland and the 52% increase in UK service revenue.&lt;/font&gt;&lt;/li&gt;&lt;li style="text-align:left;"&gt;&lt;font color="#000000"&gt;Spain hardware traction: Spain's 13% revenue growth was driven primarily by Vusion ESL hardware sales (partially offset by lower CashGuard sa&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/StrongPoint/Equity-research/2026/4/strongpoint---ebitda-beat-on-stronger-gross-margin/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 29 Apr 2026 05:30:07 GMT</pubDate>
      <isin>NO0010098247</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Alligo - Positive trend continues</title>
      <description>&lt;a id="bm-comp-08652c54-ee51-4dad-9412-8a13339e3f21" name="bm-comp-08652c54-ee51-4dad-9412-8a13339e3f21" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="08652c54-ee51-4dad-9412-8a13339e3f21" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Better organic growth, Finland surprised positively&lt;/li&gt;&lt;li&gt;Most important segment, Sweden, is performing well&lt;/li&gt;&lt;li&gt;Growth trend to drive margin recovery and substantial EPS growth&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-299f8e20-8aa6-4bfa-9678-6e984c228845" name="bm-comp-299f8e20-8aa6-4bfa-9678-6e984c228845" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="299f8e20-8aa6-4bfa-9678-6e984c228845" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Alligo delivered a solid Q1 report, with the harsh winter weather driving increased organic growth as expected, and even managing to beat our expectation of 3% with its 5%. The majority of this beat was, to our surprise, driven by Finland, which managed to more than offset the volumes lost from the two ended customer relationships with increased volumes to other customers. The margin also showed a positive trend as adj. EBITA increased to 4.8% (3.3%) of sales on the group level. The gross margin was flat y-o-y, as higher sales of own brands and favourable FX were offset by a higher share of sales from non-integrated businesses.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;The company mentioned that it has seen positive signs in the market during the quarter, but that it is still waiting for a definitive upturn. The solid growth in Sweden and surprisingly positive result in Finland despite the ongoing restructuring prompt us to raise '26e/'27e/'28e adj. EBITA by 6%/1%/3%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;The most important segment, Sweden, is performing well and should continue to benefit from favourable GDP forecasts for Sweden. In Norway, oil and gas has been slow for a few quarters, but this might benefit from the recent price surges. The Finland restructuring is progressing more rapidly than anticipated. All in all, the trend continues to be positive, and the organic growth we see should enable further margin recovery, resulting in substantial organic earnings growth over the coming years, around 25% this year and 15% in both '27e and '28e on the adj. EPS level. The share is now trading at 14x-11x '26e-'28e P/E, vs. its historical median of 14x-9x and peers at 27x-14x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/Alligo/Equity-research/2026/4/alligo---positive-trend-continues/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 28 Apr 2026 15:45:07 GMT</pubDate>
      <isin>SE0009922305</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ovzon - More orders incoming</title>
      <description>&lt;a id="bm-comp-c3a5d566-16bb-4710-882c-cc7166d3186b" name="bm-comp-c3a5d566-16bb-4710-882c-cc7166d3186b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c3a5d566-16bb-4710-882c-cc7166d3186b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Strong Q1, but orders muted in seasonally slow Q1&lt;/li&gt;&lt;li&gt;Small EBIT revisions&lt;/li&gt;&lt;li&gt;We expect more orders ahead; 19x '26e EV/EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c2389c06-b950-4262-bb42-11b6158dabe9" name="bm-comp-c2389c06-b950-4262-bb42-11b6158dabe9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c2389c06-b950-4262-bb42-11b6158dabe9" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong quarter, but muted orders &amp;#8211; as expected&lt;/h3&gt;&lt;p&gt;In terms of sales and earnings, Ovzon started 2026 with another strong quarter, driven by recent orders. Sales grew +189% y-o-y to SEK 260m, of which SATCOM accounted for 72%. Although this was 2% below our SEK 267m forecast, this was mainly due to slightly lower terminals sales, which tend to be lumpy. However, margins on terminals are lower, so the EBIT shortfall versus our forecast is only 1% (but -9% vs. FactSet consensus). EBIT was positive for the fourth consecutive quarter at SEK 80m (vs. SEK -16m in Q1'25). While the reported figures were good, orders were, as expected, subdued in the seasonally slow first quarter. Ovzon's customer concentration is high and lead times are long, impacting quarterly orders. Nonetheless, we expect this to improve over the coming quarters, and our conviction has been strengthened following the return of the US DoW, which had not placed an order since August 2024. Here, we also expect the SSC contract, which ended 1 March, to return.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Slightly negative sales revisions&lt;/h3&gt;&lt;p&gt;Given the recent slow order activity, which we see as no cause for concern, we take a slightly more cautious view on our sales 2026 assumptions, reducing them by 2%. Nonetheless, our EBIT forecasts are largely unchanged due to higher GM assumptions.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Ovzon-3 only at ~40% utilisation&lt;/h3&gt;&lt;p&gt;Demand for Ovzon's services is strong, and our estimates suggest that its proprietary satellite, Ovzon-3, is only utilised at ~40%. As seen in recent numbers, operational leverage is particularly high, which bodes well for the recent margin expansion to continue. The balance sheet is in good shape, and we expect to receive more details on a potential new satellite project before the end of the year. The stock is +35% YTD and is trading at 19x '26e EV/EBIT on our current estimates.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ovzon/equity-research/2026/4/ovzon---more-orders-incoming/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 28 Apr 2026 12:30:07 GMT</pubDate>
      <isin>SE0010948711</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ework Group - Still operating a weak market</title>
      <description>&lt;a id="bm-comp-2fe7b485-33ec-46b3-98ba-833436c65aba" name="bm-comp-2fe7b485-33ec-46b3-98ba-833436c65aba" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2fe7b485-33ec-46b3-98ba-833436c65aba" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Sales +3% vs. ABGSCe (-14% y-o-y), adj. EBIT +39% vs. ABGSCe&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Market still hesitant, cost savings to help margins&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;We expect cons to raise '26e adj. EBIT by ~5%&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-422538d7-ae8f-4220-80f1-0caee93a9fc7" name="bm-comp-422538d7-ae8f-4220-80f1-0caee93a9fc7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="422538d7-ae8f-4220-80f1-0caee93a9fc7" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Q1 sales were SEK 3,022m (+3% vs. ABGSCe 2,948m), -14% y-o-y. Gross profit was SEK 124m (2% vs. ABGSCe 121m), -13% y-o-y, while adj. EBIT was SEK 23m (+39% vs. ABGSCe 17m), -33% y-o-y. The gross margin was at a similar level as in Q4, which we assess is a decent level. In line with the company's previous communication, Q1 was affected by SEK ~9m in restructuring costs. This will lend gradual tailwinds to profitability, with the company targeting annuals savings of SEK 18m in 2027. Finally, orders remained in negative territory, down 12% y-o-y (vs. -14% y-o-y in Q4) to SEK 3,693m.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Q1 thoughts&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;The Nordic consultancy market remains soft, with cautious demand amid geopolitical uncertainty, higher energy prices and continued cost focus among clients. Denmark is the weakest region, declining -30% y-o-y, with weakness across most sectors, but Life Science was particularly soft (likely connected to layoffs at Novo Nordisk). Poland &amp;amp; Slovakia was affected by the previously flagged loss of a major client contract, but underlying demand was largely unchanged. On the positive side, Norway saw sales +19% y-o-y, mainly driven by a strong telecom market. Ework's 2026 guidande of EPS down 10-20% was reiterated (ABGSCe -16%).&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Following the Q1 report, we expect consensus to raise '26e adj. EBIT estimates by ~5%, mainly driven by slightly higher sales assumptions. There will be a conference call at 09.30 CET,&lt;/font&gt; &lt;a data-bm-trackable="false" href="https://financialhearings.com/event/52829" target="_blank"&gt;link.&lt;/a&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-34ee6bab-19df-4cd8-9d4d-fc8720c65e42" name="bm-comp-34ee6bab-19df-4cd8-9d4d-fc8720c65e42" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="34ee6bab-19df-4cd8-9d4d-fc8720c65e42" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-c397554e-ab7a-4445-8f68-cbbeb123cdd2" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ework/Equity-research/2026/4/ework-group---still-operating-a-weak-market/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 28 Apr 2026 11:00:08 GMT</pubDate>
      <isin>SE0002402701</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>CTT Systems - Solid Q1, softer Q2, improving H2'26</title>
      <description>&lt;a id="bm-comp-2ec40756-fcee-4bca-8fe3-4bd08b637f72" name="bm-comp-2ec40756-fcee-4bca-8fe3-4bd08b637f72" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2ec40756-fcee-4bca-8fe3-4bd08b637f72" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Return to high organic growth (+41% vs. ABG +29%)&lt;/li&gt;&lt;li&gt;Middle Eastern conflict behind more cautious FY'26 outlook&lt;/li&gt;&lt;li&gt;Share +5% into numbers, trades at 20-11x EBIT '26e-'27e (pre-Q1)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d01f1285-1be7-4a6a-a9e8-6d12f79a6345" name="bm-comp-d01f1285-1be7-4a6a-a9e8-6d12f79a6345" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d01f1285-1be7-4a6a-a9e8-6d12f79a6345" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 details&lt;/h3&gt;&lt;p&gt;Note that our latest published estimates are from February, while the USD/SEK has moved roughly 2-3% upwards since then. Sales were 5% above our expectations, with sales of SEK 66m up 41% y-o-y organically (ABGSCe +29%). This was driven by 39% reported growth in aftermarket sales (ABG +28% y-o-y), while system sales declined 2% y-o-y (ABG 0%). AM share of sales was 67% (ABG 64%). According to the CEO, the OEM business is now in a ramp-up phase while inventory adjustments in the aftermarket channel among distributors was now complete. EBIT grew ~150% y-o-y (ABG +172% y-o-y), as the margin came in at 15% (ABG 17%, 7% Q1'25), but would have been 19% when adjusting for one-time cost in the VIP project business and fully taking into account savings actions. Free cash flow of -11m was soft (+4m last year) due to customer payments being deferred into Q2.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and estimate changes&lt;/h3&gt;&lt;p&gt;For Q2, the CEO expects the conflict in the Middle East to impact air travel and aftermarket revenues, but to a lesser extent than the overall industry. For Q2 then, the CEO expects revenue (in USD terms) to grow q-o-q but not reach last year (we have +7% organic growth y-o-y), and that the margin will remain below the 25% ambition (we have 20%). For FY'26, the outlook is for OEM to grow by 45-60% adjusting for currency (ABG +82%), for AM to grow by 5-15% (ABG +30%) and that VIP sales will not exceed 2025 levels (ABG 32m vs. 30m in 2025). All other assumptions intact, the Q1 deviation on EBIT and our impression of the Q2'26+FY'26 guidance vs. ABGSCe would mechanically lower our FY'26e EBIT by ~10-15%. However, using current FX rates vs. our latest published note, we note that the USD/SEK would raise sales by 2-3%, with a greater impact on EBIT (which could have a 2-3x impact on EBIT vs. sales).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;A solid Q1 &lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/ctt-systems/Equity-research/2026/4/ctt-systems---solid-q1-softer-q2-improving-h226/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 28 Apr 2026 06:30:05 GMT</pubDate>
      <isin>SE0000418923</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Midsona - Growth lagging but execution improving</title>
      <description>&lt;a id="bm-comp-ab0dfcf1-1c62-4812-adcd-a090fd00ac59" name="bm-comp-ab0dfcf1-1c62-4812-adcd-a090fd00ac59" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ab0dfcf1-1c62-4812-adcd-a090fd00ac59" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Muted sales more than offset by margin expansion&lt;/li&gt;&lt;li&gt;Limited estimate changes on market uncertainties&lt;/li&gt;&lt;li&gt;Trading at NTM EV/EBITA of 8x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-8c9717fe-629b-4712-8611-418f42749377" name="bm-comp-8c9717fe-629b-4712-8611-418f42749377" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8c9717fe-629b-4712-8611-418f42749377" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong margins made up for soft sales&lt;/h3&gt;&lt;p style="text-align:left;"&gt;Q1 was slightly below expectations on sales, but materially stronger than expected on adj. EBIT (19% above our estimate), as both the gross and EBIT margins were ~1pp higher than anticipated. We had anticipated soft sales from contract manufacturing and licenced brands due to terminated contracts and the Spain fire. The soft growth from own consumer brands (0.1% org), however, was disappointing. Midsona partly attributes this to a timing issue with the grocery trade window in Sweden, but does not quantify how large this effect was. We assume a slight spill-over of volumes into Q2e on this. Overall, Q1 marked a strong start to 2026, and we are encouraged by the margin improvements across the board.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;2026 looks promising, with one caveat&lt;/h3&gt;&lt;p style="text-align:left;"&gt;The report provides some insight into key factors to watch for the remainder of 2026. Firstly, we expect organic growth to pick up in Q2'26e on light comps and grocery sales in Sweden. Secondly, we highlight that the acquisition of Risenta will be consolidated in Q2e. While we had hoped for more clarity on the margin profile on Risenta, management doubled down on the acquisition being margin accretive. Finally, management commented on possible future raw material price increases (see page x for more details).&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimates slightly up, trading at 8x NTM EV/EBITA&lt;/h3&gt;&lt;p&gt;We leave our sales estimates relatively unchanged, and raise '26e-'28e adj. EBIT by ~1%. Our EPS estimates are up on materially lower than expected net financials. Q1 gave us confidence in underlying improvements, but we keep a cautious eye on market developments. Based on our revised estimates, the company is trading at ~8x NTM EV/EBITA, which is ~25% below current peer multiples. We note that peers are in turn trading ~20% below their 10-year historical median of ~14x NTM EV/EBITA.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/midsona/Equity-research/2026/4/midsona---growth-lagging-but-execution-improving/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 26 Apr 2026 17:45:02 GMT</pubDate>
      <isin>SE0000565228</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Cavotec - Strong orders mask a soft quarter</title>
      <description>&lt;a id="bm-comp-df79a66a-7a00-4295-ac47-07bac10af5e2" name="bm-comp-df79a66a-7a00-4295-ac47-07bac10af5e2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="df79a66a-7a00-4295-ac47-07bac10af5e2" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1: Sales of EUR 33m (39m), EBIT of EUR -2.8m (0.8m)&lt;/li&gt;&lt;li&gt;Strong orders of EUR 60m (29m)&lt;/li&gt;&lt;li&gt;'26e adj. EBIT lowered by EUR -1.2m&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-b6f382bb-eccd-4dd7-9ce2-3b4bde3354b3" name="bm-comp-b6f382bb-eccd-4dd7-9ce2-3b4bde3354b3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b6f382bb-eccd-4dd7-9ce2-3b4bde3354b3" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Cavotec reported sales below expectations at EUR 33m, -15% y-o-y (-25% vs ABGSCe). P&amp;amp;M: -26% y-o-y, Industry: -1% y-o-y. Strong order intake of EUR 60m (+109% y-o-y) was broadly expected following the pre-announcement, but had not been incorporated into our estimates (ABGSCe 37m) as it was announced after our preview was published. Adj. EBIT was softer than expected at EUR -2.8m vs ABGSCe 2.5m. The adj. EBIT miss within P&amp;amp;M was largely driven by low sales volumes in the quarter, which weighed on capacity utilisation. Having previously extrapolated Industry's strong Q3-Q4'25 performance, we note the segment nevertheless suffered from negative mix effects, in addition to low capacity utilisation in the quarter. The highlight of the report was the exceptionally strong order intake within P&amp;amp;M, which came as a positive surprise given management's previous messaging about a cautious customer environment. As previously communicated, management introduced a cost-savings program which is expected to save EUR 3m annually, starting at the end of '26 and with full effect from '27.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;We lower our '26e-'27e sales and adj. EBIT estimates by 9-3% and 17-3% (~EUR 1.2-0.4m in '26e-'27e), respectively. While orders were up 109% y-o-y, we're reluctant to extrapolate this performance, eyeing 11% y-o-y order intake in '26e. Despite the miss on sales and earnings, we expect a conversion of the strong backlog to support sales growth of 11-9% into '27e-28e. We add IACs of EUR -3m for '26e, related to the implementation of the cost savings program.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;The share was down ~13% on the day, following a rise of +42% in the 30 days prior to the report. That leaves it trading at 53-14x EV/EBIT on '26e-'27e, vs the peer median of 15-12x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/cavotec/Equity-research/2026/4/cavotec---strong-orders-mask-a-soft-quarter/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 24 Apr 2026 15:45:12 GMT</pubDate>
      <isin>CH0136071542</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Eltel - Small quarter, but y-o-y trend should continue</title>
      <description>&lt;a id="bm-comp-8dcdb29f-b33d-40ad-8200-c7d3ad42a0b0" name="bm-comp-8dcdb29f-b33d-40ad-8200-c7d3ad42a0b0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8dcdb29f-b33d-40ad-8200-c7d3ad42a0b0" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1e: a seasonally small quarter, but positive y-o-y trend&lt;/li&gt;&lt;li&gt;We make only minor estimate revisions&lt;/li&gt;&lt;li&gt;Share trading at 10-8x '26e-'27e EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-94b29586-77a7-4424-873f-c2550c076edd" name="bm-comp-94b29586-77a7-4424-873f-c2550c076edd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="94b29586-77a7-4424-873f-c2550c076edd" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1e: seasonally small, but y-o-y improvement expected&lt;/h3&gt;&lt;p&gt;We expect Eltel to report Q1 net sales of EUR 178m, up 5% y-o-y, of which +3% organic. We expect to see mixed demand signals from Eltel's end-markets, with Communications expected to remain subdued, especially in Norway, while the order momentum in Power seems to be clearly better. Profitability should improve y-o-y, partly due to more contracts rolling over to new, better commercial terms as of 2026, and partly due to growth in "new business areas", which according to the company are also margin-accretive. However, we remind that Q1 is a seasonally small quarter, and we therefore see the y-o-y trend as more important than the absolute EBITA number. That being said, we model an adj. EBITA of EUR 2.0m (up from 0.9m in Q1'25), for a margin of 1.1% (0.5%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Minor estimate revisions for '26e-'28e&lt;/h3&gt;&lt;p&gt;We make only very minor estimate revisions ahead of the Q1 numbers, raising EBITA by 1% per year for '26e-'28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Established margin expansion track record to continue&lt;/h3&gt;&lt;p&gt;Eltel has now improved its adj. EBITA margin y-o-y for 10 consecutive quarters, a clear track record of operational improvements that we expect to continue. With that said, the 2025 adj. EBITA margin was 2.5%, meaning that the company's margin target of 5% still implies that profitability has to double within 3&amp;#8211;5 quarters per the company's own timeline. We remain more cautious than the company targets, estimating margins of 3.4-4.5% for '26e-'28e, resulting in a '25-'28e adj. EBITA CAGR of 24%. On our estimates, the share is trading at 10-8x '26e-'27e EV/EBITA, but if the margin target is reached by '27, it would instead imply an EV/EBITA multiple of ~6.5x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/eltel/Equity-research/2026/4/eltel---small-quarter-but-y-o-y-trend-should-continue/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 24 Apr 2026 11:15:13 GMT</pubDate>
      <isin>SE0006509949</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Alligo - Harsh winter drives strong organic growth</title>
      <description>&lt;a id="bm-comp-f1ce9546-f940-44fd-bfa2-500cc7771c58" name="bm-comp-f1ce9546-f940-44fd-bfa2-500cc7771c58" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f1ce9546-f940-44fd-bfa2-500cc7771c58" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales +1%, EBITA adj. +13% vs. FactSet consensus&lt;/li&gt;&lt;li&gt;Strong organic growth, but adj. EBITA beat supported by one-offs&lt;/li&gt;&lt;li&gt;Good start to the year, consensus adj. EBITA likely up 2-4%&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-3d7b0f54-026f-4445-a32d-1c82bd07098e" name="bm-comp-3d7b0f54-026f-4445-a32d-1c82bd07098e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3d7b0f54-026f-4445-a32d-1c82bd07098e" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Sales grew 6% y-o-y (+5% org.) and were 2% above our estimate (1% above FactSet consensus). With a margin of 4.8%, 0.8pp above our estimate (0.5pp above consensus), EBITA adj. was 22% above our estimate (13% above consensus). EBITA included non-recurring items with a negative margin impact of 0.7pp, relating to e.g. costs for restructuring of the Finish operations. The numbers are positive, especially the strong organic growth and a better margin in Sweden, but the majority of the adj. EBITA beat is driven by one-offs, which were likely not included as adjustments in consensus. There is a conference call at 11:00 CET: &lt;a data-bm-trackable="false" href="https://www.alligo.com/en/report/q1-2026/" target="_blank"&gt;webcast&lt;/a&gt;.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;According to management, the market is still cautious, but it did see some positive signs during the quarter. Q1 growth still benefitted somewhat from the harsh winter despite customers buying only what they need, like we expected. The restructuring efforts in Finland are proceeding according to plan, which is good to see. We expect consensus EBITA adj. to come up 2-4%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Company valuation&lt;/h3&gt;&lt;p&gt;Over the past three months, the share has returned +5%, compared to the +3% of the OMX Stockholm Allshare. The share is currently trading at 15x-10x '26e-'28e P/E, compared to its 10-year historical median of 14x-9.4x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c9ba4f42-182b-40a7-a5cc-b7759d915f02" name="bm-comp-c9ba4f42-182b-40a7-a5cc-b7759d915f02" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c9ba4f42-182b-40a7-a5cc-b7759d915f02" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-11e748b7-5650-4c85-98ea-51a9074f3fc0" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. estimates Q1'26&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company Data, FactSet&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/Alligo/Equity-research/2026/4/alligo---harsh-winter-drives-strong-organic-growth/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 24 Apr 2026 07:30:41 GMT</pubDate>
      <isin>SE0009922305</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Midsona - Margins over matter</title>
      <description>&lt;a id="bm-comp-459e944e-4137-4fc9-a7cf-86d22e0b8e40" name="bm-comp-459e944e-4137-4fc9-a7cf-86d22e0b8e40" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="459e944e-4137-4fc9-a7cf-86d22e0b8e40" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Adj. EBIT well above estimates at SEK 45m&lt;/li&gt;&lt;li&gt;Underlying performance strong, but keep an eye out for ME conflict&lt;/li&gt;&lt;li&gt;Consensus adj. EBIT revisions likely up low-single-digits&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a05b8969-c284-4fba-abd2-f4c19a18094b" name="bm-comp-a05b8969-c284-4fba-abd2-f4c19a18094b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a05b8969-c284-4fba-abd2-f4c19a18094b" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;A beat where it matters&lt;/h3&gt;&lt;p&gt;The Q1 report was slightly softer than expected on sales, but more importantly well above our earnings estimates. Sales amounted to SEK 893m (-2% vs ABGSC 909m), for an organic growth of -1.3% (-1.7pp vs ABGSC 0.4%). The sales drag came primarily from contract manufacturing (-1.9% organic) due to terminated contracts post the Spain fire, and licensed brands (-2.2%). Own consumer brands were roughly flat organically (0.1%), with organic food doing well but health foods and consumer health lagging (partly a timing issue as Swedish grocery trade shifted its launch window from Q1 to Q2). On earnings, both the gross margin and adj. EBIT margin came in above our expectations (~1pp higher, respectively), driven partly by product mix and the now fully implemented cost savings programme. Adj. EBIT came in at SEK 45m (19% vs ABGSC 38m), for a margin of 5.0% (ABGSC 4.2%). The NRI of SEK 56m is a previously announced insurance compensation. Free cash flow (ex. M&amp;amp;A) came in at SEK 32m (vs. ABGSCe 43m), and was positively affected by the insurance payment. However, this was offset by inventory build-up related Middle East supply uncertainty, Q2 launch preparations, and a notable spike in receivables from late March invoicing/payment timing. The WC build-up should normalise in Q2.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Green shoots, one cloud on the horizon&lt;/h3&gt;&lt;p&gt;We are encouraged to see South Europe return to profitability (SEK 3m vs. 0m Q1'25). Moreover, the softness in the Nordics is expected to reverse in Q2, due to the shifted launch window within Swedish health/consumer. Still no news on whether Midsona will rebuild the Spanish factory, but a decision will be made in H1'26. We are also excited about Q2 due to the Risenta acquisition. On a less positive note, management flags potential cost headwinds in H2'26 due to volatile energy an&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/midsona/Equity-research/2026/4/midsona---margins-over-matter/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 24 Apr 2026 07:00:12 GMT</pubDate>
      <isin>SE0000565228</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Cavotec - Orders strong, miss on sales &amp; earnings</title>
      <description>&lt;a id="bm-comp-a9b414e7-edcc-442a-93d6-b30fb5d88910" name="bm-comp-a9b414e7-edcc-442a-93d6-b30fb5d88910" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a9b414e7-edcc-442a-93d6-b30fb5d88910" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales EUR 60m vs ABGSCe, EBIT adj. EUR -2.8m vs. ABGSCe 2.5m&lt;/li&gt;&lt;li&gt;Strong order intake, with several large orders in the end of the quarter&lt;/li&gt;&lt;li&gt;Market still cautious, cost saving of EUR 3m introduced&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1aa5f9c7-8ca0-405d-a76a-36fd7ecd065a" name="bm-comp-1aa5f9c7-8ca0-405d-a76a-36fd7ecd065a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1aa5f9c7-8ca0-405d-a76a-36fd7ecd065a" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Cavotec reported mixed Q1 results with a strong order intake, while missing on top-line and earnings. Order intake came in at EUR 59.7m (vs. ABGSCe 37m, 109% y-o-y), for a R12m book to bill of 1.2. The order beat was expected as they had pre-announced several large orders after we released our Q1 preview. Sales came in at EUR 32.8m (-25% vs. ABGSCe 44m), -15% y-o-y (of which roughly -2% FX). EBIT adj. was EUR -2.8m (vs. ABGSCe EUR 2.5m), for a margin of -8.6% (ABGSCe 5.7%). Industry showed deteriorating sales and margins, with an EBIT margin of 6%% (vs. ABGSCe 11.2%, 13% in Q4'25). Ports &amp;amp; Maritime reported weaker sales and EBIT (sales -26% and adj. EBIT -208% y-o-y). The company is introducing a cost savings program of EUR 3m, with full effect in early 2027.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates and outlook&lt;/h3&gt;&lt;p&gt;On numbers alone, '26e-'28e sales is lowered by 7-6%, and EBIT adj. decreases by approx. EUR 2-9m. Q1 was a soft quarter, and while the strong order intake is encouraging, management says the outlook remains uncertain with customer caution persisting.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;The share has been strong into the numbers, +42% L30D (vs. OMXSALLS +9%), and is currently trading at 48x-21x '26e-'27e P/E on our pre-report estimates vs. the peer median of 20x-19x. The company is hosting a &lt;a data-bm-trackable="false" href="https://cavotec.events.inderes.com/q1-report-2026" target="_blank"&gt;conference call&lt;/a&gt; at 10:00 CET.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ebfb0f31-bcef-45c2-b01a-7643456ee099" name="bm-comp-ebfb0f31-bcef-45c2-b01a-7643456ee099" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ebfb0f31-bcef-45c2-b01a-7643456ee099" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-20582756-b5eb-4b13-b42f-28bff1622fe0" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier estimates, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/cavotec/Equity-research/2026/4/cavotec---orders-strong-miss-on-sales--earnings/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 24 Apr 2026 05:45:13 GMT</pubDate>
      <isin>CH0136071542</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Prevas - Through the soft patch</title>
      <description>&lt;a id="bm-comp-0b9d77c0-b029-4501-bd1c-b58128686f55" name="bm-comp-0b9d77c0-b029-4501-bd1c-b58128686f55" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0b9d77c0-b029-4501-bd1c-b58128686f55" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Likely to see a recovery in the latter half of 2026&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;We keep our sales estimates unchanged&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Trading ~20% below its peers&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-bcc63fb0-efce-42bc-be85-df18675e6697" name="bm-comp-bcc63fb0-efce-42bc-be85-df18675e6697" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bcc63fb0-efce-42bc-be85-df18675e6697" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Specialisation acts as a shield in a soft market&lt;/h3&gt;&lt;p&gt;Prevas stands out from the wider consulting sector through its specialisation in complex product and production development across engineering, defence and energy, and we think these verticals offer a degree of insulation that should play out well in the longer term. For Q1, we estimate sales of SEK 440m, reflecting 2.3% y-o-y growth, with M&amp;amp;A contributing the majority, as organic growth is likely flat. This reflects soft demand, a neutral calendar effect, and continued weakness in Denmark (~9% of sales). We estimate adj. EBITA of SEK 37m, an 8.4% margin and ~5% y-o-y growth, supported by ongoing cost discipline.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Patience on the recovery&lt;/h3&gt;&lt;p&gt;We leave our sales estimates unchanged. Our longer-term view on Prevas remains intact: we estimate sales growth to 5.2% in '26e (excluding unannounced M&amp;amp;A) and adj. EBITA margins reaching 9.2%, a gradual improvement trajectory as utilisation recovers and pricing pressure eases. Sweden will likely be stable, after six weaker quarters, and Finland will likely continue to be a growth driver, performing despite market softness, as evidenced by a Finnish peer's &lt;a data-bm-trackable="false" href="https://mfn.se/cis/a/etteplan/inside-information-etteplan-has-concluded-the-change-negotiations-in-its-software-and-embedded-solutions-service-area-25d56e2f" target="_blank"&gt;recent restructuring&lt;/a&gt; (although in its software unit). Denmark remains our main area of caution, as we expect the region to stay challenging near-term, though margin should gradually adjust as the company continues to right-size capacity.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Below peer average on known challenges&lt;/h3&gt;&lt;p&gt;Prevas is trading at 9-5x EV/EBITA for '26e-'28e on our updated estimates, which is ~20% below the average of peers. Worth noting is that we expect the company to have higher sales growth and EBITA margins than peers in '26. As market conditions normalise, we should see utilisation improve and the operating leverage story should become clearer.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/prevas/Equity-research/2026/4/prevas---through-the-soft-patch/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 23 Apr 2026 21:15:10 GMT</pubDate>
      <isin>SE0000356008</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Careium - Relief around the corner</title>
      <description>&lt;a id="bm-comp-b9356d7f-bc5d-42e5-8a84-cbe2b6ac3696" name="bm-comp-b9356d7f-bc5d-42e5-8a84-cbe2b6ac3696" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b9356d7f-bc5d-42e5-8a84-cbe2b6ac3696" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Underlying development looks promising&lt;/li&gt;&lt;li&gt;We raise our '26-'28 EBIT estimates by 3-1%&lt;/li&gt;&lt;li&gt;Share is trading at 10x-7x '26e-'28e EV/EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-d213836f-dcce-4c5b-9887-9c94124f4faa" name="bm-comp-d213836f-dcce-4c5b-9887-9c94124f4faa" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d213836f-dcce-4c5b-9887-9c94124f4faa" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Margins not as soft as expected&lt;/h3&gt;&lt;p&gt;Q1 came in 2% (SEK 4m) above our expectations on sales, for a solid organic growth of 11%, weighed down by FX of -5%. We are encouraged to see organic growth for the third consecutive quarter, and also note the second quarter in a row of positive growth in number of connections (which showed consecutive negative y-o-y development from Q4'22-Q3'25). The 4m sales beat was carried down to EBIT, which was 40% above our estimate (SEK 13m vs. 9m), as the margin of 5.7% was 1.6pp above our estimates. This is a margin decline of 2.3pp y-o-y, but a solid result given the guidance for elevated opex in H1 and temporary headwinds. Opex grew 10% y-o-y, partly driven by the onboarding of a large customer in Norway, which carried upfront costs.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Pressure to ease in H2&lt;/h3&gt;&lt;p style="text-align:left;"&gt;Careium reiterates that Q2e will also suffer from margin pressure, due to investment in efficiencies and organic growth, coupled with upfront costs for long-term contracts. We believe this is well guided, and that the underlying development looks promising. We believe continued organic growth and a relatively stable opex base will enable higher margins in H2'26. Moreover, Careium once again alluded to the possibility of selective M&amp;amp;A. The Nordics should show improvements in Q2 and onwards as the ADDA framework is finalised, and Careium will likely sign a framework agreement in May, if ADDA's communicated timeline holds.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#1B2634"&gt;We raise EBIT by 3-1% '26e-'28e&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#212529"&gt;We raise&lt;/font&gt; &lt;font color="#212529"&gt;'26e-'28e sales by 1%&lt;/font&gt; on the back of the report and &lt;font color="#212529"&gt;u&lt;/font&gt;pdated FX movements. Our '26e-'28e EBIT estimates are up 3-1% on operating leverage and higher gross margins. Our estimates imply '26e-'28e sales and EBIT CAGRs of 6% and 22%. &lt;font color="#000000"&gt;On our updated estimates, the s&lt;/font&gt;&lt;font color="#212529"&gt;hare is trading at 10x-7x&lt;/font&gt; &lt;font color="#212529"&gt;'26e-'28e EV/EBIT. We reiterate our fair value range to SEK 20-34.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/careium/Equity-research/2026/4/careium---relief-around-the-corner/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 23 Apr 2026 19:15:10 GMT</pubDate>
      <isin>SE0017131824</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Svedbergs Group - Looking forward to the move</title>
      <description>&lt;a id="bm-comp-0ae09c53-32da-42c8-81e6-96c4ed18b63f" name="bm-comp-0ae09c53-32da-42c8-81e6-96c4ed18b63f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0ae09c53-32da-42c8-81e6-96c4ed18b63f" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;EBITA margin +20bp y-o-y supported by price adjustments&lt;/li&gt;&lt;li&gt;Warehouse move could offset opex inflation from Q4'26&lt;/li&gt;&lt;li&gt;We reiterate our fair value range of SEK 55-75&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c872c17d-8e70-45c8-be50-a318977abe10" name="bm-comp-c872c17d-8e70-45c8-be50-a318977abe10" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c872c17d-8e70-45c8-be50-a318977abe10" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Defends margins through price&lt;/h3&gt;&lt;p&gt;Demand differed significantly across markets in Q1, although most saw a deceleration. The end of expanded ROT deductions looks like it adversely affected Swedish exposure, as country sales decelerated from growth of 23% in Q4 to -3%. Commentary from management suggests the ROT impact is already behind us. Thebalux grew 9% organically, with improved margins. Svedbergs Group's gross margin expansion continued in Q1, by 320bp y-o-y. In addition to positive effects from price adjustments, the company also highlighted lower input costs. We expect raw material prices to gradually increase, but also argue that the Group can likely offset this through price increases, as it has previously. What also became clear was the reason for Roper Rhodes' H2'26 warehouse move. The expanded assortment and organic growth has resulted in a fulfilment setup split between several (costly) 3PL suppliers. The SG&amp;amp;A ratio thus expanded by 190bp. The new warehouse should offset these additional costs over time.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We raise '26e-'28e EBITA by 1-2%&lt;/h3&gt;&lt;p&gt;We take a more cautious stance on Svedbergs' recovery considering the soft demand in Q1, and lower sales for the brand by 3% '26e-'28e. We raise Thebalux margin forecasts on the better production efficiency. We also raise our gross margin estimates and SG&amp;amp;A ratio forecasts, reflecting Q1 trends. Overall, we increase 2026e&amp;#8211;28e EBITA by 1&amp;#8211;2%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 11x-9.5x our '26e-'27e EBITA&lt;/h3&gt;&lt;p&gt;Svedbergs Group is currently trading at 11x our '26e EBITA or 14x our '26e P/E. This can be compared to its L5Y multiples of 9x and 11x NTM, respectively, or a Nordic peer group P/E around 14x. We leave our fair value range of SEK 55-75 unchanged considering our limited estimate changes.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/svedbergs/Equity-research/2026/4/svedbergs-group---looking-forward-to-the-move/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 23 Apr 2026 16:45:10 GMT</pubDate>
      <isin>SE0000407991</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ovzon - US holds more potential</title>
      <description>&lt;a id="bm-comp-83f0eb44-5a59-4b36-807d-c8a61ae40d45" name="bm-comp-83f0eb44-5a59-4b36-807d-c8a61ae40d45" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="83f0eb44-5a59-4b36-807d-c8a61ae40d45" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales +189% y-o-y on recent orders; -2%/-8% vs. ABG/cons&lt;/li&gt;&lt;li&gt;EBIT was -1% vs. ABG and -9% vs. cons&lt;/li&gt;&lt;li&gt;Expect cons to make small revisions, share in line with the market&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-29d4c23d-87b6-4114-8f4d-67df4dc8310f" name="bm-comp-29d4c23d-87b6-4114-8f4d-67df4dc8310f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="29d4c23d-87b6-4114-8f4d-67df4dc8310f" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Sales SEK 277m (18% vs ABGSCe 234m and 16% vs cons 239m), adj. EBIT 74m (83% vs ABG 41m and 82% vs cons 41m). Solid FCF, resulting in a NIBD of SEK 191m, down from 259m in Q4'25. Despite dampened order activity in the seasonality slow Q1, the order book stood at a robust SEK 0.8bn by the end of Q1.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Q1 thoughts&lt;/h3&gt;&lt;p&gt;Similar to recent quarters, terminal sales stayed elevated given the recent strong intake. While sales were slightly below expectations, Q1 was another strong quarter, with continued operating leverage. GMs were 66% (vs. 58% in Q4), driven by a favourable sales mix. In terms of outlook, Ovzon highlights that the dialogue with the US DoD has been reestablished and holds further growth potential - which we agree upon. Also, it notes that while sales cycles are long, underlying demand remains strong.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;At a first glance, we expect consensus to do small revisions, given that the miss versus consensus partly seems to related to terminal saels (which may be lumpy). All in all, another strong report, but the flat revisons coupled with a strong share price run into the report makes us expect the stock to trade in line with the market today. The valuation is sitting at 21x '26e EV/EBIT on our unrevised estimates. There is a webcast at 10.00 CET &lt;a data-bm-trackable="false" href="https://youtube.com/live/rtR5ZL6aKlo" target="_blank"&gt;(link)&lt;/a&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9f05761f-87f4-408e-9c45-3d6d8db1e4c9" name="bm-comp-9f05761f-87f4-408e-9c45-3d6d8db1e4c9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9f05761f-87f4-408e-9c45-3d6d8db1e4c9" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-345474f2-b51d-4284-8c2d-b58771d4ce87" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data, Modular Finance for cons&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ovzon/equity-research/2026/4/ovzon---us-holds-more-potential/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 23 Apr 2026 07:00:51 GMT</pubDate>
      <isin>SE0010948711</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Careium - Strong growth makes up for elevated costs</title>
      <description>&lt;a id="bm-comp-bd6626a5-cefd-4619-b200-6322d8f669f6" name="bm-comp-bd6626a5-cefd-4619-b200-6322d8f669f6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bd6626a5-cefd-4619-b200-6322d8f669f6" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 sales 2% above our ests. at SEK 220m, for 11% org. growth&lt;/li&gt;&lt;li&gt;Adj. EBIT SEK 13m vs. ABGSCe 9m&lt;/li&gt;&lt;li&gt;Trading at 10x-7x '26e-'28e EV/EBITA adj.&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-56b05da4-66bc-43ca-9a89-bd4a654030f4" name="bm-comp-56b05da4-66bc-43ca-9a89-bd4a654030f4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="56b05da4-66bc-43ca-9a89-bd4a654030f4" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;A strong Q1 given ongoing headwinds&lt;/h3&gt;&lt;p&gt;Q1 came in slightly above expectations on sales, and materially above expectations on earnings. Careium delivered sales of SEK 220m (2% vs ABGSCe 216m), corresponding to y-o-y organic growth ex. FX of 10.9% (0.8pp vs ABGSCe 10.1%). Segment wise, service sales was SEK 164m (2% vs ABGSCe 160m), and product sales was SEK 56m (1% vs ABGSCe 55m). The gross margin decreased 1.3pp to 43.2% (0.7pp vs ABGSCe 42.5%). Opex came in at SEK -83m (0% vs ABGSCe -83m). EBIT amounted to SEK 13m (41% vs ABGSCe 9m), for a margin of 5.7% (1.6pp vs ABGSCe 4.1%), vs. 8% Q1'25. The Nordics were the strongest region at 16%, driven by both Sweden performing well and the Norway customer ramp-up (though the latter came with margin costs). The Netherlands grew 10.4% and Other Markets 13%. UK &amp;amp; Ireland was the weak spot, down 7%, though positive when adjusted for FX (we assess ~4% lccy growth). Keep in mind that Q1'25 benefited from a favourable timing of accruals in the UK. Careium flags this multiple times, and notes that the GM, EBIT and EBITDA all improved y-o-y adjusted for this.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and cash flow&lt;/h3&gt;&lt;p&gt;FCF was soft in the quarter and came in at SEK -14m (vs. -4m Q1'25), driven by a working capital build. Careium notes that working capital is normalising to expected levels, implying Q1 seasonality. R&amp;amp;D spend is continuing to run well above prior year levels, which is compressing margins now but is positioned as an investment in the platform. While Careium does not provide guidance, it comments that the Norway customer onboarding costs and the product development/business integration initiatives are expected to continue pressuring margins in Q2 as well. Moreover, new service contracts in UK &amp;amp; Ireland will have full effect of SEK ~3m per quarter starting in April, implying a modest Q2 tailwind.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation and conference ca&lt;/h3&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/careium/Equity-research/2026/4/careium---strong-growth-makes-up-for-elevated-costs/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 23 Apr 2026 06:45:09 GMT</pubDate>
      <isin>SE0017131824</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Svedbergs Group - Thebalux delivered a Q1 beat</title>
      <description>&lt;a id="bm-comp-8f68cb9a-d79b-4fef-898d-da7664e86573" name="bm-comp-8f68cb9a-d79b-4fef-898d-da7664e86573" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8f68cb9a-d79b-4fef-898d-da7664e86573" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Net sales SEK 584m, +1% vs ABGSCe, -2% vs Factset cons.&lt;/li&gt;&lt;li&gt;EBITA SEK 93m, +8% vs ABGSCe, +3% vs cons&lt;/li&gt;&lt;li&gt;Says diverse supplier base is an advantage&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c7d6a52f-ee86-4ae5-b2bd-ba6b1e6f3ba2" name="bm-comp-c7d6a52f-ee86-4ae5-b2bd-ba6b1e6f3ba2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c7d6a52f-ee86-4ae5-b2bd-ba6b1e6f3ba2" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 in brief: gross margin-driven beat&lt;/h3&gt;&lt;p&gt;Our impression is that Svedbergs Group's Q1 report is better than Factset consensus estimates. The Group reports net sales of SEK 584m, for organic growth of 3% y-o-y. This is +1% vs ABGSCe and -2% vs cons. Looking closer at the three largest segments, Svedbergs grew -2%, Roper Rhodes by -3.5% (+5% org.) and Thebalux by +4% (+9% org.), which means the deviation to our sales estimate was driven by Thebalux primarily. Gross margins grew 320bp y-o-y to 49.2% driven by the soft USD primarily. This margin expansion was offset by higher distribution costs related to Roper Rhodes, growth (and growth in SKUs) in recent years have meant it was necessary to add third-party logistics partners with a higher cost. This is the reason for iRhoper Rhodes' upcoming move to a new consolidated warehouse. EBITA margins grew by 20bp y-o-y to 15.9% for EBITA of SEK 93m, -1% y-o-y. This was +8% vs ABGSCe and +3% vs cons. By segment, the EBITA beat looks driven by the Thebalux segment, which reported an EBITA margin of 28% driven by the higher volumes and efficiency improvement in production.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook: geopolitical tension presents manageable issues so far&lt;/h3&gt;&lt;p&gt;In Q4, Svedbergs Group stated that it looked forward to a gradually improving market in 2026, while also noting material geopolitical uncertainty. In the Q1 report, it flags that geopolitical tension presents a challenge. It says that there are some issues with global logistics but that it so far has not been negatively impacted thanks to its diverse supplier base and long supplier relationships. The CEO highlights that the geographical diversification in the Group gives maneouverability.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;The report moves consensus '26e EBITA by +1%&lt;/h3&gt;&lt;p&gt;The share has returned -18% L3M, which can suggest low expectations into numbers, and is now trading at 11x-9x our '26e-'27e EV/EBITA vs a h&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/svedbergs/Equity-research/2026/4/svedbergs-group---thebalux-delivered-a-q1-beat/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 23 Apr 2026 06:15:09 GMT</pubDate>
      <isin>SE0000407991</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Skolon - Growth holding up as scale builds</title>
      <description>&lt;a id="bm-comp-50bc463c-f4f2-46ad-84e5-8c7762e3eb70" name="bm-comp-50bc463c-f4f2-46ad-84e5-8c7762e3eb70" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="50bc463c-f4f2-46ad-84e5-8c7762e3eb70" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We expect 35% organic growth in Q1e&lt;/li&gt;&lt;li&gt;Q1 mix likely to be somewhat favourable&lt;/li&gt;&lt;li&gt;FVR of SEK 30-45 reiterated&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-54c8bfc1-6987-4294-9c78-96f8b120560a" name="bm-comp-54c8bfc1-6987-4294-9c78-96f8b120560a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="54c8bfc1-6987-4294-9c78-96f8b120560a" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 expectations&lt;/h3&gt;&lt;p&gt;We expect a solid Q1, with sales of SEK 43m, corresponding to an organic growth rate of 35%. While sales are affected by timing, likely with fewer contracts signed early in the year (given a relative lack of publicly announced customer wins), this is not unusual, as Q1 is the smallest quarter following the start of the academic spring term. We think that monetisation per user is continuing to grow, and that ARPPU will remain strong, at SEK 196. We expect a gross margin of 39% (36% less capitalised work), reflecting a more favourable revenue mix, and we expect EBITDA to come in at SEK -0.5m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We make small adjustments to our estimates and lower '26e-'28e sales by 1% so that our EBITDA estimates come down 10-2%, reflecting a softer margin trajectory. Even so, Skolon has already reached profitability in more mature markets such as Sweden and the company continues to grow and gain market share in newer markets, although this may result in more volatile earnings.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Implied valuation&lt;/h3&gt;&lt;p&gt;Based on our revised estimates, the company is trading at '26e-'27e EV/Gross profit of 6-4x, which is slightly above peers. However, we expect Skolon to grow &amp;gt;3x faster than the average peer because it is growing both its user base and revenue per paying user due to a higher platform usage, unlike some peers that only have one growth avenue. We maintain our fair value range of SEK 30-45.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/company-name/Equity-research/2026/4/skolon---growth-holding-up-as-scale-builds/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 23 Apr 2026 04:45:09 GMT</pubDate>
      <isin>SE0017615784</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Infrea - Done fixing the pipes</title>
      <description>&lt;a id="bm-comp-f06f93bc-2460-41c2-be23-344b84d5a2cc" name="bm-comp-f06f93bc-2460-41c2-be23-344b84d5a2cc" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f06f93bc-2460-41c2-be23-344b84d5a2cc" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Entering 2026e in better shape&lt;/li&gt;&lt;li&gt;Early signs of an improving market&lt;/li&gt;&lt;li&gt;7-5x EV/EBITA '26e-'28e, 16-10% FCF yields&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1d6da4cd-6a2a-4946-b637-041bc2b088cd" name="bm-comp-1d6da4cd-6a2a-4946-b637-041bc2b088cd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1d6da4cd-6a2a-4946-b637-041bc2b088cd" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;In better shape&lt;/h3&gt;&lt;p&gt;Infrea is entering 2026e with a clearer business model and in better internal shape. The Water &amp;amp; Sewage segment has been sold, and Martin Reinholdsson has now held the CEO position for one and a half years. During this time, Infrea's main focus has been to streamline its processes. In 2025 we saw continuous steps forward, and we believe that with this internal uplift and an improving market (higher order intakes for the construction companies, better outlooks etc.), Infrea should be positioned to capitalise on the momentum. Regarding Q1e, we believe that the cold winter affected the beginning of the year and the higher fuel and bitumen prices at the end of the quarter will impact margins. We expect Infrea to deliver Land &amp;amp; Construction (L&amp;amp;C) y-o-y sales growth of 0% and Paving Services (PS) growth of 2%. We look for L&amp;amp;C and PS EBITA of SEK -7m and SEK -36m, respectively, as Q1 is a slow quarter for construction companies (19% of sales).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We still think the market is regionally tough in some areas, but we can see some light in the tunnel for Swedish construction e.g. higher residential starts (even if it is from a low level), which should take away some competition and price pressure for Infrea. We now forecast '26 adj. EBITA of SEK 62m (SEK 49m '25), accelerating to SEK 72m in 2027e, as margins improve from 2.2% in '25 to 3.3% in '27e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Margins to improve and FCF to stabilise&lt;/h3&gt;&lt;p&gt;We believe Infrea is well-positioned to grow organically and improve margins, given its exposure to underlying demand and public customers (~55%), with support from M&amp;amp;A (24% sales CAGR in '20-'23). For '25-'28e, we expect Infrea to deliver EBITA growth and FCF in line with peers. The share is currently trading at 7-5x EV/EBITA with a 16-10% FCF yield.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/infrea/Equity-research/2026/4/infrea---done-fixing-the-pipes/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 22 Apr 2026 16:15:08 GMT</pubDate>
      <isin>SE0010600106</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Coor - Cleaning up margins</title>
      <description>&lt;a id="bm-comp-c8810310-dab6-48bd-8bf8-fddfb3694c30" name="bm-comp-c8810310-dab6-48bd-8bf8-fddfb3694c30" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c8810310-dab6-48bd-8bf8-fddfb3694c30" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 highlights long-term upside to margins&lt;/li&gt;&lt;li&gt;Adj. EBITA +0-2% on '26e-'28e; 8% CAGR '25-'28e&lt;/li&gt;&lt;li&gt;Near-term focus will be on allocating cash flow&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-39e5b21a-04f7-4114-bed2-5d39a3928bd2" name="bm-comp-39e5b21a-04f7-4114-bed2-5d39a3928bd2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="39e5b21a-04f7-4114-bed2-5d39a3928bd2" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong performance in Sweden partly offset by DK/NO&lt;/h3&gt;&lt;p&gt;Coor continued to demonstrate better margins in Q1, driven by the actions taken by the new management team to simplify the company's structure. This was demonstrated by the strong margins in Sweden as well as lower central costs, which is something we expect to carry forward into the rest of the year. On the other hand, Denmark and Norway underperformed, and we think both segments will continue to face challenges in the coming quarters due to churning contracts in Denmark and lower variable volumes in Norway (due to unusually high volumes in Q2-Q3 last year). But taken together, the report made us more confident that management's actions are bearing fruit and that margins should continue to expand longer-term, driven by Sweden (&lt;a data-bm-trackable="false" href="https://abg-portal.bluematrix.com/links2/pdf/ad313001-67a7-40a7-91cc-499e5e395293?firmId=45691" target="_blank"&gt;read more in our CMD note&lt;/a&gt;). Thus, we raise '27e-'28e adj. EBITA 1-2% ('26e unchanged), held back somewhat by Denmark and Norway.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We see margins above target from 2027&lt;/h3&gt;&lt;p&gt;Even though we see organic growth remaining muted, we see 11% adj. EBITA growth in 2026, and 7% in 2027, supported by a margin slightly above the target in 2027 (5.6% vs. targeted 5.5%). We think this is achievable due to the strong performance in Sweden, even as margins in Denmark and Norway remain below historical levels, meaning that there could be more margin upside in the longer term (we have 5.7% in 2028).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Becoming a cash flow machine again&lt;/h3&gt;&lt;p&gt;While cash flow has improved, we expect FCF to be 30% higher in 2027 (SEK 500m) vs. 2025 as Coor returns to a normalised cash conversion. With gearing already at a good level in Q1 (2.3x), the company has the firepower for both smaller bolt-on acquisitions and buybacks already in 2026. We view this as a key factor in the near term. The valuation remains in line with ISS and Nordic service sector at 11x EBITA '26e on our estimates.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/coor/Equity-research/2026/4/coor---cleaning-up-margins/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 22 Apr 2026 13:15:07 GMT</pubDate>
      <isin>SE0007158829</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Coor - Margin beat to drive positive revisions</title>
      <description>&lt;a id="bm-comp-3b5a0e57-c018-4c53-ad2a-79fce0f8596a" name="bm-comp-3b5a0e57-c018-4c53-ad2a-79fce0f8596a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3b5a0e57-c018-4c53-ad2a-79fce0f8596a" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Adj. EBITA +16% y-o-y, 9% above Infront consensus&lt;/li&gt;&lt;li&gt;Beat driven by strong margins, while organic growth remains muted&lt;/li&gt;&lt;li&gt;Estimates to come up 3-4% on '26e-'27e; CC at 10:00 CET&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ce1a59fb-7052-4d52-a5c1-4c038826d844" name="bm-comp-ce1a59fb-7052-4d52-a5c1-4c038826d844" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ce1a59fb-7052-4d52-a5c1-4c038826d844" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Sales were SEK 3,014m (-2% vs ABGSC 3,087m and -1% vs cons 3,058m), -1% y-o-y whereof 0% organic (vs ABGSC 2%). Sweden was a tad better (1%) while other segments were below. Adj. EBITA was SEK 167m (7% vs ABGSC 156m and 9% vs cons 153m), +16% y-o-y due to positive effects of the reorganisation and higher volumes in Sweden for a group margin of 5.5% (4.7%) compared to ABGSC and consensus at 5.0%. Adj. EBITA was 7% better in Sweden and below in other segments. Lower central cost also contributed to the margin beat. Cash flow was solid, but with a lower conversion y-o-y: the r12m FCF/EBITA conversion declined to 47% (64% in Q4). Gearing continued to improve to 2.3x (2.6x in Q4).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and estimate changes&lt;/h3&gt;&lt;p&gt;Management said activity in the market remains high, highlighting the public sector in Sweden and Denmark (Denmark has been highlighted as a weaker market earlier). That said, it expects organic growth to remain muted near-term due to churning contracts. We expect that the stronger than expected margins will drive 3-4% higher consensus EBITA for '26e-'27e with growth relatively unchanged (if anything a bit lower).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;The share is +13% YTD but has underperformed recently, -5% L1M vs OMXSGI +12%, which should warrant a positive reaction on the report. The share is trading at 11-10x EBITA on our unrevised '26e-'27e (8-10% lease adj. FCF yield). Management will host a conference call at 10:00 CET, use this &lt;a data-bm-trackable="false" href="https://coor.events.inderes.com/q1-report-2026" target="_blank"&gt;link&lt;/a&gt; to participate.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-8dfbbdc4-39c8-4ae8-8784-d5c7128e6641" name="bm-comp-8dfbbdc4-39c8-4ae8-8784-d5c7128e6641" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8dfbbdc4-39c8-4ae8-8784-d5c7128e6641" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-c54f73be-5961-4dc4-934a-e45454b01875" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviations&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data, Infront consensus&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/coor/Equity-research/2026/4/coor---margin-beat-to-drive-positive-revisions/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 22 Apr 2026 06:30:07 GMT</pubDate>
      <isin>SE0007158829</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>StrongPoint - Slow and steady</title>
      <description>&lt;a id="bm-comp-3f0259dd-9dcd-4a27-8430-2f1f2f80efac" name="bm-comp-3f0259dd-9dcd-4a27-8430-2f1f2f80efac" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3f0259dd-9dcd-4a27-8430-2f1f2f80efac" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;More of the same&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Pricer transition a temporary drag, offset by Vusion momentum&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range of NOK 8-18 per share&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-4052008a-b29e-403f-858d-0c164c193190" name="bm-comp-4052008a-b29e-403f-858d-0c164c193190" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4052008a-b29e-403f-858d-0c164c193190" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;More of the same&lt;/h3&gt;&lt;p&gt;Q4'25 saw flat revenues (+1% y-o-y) and adjusted EBITDA of ~NOK 2m (NOK -5m reported, including NOK 7m in M&amp;amp;A costs). For Q1'26, we expect more of the same with no major surprises. On revenues, we pencil in NOK 356m, up 3% y-o-y. StrongPoint delivered a strong 43% gross margin in '25, but we model this slightly lower at ~42% for Q1'26, yielding NOK 150m in gross profit (+2% y-o-y). On costs, '25 saw clean opex grow 7% y-o-y - a trend we expect to continue through Q1'26 and FY'26. This brings our Q1'26 clean EBITDA estimate to NOK 4m. We make limited estimate revisions ahead of the Q1 report, and our focus will be on comments regarding UK, order picking and the Vusion partnership.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Pricer transition temporary drag, offset by Vusion momentum&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;The phase-out of Pricer-related recurring revenue (NOK 52m in 2025) will weigh on near-term financials through 2026. However, the Vusion partnership has already delivered NOK 90m in installation revenue and NOK 19m gross profit in 2025, partially offsetting the ~NOK 26m gross profit lost from Pricer. Management views the transition as strategically positive, expanding the addressable market beyond traditional ESLs to include battery-less labels, shelf-edge cameras and retail media infrastructure, while enabling cross-selling and integrated picking solutions leveraging Vusion's capabilities.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of NOK 8-18 per share&lt;/h3&gt;&lt;p&gt;The past few years have not been smooth sailing, as project delays and long decision cycles have hampered momentum. However, StrongPoint delivered improved EBITDA and recurring revenue in FY25, pointing to strengthening core fundamentals. Over the medium to long term, we expect grocery retailers to increase technology investments. Our DCF indicates an equity value of ~NOK 600m, and we see a fair value range of NOK 8-18 per share.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/StrongPoint/Equity-research/2026/4/strongpoint---slow-and-steady/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 21 Apr 2026 17:00:06 GMT</pubDate>
      <isin>NO0010098247</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nexam Chemical - Q1 soft but structural tailwinds building</title>
      <description>&lt;a id="bm-comp-94348147-f116-43fc-9549-d3cb0ee03b26" name="bm-comp-94348147-f116-43fc-9549-d3cb0ee03b26" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="94348147-f116-43fc-9549-d3cb0ee03b26" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales SEK 44m (-5% vs. ABGSCe), EBIT -5.5m (vs. -3.3m)&lt;/li&gt;&lt;li&gt;We cut '26e-'28e sales by 1-2%, total EBIT by SEK 6m&lt;/li&gt;&lt;li&gt;Rising virgin plastic prices present an opportunity for Nexam&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-0bfb9221-f378-487b-8379-9c5ac6a51bca" name="bm-comp-0bfb9221-f378-487b-8379-9c5ac6a51bca" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0bfb9221-f378-487b-8379-9c5ac6a51bca" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 a bit softer, more optimistic on Q2&lt;/h3&gt;&lt;p&gt;Nexam reported slightly softer sales than we had expected, at SEK 44m (-11% y-o-y, -5% vs. ABGSCe). The overall weakness was driven by a 'wait-and-see' market, particularly in the Lightweight segment, while Performance Chemicals sales fell 25% y-o-y. Masterbatch held up relatively well at -1% y-o-y (+19% vs. ABGSCe). The bright spot remains Recycling, where sales reached SEK 6.8m (+89% y-o-y). Due to the lower sales, EBIT was also lower than we expected at SEK -5.5m (ABGSCe -3.5m). Management guides for a strong Q2 vs. Q1, which is also reflected in our estimates. We expect this to be driven by: 1) a gradual recovery across all segments, 2) contribution from the NA customer 3) continued growth in Recycling.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We lower our '26e-'28e sales by 1-2% and total '26e-'28e EBIT by 6m after the Q1 report. We continue to expect Nexam to reach positive EBIT in '27e driven by the scaling-up of Recycling, with several customers transitioning into industrial production, a return to growth in key segments (e.g. Lightweight) and a broader customer base.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Rising virgin plastic prices strengthen Recycling case&lt;/h3&gt;&lt;p&gt;Nexam highlights the recent surge in virgin plastic prices, where prices are up 40-80% vs. 2025 levels. This shifts recycling from a sustainability choice to a cost necessity, playing directly into Nexam's Reactive Recycling platform. Moreover, management reiterates its ambition to double Recycling sales in 2026 vs. 2025. The share has returned +2% over the last three months (vs. peers at -10% and OMXSALLS at +6%) and is trading at 1.1x-0.9x '26e-'28e EV/Sales.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nexam-chemical/Equity-research/2026/4/nexam-chemical---q1-soft-but-structural-tailwinds-building/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 21 Apr 2026 16:30:06 GMT</pubDate>
      <isin>SE0005101003</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nexam Chemical - A slightly softer quarter than expected</title>
      <description>&lt;a id="bm-comp-07143e37-93ef-4776-a5bc-f4ca49393d27" name="bm-comp-07143e37-93ef-4776-a5bc-f4ca49393d27" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="07143e37-93ef-4776-a5bc-f4ca49393d27" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1 sales of SEK 44m (-11% y-o-y), -5% vs. ABGSCe&lt;/li&gt;&lt;li&gt;EBIT SEK -5.5m (vs. ABGSCe -3.5m)&lt;/li&gt;&lt;li&gt;Recycling continues to show strength (+89% y-o-y)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-3da5ee10-fe29-41bd-b66d-9ff6ba35a8a1" name="bm-comp-3da5ee10-fe29-41bd-b66d-9ff6ba35a8a1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3da5ee10-fe29-41bd-b66d-9ff6ba35a8a1" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 results&lt;/h3&gt;&lt;p&gt;Sales came in at SEK 44m (-5% vs. ABGSCe 46m), -11% y-o-y. EBIT adj. came in lower at SEK -5.5m (vs. ABGSCe -3.5m). The company writes that the lower results are due to cautious customers reducing inventories, which has led to low deliveries in the quarter, particularly within Lightweight and High Temperature. Masterbatch sales of SEK 29m, were +19% vs. ABGSCe and -1% y-o-y. Recycling continues to show strength and sales were up +89% y-o-y (albeit from a low base). FCF came in at SEK -8.1m (vs. ABGSCe -8.3m)&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates and outlook&lt;/h3&gt;&lt;p&gt;On numbers alone, '26e-'28e sales change by -1%, and EBIT adj. changes by -2m. On outlook the company writes that its ambition of doubling Recycling sales in '26 vs '25 remains unchanged. Moreover, the company highlights structural changes such as high raw material prices which is positive for Recyling. Supporting this, the recent 40-80% surge in virgin plastic raw material prices is turning recycled material from an ESG preference into an economic necessity which should be a structural tailwind for Nexam.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;Prior to today's open, the share had returned +2% L3M (vs. peer median -11% and OMX Stockholm Allshare +6%), traded at 1.1x-0.8x '26e-'28e EV/Sales on our pre-report estimates vs. the peer median of 1.3x-1.0x. The company will host a &lt;a data-bm-trackable="false" href="https://www.youtube.com/live/yaWXA488tZ0?si=vDeq6KPpb0uRG4Ue" target="_blank"&gt;presentation&lt;/a&gt; of the Q1 results at 12:00 CEST.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-6d8768b3-3024-4c65-acdf-2f18656e44c2" name="bm-comp-6d8768b3-3024-4c65-acdf-2f18656e44c2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="6d8768b3-3024-4c65-acdf-2f18656e44c2" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-1934d8b4-79f2-4901-adb9-d024cfc21883" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nexam-chemical/Equity-research/2026/4/nexam-chemical---a-slightly-softer-quarter-than-expected/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 21 Apr 2026 07:30:05 GMT</pubDate>
      <isin>SE0005101003</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Qben Infra - Agreement to sell Nordic Inspekt Group</title>
      <description>&lt;a id="bm-comp-d0bbe7f6-d0af-444e-9824-f4060d02ef07" name="bm-comp-d0bbe7f6-d0af-444e-9824-f4060d02ef07" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d0bbe7f6-d0af-444e-9824-f4060d02ef07" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;New divestment sees Qben Infra...&lt;/li&gt;&lt;li&gt;...selling Nordic Inspekt group...&lt;/li&gt;&lt;li&gt;...to Framheim Capital Partners AS&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-52cbce79-22cd-4340-aa38-08a31e325c11" name="bm-comp-52cbce79-22cd-4340-aa38-08a31e325c11" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="52cbce79-22cd-4340-aa38-08a31e325c11" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Starting the year by cleaning&lt;/h3&gt;&lt;p&gt;Qben Infra (Qben) has entered an agreement to sell its shares in Nordic Inspekt Group AB to Framheim Capital Partners AS for SEK 150m, whereof Qben Infra (through ININ Group) owns 62.86% of Nordic Inspekt Group. The Inspect segment was about 14% of '25 sales and had EBITA of -SEK 21m. According to Qben, the transaction should allow for further focus on the remaining business, i.e. the Power segment, which has a strong market and a growing order backlog. Qben recently announced a strategic cooperation agreement with the Swedish energy technology company Byhmgard AB (publ). The transaction is subject to completion of due diligence and agreement on the final terms of a Share Purchase Agreement, which will be communicated by the end of June 2026.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;On the financials&lt;/h3&gt;&lt;p&gt;The Inspekt segment was a smaller part of sales and had negative earnings, and we therefore view the divestment as minor and positive for EBITA. For the transaction, net cash flow to Qben Infra, including debt repayment, amounts to SEK 116m, with a potential earn-out of up to SEK 30m, implying a total value of up to SEK 146m. Reported net debt as of Q4'25 was SEK 797m. The buyer, Framheim Capital Partners AS, has former Qben Infra CFO Patrik Egeland as managing parter.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;What is left?&lt;/h3&gt;&lt;p&gt;Qben Infra should be seen as an investment company. According to management, the transaction will free up resources that can be better utilised in the other fast-growing infrastructure business areas, which are benefiting from healthy market activity and a growing order backlog. Following completion of the divestment, Qben will consist of Qben Power and Qben Construction, which develops residential properties in Norway.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/qben-infra/Equity-research/2026/4/qben-infra---agreement-to-sell-nordic-inspekt-group/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 20 Apr 2026 15:30:04 GMT</pubDate>
      <isin>SE0023114012</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Proact - Adj. EBITA beat in prel Q1</title>
      <description>&lt;a id="bm-comp-ef03f4ff-a80c-4613-bd5a-3c6f59a26af4" name="bm-comp-ef03f4ff-a80c-4613-bd5a-3c6f59a26af4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ef03f4ff-a80c-4613-bd5a-3c6f59a26af4" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Positive PW: Adj. EBITA +36% vs ABG (mid-point)&lt;/li&gt;&lt;li&gt;Temporary boost from memory crisis and positive effects from cost-efficiencies&lt;/li&gt;&lt;li&gt;FY 2026 adj. EBITA likely up 10-15%&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-05f9e2b1-4bc1-4206-a5ad-62bbd8d086b2" name="bm-comp-05f9e2b1-4bc1-4206-a5ad-62bbd8d086b2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="05f9e2b1-4bc1-4206-a5ad-62bbd8d086b2" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Positive PW in Q1&lt;/h3&gt;&lt;p&gt;Proact published preliminary Q1 numbers this morning, above market expectations, with adj. EBITA 110-120m (+29-41% vs ABG, no cons), adj. EBITA margin 9-9.5% (ABG 6.9%). This is implies sales of SEK ~1,222-1,263m (-1% to +3% vs ABG). The positive adj. EBITA deviation is explained by both higher gross margin driven by temporary market conditions (pre-buying due to higher memory prices), as well as effects following cost-efficiency measures mainly implemented in 2025. Full report is due 5 May.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;2026 EBITA likely up 10-15%&lt;/h3&gt;&lt;p&gt;Proact mentions "temporary market conditions", so limited long-term effects, but as deviation is also driven by cost reductions these are of recurring nature and most likely linked to segments West (Netherlands) and Central (Germany). We expect the pre-buying boost to stick for another 1-2 quarters, but could linger into 2027. Consensus FY EBITA likely raised by 10-15%, and stock to outperform today.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-b9c86514-42dc-4566-bcfd-9f0b9e49847e" name="bm-comp-b9c86514-42dc-4566-bcfd-9f0b9e49847e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b9c86514-42dc-4566-bcfd-9f0b9e49847e" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-cbacd1c3-6230-4083-b3d7-c0dbc8a5ed11" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Prel Q1'26 deviation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-80259b2c-7355-41d7-adbf-ade36263ae02" name="bm-comp-80259b2c-7355-41d7-adbf-ade36263ae02" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="80259b2c-7355-41d7-adbf-ade36263ae02" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-cf43dbab-1d06-4476-80fc-37d62477c324" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;NTM EV/EBITA vs peers (Friday close)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, FactSet, peers: ATEA, Dustin, Bechtle, Cancom, Computacenter&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/proact/Equity-research/2026/4/proact---adj.-ebita-beat-in-prel-q1/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 20 Apr 2026 08:45:03 GMT</pubDate>
      <isin>SE0015961222</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Donkey Republic - Wet wheels won't stop the roll</title>
      <description>&lt;a id="bm-comp-8db434f8-15f5-4009-8b63-c5b0cad4e16e" name="bm-comp-8db434f8-15f5-4009-8b63-c5b0cad4e16e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8db434f8-15f5-4009-8b63-c5b0cad4e16e" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Small Q1e: +10% revenue growth, EBITDA of DKK -3.2m&lt;/li&gt;&lt;li&gt;German roll-outs on track; we remain in upper end of guidance&lt;/li&gt;&lt;li&gt;+20% revenue CAGR and hefty margin uplift; FVR of DKK 7-10&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-3be555c2-2aa1-473b-ae64-edcec8dad42c" name="bm-comp-3be555c2-2aa1-473b-ae64-edcec8dad42c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3be555c2-2aa1-473b-ae64-edcec8dad42c" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;We see +10% growth in Q1 despite weather drag&lt;/h3&gt;&lt;p&gt;Donkey Republic ("DONKEY") is due to report Q1 earnings late in April (exact date not disclosed). We forecast revenues of DKK 28.9m in the seasonally small Q1, for +10% growth y-o-y, driven by flattish revenue/bike (DKK 407) and a fleet size of 23.7k bikes. Q1 precipitation and temperatures in certain key markets should be a drag on revenue/bike, likely offsetting underlying improvements. Note roll-outs in Germany will not impact Q1, but we expect revenue/bike to decline slightly from Q2e onwards. We forecast Q1 EBITDA of DKK -3.2m, a strong improvement from the DKK -6.3m in Q1'25, with recent layoffs gradually visible.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Roll-outs appear on track; we remain in upper end of guidance&lt;/h3&gt;&lt;p&gt;We sense roll-outs in D&amp;#252;sseldorf and the Ruhr Region are tracking well, so we continue to expect FY'26 figures in the upper end of guidance, forecasting revenues of DKK 192m (guidance DKK 179m-194m) and EBIT of DKK 7.4m (guidance DKK 1m-9m).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;+20% revenue CAGR and hefty margin uplift; FVR of DKK 7-10&lt;/h3&gt;&lt;p&gt;Europe's bike-sharing fleet, part of the broader shared micromobility market, is projected to grow at +15% CAGR until '30e, and we see DONKEY's competitive edge centred around its high-quality fleet (especially after roll-out of its Gen4 bike), its lower prices (price/cost is 50% of scoring in EU tenders), and stronger relations with the cities it serves, coupled with solid positions in the Tier 2 and Tier 3 segments. Considering market tailwinds and DONKEY's pipeline and commercial momentum, including two recent large-scale wins in Germany, we forecast a revenue CAGR of +20% in '25-'28e (vs. +35% in '18-'25). With improving operating leverage, we model adj. EBITDA increasing from DKK 30m in '25 to DKK 84m in '28e and adj. EBIT reaching DKK 39m. We set a fair value range of DKK 7-10&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/donkey-republic/Equity-research/2026/4/donkey-republic---wet-wheels-wont-stop-the-roll/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 19 Apr 2026 17:30:02 GMT</pubDate>
      <isin>DK0061540770</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Catella - Macro uncertainty to weigh on Q1'26</title>
      <description>&lt;a id="bm-comp-851cc98a-8e5b-43c4-b027-1446bb47ddbd" name="bm-comp-851cc98a-8e5b-43c4-b027-1446bb47ddbd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="851cc98a-8e5b-43c4-b027-1446bb47ddbd" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q1 burdened by macro uncertainty&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;EPS scenario only tweaked&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;2026e-27e EV/EBIT of 3-7x with 4-8% yield&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c2110d29-7dbe-4263-bf86-efd6c6edf908" name="bm-comp-c2110d29-7dbe-4263-bf86-efd6c6edf908" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c2110d29-7dbe-4263-bf86-efd6c6edf908" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Macro uncertainty negative for transaction activity&lt;/h3&gt;&lt;p&gt;For the Q1&amp;#8217;26 report due 8 May, we expect EBIT of SEK 18m (-43m). We expect that the global macro uncertainty has negatively impacted transaction activity here in the start of 2026, burdening earnings generation, especially within the Corporate Finance segment. Q1'26 will be the first quarter with Catella's new segment reporting, where Principal investments will be incorporated into the Investment management segment. Following this change, we estimate that the AUM base within Investment Management (IM) will increase by SEK 8bn q-o-q to SEK 161bn, helped by FX tailwinds, but primarily due to the new inclusion of development mandates (we forecast SEK 6bn). We expect the Investment Management segment to deliver operating profit of SEK 42m in the quarter, driven by fixed fees as we pencil in a very small contribution from variable fees in Q1'26.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;'26e reduced on lower Corporate Fin. assumptions&lt;/h3&gt;&lt;p&gt;In this preview, we lower our Corporate Finance estimates for the next two quarters on weaker activity assumptions, reducing 2026e EBIT by 14%. Positive FX effects and lower financial expenses following bond buybacks reduce the negative EPS effect, which is only down by 2% for 2026. Our estimates for 2027 and 2028 remain unchanged.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;2026e-27e EV/EBIT of 3-7x with dividend yield of 4-8%&lt;/h3&gt;&lt;p&gt;Reduced global macro uncertainty would be positive for the transaction activity outlook as well as Catella's earnings generation the coming years. Applying our latest revisions, Catella is trading at a 2026e-27e EV/EBIT of 3-7x and offers an appealing dividend yield of 4-8% p.a. across our forecast horizon. In addition, the company offers a strong balance sheet, providing Catella with the necessary resources to act should the right attractive opportunities arise.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/catella/Equity-research/2026/4/catella---macro-uncertainty-to-weigh-on-q126/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 17 Apr 2026 09:00:05 GMT</pubDate>
      <isin>SE0000188518</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ferronordic - Germany weighs, recovery signals emerging</title>
      <description>&lt;a id="bm-comp-92bac66c-6849-46d6-9a77-3850ec92d9dd" name="bm-comp-92bac66c-6849-46d6-9a77-3850ec92d9dd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="92bac66c-6849-46d6-9a77-3850ec92d9dd" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font style="background-color:#ffffff;"&gt;Q1e: Sales of SEK 1,143m (1,206m), EBIT of SEK 35m (13m)&lt;/font&gt;&lt;/li&gt;&lt;li&gt;US good but not great, Germany soft&lt;/li&gt;&lt;li&gt;Trading at 12-7x EV/EBIT '26e-'27e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-823622b3-2eae-4366-9e2e-e6a55750a722" name="bm-comp-823622b3-2eae-4366-9e2e-e6a55750a722" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="823622b3-2eae-4366-9e2e-e6a55750a722" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;font style="background-color:#ffffff;"&gt;Q1 expectations&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;We expect Ferronordic to deliver Q1 sales of SEK 1,143m, -5% y-o-y (of which -10% FX). We expect adj. EBIT of SEK 35m, rendering a margin of 3.0% (1.1% in Q1'25, 4.5% in Q4'25). We do not fully extrapolate the seasonally strong Q4, which was reached with ATH EBIT margins in the US.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Mixed regional trends, but leading indicators improving&lt;/h3&gt;&lt;p&gt;For the US, we make slight negative margin adjustments following the integration of Housby Heavy Equipment. Management reports that the underlying market remains solid so far, despite increasing geopolitical uncertainties. This is also mirrored by continued strong ISM figures (52.7 in March). We estimate that the NWC build-up during Q4 will continue as Rudd sales remain relatively high. In Germany, we expect truck sales to remain subdued in the near term. Management flagged persistent customer caution, with order deferrals into H2'26, partly reflecting the ongoing geopolitical uncertainty. We cut Germany '26e EBIT by ~SEK 7m, primarily based on lower margin assumptions, with a lack of operational leverage continuing to weigh on earnings. That said, there are some encouraging leading indicators, which prevents us from extrapolating the current weakness. Volvo Trucks raised its European 2026 market guidance by 10,000 units (~3%) in Q4, and the German manufacturing PMI expanded sequentially to 52.2 in March (50.9 in February), both pointing to gradually improving end-demand. Zooming out, we cut '26e group EBIT by 4% with sales unchanged (+2% FX, -2% org.).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font style="background-color:#ffffff;"&gt;Trading at 12-7x EV/EBIT vs. peers at 15-14x&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;Finally, we expect ageing truck fleets to eventually reach an inflection point at which fleet renewal will drive a German recovery. The share is currently trading at 12-7x EBIT '26e-'27e vs our distributor peer group at 15-14x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ferronordic/Equity-research/2026/4/ferronordic---germany-weighs-recovery-signals-emerging/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 15 Apr 2026 15:45:05 GMT</pubDate>
      <isin>SE0005468717</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Nexam Chemical - We expect another quarter of mixed signals</title>
      <description>&lt;a id="bm-comp-60150a9f-e7e2-4fc2-bc5e-0bd303df86e7" name="bm-comp-60150a9f-e7e2-4fc2-bc5e-0bd303df86e7" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="60150a9f-e7e2-4fc2-bc5e-0bd303df86e7" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Report out on 21 April&lt;/li&gt;&lt;li&gt;Q1e sales of SEK 46m (49m), EBIT SEK -3.5m (-2.8m)&lt;/li&gt;&lt;li&gt;Recycling remains the key growth driver&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-38ae9db6-ccc2-48ad-a160-7624b340089c" name="bm-comp-38ae9db6-ccc2-48ad-a160-7624b340089c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="38ae9db6-ccc2-48ad-a160-7624b340089c" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 expectations&lt;/h3&gt;&lt;p style="text-align:left;"&gt;We estimate Q1 sales of SEK 46m, -7% y-o-y. In Performance Chemicals, Recycling should sustain its momentum (~20% of sales in Q4'25) to continue to drive growth in the segment. We expect High Temperature to normalise after the temporary inventory build-up among its largest customer in Q4; we estimate segment sales of SEK 22m (20m). We think Masterbatch, which is more exposed to general industry, will continue to face soft end-markets; we estimate sales of SEK 24m, down 17% y-o-y. On EBIT, we estimate SEK -3.5m (-2.8m).&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We cut '26e-'28e sales by 3-2% and total '26e-'28e EBIT by SEK 7m ahead of the Q1 report. We still expect Nexam to reach positive EBIT in '27, supported by growing Recycling volumes.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We remain positive on Recycling&lt;/h3&gt;&lt;p&gt;Our long-term view is largely unchanged. The Recycling segment has been expanding rapidly, offsetting weakness in areas such as PET-form. Notably, a US-based customer is broadening its use of Nexam additives for food packaging, with an expected annual run-rate of SEK 11m from Q2'26. Management sees an obtainable market of ~EUR 70m (assuming 5% penetration in Europe and 2% elsewhere), compared with Recycling sales of ~EUR 2.2m in 2025, implying substantial upside. The share has returned +7% over the last three months (vs. peers at -16% and OMXSALLS at +3%) and is trades at 1.2x-0.9x '26e-'28e EV/Sales. We lower our fair value range to SEK 3.0-4.0 on our estimate cuts (previously SEK 3.0-5.0).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/nexam-chemical/Equity-research/2026/4/nexam-chemical---we-expect-another-quarter-of-mixed-signals/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 15 Apr 2026 13:30:06 GMT</pubDate>
      <isin>SE0005101003</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ovzon - Strong backlog fuels confidence in 2026 </title>
      <description>&lt;a id="bm-comp-60103424-88e5-4eab-8f6e-71fa3bed0016" name="bm-comp-60103424-88e5-4eab-8f6e-71fa3bed0016" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="60103424-88e5-4eab-8f6e-71fa3bed0016" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Strong Q1e: sales +196% y-o-y, 30% EBIT margin&lt;/li&gt;&lt;li&gt;Small estimate revisions&lt;/li&gt;&lt;li&gt;Ovzon-3 still not at full capacity: 18x 2026e EV/EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9c4483f6-a2ba-45e1-8d1f-125f08b2700a" name="bm-comp-9c4483f6-a2ba-45e1-8d1f-125f08b2700a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9c4483f6-a2ba-45e1-8d1f-125f08b2700a" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong Q1 on the cards&lt;/h3&gt;&lt;p&gt;Demand for SATCOM continues to grow, and Ovzon, being a market leader in its niche, is capitalising on this well. Although order activity has recently been slow in the seasonally quiet Q1, the end-of-Q4 backlog was SEK 1bn (of which ~SEK 800m is to be delivered in 2026), which bodes well for strong sales in the near term. Apart from the ongoing contribution of the breakthrough FMV order, which reached full capacity in Q4, the company has signed an Ovzon-3-related order with the UK MoD that was utilised by mid-Q1. On the flipside, we expect a slight sequential headwind from the SSC contract from Dec'25 that has so far not been renewed. All in all, we forecast SATCOM revenue of SEK 192m, up 152% y-o-y. Combined with Terminal sales of SEK 75m, we estimate Q1 sales at SEK 267m, +196% y-o-y. Regarding GMs, we expect a favourable mix given the high share of SATCOM sales. Although opex is gradually increasing, operational leverage remains high, leading us to forecast Q1 EBIT of SEK 81m (30% EBIT margin), up from SEK -16m in Q1'25.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fine-tuned estimate revisions&lt;/h3&gt;&lt;p&gt;We make small revisions to our forecasts, and now expect 2026e sales of SEK 1,072m, up from SEK 735m in 2025, with estimate visibility comparably high. While the recent USD 1.3m order with the US DoW was small in absolute terms, the signal value is much more significant given that it is the first order from this customer since August 2024. Therefore, we anticipate that more orders will be announced.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We expect more Ovzon-3 signings ahead&lt;/h3&gt;&lt;p&gt;The stock is +27% YTD and is trading at 18x 2026e EV/EBIT. We expect more Ovzon-3-related signings throughout the year and are looking forward to getting more details on potentially new satellite projects (which current demand is supporting, we argue).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ovzon/equity-research/2026/4/ovzon---strong-backlog-fuels-confidence-in-2026-/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 15 Apr 2026 09:00:05 GMT</pubDate>
      <isin>SE0010948711</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Embellence Group - Investing for the longer term</title>
      <description>&lt;a id="bm-comp-f8cebb8e-50e6-42fd-85b7-90acb0ef970f" name="bm-comp-f8cebb8e-50e6-42fd-85b7-90acb0ef970f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f8cebb8e-50e6-42fd-85b7-90acb0ef970f" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We expect EBITA adj. of SEK 27m in Q1, -15% y-o-y&lt;/li&gt;&lt;li&gt;We cut '26e EBITA by 3%&lt;/li&gt;&lt;li&gt;We reiterate our fair value range of SEK 36-43&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9a578231-8d24-426b-8b42-6f9feb4b97b0" name="bm-comp-9a578231-8d24-426b-8b42-6f9feb4b97b0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9a578231-8d24-426b-8b42-6f9feb4b97b0" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;We expect EBITA adj. growth of -15% in Q1'26e&lt;/h3&gt;&lt;p&gt;Embellence Group's net sales development keeps being dictated by previous comparable growth, in our view. While Group comps appear to be markedly easier than Q4 in Q1, we forecast muted growth, as Artscape comparables are affected by a large order in Q1'24. We expect stronger performance for segments with larger Swedish exposure (Bor&amp;#229;stapeter, Pappelina, External manufacturing), while we expect the soft UK market to weigh on Cole &amp;amp; Son. All in all, we expect organic growth of 3.5% in Q1'26e for net sales of SEK 199m. We expect a flat gross margin y-o-y, as we expect positive volume effects in the factory to be offset by a higher share of Artscape in the sales mix. Initiatives to drive the DTC move, upgrade websites and having both a CEO and a CFO in Q1'26 (vs. a CFO also acting as CEO in Q1'25) mean that we expect a 1.4pp higher SG&amp;amp;A ratio for SEK 27m EBITA adj., -15% y-o-y.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We cut our '26e EBITA by 3%&lt;/h3&gt;&lt;p&gt;We lower our 2026 organic growth estimates by 70bp in this note, seeing e.g. softer CPA forecasts for renovation in the UK. We also raise our SG&amp;amp;A estimates to better reflect costs related to the ongoing move to DTC, which means we cut our EBITA adj. margin forecasts by 60-30bp for '26e-'28e. Offsetting these downward revisions are positive FX effects, which boost EBITA by 2-3%. In total, we cut our '26e EBITA by 3% and leave '27e-'28e unchanged. Our forecasts reflect an 8% EBITA CAGR '25-'28e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We reiterate our fair value range of SEK 36-43&lt;/h3&gt;&lt;p&gt;The Embellence share is trading at 7.4x-6.1x our '26e-'27e EBITA after returning -14% YTD. As we make only minimal adjustments to our forecasts, we reiterate our fair value range of SEK 36-43, which corresponds to 7.6x-9x '26e EBITA. At the current share price, the implied annual FCF yield after leasing costs is 9-13% for '26e-'28e.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/embellence-group/Equity-research/2026/4/embellence-group---investing-for-the-longer-term/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 14 Apr 2026 06:00:17 GMT</pubDate>
      <isin>SE0013888831</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Petrolia Noco - Estimate changes from Crude Quarterly</title>
      <description>&lt;a id="bm-comp-303705ae-6e9a-4bb2-8ce1-3b40bc680721" name="bm-comp-303705ae-6e9a-4bb2-8ce1-3b40bc680721" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="303705ae-6e9a-4bb2-8ce1-3b40bc680721" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We raise our '26 oil price estimate to USD 81/bbl (prev. 65). We reiterate our long-term oil price estimate for '27-'30 of USD 75/bbl.&lt;/li&gt;&lt;li&gt;We raise our '26/'27 gas price estimate to USD 14.6/11.0/mmBTU (prev. 9.0/8.5). We also raise our long-term gas price estimate for '28-'30 to USD 9.0/mmBTU (prev. 8.0).&lt;/li&gt;&lt;li&gt;We reiterate our USD/NOK assumption of 10.0.&lt;/li&gt;&lt;li&gt;Please see the table below for a summary of the estimate changes, and refer to our &lt;em&gt;Crude Quarterly&lt;/em&gt; report for further details.&lt;/li&gt;&lt;/ul&gt;&lt;br /&gt;&lt;p style="text-align:left;"&gt;In our 14 April Crude Quarterly report, we update our oil and gas price assumptions for our covered E&amp;amp;Ps. See the report for more details on our new oil market estimates and our updated price assumptions. Also, see below in this report for quarterly and annual company estimates.&lt;/p&gt;&lt;p style="text-align:left;"&gt;&lt;strong&gt;Note:&lt;/strong&gt; For Petrolia Noco specifically, we make negative revisions to our estimates despite our raised oil and gas price assumptions. This is because we applied the forward curves rather than the ABGSC oil price deck in our &lt;a data-bm-trackable="false" href="https://abg-portal.bluematrix.com/links2/pdf/df26ecd0-31dc-47d2-abc6-a3d9989689d1?firmId=45691" target="_blank"&gt;previous report&lt;/a&gt;, published on 31 March.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-af37fe1c-244a-488e-82ae-4f0b51040d09" name="bm-comp-af37fe1c-244a-488e-82ae-4f0b51040d09" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="af37fe1c-244a-488e-82ae-4f0b51040d09" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-c0b77a1e-e899-4f4e-950c-18f5bf4a71c2" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/petrolia-noco/Equity-research/2026/4/petrolia-noco---estimate-changes-from-crude-quarterly/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 14 Apr 2026 04:30:06 GMT</pubDate>
      <isin>CY0102630916</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Alligo - Organic growth should accelerate in Q1</title>
      <description>&lt;a id="bm-comp-d755365a-dfcc-467e-b93d-6e4402ff7e2b" name="bm-comp-d755365a-dfcc-467e-b93d-6e4402ff7e2b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d755365a-dfcc-467e-b93d-6e4402ff7e2b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We see 3% organic growth in Q1, supported by cold January weather&lt;/li&gt;&lt;li&gt;Swedish and Norwegian earnings developing well, while Finland lags&lt;/li&gt;&lt;li&gt;Samuel Alteborg announced as new CEO starting in August&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-f2c678d3-5211-404a-a7fb-635ce80b06b1" name="bm-comp-f2c678d3-5211-404a-a7fb-635ce80b06b1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f2c678d3-5211-404a-a7fb-635ce80b06b1" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 expectations&lt;/h3&gt;&lt;p&gt;After returning to organic growth in Q4 (albeit barely), we expect the positive trend to accelerate in Q1 and forecast 3% organic growth, which should be supported by the cold January weather. The positive gross margin development should also persist into Q1, where we have 41.3% (40.9%). With the underlying cost base unchanged from H2, this leads us to an adj. EBITA margin estimate of 4.0% (3.3%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We only make very minor adjustments to our estimates. Sweden and Norway are developing in the right direction, but Finland will likely continue to underperform in the near term, at least until the cost reductions associated with the ended customer relationships announced last quarter take full effect in Q3.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;On 19 February, Alligo announced that it has found a successor to current CEO Clein Ullenvik in Samuel Alteborg, most recently CEO of Cramo, a rental company supplying machinery and equipment to both construction companies and industrial customers. Mr. Alteborg will take over the helm in August. Our initial take is that Mr. Alteborg's experiences seem highly relevant for his new role as CEO of Alligo, and look forward to hearing about his strategy for Alligo once he takes over. Our overall view of Alligo remains largely unchanged, as the company looks set to reap the rewards of an improving market over the coming years.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/Alligo/Equity-research/2026/4/alligo---organic-growth-should-accelerate-in-q1/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 13 Apr 2026 04:47:13 GMT</pubDate>
      <isin>SE0009922305</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Inission - Expect momentum to continue in Q1</title>
      <description>&lt;a id="bm-comp-4737d977-a5e0-45fd-867d-266bd410cb31" name="bm-comp-4737d977-a5e0-45fd-867d-266bd410cb31" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4737d977-a5e0-45fd-867d-266bd410cb31" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We see 21% sales growth and an EBITA margin of 7.2% (4.8%)&lt;/li&gt;&lt;li&gt;Expect company will beat somewhat conservative '26e guidance&lt;/li&gt;&lt;li&gt;Strong operational momentum, 12x-9x P/E vs peers at 17x-13x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-e55899e4-03dc-4b56-a2dd-020227f9bb09" name="bm-comp-e55899e4-03dc-4b56-a2dd-020227f9bb09" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e55899e4-03dc-4b56-a2dd-020227f9bb09" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 expectations&lt;/h3&gt;&lt;p&gt;We expect the strong momentum built in H2 will continue in Q1 and forecast sales growth of 21% (16% organic), supported by the order book, and an adj. EBITA margin of 7.2% (4.8%), as the Inission segment leverages growing volumes and the Enedo segment improves thanks to its new cost base and return to growth.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We only make minor adjustments to our estimates, mainly driven by improved FX. We now forecast '26e sales of SEK 2.46bn at an adj. EBITA margin of 6.8% (7.0% Inission, 2.0% Enedo), which is a bit above the company's guidance of 2.3-2.5bn sales at a margin &amp;gt;6%, but as we stated in our Q4 comment, we believe the company is being a bit conservative with its guidance.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;We remain positive on Inission's outlook for '26e, as the company has clearly started converting the high book-to-bill in '25 into both sales and margin expansion. This started first in the Inission segment during Q3, but should now gradually start spreading to Enedo at the same time as the cost savings implemented in the segment during '25 take full effect. The share is now trading at 12x-9x '26e-'28e P/E, compared to peers at 17x-13x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/inission/Equity-research/2026/4/inission---expect-momentum-to-continue-in-q1/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 13 Apr 2026 04:46:26 GMT</pubDate>
      <isin>SE0016275069</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>SinterCast - Headwinds to persist in Q1</title>
      <description>&lt;a id="bm-comp-65c0ad4a-b676-4e2e-a198-ed130f568499" name="bm-comp-65c0ad4a-b676-4e2e-a198-ed130f568499" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="65c0ad4a-b676-4e2e-a198-ed130f568499" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1e: 2.8m EEs, -15% sales growth, 18% (37%) EBIT margin&lt;/li&gt;&lt;li&gt;FX headwinds to abate from Q2, market outlook improving&lt;/li&gt;&lt;li&gt;Growth outlook confirmed by incoming CEO in &lt;a data-bm-trackable="false" href="https://www.youtube.com/watch?v=MLXmabMecwY" target="_blank"&gt;fireside chat&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-e8e5408f-275b-4511-9f76-9ff59239a7a9" name="bm-comp-e8e5408f-275b-4511-9f76-9ff59239a7a9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e8e5408f-275b-4511-9f76-9ff59239a7a9" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 expectations&lt;/h3&gt;&lt;p&gt;While the market outlook is improving for SinterCast, Q1 will likely still be a quarter of subdued earnings. We forecast engine equivalent production of 2.8m (3.1m) and limited equipment sales, due to seasonality, for total sales of SEK 23m, down 15% y-o-y, of which 12% FX. SinterCast's high operating leverage combined with likely negative FX revaluations therefore lead us to expect an adj. EBIT margin of 17.9% (37.4%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;Q1 currently looks to be the last quarter with such a strong FX headwind, and improved FX rates since our Q4 comment are the primary driver of our estimate upgrades in this note.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;We recently hosted SinterCast's incoming CEO, V&amp;#237;tor Anjos, for a &lt;a data-bm-trackable="false" href="https://www.youtube.com/watch?v=MLXmabMecwY" target="_blank"&gt;fireside chat&lt;/a&gt;. Anjos, who is set to succeed Steve Dawson in May, outlined a strategy of continuity but with a new emphasis on inorganic growth, aiming to pursue M&amp;amp;A close to SinterCast's core expertise. He reiterated the updated production milestones of 6m EEs (peak monthly rate) by '29 and 8m by '31, noting that annual volumes typically land 0.2-0.4m below the peak achieved in a given year. Underpinning these targets are two new engine platforms launching over the next two years and a third programme in development for '31 &amp;#8212; in some cases representing first-generation CGI engines for the respective OEM. He highlighted that CGI penetration in commercial vehicles is set to rise from 40% today to 80% by 2030, growing roughly five times faster than electrification in the segment. On capital allocation, Anjos signalled a balanced approach between reinvesting for growth and maintaining the dividend, emphasising SinterCast's scalability given its 90% recurring revenue base and lean cost structure. We maintain our view that SinterCast looks set for substantial growth as the commercial vehic&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/sintercast/Equity-research/2026/4/sintercast---headwinds-to-persist-in-q1/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 13 Apr 2026 04:45:10 GMT</pubDate>
      <isin>SE0000950982</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>OssDsign - Declining sales in Q1</title>
      <description>&lt;a id="bm-comp-f3dd9658-6c16-409b-b343-ad4460a6a4dd" name="bm-comp-f3dd9658-6c16-409b-b343-ad4460a6a4dd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f3dd9658-6c16-409b-b343-ad4460a6a4dd" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Profit warning ahead of Q1'26 - results due 5 May&lt;/li&gt;&lt;li&gt;3.6% organic decline in sales (-17% in SEK)&lt;/li&gt;&lt;li&gt;Mid-range EBIT for Q1'26e implies -23% on ABGSCe FY'26e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-cb7d7275-8418-4e8c-9f88-c696149de8c5" name="bm-comp-cb7d7275-8418-4e8c-9f88-c696149de8c5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cb7d7275-8418-4e8c-9f88-c696149de8c5" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Q1 sales 24% below ABGSCe&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;OssDsign has pre-announced Q1'26 sales of USD 4m, or SEK 37m, and EBIT of SEK -14m to -12m. This compares with our Q1'26e sales of SEK 49m and EBIT of SEK -7m. Hence, sales were 24% below ABGSCe and down 17% y-o-y, versus our expectation of 9% growth. In USD terms, sales declined 4% y-o-y. The company attributes the shortfall to limited sales channel expansion in late 2025, departures among sales staff, and temporarily slower activity in key accounts during contract negotiations.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates to come down&lt;/h3&gt;&lt;p&gt;We expect negative estimate revisions following the preliminary numbers. The EBIT guidance mid-point of SEK -13m is SEK 6m below our Q1'26e expectations of SEK -7m and implies -23% on our FY'26e EBIT estimate of SEK -27m. While management highlights that some of the issues were temporary, it points to weaker commercial execution, which may take time to normalise.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Warranted share price reaction&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;The miss in Q1'26 is substantial, both on sales and EBIT, and it is likely to weaken confidence in the near-term growth trajectory for Catalyst after several quarters with flattish development. Even if some of the weakness proves temporary, the market is likely to focus on the increased uncertainty around the sales growth. The new CEO is in the process of building up, to some degree, a new sales and marketing team in the US, which may take some time, creating short term volatility in the sales development, as illustrated in Q1. The share is currently down 36%, which is more than the expected earnings revisions, but likely factors in the risk of continued sales disruptions in Q2, which we do not believe is unrealistic.&lt;/p&gt;&lt;br /&gt;&lt;table id="bm-img-c8155b3e-c927-4f99-9b20-9af14c06fff2" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Q1 prel deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ossdsign/Equity-research/2026/4/ossdsign---declining-sales-in-q1/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 10 Apr 2026 13:15:04 GMT</pubDate>
      <isin>SE0012570448</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Xplora Technologies - Si si senior</title>
      <description>&lt;a id="bm-comp-c6cca4b7-b9de-404e-9bce-f6f587cf3737" name="bm-comp-c6cca4b7-b9de-404e-9bce-f6f587cf3737" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c6cca4b7-b9de-404e-9bce-f6f587cf3737" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Xplora has the tools to drive a good senior conversion rate&lt;/li&gt;&lt;li&gt;We forecast a ~30% EBITA CAGR from '25e to '28e...&lt;/li&gt;&lt;li&gt;... leading EV/EBITA to drop from 17x in '25 to 6.5x in '28e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-0fee97f5-095f-4279-947c-2fd93fcae3e4" name="bm-comp-0fee97f5-095f-4279-947c-2fd93fcae3e4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0fee97f5-095f-4279-947c-2fd93fcae3e4" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;We slightly postpone the ramp-up of senior subscriptions...&lt;/h3&gt;&lt;p&gt;Q4 was another strong quarter, driven by strong device revenue and GM in the senior segment. The ARPU was disappointing, however, and we therefore cut ARPU by 8% for &amp;#8216;27e-&amp;#8216;28e. We have also delayed the ramp-up of subscriptions in the senior segment, as Xplora has not yet announced that it has reached a meaningful number of subs (&amp;gt;10k). Hence, we lower our expectation for senior subscriptions at YE'26 from to 62k to 34k. Additionally, we extend the ramp-up period, and now expect it to reach a steady state conversion rate of 12% in Q4&amp;#8217;27e (from Q1&amp;#8217;27e, which was likely too optimistic) with a gradual ramp-up until then. This is, however, mostly offset by a higher conversion rate in the Kids segment. This lifts &amp;#8216;26e EBITA by 17%, but lowers &amp;#8216;28e by 4%.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;... but still see good long-term potential&lt;/h3&gt;&lt;p&gt;With ~1.2m senior phones sold annually, converting senior customers to recurring subscribers is the key value driver. By the end of H1&amp;#8217;26, Doro Connect will be live on its own webstores across all markets, followed by a retail rollout. We have looked at the LTV/CAC of product discounting and argue that as long as the GM is 60% or higher, the LTV/CAC of giving free feature phones in exchange for subscriptions is very attractive (see inside the report). We therefore argue that Xplora has the necessary tools to drive a high conversion rate in the senior segment. Keep in mind that we have assumed some CAC in our estimates which is directly expensed over the P&amp;amp;L, underestimating the underlying earnings. If we rather were to capitalise it and depreciate it over five years, '27e EBITA would increase by NOK 30m or 12%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of NOK 47-81/share&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Xplora is now trading at 13.9x '26e EV/EBITA, which drops to 6.5x &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/xplora_technologies/Equity-research/2026/4/xplora-technologies---si-si-senior/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 10 Apr 2026 05:00:06 GMT</pubDate>
      <isin>NO0010895782</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Proact - Low top-line visibility, better bottom-line</title>
      <description>&lt;a id="bm-comp-d6ccb48b-3a56-469f-be92-908169bdfdc9" name="bm-comp-d6ccb48b-3a56-469f-be92-908169bdfdc9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d6ccb48b-3a56-469f-be92-908169bdfdc9" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Memory prices could cause pre-buying in H1 and setback thereafter&lt;/li&gt;&lt;li&gt;Good earnings resilience, 8% adj. EBITA growth in 2026e&lt;/li&gt;&lt;li&gt;7.2x 2026e EV/EBITA and good financial headroom&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-e2f4f9d6-c448-4d0e-9f36-3abc9bc11d70" name="bm-comp-e2f4f9d6-c448-4d0e-9f36-3abc9bc11d70" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e2f4f9d6-c448-4d0e-9f36-3abc9bc11d70" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Effects from rising memory prices yet to be seen&lt;/h3&gt;&lt;p&gt;Dell and NetApp have concluded price increases on storage products amid the rises in input costs, which Proact will pass on to customers as a re-seller. This therefore has a larger impact on the top line than the bottom line. Some customers may have tried to pre-buy products before the price increases, which could support volumes in Q1, while some may become more cautious about new orders, which instead would serve as a headwind. Another factor to have in mind is prolonged delivery times in the recent demand environment and the potential for inflated orders, which we will have limited insight into as Proact does not report orders but only recognises revenues at the time of delivery. We expect H1'26 volumes to be OK, supported by both some pre-buying and price increases, while there is a risk of a setback in system sales in H2'26 if delivery times move volumes into 2027. For Q1, we estimate 3% organic growth and adj. EBITA of SEK 85m, up 8% y-o-y for a margin of 6.9% (6.5%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Reduced estimate visibility, but resilient earnings power&lt;/h3&gt;&lt;p&gt;We make small positive adjustments to our organic growth estimates for system sales in H1'26, but small negative changes in H2, followed by somewhat higher ones in 2027e. However, we acknowledge that there are several moving parts, and the estimate risks are therefore high. Combined with good cost control, we see adj. EBITA growth throughout the whole of 2026e (+5-15% on quarterly basis and +8% full-year). All in all, we raise adj. EBITA by 1-2% in 2026e-28e including small positive FX effects.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Share at ~7x 2026e EV/EBITA&lt;/h3&gt;&lt;p&gt;On our revised estimates, the share is trading at 7.2x 2026e EV/EBITA, 28% below peers, and Proact has the financial capability to pay dividends, buy back shares and acquire companies with its net cash balance shee&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/proact/Equity-research/2026/4/proact---low-top-line-visibility-better-bottom-line/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 09 Apr 2026 06:30:05 GMT</pubDate>
      <isin>SE0015961222</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Svedbergs Group - UK outlook has become bleaker</title>
      <description>&lt;a id="bm-comp-b973f653-db11-4368-9bca-18ee0e1bd738" name="bm-comp-b973f653-db11-4368-9bca-18ee0e1bd738" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b973f653-db11-4368-9bca-18ee0e1bd738" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We expect near-term headwinds: Q1 EBITA -8% y-o-y&lt;/li&gt;&lt;li&gt;Soft UK forecasts mean we lower '26e-'28e EBITA by 4-1%&lt;/li&gt;&lt;li&gt;We lower our fair value range to SEK 55-75, 10x-13x '26e EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-8cb6361e-9711-4744-879d-efeccd33b66c" name="bm-comp-8cb6361e-9711-4744-879d-efeccd33b66c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8cb6361e-9711-4744-879d-efeccd33b66c" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Higher shipping rates and ROT hangover could weigh on Q1&lt;/h3&gt;&lt;p&gt;Seeing soft macro signals from the UK and Sweden, Svedbergs Group's two largest markets, and also tougher comparable growth figures sequentially, we expect a deceleration in organic growth of 4% in Q1, for net sales of SEK 580m. We expect freight-related gross margin pressure in Roper Rhodes to partly offset pricing initiatives, for a 30bp gross margin expansion, but higher opex related to selling initiatives will weigh on margins, for an EBITA margin contraction of 80bp to 14.9% and EBITA of SEK 86m, -8% y-o-y.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Soft signals from the UK lead to 4% lower '26e EBITA&lt;/h3&gt;&lt;p&gt;We cut our group '26e-'28e EBITA estimates by 4-1%, lowering our EBITA forecasts for the Svedbergs and Roper Rhodes segments. We cut our Svedbergs estimates near-term on a soft ROT backdrop, as we assess that a disproportionate number of bathroom projects were done before the new year to benefit from the then-higher tax deductions. We cut our Roper Rhodes figures as well on the back of soft CPA forecasts and higher freight rates, which we believe could have a negative impact on Roper Rhodes' gross margins, in particular given the business model with production in China. Updated FX rates offset some of our estimate cuts, however.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;We lower our fair value range to SEK 55-75 (57-77)&lt;/h3&gt;&lt;p&gt;The Svedbergs share has returned 2% YTD, and is now trading at 12.1x '26e EV/EBITA. We lower our fair value range to SEK 55-75 (57-77) in this note, which corresponds to '26e EV/EBITA of 10x-13x. We argue the most relevant peers to Svedbergs Group are Nordic home improvement companies, which are trading at an average 11.6x '26e EV/EBITA.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/svedbergs/Equity-research/2026/4/svedbergs-group---uk-outlook-has-become-bleaker/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 07 Apr 2026 15:00:03 GMT</pubDate>
      <isin>SE0000407991</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Proact - Fireside chat with President &amp; CEO Magnus Lönn</title>
      <description>&lt;a href='https://cr.abgsc.com/foretag/proact/Media/2026/03/proact---fireside-chat-with-president--ceo-magnus-lonn/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 07 Apr 2026 13:30:00 GMT</pubDate>
      <isin>SE0015961222</isin>
      <youtube>5neTU0vl-m0</youtube>
      <category>Media</category>
    </item>
    <item>
      <title>Careium - Entering a growth-focused period</title>
      <description>&lt;a id="bm-comp-3f5ca999-a7df-433c-8801-51ed5acd5b4b" name="bm-comp-3f5ca999-a7df-433c-8801-51ed5acd5b4b" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3f5ca999-a7df-433c-8801-51ed5acd5b4b" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1e: 10% organic sales growth, 4% adj. EBITA margin&lt;/li&gt;&lt;li&gt;We cut our EBITA estimates by 7-2%&lt;/li&gt;&lt;li&gt;Trading at 9x '26e EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-bece69cd-a836-4b21-af03-d5c8f4ffb2f4" name="bm-comp-bece69cd-a836-4b21-af03-d5c8f4ffb2f4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bece69cd-a836-4b21-af03-d5c8f4ffb2f4" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1e: strong organic growth, but soft margins&lt;/h3&gt;&lt;p&gt;We expect Q1 to be strong in terms of organic growth, as Careium will no longer face comps that include financial lease agreements. We reiterate our view that Q1e will be soft on earnings, as margins will be highly affected by investments in organic growth and negative sales mix. We expect Q1 sales and adj. EBITA of SEK 216m and SEK 9m, respectively, corresponding to y-o-y organic sales growth of 10% and a margin of 4.1%, compared to 8.4% Q1'25. In the UK &amp;amp; Ireland, we expect 2% organic growth, which is offset by an FX effect of -11%. We keep in mind that service sales in this segment were positively affected by a one-time revenue recognition in Q1'25, therefore presenting tough comps. The UK one-off also had a positive effect on the gross margin, and as such we expect a GM of 42.5%, which is an arguably strong GM in a broader context, but down 2pp y-o-y.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Growth investments a necessary evil&lt;/h3&gt;&lt;p&gt;We have revised our estimates and lower '26e-'28e sales by 2%, driven by a decrease in the '26e organic growth rate of 1.3pp and an updated FX drag of an additional 1.1pp. Due to the scalable nature of Careium's business, this spills over into lowered adj. EBITA of 7-2% in '26e-'28e. We slightly lower the '26e adj. EBITA margin by 0.4pp, which coupled with FX headwinds contributes to the lowered earnings estimates. We believe that keeping the opex base slightly elevated is a regrettable necessity to enable growth, and view this phase as positive from a LT perspective.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 9x NTM EBITA&lt;/h3&gt;&lt;p&gt;On our updated estimates, Careium is trading at '26e-'28e multiples of 9x-6x EV/EBITA and 10x-7x P/E, where we highlight '26e-'28e organic sales and adj. EBITA CAGRs of 8% and 23%, respectively. For context, Careium has historically traded at an average of 8x NTM EV/EBITA and 11x NTM P/E.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/careium/Equity-research/2026/4/careium---entering-a-growth-focused-period/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 01 Apr 2026 16:15:04 GMT</pubDate>
      <isin>SE0017131824</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Medicover - Weather is set to be a drag</title>
      <description>&lt;a id="bm-comp-d19fcf9f-14c0-4046-a498-9148c58c798e" name="bm-comp-d19fcf9f-14c0-4046-a498-9148c58c798e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="d19fcf9f-14c0-4046-a498-9148c58c798e" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1'26 numbers due on 29 April at 07:45 CET&lt;/li&gt;&lt;li&gt;Near-term caution, but the model should continue to prove itself&lt;/li&gt;&lt;li&gt;Fair value range down to SEK 190-270 (200-280)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-643bca6e-0b03-4d73-b1bf-3a3529fa683c" name="bm-comp-643bca6e-0b03-4d73-b1bf-3a3529fa683c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="643bca6e-0b03-4d73-b1bf-3a3529fa683c" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1'26 should be marked by cold weather&lt;/h3&gt;&lt;p&gt;We expect colder-than-usual temperatures and severe weather warnings in Poland, Germany and Romania to have impacted patient activity in Q1, although an improvement in March likely softened the overall impact. In HS, we forecast organic growth of 7% and an EBITDAaL margin of 10.0%, as lower activity during periods of severe weather should be partly offset by continued operational progress and improving efficiency across the network. Within DS, we pencil in organic growth of 6% and an EBITDAaL margin of 15.9%, with volumes also likely affected by disrupted patient flows. Overall, this translates into total sales of EUR 607m, driven by organic growth of 7% and adj. EBITDA of EUR 97m, corresponding to a margin of 16.0%, up 30bps y-o-y.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Near-term volumes down, but margins should be protected&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Ahead of Q1, we lower our estimates to reflect our expectation of weaker short-term activity and FX, taking down adj. EBITDA by 2% for '26e-'28e, but with no changes to the long-term case. If anything, our recent Warsaw visit reinforced our view of Poland as a key growth and margin driver over the coming years, supported by a more margin-accretive capex mix, improving utilisation and stronger network effects. We therefore continue to see scope for profitable growth as the Polish business scales, while the operating improvements delivered over the past quarters should help protect margins despite softer Q1 volumes.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range down to SEK 190-270 (200-280)&lt;/h3&gt;&lt;p&gt;On the back of our estimate revisions and relative valuation, we adjust our fair value range to SEK 190-270 (200-280). We derive our range from the trading multiples of two peer groups, one with healthcare providers in developing countries and one in developed countries, alongside a DCF. The range corresponds to a '26e EV/EBITDA of 9x-12x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/medicover/Equity-research/2026/4/medicover---weather-is-set-to-be-a-drag/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 01 Apr 2026 15:45:05 GMT</pubDate>
      <isin>SE0009778848</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Midsona - Skipping down Sesame Street</title>
      <description>&lt;a id="bm-comp-392b4478-b0d5-4570-8a3d-8ab89e02b1fd" name="bm-comp-392b4478-b0d5-4570-8a3d-8ab89e02b1fd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="392b4478-b0d5-4570-8a3d-8ab89e02b1fd" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1e: flat organic growth and minor margin improvements&lt;/li&gt;&lt;li&gt;Risenta acquisition adds 3.5% to FY sales&lt;/li&gt;&lt;li&gt;Trading at '26e EV/EBITA of ~9.5x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-1bc75960-e4e5-4b12-8405-9284db95a914" name="bm-comp-1bc75960-e4e5-4b12-8405-9284db95a914" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1bc75960-e4e5-4b12-8405-9284db95a914" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;We expect a fairly uneventful Q1&lt;/h3&gt;&lt;p style="text-align:left;"&gt;We anticipate flat organic growth y-o-y in Q1'26e, implying sales of SEK 909m and adj. EBIT of SEK 38m, for a margin of 4.2%. We expect continued headwinds in South Europe, which are partly offset by organic growth improvements in North Europe and the Nordics. For the quarter, we expect an FX impact of -3% on net sales. We expect continued strength in the GM on product mix in Q1e. Our estimated adj. EBIT margin is up 0.3pp y-o-y, as we expect total opex to decline by 8%, partly on the recent cost savings initiatives. Moreover, Q1 will be positively affected by SEK 58m due to insurance compensation after the fire in Spain.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Back to M&amp;amp;A&lt;/h3&gt;&lt;p style="text-align:left;"&gt;Midsona issued a press release this morning stating that it is acquiring Swedish health food company Risenta, well know for its sesame-based snacks. The acquisition cost is SEK 45m and Risenta has an annual turnover of SEK ~130m, which would add ~3.5% to Midsona's full-year sales. The acquisition will go through on 1 June, and our estimated M&amp;amp;A growth for '26e-'27e is 2-1%. Midsona has not disclosed Risenta's profitability, although commented that it should be EBIT- and EPS-accretive. Assuming an EBIT margin in line with Midsona's '27e of ~6%, this would imply an EV/EBIT of ~7x compared to Midsona's 10x. We make limited changes to our organic estimates, with '26e-'27e sales and adj. EBITA are up 1-2% and 1-4%. We expect the nature of Risenta's business to weigh slightly on the GM, but carry less opex. Unadjusted '26e earnings are up significantly on the insurance payment.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Implied valuation&lt;/h3&gt;&lt;p&gt;Based on our revised estimates, the company is trading at ~9.5x '26e adj. EV/EBITA, which is ~30% below current peer multiples. We note that peers are in turn trading ~7% below the 10-year historical median of ~14x NTM EV/EBITA.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/midsona/Equity-research/2026/3/midsona---skipping-down-sesame-street/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 31 Mar 2026 16:00:05 GMT</pubDate>
      <isin>SE0000565228</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Petrolia Noco - Brage builds momentum into 2026</title>
      <description>&lt;a id="bm-comp-832c5f85-cae8-4da7-9b10-2cb4b4494db6" name="bm-comp-832c5f85-cae8-4da7-9b10-2cb4b4494db6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="832c5f85-cae8-4da7-9b10-2cb4b4494db6" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Strong A15 contribution, &amp;#8217;26e production up ~20%&lt;/li&gt;&lt;li&gt;Recent Brage updates imply ~NOK 0.35 uplift to NAV&lt;/li&gt;&lt;li&gt;Fair value range NOK 1.1-4.5&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c7a5d2c9-d065-4968-b841-91ca388794d6" name="bm-comp-c7a5d2c9-d065-4968-b841-91ca388794d6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c7a5d2c9-d065-4968-b841-91ca388794d6" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4 production 2.1 kboe/d vs. ABGSCe 2.2 kboe/d&lt;/h3&gt;&lt;p&gt;Q4'25 production was 2.1 kboe/d vs. ABGSCe 2.2 kboe/d, driven by slightly lower efficiency due to drilling the A15 well, which came on stream in Jan. EBITDA was USD 62m vs. ABGSCe of USD 77m, driven by higher costs despite the lower production, mainly caused by a change in over/underlift (a timing effect that evens out over time). PNO exited Q4 with a cash position of USD 74m, and we expect USD 166m at the end of Q1.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Tallisker upgrade and discovery add ~NOK 0.35 to our NAV&lt;/h3&gt;&lt;p&gt;Based on January and February production updates from Lime Petroleum (34% interest in Brage), we know that the initial production contribution from the A15 well has been significantly higher than expected. This prompts us to lift &amp;#8217;26e production by ~20%. As we have not updated our oil price deck since the outbreak of the Iran conflict, we apply the forward curve for &amp;#8217;26e-&amp;#8217;28e, while reiterating our long-term oil price assumption of USD 75/bbl thereafter. This lifts &amp;#8217;26e EBITDA by ~50%, while revisions to &amp;#8217;27e-&amp;#8217;28e are more modest. Importantly, OKEA (operator on Brage) last week announced that estimated recoverable resources at Tallisker have increased from 16-33 mmboe to 23-44 mmboe. Additionally, a discovery at Knockando Fensfjord of 3.1-9.4 mmboe (if oil) or 2.5-5.7 mmboe (if gas) was announced in January. All else equal, these events lift our NAV by ~NOK 0.35/sh. We expect drilling at Tallisker to commence during H2&amp;#8217;27, but keep this outside our estimates for now.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Fair value range of NOK 1.1-4.5/sh&lt;/h3&gt;&lt;p&gt;Assuming a long-term Brent price of USD 50-100/bbl, we estimate a NAV of NOK 1.1-4.5/sh for PNO. We argue that the current share price of NOK 2.1 implies a discounted oil price of USD 64/bbl.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/petrolia-noco/Equity-research/2026/3/petrolia-noco---brage-builds-momentum-into-2026/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 31 Mar 2026 04:45:06 GMT</pubDate>
      <isin>CY0102630916</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Cavotec - Industry leading the way</title>
      <description>&lt;a id="bm-comp-c304b1d1-4cf3-4fda-b9cd-be41702b328c" name="bm-comp-c304b1d1-4cf3-4fda-b9cd-be41702b328c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c304b1d1-4cf3-4fda-b9cd-be41702b328c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1: Sales of EUR 44m (39m), EBIT of EUR 2.5m (0.8m)&lt;/li&gt;&lt;li&gt;4% '26e EBIT raised following continued strength in Industry&lt;/li&gt;&lt;li&gt;Trading at 16-9x EV/EBIT '26-'27e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-55b586b4-2fbc-4827-b700-9bdeedff45b3" name="bm-comp-55b586b4-2fbc-4827-b700-9bdeedff45b3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="55b586b4-2fbc-4827-b700-9bdeedff45b3" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 expectations&lt;/h3&gt;&lt;p&gt;We expect Q1 sales of EUR 44m, +13% y-o-y and -11% q-o-q. We expect sales of EUR 26m (+17% y-o-y) for Ports &amp;amp; Maritime, and EUR 18m (8% y-o-y) for Industry. During Q1, the company announced a shore power order for ports in southern Italy worth ~EUR 3.2m (~3% of Q4 backlog), with delivery expected within 9-18 months. In addition, delayed Ports &amp;amp; Maritime deliveries from the large Q4&amp;#8217;24 orders are expected to be completed by June. We estimate Q1 order intake of ~EUR 37m (30% y-o-y, -23% q-o-q). On EBIT, we forecast EUR 2.5m (vs. 0.8m Q1'25) for a margin of 5.7% (1.9%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;We extrapolate Industry's strong Q3-Q4&amp;#8217;25 profitability and raise '26e group EBIT by 4%, primarily reflecting continued margins in excess of 10% within the segment. The industry benefits from a strong mining backdrop, with rising customer capex and increasing integration along the value chain. We also eye further potential for small, incremental innovation within the existing product portfolio as a driver of price increases ahead. Within the segment, construction activity remains subdued pending a broader sector recovery. The group-level EBIT raise also incorporates a slight cut on Ports &amp;amp; Maritime's EBIT, as we perceive margins to be somewhat softer following deliveries of Q4&amp;#8217;24 orders proving less profitable than expected in Q4'25. However, we remain optimistic about the prospects for P&amp;amp;M overall, as we consider the customers' window for delaying investment decisions within P&amp;amp;M to be narrowing, with orders consequently materialising during the rest of the year.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;We view Industry&amp;#8217;s development as encouraging and expect continued progress towards a more stable business in the coming quarters. The share is currently trading at 16-9x EV/EBIT and 33-15x P/E on '26-'27e.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/cavotec/Equity-research/2026/3/cavotec---industry-leading-the-way/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 30 Mar 2026 16:45:03 GMT</pubDate>
      <isin>CH0136071542</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Impact Coatings - Waiting for renewed momentum</title>
      <description>&lt;a id="bm-comp-52b021f4-ded2-4486-8476-8dd4e4263756" name="bm-comp-52b021f4-ded2-4486-8476-8dd4e4263756" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="52b021f4-ded2-4486-8476-8dd4e4263756" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1e sales SEK 8m (10m), EBIT SEK -12m (-14m)&lt;/li&gt;&lt;li&gt;Softer quarter due to absence of machine orders&lt;/li&gt;&lt;li&gt;Trading at 1.3x-1.2x '26e-'28e EV/Sales&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-0e3b3c97-f5b3-4b69-820e-2d3b11cac2d3" name="bm-comp-0e3b3c97-f5b3-4b69-820e-2d3b11cac2d3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0e3b3c97-f5b3-4b69-820e-2d3b11cac2d3" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 expectations&lt;/h3&gt;&lt;p&gt;We expect Q1 sales of SEK 8m (10m), implying R12M sales of SEK 11m (29m). With no machine orders announced in the quarter, we expect a softer result, with sales driven by Coating Services (SEK 7m) and Aftermarket (SEK 2m). On EBIT, we forecast SEK -12m (-14m), and we expect the company to end the quarter with a cash balance of SEK 27m (26m), which can be compared to the R12m FCF lease adj. of SEK -47m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;We lower '26e-'28e sales and EBIT by 2-1% and 4-2%, respectively, ahead of the Q1 report. We forecast two System deliveries for '26e, but highlight that estimate risk is high due to the current market situation.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;China's new hydrogen push&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;China recently announced a comprehensive hydrogen pilot program to aggressively scale the industry by 2030, which could provide a much-needed momentum boost for Impact Coatings. Management has noted that slow market growth in China has delayed new machine orders. However, with government subsidies now driving demand for fuel cell vehicles and electrolysers, gradually increasing market volumes should encourage customers to transition from Services to in-house coating aiding the recovery of Impact's System sales. The company is currently trading at 1.3x-1.2x '26e-'28e EV/sales.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/impact_coatings/Equity-research/2026/3/impact-coatings---waiting-for-renewed-momentum/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 30 Mar 2026 15:01:09 GMT</pubDate>
      <isin>SE0001279142</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>I-tech - Another growth breather in Q1e</title>
      <description>&lt;a id="bm-comp-e5ea4757-ff7e-4d90-b162-dbdbcd5ccc1c" name="bm-comp-e5ea4757-ff7e-4d90-b162-dbdbcd5ccc1c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e5ea4757-ff7e-4d90-b162-dbdbcd5ccc1c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q1e sales 42m (57m), adj. EBIT SEK 9.8m (18m)&lt;/li&gt;&lt;li&gt;Updated FX forecasts, we raise '26e-'28e sales by 4-5%&lt;/li&gt;&lt;li&gt;Trading at '26e-'28e EV/EBIT of 8x-3x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-39f64ca8-2abf-4270-9fa2-9185a0ebad48" name="bm-comp-39f64ca8-2abf-4270-9fa2-9185a0ebad48" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="39f64ca8-2abf-4270-9fa2-9185a0ebad48" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q1 expectations&lt;/h3&gt;&lt;p style="text-align:left;"&gt;We estimate sales of SEK 42m (57m), -27% y-o-y (-15%% org., -12% FX). I-Tech is facing tough comps into Q1, as the quarter was particularly strong last year (sales +49% y-o-y), as the Q1'25 result also included volumes from a large customer that has since reported financial constraints. On EBIT, we forecast SEK 9.8m (18m) for a margin of 24% (31%).&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;We raise '26e-'28e sales by 4-5% on our updated FX forecasts, but lift personnel costs to reflect the recent hiring tied to the company's business development initiatives. This results in '26e-'28e adj. EBIT adjustments of +2-4%.&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;Remain positive on long-term case&lt;/h3&gt;&lt;p&gt;Despite near-term organic headwinds, we think I-Tech is continuing to gain market share. Customer diversification is progressing well, with PPG (+126%), Kansai (+109%), and Jotun (+108%) all delivering triple-digit volume growth in FY'25, albeit from low bases. CMP volumes grew +21% in '25, and we expect a similar pace in '26e. We also see potential for normalisation in the financially constrained customer noted above. China, which is now ~26% of sales, remains a key growth market given its dominance in newbuild and drydocking, where new Selektope products are gaining traction. The stock is trading at 8x-3x EV/EBIT on '26e-'28e and 12x-7x P/E, i.e. ~50% below peers.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/i-tech/Equity-research/2026/3/i-tech---another-growth-breather-in-q1e/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 30 Mar 2026 15:00:03 GMT</pubDate>
      <isin>SE0011167725</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Donkey Republic - A donkey worth riding</title>
      <description>&lt;a id="bm-comp-0f0769d3-d11b-4e57-9eeb-12c18d6d36f4" name="bm-comp-0f0769d3-d11b-4e57-9eeb-12c18d6d36f4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0f0769d3-d11b-4e57-9eeb-12c18d6d36f4" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Pedalling in a structurally growing European bike-sharing market&lt;/li&gt;&lt;li&gt;+20% revenue CAGR in '25-'28e with strong margin expansion&lt;/li&gt;&lt;li&gt;Fair value range of DKK 7-10/share&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-b086ea33-fdf5-488f-b566-9c7e108449be" name="bm-comp-b086ea33-fdf5-488f-b566-9c7e108449be" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b086ea33-fdf5-488f-b566-9c7e108449be" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Pedalling in high-growth European bike-sharing market&lt;/h3&gt;&lt;p&gt;Donkey Republic ("DONKEY") is a Danish bike-sharing operator, with core markets including Nordics (33%), Benelux (39%) and DACH (22%). Its fleet of ~24k pedal bikes and e-bikes is supported by a propietary software stack, with monetisation across rider revenues (66%), B2G and B2B revenues (31%) and software/hardware (3%).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Competitive moats to drive market share gains&lt;/h3&gt;&lt;p&gt;Europe's bike-sharing fleet, part of the broader shared micromobility market, is projected to grow at +15% CAGR until '30e, with drivers including sustainability and health trends, seamless integration with public transportation systems and regulation. We believe several operational capabilities, such as the company's scalable operating model and data-driven approach, should be considered licences to operate rather than true moats, and we instead see DONKEY's competitive edge centred around its high-quality fleet (especially after roll-out of its Gen4 bike), its lower prices (price/cost is 50% of scoring in EU tenders), and stronger relations with cities it serves, coupled with solid positions in the Tier 2 and Tier 3 segments. Coupled with proven tender execution capabilities, we expect DONKEY to grow its European market share by 0.4pp up to '28e, to 6.2%.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;+20% revenue CAGR and hefty margin uplift; FVR of DKK 7-10&lt;/h3&gt;&lt;p&gt;Considering market tailwinds and DONKEY's pipeline and commercial momentum, including two recent large-scale wins in Germany, we forecast a revenue CAGR of +20% in '25-'28e (vs. +35% in '18-'25). With improving operating leverage, we model adj. EBITDA increasing from DKK 30m in '25 to DKK 81m in '28e and adj. EBIT reaching DKK 36m. Valuing DONKEY against shared mobility peers yields DKK 7.1-8.8/share, while our DCF points to DKK 10.2/share. We set a fair value range of DKK 7-10/share.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/donkey-republic/Equity-research/2026/3/donkey-republic---a-donkey-worth-riding/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 24 Mar 2026 05:45:05 GMT</pubDate>
      <isin>DK0061540770</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Coor - CMD added confidence in margin target</title>
      <description>&lt;a id="bm-comp-87c81f20-e360-43a8-9ba1-16034b43410c" name="bm-comp-87c81f20-e360-43a8-9ba1-16034b43410c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="87c81f20-e360-43a8-9ba1-16034b43410c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Clear initiatives for efficiency gains presented&lt;/li&gt;&lt;li&gt;Focus on add-on sales and M&amp;amp;A to re-accelerate growth&lt;/li&gt;&lt;li&gt;Potential upside to cons '27e as 5.5% margin could be reached&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-958cb99d-84f3-453b-af0b-73c719c4bd76" name="bm-comp-958cb99d-84f3-453b-af0b-73c719c4bd76" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="958cb99d-84f3-453b-af0b-73c719c4bd76" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Clear case for further efficiency gains&lt;/h3&gt;&lt;p&gt;We attended Coor's CMD held at its HQ in Solna on Thursday. While the financial targets were reiterated, management provided us with more colour on how it will accelerate organic growth and reach the margin target of 5.5% (4.8% in 2025). Most importantly, we think the new CEO Ola Klingenborg continues to give a very solid impression, and we have confidence in how the company is acting to deliver on its efficiency ambitions. One of the issues until now has been a messy organisational structure with several management matrixes and unnecessary layers, leading to unclear responsibilities. This is now being simplified, which clarifies lines of responsibility and accountability. Second, the company's new IT systems are state of the art, but not implemented properly. This means that front-line managers lack the tools and data to plan efficiently. This is now also being fixed, giving front-line managers clear KPIs to follow. Last, the company is changing from scheduling employees on a four-week basis to a four-month basis, which should lead to more efficient planning. According to the CEO, one of the biggest extra costs recently has been paying too much for overtime workers, due to bad planning. In addition to efficiency gains, management also sees cost savings from coordinating procurement. Thus, we are now even more confident that additional margin improvements should come through.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;New sales mindset to drive more add-on sales&lt;/h3&gt;&lt;p&gt;In addition to the usual focus on retaining and acquiring new customers, management highlighted a (so far) largely missed opportunity from add-on sales, which is something it believes could be as important as new customer intake to drive better organic growth (4-5% CAGR target). Mr. Klingenborg said that every employee should now think like a sales pe&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/coor/Equity-research/2026/3/coor---cmd-added-confidence-in-margin-target/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 20 Mar 2026 08:30:03 GMT</pubDate>
      <isin>SE0007158829</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Xplora Technologies - Acquires DACH's leading senior mobile player</title>
      <description>&lt;a id="bm-comp-636a0d14-659c-4010-bce7-15f49a4e4c46" name="bm-comp-636a0d14-659c-4010-bce7-15f49a4e4c46" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="636a0d14-659c-4010-bce7-15f49a4e4c46" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;300k phones sold annually with +30% GM&lt;/li&gt;&lt;li&gt;Same playbook as Doro: add subscriptions&lt;/li&gt;&lt;li&gt;Price not disclosed, but financed with cash at hand&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-80d81f0b-bde5-49f0-8452-79b863713e5a" name="bm-comp-80d81f0b-bde5-49f0-8452-79b863713e5a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="80d81f0b-bde5-49f0-8452-79b863713e5a" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Aquires Emporia Group for an undisclosed price&lt;/h3&gt;&lt;p&gt;This morning, Xplora announced that it has agreed on key terms for the acquisition of 100% of the shares in the Emporia Group for an undisclosed consideration. The company is the market leader in senior mobile phones in Germany, Austria, and Switzerland, with annual sales of approximately 300,000 devices across Europe.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Seem to be a strategic sound acquisition&lt;/h3&gt;&lt;p&gt;We argue that from a strategic point of view, the acquisition makes sense from two perspectives. First, the deal folles the exact same Playbook as in the Doro acquisition where Xplora can leverage its MVNO licenses and existing infrastructure to introduce its own Cellular subscriptions to Emporia customers and thereby build a base of recurring subscription revenue. Second, Emporia&amp;#8217;s strong market position in the DACH region complements Doro&amp;#8217;s strong position in UK, France and the Nordics making the combined company a clear European market leader with strong positions in all the major European countries. Emporia has strong market positions in several markets where Xplora does not have an MVNO licence today such as Austria and Italy and we would therefore expect Xplora to add MVNO licenses in some of these markets to fully capitalise on the acquisition, but that has not yet been decided.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Price not yet disclosed, but likely earnings accretive&lt;/h3&gt;&lt;p&gt;Emporia&amp;#8217;s device margins are in-line with Xplora&amp;#8217;s, but according to our understanding Emporia does not have very high EBITDA margins today, but Xplora expect to lift the profitability over time by adding subcriptions. We also assess that their could be some cost synergies due to overlapping functions with Doro/Xplora. The price is not disclosed, but is financed with cash on hand. Thus, the price has to be less than the NOK 422m that Xplora had in cash as of Q4&amp;#8217;25. The deal is e&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/xplora_technologies/Equity-research/2026/3/xplora-technologies---acquires-dachs-leading-senior-mobile-player/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 16 Mar 2026 08:15:02 GMT</pubDate>
      <isin>NO0010895782</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>StrongPoint - Investor update</title>
      <description>&lt;a id="bm-comp-69338922-18f1-4fea-8de8-59a4d59c677f" name="bm-comp-69338922-18f1-4fea-8de8-59a4d59c677f" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="69338922-18f1-4fea-8de8-59a4d59c677f" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Order picking as core growth engine&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Vusion partnership broadens store digitalisation scope&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Financial ambitions reiterated&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-35de9052-c116-4710-8f97-6770cff6ee82" name="bm-comp-35de9052-c116-4710-8f97-6770cff6ee82" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="35de9052-c116-4710-8f97-6770cff6ee82" style="vertical-align: top; width:100.000000%;"&gt;&lt;p&gt;&lt;font color="#000000"&gt;Today, StrongPoint held an investor update to provide additional insight into the company. Below, we summarise the main points from the presentation. For the full update, please see&lt;/font&gt; &lt;a data-bm-trackable="false" href="https://qcnl.tv/p/SRQu-Z_ENpHHA3HCHlAS3w" target="_blank"&gt;&lt;font color="#000000"&gt;here&lt;/font&gt;&lt;/a&gt;&lt;font color="#000000"&gt;.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;&lt;strong&gt;Order picking as core growth engine&lt;/strong&gt;&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;StrongPoint positioned in-store order picking as its primary growth driver, supported by rising grocery e-commerce penetration and a shift from centralised CFC models toward store-based fulfillment and quick commerce. The company commented on its ambition to &amp;#8220;dominate&amp;#8221; in-store picking, underpinned by what it describes as a leading solution globally and a steadily expanding international footprint. Beyond its legacy Swedish base, deployments now include retailers such as Sainsbury&amp;#8217;s (UK), Carrefour (Belgium) and Sonae (Portugal), reflecting growing traction across key European markets.&lt;/font&gt;&lt;/p&gt;&lt;p&gt;&lt;font color="#000000"&gt;We argue that the structural growth in grocery e-commerce - with penetration only at ~15% in the US and 14% in the UK, and still rising - underpins a multi-year demand tailwind for efficient in-store fulfillment. As volumes scale, retailers are increasingly prioritising labour productivity, accuracy and basket quality, areas where StrongPoint&amp;#8217;s picking solution is positioned to deliver measurable ROI. At the same time, the significant whitespace in large future markets such as the UK &amp;amp; Ireland (~NOK 2,900bn market size) and Spain (~NOK 1,320bn), where chain coverage and solution penetration remain materially below Nordic levels, providing an attractive set-up for cross-sell of picking, ESL, self-checkout and Vensafe. In our view, the combination of structural e-commerce growth, large underpenetrated addressable markets and a scalable order-picking model lays the foundation for an attractive long-term growth opportunity.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#000000"&gt;&lt;strong&gt;Vusion partnership broadens store&lt;/strong&gt; digitalisation &lt;strong&gt;scope&lt;/strong&gt;&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;The Vusion partnership represents a strategic reset &lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/StrongPoint/Equity-research/2026/3/strongpoint---investor-update/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 12 Mar 2026 14:30:04 GMT</pubDate>
      <isin>NO0010098247</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Skolon | Q4 Earnings Call with CEO Oliver Lundgren</title>
      <description>&lt;a href='https://cr.abgsc.com/foretag/company-name/Media/2026/12/Skolon-q4-earnings-call-with-ceo-oliver-lundgren/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 09 Mar 2026 08:00:00 GMT</pubDate>
      <isin>SE0017615784</isin>
      <youtube>QPB3K2zm-Dg</youtube>
      <category>Media</category>
    </item>
    <item>
      <title>SinterCast - Fireside Chat with Deputy CEO Vitor Anjos</title>
      <description>&lt;a href='https://cr.abgsc.com/foretag/sintercast/Media/2026/12/SinterCast-fireside-chat-with-deputy-ceo-vitor-anjos/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 09 Mar 2026 08:00:00 GMT</pubDate>
      <isin>SE0000950982</isin>
      <youtube>MLXmabMecwY</youtube>
      <category>Media</category>
    </item>
    <item>
      <title>Medicover - From build-out to fill-up</title>
      <description>&lt;a id="bm-comp-1b6ac4f7-af6a-412e-a185-0311b4b452a9" name="bm-comp-1b6ac4f7-af6a-412e-a185-0311b4b452a9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="1b6ac4f7-af6a-412e-a185-0311b4b452a9" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Focus on sport/wellness, dental and smaller centres&lt;/li&gt;&lt;li&gt;Adj. EBITDAaL margin expansion: 11.7% to 12.9% during '26e-'28e&lt;/li&gt;&lt;li&gt;~25% below its historical average on NTM EV/EBITDA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-ff78428e-5f33-43d9-8f62-17df44359aa2" name="bm-comp-ff78428e-5f33-43d9-8f62-17df44359aa2" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="ff78428e-5f33-43d9-8f62-17df44359aa2" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Polish capex skewing to margin-accretive growth levers&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Last Wednesday we visited Medicover&amp;#8217;s hospitals and clinics in Warsaw, with discussions centred on Poland as a core growth engine and driver of margin expansion over the next few years. In line with our recent investor-update takeaways, we expect capital allocation to become more aligned with the sales mix, implying a greater focus on Poland, but with a clearer tilt towards margin-accretive investment: 1) sports/wellness (incl. CityFit integration), 2) dental, and 3) smaller, local centres that broaden the network, improve convenience and lift fee-for-service capture.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;strong&gt;Utilisation and network effects now the playbook&lt;/strong&gt;&lt;/h3&gt;&lt;p&gt;Management reiterated that utilisation still &amp;#8220;leaves room&amp;#8221; for growth without a step-up in capex, with prepaid primary care/occupational health acting as the anchor and a denser layer of smaller sites designed to drive referral flows, improve access and capture more FFS. Wellness is increasingly positioned as part of the same ecosystem, supporting retention and cross-sell as healthcare shifts from medicine towards lifestyle. At group level, capex is expected to stay around 6% of sales, and encouragingly, in '25 ROIC increased to 13% driven by utilisation/efficiency, which we believe will continue over the coming years.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;No estimate/FVR changes, trading below historical averages&lt;/h3&gt;&lt;p&gt;We make no changes to estimates or our FVR. We still forecast organic growth of 12-10% for &amp;#8217;26e-&amp;#8217;28e and adj. EBITDAaL margins expanding from 11.7% to 12.9% (adj. EBITDA 16.9% to 18.1% for '26e to '28e), driven by mix and operating leverage as these Polish businesses scale. As a reference point, Benefit Systems, a Polish listed fitness peer, delivered an EBITDA margin of ~29% in FY&amp;#8217;24, which we view as supportive for the long-term profi&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/medicover/Equity-research/2026/3/medicover---from-build-out-to-fill-up/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Sun, 08 Mar 2026 18:45:03 GMT</pubDate>
      <isin>SE0009778848</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Qben Infra - Portfolio reshaping continues</title>
      <description>&lt;a id="bm-comp-e7c16844-4968-4818-af46-13c1d137249a" name="bm-comp-e7c16844-4968-4818-af46-13c1d137249a" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e7c16844-4968-4818-af46-13c1d137249a" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;The reshaping continues...&lt;/li&gt;&lt;li&gt;...with a potential IPO of the land bank...&lt;/li&gt;&lt;li&gt;...and large cost-cutting measures&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7660b2e6-c4a5-4f75-b593-43b24ffcc149" name="bm-comp-7660b2e6-c4a5-4f75-b593-43b24ffcc149" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7660b2e6-c4a5-4f75-b593-43b24ffcc149" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4 highlights&lt;/h3&gt;&lt;p&gt;Qben Infra reported Q4 sales of SEK 301m and EBITA of SEK -88m. The sale of Rail was completed in January 2026 and the sale of Kvalitetsbygg was completed in December 2025, but with a vendor note due in 2027. Qben is also looking into a spin-off of the land bank portfolio, which according to the company is valued at NOK 655m. This is a strategic decision that follows Qben's increased focus on the Power segment and market. Adj. EBITA was SEK -74m, corresponding to a -7% adj. EBITA margin. The decrease is mainly due to an adjustment to the PPA analysis (Purchase Price Allocation) made in connection with the acquisition of Team Bygg.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and estimate changes&lt;/h3&gt;&lt;p&gt;The remaining parts of Qben &amp;#8211; Power, Inspect and Construction (Team Bygg) &amp;#8211; have good demand. Qben guides for SEK 1.5bn in sales and SEK 111m EBITA (local GAAP) in '26, for an EBITA margin of 7.2% driven by Power, Inspect and cost reductions. Qben also carried out a bond redemption, resulting in higher financial expenses in 2025 but providing greater balance sheet flexibility going forward&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Looking ahead&lt;/h3&gt;&lt;p&gt;Qben Infra should be viewed as an investment company. Management states that the transactions will free up resources for redeployment into the faster-growing infrastructure segments (Inspect and Power), which benefit from solid market conditions and a strong order backlog. Following completion of the divestment, the Construction business area will consist solely of residential property development operations in Norway&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/qben-infra/Equity-research/2026/3/qben-infra---portfolio-reshaping-continues/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 02 Mar 2026 14:45:04 GMT</pubDate>
      <isin>SE0023114012</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Xplora Technologies - Record quarter driven by Senior</title>
      <description>&lt;a id="bm-comp-360b952c-40ac-4b5e-89c5-dc2cd39b80a6" name="bm-comp-360b952c-40ac-4b5e-89c5-dc2cd39b80a6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="360b952c-40ac-4b5e-89c5-dc2cd39b80a6" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q4 sales and EBITDA 7% and EBITDA 23% above driven by Senior&lt;/li&gt;&lt;li&gt;Strong growth in senior device revenue +35% y-o-y&lt;/li&gt;&lt;li&gt;Expect cons to lift '26 EBITDA by 10-15%, share to follow&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-877dbdd2-762b-44c3-9e75-b90d0e8037bc" name="bm-comp-877dbdd2-762b-44c3-9e75-b90d0e8037bc" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="877dbdd2-762b-44c3-9e75-b90d0e8037bc" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Adj. EBITDA NOK 101m, +23% vs cons&lt;/h3&gt;&lt;p&gt;Revenue was NOK 606m, 7% above FactSet cons of NOK 568m (+12% vs. ABGSCe NOK 540m). This was driven by strong growth in the Senior Segment from the shift from 2G and 3G to 4G technology. The gross margin was 51.5% in line with ABGSCe. Opex was NOK 212m, 6% higher than ABGSCe of NOK 200m. This gave an EBITDA of NOK 101m, 23% above cons of NOK 82m (+29% vs. ABGSCe NOK 61m), corresponding to an EBITDA margin of 16.6% vs. 9.4% in Q4'24. Capex was NOK 4m (ABGSCe NOK 15m), resulting in adj. EBITDA-capex of NOK 97m, 54% above ABGSCe of NOK 63m.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Strong senior device sales, lower ARPU&lt;/h3&gt;&lt;p&gt;Total device revenue was NOK 515m, 18% above ABGSCe of NOK 438m. Kids &amp;amp; Youth device sales of NOK 152m was 8% below ABGSCe, and Senior device sales (Doro) of NOK 363m was 33% above ABGSCe. Service revenue was NOK 91m, 11% below ABGSCe of NOK 102m, corresponding to a growth of 18% y-o-y. Number of Kids subscriptions ended at 476k as pre-announced, of which 306k were Connectivity (ABGSCe 301k), 121k were Premium (ABGSCe 113k), 32k were B2B (ABGSCe 38k), and 15k were Service fee (ABGSCe 16k). This gave a monthly ARPU of NOK 66 vs. ABGSCe of NOK 74, which compares to NOK 72 in Q4'24.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Expect a strong share outperformance today&lt;/h3&gt;&lt;p&gt;On the back of today's report we expect consensus to lift estimates driven by strong device sales and gross margin in the senior segment, however, somewhat offset by a lower ARPU and higher opex. All in all we expect cons to lift 2026 EBITDA by 10-15% on the back of today's report.&lt;/p&gt;&lt;p&gt;Conclusion: We expect the share to outperform by 10-15% today.&lt;/p&gt;&lt;p&gt;&lt;a data-bm-trackable="false" href="https://investor.xplora.com/" target="_blank"&gt;Xplora will host a conf call at 08:00 CEST.&lt;/a&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;pagebreak &lt;a id="bm-comp-bba331d9-bd4c-44e5-be82-aa8553cfdadd" name="bm-comp-bba331d9-bd4c-44e5-be82-aa8553cfdadd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bba331d9-bd4c-44e5-be82-aa8553cfdadd" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-52d02884-fedb-436e-a02c-3828bca7fc29" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier &amp;amp; company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/xplora_technologies/Equity-research/2026/2/xplora-technologies---record-quarter-driven-by-senior/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 27 Feb 2026 07:15:04 GMT</pubDate>
      <isin>NO0010895782</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Isofol Medical - From first lessons to second execution</title>
      <description>&lt;a id="bm-comp-aea7ed2e-cee6-457b-a451-b8f4277c2dec" name="bm-comp-aea7ed2e-cee6-457b-a451-b8f4277c2dec" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="aea7ed2e-cee6-457b-a451-b8f4277c2dec" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Strong early efficacy signal&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Solid cost management&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range of SEK 0.1-10.5/share&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-fb8b7b10-2815-4864-ad06-eb22f68804b8" name="bm-comp-fb8b7b10-2815-4864-ad06-eb22f68804b8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fb8b7b10-2815-4864-ad06-eb22f68804b8" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong early efficacy signal&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Isofol today announced that all six currently evaluable RAS-mutated metastatic colorectal cancer patients in Part 1 of its Phase 1b/2 trial, treated with an optimised arfolitixorin regimen, experienced tumour shrinkage, with reductions in total tumour burden of up to ~50%. Furthermore, half of the patients improved to such a degree that they were removed from the trial for consideration of surgical removal, which is rare in this hard-to-treat population. Additionally, no dose-limiting toxicities have been observed. The reported efficacy results are based on patients treated at the first two dose levels, while the trial has now progressed to the third dose cohort. Although based on a small and early dataset, the findings provide clinical support for Isofol's optimised dosing strategy. We raise the LOA for the risk-weighted scenario B to 22.5% (20%).&lt;/font&gt;&lt;font color="#212529"&gt;&lt;font color="#000000"&gt;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Solid cost management&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;These encouraging results come following a solid Q4 report in which opex came in better than expected (SEK 13m vs. ABGSCe at SEK 16m). We slightly reduce opex for FY'26-'27e, though the valuation impact is offset by the continued USD headwind. Cash and cash equivalents came in at SEK 127m (SEK 139m at the end of Q3'25). As before, if all TO1 and TO2 warrants are exercised in full, we estimate a cash runway into 2028e.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#1B2634"&gt;Fair value range of SEK 0.1-10.5/share&lt;/font&gt;&lt;/h3&gt;&lt;p style="text-align:left;"&gt;&lt;font color="#000000"&gt;Our raised LOA for the risk-weighted scenario B to 22.5% (20%) yields SEK 1.8/share (1.6). As before, scenario A (no hierarchical order) assumes clinical failure (LOA 0%) yielding SEK 0.1/share, while scenario C assumes full clinical and commercial success in first-line mCRC (LOA 100%) with a value of SEK 10.5/share. This implies a fair value range of SEK 0.1-10.5/share.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/isofol-medical/Equity-research/2026/2/isofol-medical---from-first-lessons-to-second-execution/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Tue, 24 Feb 2026 19:00:06 GMT</pubDate>
      <isin>SE0009581051</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ework Group - Market conditions yet to improve</title>
      <description>&lt;a id="bm-comp-29b71510-6cf3-4322-9e5d-e76f73261055" name="bm-comp-29b71510-6cf3-4322-9e5d-e76f73261055" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="29b71510-6cf3-4322-9e5d-e76f73261055" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Market remains challenging; soft near-term outlook&lt;/li&gt;&lt;li&gt;We lower '26e-'27e adj. EBIT by 33%&lt;/li&gt;&lt;li&gt;12x-10x 2026e EV/EBIT adj.&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-eefa5591-2808-4f6a-87d1-c698367fc44d" name="bm-comp-eefa5591-2808-4f6a-87d1-c698367fc44d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="eefa5591-2808-4f6a-87d1-c698367fc44d" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Weak Q4, automotive remains the main culprit&lt;/h3&gt;&lt;p&gt;Ework's Q4 was challenging, with sales -13% y-o-y coupled with adj. EBIT of SEK 36m, down 33% y-o-y. While the latter was 9% ahead of our forecast, this was mainly due to lower costs, with sales volumes remaining poor. As we have repeatedly emphasised, the weaker market is a broad-based phenomenon. However, Ework's high exposure to the automotive sector (19% of gross profit, down from 21% in Q4'24) and an intensified competitive landscape (excess supply of consultants) have further exacerbated the situation. On a positive note, however, Norway has finally started to stabilise, and the gross margin has continued to strengthen. Furthermore, Ework has implemented additional cost-saving measures to improve profitability in 2026. These measures include SEK 18m of cost savings, which will be realised gradually throughout 2026. This includes halving the size of the management team, partly in an attempt to improve sales efforts and move closer to the customer by simplifying the organisation. Given the targeted areas for cost reductions, we welcome the savings.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;No clear signs of near-term recovery&lt;/h3&gt;&lt;p&gt;Given Q4 orders -14% y-o-y (vs. -7% y-o-y in Q3), the outlook for 2026 is poor, and we see no clear signs of an imminent recovery. Consequently, we lower '26e-'27e sales forecasts by 16-18%, resulting in a 33% cut to the corresponding adj. EBIT figures. We now expect 2026 sales to decrease by 14% y-o-y, and EPS by -16% y-o-y (vs. Ework's guidance of 2026 EPS down 10-20% y-o-y), despite easy comps.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;12x-10x '26e-'27e EV/EBIT adj.&lt;/h3&gt;&lt;p&gt;The share is trading at 12x-10x '26e-'27e EV/EBIT adj. (vs. peers at 12x-8x), which is largely in line with its 10Y avg. of ~12x. The balance sheet remains in good shape and cost control is decent, but volumes need to improve for profits to return to growth.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ework/Equity-research/2026/2/ework-group---market-conditions-yet-to-improve/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 23 Feb 2026 16:15:04 GMT</pubDate>
      <isin>SE0002402701</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Fastpartner - Outlook taking a hit</title>
      <description>&lt;a id="bm-comp-f38af924-e7ea-4b96-94b5-f32220dada29" name="bm-comp-f38af924-e7ea-4b96-94b5-f32220dada29" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="f38af924-e7ea-4b96-94b5-f32220dada29" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q4 numbers largely in-line with expectations&lt;/li&gt;&lt;li&gt;Large move-out in Q1 weighs on outlook&lt;/li&gt;&lt;li&gt;2026e P/CEPS of 14x vs coverage average of 16x&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a0a6a789-b5df-4a43-883d-e8185e63f635" name="bm-comp-a0a6a789-b5df-4a43-883d-e8185e63f635" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a0a6a789-b5df-4a43-883d-e8185e63f635" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Rec. PTP +1% on stronger NOI margin&lt;/h3&gt;&lt;p&gt;Fastpartner delivered Q4 results with rec. PTP 1% ahead of our forecast, driven by lower operating costs in the quarter, with an NOI margin of 68.9% (1.1pp y-o-y). This was somewhat counteracted by higher central administration costs and net financials. The proposed dividend was SEK 1.15 per share (1.10), compared to our expectations of SEK 1.10 and Infront consensus of SEK 1.20.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Underestimated termination weighs on outlook&lt;/h3&gt;&lt;p&gt;The economic occupancy flat q-o-q at 91.3% (92.4%), and occupancy adjusted for projects was down -0.1pp q-o-q to 91.6% (92.4%). Furthermore, the average paid interest rate decreased by -0.1pp q-o-q to 3.60% at year-end. Despite these supporting data points, the IFPM guidance was down 8.1% q-o-q to SEK 790m NTM. The driver is the Nasdaq premises in Frihamnen being vacated by year-end, where the previous guidance apparently assumed it would be fully let once vacated. According to management, it has ongoing discussions with potential tenants for the premises, some of which it had expected to materialise into signed leases in H2'25, but which have been prolonged. While we already had the termination in our estimates, it seems the lease was larger than we previously expected, leading to negative CEPS revisions of ~9% for '26e-'27e. On the back of this we are 0.6% ahead of the IFPM guidance NTM.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;2026e P/CEPS of 13x, coverage average of 16x&lt;/h3&gt;&lt;p&gt;The share is trading at 2026e P/CEPS of 13x, below the average in our coverage of 15x. On 2025 P/EPRA NRV, the share is trading at 0.49x compared to the average in our coverage of 0.85x. On the back of the larger than expected impact from the Nasdaq termination we expect CEPS growth of -4% in 2026e, and +5% in 2027e, taking the average to +1% vs the average in our coverage of 9%.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/fastpartner/Equity-research/2026/2/fastpartner---outlook-taking-a-hit/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 23 Feb 2026 08:15:02 GMT</pubDate>
      <isin>SE0013512506</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Cavotec - Industry shines in cautious environment</title>
      <description>&lt;a id="bm-comp-039ccfa7-035f-4c60-b02e-2fc4e6303775" name="bm-comp-039ccfa7-035f-4c60-b02e-2fc4e6303775" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="039ccfa7-035f-4c60-b02e-2fc4e6303775" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Solid Q4 but continued cautious order environment&lt;/li&gt;&lt;li&gt;Industry bright spot, initiatives delivering&lt;/li&gt;&lt;li&gt;Customer caution in P&amp;amp;M, expected to soften up into '26e&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-32b841d6-1b37-4a3c-8576-47af831220b3" name="bm-comp-32b841d6-1b37-4a3c-8576-47af831220b3" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="32b841d6-1b37-4a3c-8576-47af831220b3" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4 results&lt;/h3&gt;&lt;p&gt;Cavotec reported sales above expectations at EUR 50m (+9% y-o-y, 34% vs ABGSCe). P&amp;amp;M: -5% y-o-y, Industry: +36% y-o-y. Order intake of EUR 48m was in line with estimates. Adj. EBIT was better than expected at EUR 3.9m vs. ABGSCe 0.7m, mainly due to the higher volumes. The highlight of the report was the continued momentum in Industry, with good demand for motorised cable reel systems. This, coupled with recent operational improvements, drove EBITDA margins to 16.1% vs. 6.7% LY. For P&amp;amp;Ms, however, EBITDA margins contracted (11.7% vs 17.6% Q4'24), albeit against tough comps. Management pointed towards increased customer caution towards the end of the year in P&amp;amp;M, which we expect will weigh on Q1 orders.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;We raise '26e-27e sales by 4% on stronger-than-expected sales in Q4, but lower total '26e-'27e EBIT by 2-5%, mainly reflecting our lowered margin expectations in P&amp;amp;M. Management reiterated that P&amp;amp;M softness is largely linked to delayed decisions (pushing forward rather than cancellations) and said customer caution is already &amp;#8220;softening up&amp;#8221; into 2026. In addition, the company is initiating cost-savings in '26, with details to be announced in Q1.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;A soft year&lt;/h3&gt;&lt;p&gt;While FY'25 was a soft year for Cavotec, we continue to see attractive long-term potential in shore power and mining electrification. Despite a more cautious order environment, we find it positive that Industry is showing a positive trend. Notably, management also highlighted that Industry momentum is supported by increased field activity and earlier customer involvement/co-development. The share is trading at 19x-11x '26e-'27e EV/EBIT on our post-report estimates vs. the peer median of 17x-13x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/cavotec/Equity-research/2026/2/cavotec---industry-shines-in-cautious-environment/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Mon, 23 Feb 2026 07:30:02 GMT</pubDate>
      <isin>CH0136071542</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Arctic Paper - Still challenging</title>
      <description>&lt;a id="bm-comp-e66f138a-a945-442f-a7d8-43ad721afac8" name="bm-comp-e66f138a-a945-442f-a7d8-43ad721afac8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e66f138a-a945-442f-a7d8-43ad721afac8" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q4 Paper EBIT of ~PLN 13.2m&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Lower wood costs ahead, but markets still challenging&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Fair value range of SEK 17-50&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-c78e8d07-f8b8-4c68-aa4f-93ebd48c7c86" name="bm-comp-c78e8d07-f8b8-4c68-aa4f-93ebd48c7c86" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="c78e8d07-f8b8-4c68-aa4f-93ebd48c7c86" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3" style="text-align:left;"&gt;&lt;font color="#000000"&gt;Q4 Paper EBIT of ~PLN 13.2m&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Arctic Paper delivered Q4 Paper EBIT of ~PLN 13.2m, compared to our estimate of PLN 25m. However, note that the reported figure included an energy refund of ~PLN 40m, i.e clean Paper EBIT was PLN -27m vs. our clean estimate of PLN -14m. Weak demand and increased Asian competition have put pressure on prices, which impacted the Paper profitability. An announced 8-10 percent paper price increase aims to restore margins, though H1 2026 demand visibility remains weak. Pulp EBITDA was somewhat softer than expected at PLN -74m vs. our estimate of PLN -70m. Regarding the pulp business, the quarter was characterised by lower pulp prices in USD combined with a stronger SEK, as well as high wood costs. A write-down of finished goods inventory linked to lower pulp prices weighed on earnings by ~SEK -35m. In addition, the annual maintenance shutdown at Vallvik Mill impacted results by ~SEK 70-80m.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;Lower wood costs ahead, but markets still challenging&lt;/font&gt;&lt;/h3&gt;&lt;p style="text-align:left;"&gt;&lt;font color="#000000"&gt;Pulpwood prices are dropping 25-30% across Scandinavia as high inventories and low demand pressure the market. This should provide some cost relief. Paper markets are helped by 10% supply cuts in '25-'26e, but with (too) low demand the utilisation rate is only 75-80%. We need 3mt more cuts to reach the historical average. The pulp market has had its short-term issues, but Suzano has hiked hardwood prices seven times, or +26%. Rottneros' exposure mainly lies within softwood and CTMP, which has lagged hardwood. However, SCA's recent USD 100/t NBSK price hike is good news for Rottneros, which could also see prices up in '26.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;&lt;font color="#000000"&gt;Fair value range of SEK 17-50&lt;/font&gt;&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;The company is trading at an EV/CE multiple of ~0.45x, which is ~40% below its historical average. We have applied three valuation methodologies and arrive at a fair value range of SEK 17-50.&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/arctic-paper/Equity-research/2026/2/arctic-paper---still-challenging/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 20 Feb 2026 17:30:07 GMT</pubDate>
      <isin>PLARTPR00012</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Inission - Set for substantial earnings growth</title>
      <description>&lt;a id="bm-comp-8fbb9680-fd0c-43b6-8d93-714272168a52" name="bm-comp-8fbb9680-fd0c-43b6-8d93-714272168a52" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8fbb9680-fd0c-43b6-8d93-714272168a52" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Adj. EBITA margin up 1.7pp as sales grew 15% ex. M&amp;amp;A&lt;/li&gt;&lt;li&gt;Likely to exceed conservative guidance in '26&lt;/li&gt;&lt;li&gt;Belief that earnings trough is behind us reinforced&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-7ce17c14-8ae8-428c-9ede-1c7c9656c0e6" name="bm-comp-7ce17c14-8ae8-428c-9ede-1c7c9656c0e6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7ce17c14-8ae8-428c-9ede-1c7c9656c0e6" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4 results&lt;/h3&gt;&lt;p&gt;Inission delivered a strong Q4, growing 15% y-o-y ex. M&amp;amp;A and achieving an adjusted EBITA margin of 6.9%, beating our expectations by 4% on orders, 6% on sales and 15% on adj. EBITA. There were restructuring costs of SEK 6.8m in the quarter, mainly in Enedo, but these will, according to management, be gone starting in Q1. The effect of the cost cuts seems very promising given Enedo's adjusted margin of 5.2% in the quarter. Note that both segments' sales now include significant intra-group sales (which are then eliminated at the group level) following the move of the Tunis factory from the Enedo to the Inission segment, partially contributing to their substantial y-o-y increases. There was also a SEK 21m non-cash financial one-off related to the early acquisition of the remaining shares in AXXE, which we have adjusted for.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;The company guided for sales of SEK 2.3-2.5bn in '26 and an EBITA margin above 6%. During the earnings call, the CEO gave the impression that this guidance is, if anything, conservative, like we expected. We raise '26e-'27e adj. EBITA by 2-5%, now forecasting sales of SEK 2.42bn with an adj. EBITA margin of 6.8% in '26e.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Outlook and valuation&lt;/h3&gt;&lt;p&gt;Our belief that the trough in Inission's earnings is behind us, which &lt;a data-bm-trackable="false" href="https://abg-portal.bluematrix.com/report/c3c02252-f559-4a71-a8a1-496b6c8a86e9" target="_blank"&gt;we expressed following the Q3 report&lt;/a&gt;, is now reinforced by another strong report. The book-to-bill remains solid, and the growing order book is being converted into sales growth, which in turn is yielding improved profitability, a trend we believe will continue, especially given cost savings coming through in Enedo at the same time as sales growth is set to accelerate, backed up by its strong book-to-bill. The share is now trading at 11x-8x '26e-'28e P/E, compared to peers at 16x-13x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/inission/Equity-research/2026/2/inission---set-for-substantial-earnings-growth/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 20 Feb 2026 17:00:08 GMT</pubDate>
      <isin>SE0016275069</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>BTS Group - Ahead of plan on growth recovery</title>
      <description>&lt;a id="bm-comp-a0a9205e-8f47-48f1-813e-6a3a6128952c" name="bm-comp-a0a9205e-8f47-48f1-813e-6a3a6128952c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a0a9205e-8f47-48f1-813e-6a3a6128952c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;FY guidance as expected, but Q1 comments ahead of plan&lt;/li&gt;&lt;li&gt;'26e adj. EBITA -5-7% on lower '25 base and FX but growth recovers&lt;/li&gt;&lt;li&gt;15% adj. EBITA growth 2026e, share at 7.4x EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-73e7fbcc-75ad-4c9e-9c28-bef4137abe01" name="bm-comp-73e7fbcc-75ad-4c9e-9c28-bef4137abe01" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="73e7fbcc-75ad-4c9e-9c28-bef4137abe01" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Focus on the positive growth outlook&lt;/h3&gt;&lt;p&gt;The Q4 report was below both our and FactSet consensus estimates on sales and adj. EBITA, but the focus on the day was on the forward-looking guidance. The FY guidance of "2026 EBITA better than 2025" was expected, in our view, as if one assumes no non-recurring items in 2026, reported EBITA would rise by ~10%. BTS has also entered a period when it sees major cost reductions behind it, and the challenging North American market in 2025 is starting to show positive momentum. In the conference call, BTS therefore guided for positive organic growth and EBITA growth in North America already in Q1 and for the FY, which shows that BTS is ahead of plan to return the important region to growth.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Adj. EBITA cut by 5-7%&lt;/h3&gt;&lt;p&gt;The FY guidance has no major impact on our estimates, as we already expected BTS to deliver organic growth and better margins. However, the Q4 miss reduces the starting point somewhat combined with less favourable FX movements, meaning that we reduce '26e and '27e sales and adj. EBITA by 5% and 7%, respectively.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Important to dispel AI worries&lt;/h3&gt;&lt;p&gt;The global management consulting sector has had a tough time on the stock market, partly due to worries about lower demand and higher competition from AI. BTS's share is down 22% in the past 6 months (despite +28% today) and Accenture is down -25% the last month. The positive growth outlook from BTS is therefore appreciated and the share is trading at 7.4x 2026e EV/EBITA on our updated estimates. In 2026, we estimate 6% organic growth, 15% adj. EBITA growth and 27% reported EBITA growth (BTS does not adjust for one-offs when it provides its FY outlook). Given the net cash position, growth guidance and current valuation, we argue that buybacks would be welcome.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/bts-group/Equity-research/2026/2/bts-group---ahead-of-plan-on-growth-recovery/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 20 Feb 2026 16:15:08 GMT</pubDate>
      <isin>SE0000805426</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>BTS Group - Q4 Earnings Call with President &amp;  CEO Jessica Skon</title>
      <description>&lt;a href='https://cr.abgsc.com/foretag/bts-group/Media/2026/02/bts-group-q4-earnings-call-with-president-and-ceo-jessica-skon/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 20 Feb 2026 13:00:00 GMT</pubDate>
      <isin>SE0000805426</isin>
      <youtube>UxbATpe7ZAk</youtube>
      <category>Media</category>
    </item>
    <item>
      <title>BTS Group - North America behind Q4 miss</title>
      <description>&lt;a id="bm-comp-7cd8d111-da23-4b6c-b329-9010a4d9b374" name="bm-comp-7cd8d111-da23-4b6c-b329-9010a4d9b374" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="7cd8d111-da23-4b6c-b329-9010a4d9b374" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales -1% vs cons, adj. EBITA -14%, but North America guided to grow in Q1e&lt;/li&gt;&lt;li&gt;2026 guidance: "Better EBITA than in 2025" (cons +12%) but base will come down&lt;/li&gt;&lt;li&gt;Estimates likely cut 5-10%, share to underperform somewhat&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a000e760-bab0-42b4-9b9f-ac103918c2a0" name="bm-comp-a000e760-bab0-42b4-9b9f-ac103918c2a0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a000e760-bab0-42b4-9b9f-ac103918c2a0" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4 details&lt;/h3&gt;&lt;p&gt;Sales SEK 710m (-1% vs ABG 718m, -1% vs cons 718m), adj. EBITA 96m (-13% vs ABG 111m, -14% vs cons 112m), adj. EBITA margin 12.1% (ABG 15.4%, cons 15.6%). Adj. EBITA -29% y-o-y (ABG -18%, cons -17%). Organic growth -5% (ABG -2%, cons -2%). DPS SEK 4.40 (24% vs ABG 3.55, -2% vs cons 4.49).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;North America behind miss in Q4&lt;/h3&gt;&lt;p&gt;Still challenging in North America (EBITA -37% vs cons) while Ok performance in Europe and Other markets. The North American turnaround is progressing well however. Guides for "higher EBITA 2026 vs 2025" on group level as expected (cons +12%). Q-o-q EBITA decline in North America marks the end in Q4 and will grow organically and improve profit y-o-y already in Q1 given actions taken, according to BTS. AI innovation across the firm is benefitting BTS in three ways: 1) a more competitive portfolio with bookings from the AI bot technology at USD 5m in 2025 (5x vs 2024), 2) new services spanning AI adoption and workflow with AI related services of USD 14m in 2025 (+690% vs 2024), and 3) internal simplifications with another SEK 24m cost reductions realised in 2026. All of these drivers are behind the outlook guidance to drive EBITA growth again.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates down 5-10%&lt;/h3&gt;&lt;p&gt;We expect consensus to reduce 2026 EBITA by 5-10% due to the Q4 miss and lower base although guidance was as expected, and share should underperform similarly today, although it has traded weak into numbers (-28% YTD). Conf call CET 9.30.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-5e15c551-d013-4589-bc19-c39a59106dda" name="bm-comp-5e15c551-d013-4589-bc19-c39a59106dda" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5e15c551-d013-4589-bc19-c39a59106dda" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-127a392d-9c28-4f0a-9b33-6f7d025423fb" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, FactSet, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/bts-group/Equity-research/2026/2/bts-group---north-america-behind-q4-miss/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 20 Feb 2026 08:00:07 GMT</pubDate>
      <isin>SE0000805426</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Skolon - Q4'25 momentum to also pay off in H1'26</title>
      <description>&lt;a id="bm-comp-cc5678ba-1540-4145-9f60-fec160ee6aec" name="bm-comp-cc5678ba-1540-4145-9f60-fec160ee6aec" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cc5678ba-1540-4145-9f60-fec160ee6aec" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;We expect nearly 40% organic growth...&lt;/li&gt;&lt;li&gt;...and gross margin expansion in '26e&lt;/li&gt;&lt;li&gt;Reiterate fair value range of SEK 30-45&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-43872c9d-fa42-4041-901b-02a3b252dc17" name="bm-comp-43872c9d-fa42-4041-901b-02a3b252dc17" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="43872c9d-fa42-4041-901b-02a3b252dc17" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Higher platform usage drove growth&lt;/h3&gt;&lt;p&gt;The Q4'25 report was better than we had expected. Sales increased by ~75% y-o-y, mainly driven by higher platform usage among users. In constant currency terms, the y-o-y growth was 86%. A large contributor to the growth was increased platform usage, i.e. users consuming more digital learning materials (revenue from partners). This meant that ARPPU also grew sequentially, but that the gross margin (less capitalised costs) of 26% took a small hit. This was also partly due to contract signings seemingly being tilted toward the end of the year.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Raising EBITDA by 4-2% for '26e-'27e&lt;/h3&gt;&lt;p&gt;We raise '26e-'27e sales by 4-3% after the report. We also raise our EBITDA estimates by 4-2% for the same period. This reflects the continued user growth, slightly higher ARPPU and continued investments in the business. However, it also reflects a somewhat lower gross margin than we had previously forecast because users seem to increasingly be using third-party apps through Skolon's platform.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Implied valuation&lt;/h3&gt;&lt;p&gt;Based on our revised estimates, the company is trading at '26e-'27e 7-5x EV/Gross profit (GP less capitalised work). We continue to see clear scalability in the model, as the platform supports additional users in existing geographies without significant cost increases. Even though EBITDA may be volatile from time to time due to growth investments and the timing of contract signings, the earnings power potential is significant over longer time horizons.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/company-name/Equity-research/2026/2/skolon---q425-momentum-to-also-pay-off-in-h126/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 20 Feb 2026 07:45:07 GMT</pubDate>
      <isin>SE0017615784</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ogunsen - Easier comps await in '26e </title>
      <description>&lt;a id="bm-comp-4536a881-ab27-4916-aa66-995120b438aa" name="bm-comp-4536a881-ab27-4916-aa66-995120b438aa" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4536a881-ab27-4916-aa66-995120b438aa" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;An EBIT increase to SEK 6m (3m) in Q4'25&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;We raise EBIT by 2-3% for '26e-'27e&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Well positioned for a market recovery in 2026&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-feed0a06-7c40-457b-950d-0058dacb1265" name="bm-comp-feed0a06-7c40-457b-950d-0058dacb1265" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="feed0a06-7c40-457b-950d-0058dacb1265" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4'25 report&lt;/h3&gt;&lt;p&gt;Ogusen reported Q4'25 sales of SEK 115m, up 1% y-o-y, ending nine consecutive quarters of declining revenue. The consulting segment grew 2% y-o-y, to SEK 106m, reflecting gradually improving demand. Recruitment sales (~8% of total sales LTM) declined 16% y-o-y, to SEK 9m, as the market remains weak and slightly volatile. Overall, competition continues to be tough, and pricing pressure remains high, limiting the margin expansion potential. Demand is somewhat stable but dependent on winning new assignments, and pricing continues to vary by client. Total FTEs amounted to 372, up q-o-q and flat y-o-y. We expect the headcount to remain broadly stable in the near term. EBIT improved to SEK 6m, with a 5.2% margin, compared to SEK 3m last year, supported by stable volumes. The company proposed a dividend of SEK 1.50 for a payout ratio of ~100%, which is in line with the five-year average.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;EBIT up by 2-3% for '26e-'27e&lt;/h3&gt;&lt;p&gt;With signs of stabilisation and easier comparables in 26'e, we increase our estimates slightly. We raise sales by 2% and EBIT by 2-3% for '26e-'27e. We expect a gradual market improvement, although margin expansion is likely to remain limited in the near team due to continued price sensitivity. As demand gradually improves and activity levels normalise, we expect revenue momentum to continue building through '26.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Trading at 10-8x EV/EBIT for '26e-'27e&lt;/h3&gt;&lt;p&gt;Ogunsen is trading at 10-8x EV/EBIT for '26e-'27e. 2026 should benefit from easier comps and gradual improvement in activity. The consulting segment continues to show relative strength, positioning the company well in the early phase of a recovery cycle. As recruitment activity normalises, this could provide additional upside to estimates. Overall, we see improving fundamentals supporting a stronger earnings profile over the coming years.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ogunsen/Equity-research/2026/2/ogunsen---easier-comps-await-in-26e-/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 20 Feb 2026 07:30:07 GMT</pubDate>
      <isin>SE0008406151</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Inission - Recovery continues to materialise</title>
      <description>&lt;a id="bm-comp-b11610d6-86ca-487e-b277-0b32d1139bb1" name="bm-comp-b11610d6-86ca-487e-b277-0b32d1139bb1" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="b11610d6-86ca-487e-b277-0b32d1139bb1" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Orders +4%, sales +6%, adj. EBITA +15% vs. ABGSCe&lt;/li&gt;&lt;li&gt;Guides for 2.3-2.5bn sales and 6% margin in '26: in line&lt;/li&gt;&lt;li&gt;Strong report with recovery materialising as expected&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-febc0f0f-9748-4693-b135-d4cc40d6d498" name="bm-comp-febc0f0f-9748-4693-b135-d4cc40d6d498" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="febc0f0f-9748-4693-b135-d4cc40d6d498" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4 results&lt;/h3&gt;&lt;p&gt;Orders were down 9% y-o-y and 4% above our estimate. Sales grew 24% y-o-y and were 6% above our estimate. With a margin of 6.9%, 0.5pp above our estimate, EBITA adj. was 15% above our estimate. EBITA included non-recurring items with a negative margin impact of 1.0pp, pertaining mainly to restructuring costs in Enedo. Lease adj. FCF was 17m, bringing the R12m figure to 43m, i.e. 142% of net income. The strong results were driven by y-o-y improvements in both segments. There is a conference call at 09:00 CET: &lt;a data-bm-trackable="false" href="https://www.inissiongroup.com/sv/webcasts-inission-ab/" target="_blank"&gt;webcast&lt;/a&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;The Q4 numbers in isolation imply EBITA adj. comes up 5%. The company guided for sales of SEK 2.3-2.5bn with an EBITA margin &amp;gt;6% in '26, which can be compared to our estimates of 2.39bn with a margin of 6.8%. We consider this in line with our expectations as the margin target should likely be read as a lower limit.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Company valuation&lt;/h3&gt;&lt;p&gt;Over the past three months, the share has returned +12%, compared to the Nordic EMS peer median of +7% and the +11% of the OMX Stockholm Allshare. The share is currently trading at 15x-9.0x '25e-'27e P/E, compared to its 10-year historical median of 13x-8.9x and peers at 22x-13x.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-89df4642-0034-4a24-a4c4-bf9b8808011d" name="bm-comp-89df4642-0034-4a24-a4c4-bf9b8808011d" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="89df4642-0034-4a24-a4c4-bf9b8808011d" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-0e3bfe74-24de-412f-8a56-080e788fab07" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. estimates Q4'25&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/inission/Equity-research/2026/2/inission---recovery-continues-to-materialise/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 20 Feb 2026 07:00:06 GMT</pubDate>
      <isin>SE0016275069</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Cavotec - Strong Q4 but cautious outlook</title>
      <description>&lt;a id="bm-comp-a2a3ea70-bcce-4570-b849-69f39d3be1d8" name="bm-comp-a2a3ea70-bcce-4570-b849-69f39d3be1d8" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a2a3ea70-bcce-4570-b849-69f39d3be1d8" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales +34% vs EBIT adj. EUR 3.9m vs. ABGSCe 0.7m&lt;/li&gt;&lt;li&gt;Orders in line vs. ABGSCe, several large orders in the quarter&lt;/li&gt;&lt;li&gt;Market still cautious, cost saving initiatives in 2026&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-4f5f10b7-c3e3-4244-b769-76800589cbc4" name="bm-comp-4f5f10b7-c3e3-4244-b769-76800589cbc4" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="4f5f10b7-c3e3-4244-b769-76800589cbc4" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4 results&lt;/h3&gt;&lt;p&gt;Cavotec reported strong Q4 results with a beat on all line items. Order intake came in at EUR 48m (in line vs. ABGSCe 48m). Sales came in at EUR 50m (+34% vs. ABGSCe 37m), +9% y-o-y (+11% org.). EBIT adj. was EUR 3.9m (vs. ABGSCe 0.70m), for a margin of +8% (ABGSCe 1.9%). EBIT has been adjusted for a one-off of EUR 0.24m related to the relocation of Cavotec's registered office from Switzerland to Sweden. Industry showed improved margins, with an EBITDA margin of 16% (vs. ABGSCe 4.3%), thanks to the recently implemented change programmes. While, Ports &amp;amp; Maritime reported weaker EBITDA margins y-o-y (12% vs. 18% LY). Cash flow was strong in the quarter and FCF lease adj. came in at EUR 4.4m (vs. ABGSCe -1.4m).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimates and outlook&lt;/h3&gt;&lt;p&gt;On numbers alone, '25e-'27e sales change by +8%, and EBIT adj. changes by +EUR 3m. While Q4 was a strong quarter, management says the outlook is uncertain and customers remain cautious, so the company has decided to initiate cost savings heading into 2026.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Valuation&lt;/h3&gt;&lt;p&gt;The share has returned -15% L3M (vs. peer median +17% and OMXSALLS +11%), and is currently trading at 39x-19x '26e-'27e P/E on our pre-report estimates vs. the peer median of 21x-18x. The company is hosting a &lt;a data-bm-trackable="false" href="https://cavotec.events.inderes.com/q4-report-2025/register" target="_blank"&gt;conference call&lt;/a&gt; at 10:00 CET.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-dea83c14-2188-4942-afa4-dfa5354b0684" name="bm-comp-dea83c14-2188-4942-afa4-dfa5354b0684" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="dea83c14-2188-4942-afa4-dfa5354b0684" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-908bdfdb-7284-4e18-a98c-23ca84e1727e" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier Estimates, Company Data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/cavotec/Equity-research/2026/2/cavotec---strong-q4-but-cautious-outlook/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 20 Feb 2026 06:45:06 GMT</pubDate>
      <isin>CH0136071542</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Tempest Security - Guarding gains ground</title>
      <description>&lt;a id="bm-comp-aad6f2ad-0e10-4639-94dc-16336c9ad7ab" name="bm-comp-aad6f2ad-0e10-4639-94dc-16336c9ad7ab" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="aad6f2ad-0e10-4639-94dc-16336c9ad7ab" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q4: +27% sales growth, 1.5% EBITDA margin&lt;/li&gt;&lt;li&gt;'26e-'27e EBITDA up 2-3%&lt;/li&gt;&lt;li&gt;Continues to show improvements&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-5126b796-2b35-4d05-aea8-73a08cb7bdac" name="bm-comp-5126b796-2b35-4d05-aea8-73a08cb7bdac" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="5126b796-2b35-4d05-aea8-73a08cb7bdac" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;2025 was an important year&lt;/h3&gt;&lt;p&gt;Tempest continues to deliver improvements, with Q4 sales 12% above ABGSCe but EBITDA SEK 1.2m below. Guarding grew sales by 35% and EBITDA from SEK 1m to SEK 8m. A solid improvement, where the contracts signed in late 2024 are starting to show in the numbers. It is still far from historical levels, and we think more can be done on efficiency. Risk Solutions declined SEK 1m on top line but improved its EBITDA from loss-making in Q4'24 to SEK 2m profit in Q4'25, with solid results in the UK and profitable results in Denmark. Looking ahead, management pointed to good demand with the need for reliable deliveries, flexibility and long-term thinking rather than short-term needs, and that price is not always the decisive factor. Pricing has been a factor in the security space, and we think that Tempest, with help from the shifting focus in the market, can raise its margins by having price discipline and being selective on bidding.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;'26e sales up 8% and EBITDA up 2%&lt;/h3&gt;&lt;p&gt;We raise '26e sales by 8% on the good performance and momentum in Guarding. We expect the performance to continue as Tempest maintains its core business focus and continues its efficiency improvements, while Denmark and the UK are delivering better results. Q4 is a seasonally weaker quarter, but we expect the progress to continue.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Focus on core operations&lt;/h3&gt;&lt;p&gt;We believe the company has taken important steps throughout the year, with the divestment of the US and the turnaround in Denmark. There are further efficiencies to be gained from the newly signed contracts in Guarding, as profitability typically increases gradually after the initial start-up period. This is because the additional costs associated with extra hiring decrease, planning and efficiency improve and Tempest can sell additional services that improve profitability.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/tempest-security/Equity-research/2026/2/tempest-security---guarding-gains-ground/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Fri, 20 Feb 2026 05:45:08 GMT</pubDate>
      <isin>SE0010469221</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ovzon - Operating leverage coming through</title>
      <description>&lt;a id="bm-comp-014a4155-5854-42ee-b2ef-97bb8ae5cb6e" name="bm-comp-014a4155-5854-42ee-b2ef-97bb8ae5cb6e" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="014a4155-5854-42ee-b2ef-97bb8ae5cb6e" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Strong Q4, with EBIT 82% ahead of our forecast&lt;/li&gt;&lt;li&gt;We lift '26e EBIT by 17% on positive sales revisions&lt;/li&gt;&lt;li&gt;Ovzon-3 still not at full capacity: 19x 2026e EV/EBIT&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-3d8f42e1-9440-4f40-b031-c7169da940b5" name="bm-comp-3d8f42e1-9440-4f40-b031-c7169da940b5" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="3d8f42e1-9440-4f40-b031-c7169da940b5" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Strong Q4, both in terms of sales and margins&lt;/h3&gt;&lt;p&gt;Ovzon ended 2025 on a strong note, with Q4 sales +159% y-o-y, driven by recent order announcements. This was 18% above our estimate, primarily due to higher terminal sales (coming in at SEK 100m vs our forecast of SEK 65m), but also due to higher SATCOM sales. Typically, this sales mix would have a negative impact on margins, but the gross margin in Q4 was surprisingly strong at 58%, which we believe was potentially due to favourable FX and price adjustments. With an incremental EBIT margin of 54%, Ovzon demonstrated the high operational leverage in its business model, driving EBIT 83% ahead of our forecast. FCF was also good, driven by pre-payments. In our view, this shift in payment terms signals strength and underlines robust demand and Ovzon's strong market position.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Positive estimate revisions&lt;/h3&gt;&lt;p&gt;The recent increase in order activity meant that the Q4 backlog of SEK 1bn remained robust. This provides high visibility for estimates, with ~800m of our SEK 1,068m sales forecast for 2026 being covered by the current backlog. Throughout the year, we expect Ovzon to announce more orders, including those related to Ovzon-3. We expect Ovzon-3 will reach ~50% utilisation in Q2e (driven by an order from a NATO customer), and ~70% in Q4e. Also, we highlight that 2026 will be another strong year in terms of terminals, which is positive for the future as it is a good indicator for SATCOM demand. All in all, we lift '26e adj. EBIT by 17% on positive sales revisions.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Demand is supporting more satellite projects&lt;/h3&gt;&lt;p&gt;The stock is up 34% YTD, trading at 19x '26e EV/EBIT on our new estimates. Given the recent momentum, we continue to see upside risks to forecasts, and look forward towards getting more details around potentially new satellite projects (which current demand is supporting).&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ovzon/equity-research/2026/2/ovzon---operating-leverage-coming-through/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 19 Feb 2026 16:15:06 GMT</pubDate>
      <isin>SE0010948711</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Tempest Security - Solid steps forward</title>
      <description>&lt;a id="bm-comp-af7e6e72-9797-47e6-8b33-3932f7fd597c" name="bm-comp-af7e6e72-9797-47e6-8b33-3932f7fd597c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="af7e6e72-9797-47e6-8b33-3932f7fd597c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales +SEK 17m, EBITDA -SEK 1.2m vs. ABGSCe&lt;/li&gt;&lt;li&gt;'26e-'27e EBITDA estimates likely flat&lt;/li&gt;&lt;li&gt;Share to focus on the volume and earnings improvements&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-9b0db0eb-3b3b-4d1e-b581-57316216baba" name="bm-comp-9b0db0eb-3b3b-4d1e-b581-57316216baba" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="9b0db0eb-3b3b-4d1e-b581-57316216baba" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4 details&lt;/h3&gt;&lt;p&gt;Tempest delivered a Q4 report with both sales and EBITDA growth. Sales came in at SEK 155m (12%% vs. ABGSCe), 27% y-o-y, driven by Guarding, and partly offset by Risk Solutions. EBITDA grew SEK 8m y-o-y to SEK 2.4m (-SEK 1.2m, vs. ABGSCe), for a margin of 1.5% (ABGSCe 2.6%, -4.4% Q4'24) driven by both Guarding and Risk Solutions. Looking at y-o-y development, we see positive progress in Guarding, where the new contracts signed in late 2024 are now starting to show in the numbers; the initial costs have been absorbed and volumes have increased. There is a SEK 0.5m one-off cost due to restructuring.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes and outlook&lt;/h3&gt;&lt;p&gt;Looking ahead, management is not providing a formal outlook. However, they acknowledge that focus remains to increase the internal efficiency, cost control after a period of streamlining the organisation. We consider Tempest's positive internal development to be signs that it is taking important steps in the right direction. We expect estimates for '26e-'27e adj. EBITDA to stay relatively flat.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Final thoughts&lt;/h3&gt;&lt;p&gt;A report in the right direction report with sales and profitability growth. The share has underperformed the broader market into numbers (-13% YTD vs. OMXSGI +5%). We believe that the market will recognise the volume and earnings improvements resulting from Tempest's hard internal work.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;pagebreak &lt;a id="bm-comp-edf05949-74dd-418b-bff2-7e591dbabd33" name="bm-comp-edf05949-74dd-418b-bff2-7e591dbabd33" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="edf05949-74dd-418b-bff2-7e591dbabd33" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-2226d53b-33e9-4c0a-86f0-d0ab36fb7985" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Outcome vs. expectations&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, Company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/tempest-security/Equity-research/2026/2/tempest-security---solid-steps-forward/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 19 Feb 2026 08:30:05 GMT</pubDate>
      <isin>SE0010469221</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ework Group - Soft orders, taking actions on costs</title>
      <description>&lt;a id="bm-comp-0190f94d-a253-4b0b-9d47-f85cc5ea5e93" name="bm-comp-0190f94d-a253-4b0b-9d47-f85cc5ea5e93" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0190f94d-a253-4b0b-9d47-f85cc5ea5e93" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Sales +1% vs. ABGSCe (-13% y-o-y), adj. EBIT +9% vs. ABGSCe&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Has initiated cost measures, aiming to save SEK 18m (5% of opex)&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;We expect cons to cut '26e adj. EBIT ~25%&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-87b437ae-c6f1-4ce5-9e53-a074ae5f3800" name="bm-comp-87b437ae-c6f1-4ce5-9e53-a074ae5f3800" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="87b437ae-c6f1-4ce5-9e53-a074ae5f3800" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4 results&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Q4 sales were SEK 3,639m (+1% vs. ABGSCe 3,609m), -13% y-o-y. Gross profit was SEK 150m (0% vs. ABGSCe SEK 150m), -10% y-o-y, while adj. EBIT was SEK 36m (+9% vs. ABGSCe 33m), down 33% y-o-y. Note that we have adjusted for a SEK 20m amortisation of immaterial assets (capitalised development costs). The gross margin improved well in y-o-y terms, but took a step back sequentially after a period of significant improvements. Q4 orders declined 14% y-o-y.&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Q4 thoughts&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;The Nordic consultancy market has recently been challenging, which continues to affect demand for Ework's services. In particular, we have observed weakness in the automotive industry, a situation that has been exacerbated recently by Volvo Car's layoffs. As this is a significant end market for Ework, the impact is substantial. Alongside the results, Ework announced that it has initiated a transformation programme to increase operational efficiency, including changes to the management framework. This will drive annual cost savings of ~SEK 18m, with an impact that will build gradually throughout 2026, and corresponds to ~5% of opex. In light of the recent profitability trend, this is welcome news and will support margins going forward. Even so, the outlook is lacklustre, with Ework noting a weak market, and that it has entered 2026 with lower volumes and a weak trend in orders. Consequently, it expects 2026 EPS down 10-20% versus 2025.&lt;/font&gt;&lt;font color="#000000"&gt;&lt;/font&gt;&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;&lt;font color="#000000"&gt;Following the Q4 report, we expect consensus to cut '26e adj. EBIT estimates by ~25% due to lower sales assumptions, slightly offset by the cost out measures. There will be a conference call at 09.30 CET,&lt;/font&gt; &lt;a data-bm-trackable="false" href="https://financialhearings.com/event/52788" target="_blank"&gt;link.&lt;/a&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-8ec9e37c-2271-42a5-b7fc-9191f10f70f9" name="bm-comp-8ec9e37c-2271-42a5-b7fc-9191f10f70f9" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="8ec9e37c-2271-42a5-b7fc-9191f10f70f9" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-4782d5d8-ab94-496c-a1bb-c4bc5188deaa" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ework/Equity-research/2026/2/ework-group---soft-orders-taking-actions-on-costs/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 19 Feb 2026 08:15:06 GMT</pubDate>
      <isin>SE0002402701</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Skolon - Continues to execute well</title>
      <description>&lt;a id="bm-comp-2ae3804f-c886-4ff1-a1a1-a78729d2bfd6" name="bm-comp-2ae3804f-c886-4ff1-a1a1-a78729d2bfd6" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="2ae3804f-c886-4ff1-a1a1-a78729d2bfd6" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Q4 sales 20% higher than ABGSCe SEK 41m&lt;/li&gt;&lt;li&gt;Lower gross margin likely due to higher share of partner revenues&lt;/li&gt;&lt;li&gt;Likely slightly positive consensus estimate revisions&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-0c78d163-e31b-4a68-9db2-0f90e2f3d553" name="bm-comp-0c78d163-e31b-4a68-9db2-0f90e2f3d553" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0c78d163-e31b-4a68-9db2-0f90e2f3d553" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4'25 report&lt;/h3&gt;&lt;p&gt;Skolon delivered net sales of SEK 50m (20% vs ABGSCe 41m), corresponding to y-o-y organic growth of 76% (26pp vs ABGSCe 50%), higher than expected. The gross margin decreased to 26% (-5pp vs ABGSCe 31%), likely impacted a higher share of partner sales. EBITDA amounted to SEK -1m (1m vs ABGSCe -2m), ARPPU came in at SEK 191 (6% vs ABGSCe 180), and the number of paying users amounted to SEK 1,031k (-1% vs ABGSCe 1,044k).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Thoughts and outlook&lt;/h3&gt;&lt;p&gt;The report was better than expected, and Skolon continues to grow strongly, with increasing traction internationally. ARPPU continues to improve, demonstrating the company's ability to upsell, notably through higher partner revenues (as indicated by the lower gross margin in the quarter). At the same time, Skolon has made investments across Europe, which are reflected in lower profitability. While these investments have a near-term impact on profitability, they are in line with the strategy, which we believe will strengthen the company&amp;#8217;s long-term position.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Consensus estimate revisions and valuation&lt;/h3&gt;&lt;p&gt;The share is down nearly 20% YTD and is trading at 7-5x '26e-'27e EV/Gross profit on our unrevised estimates. Following the report, we believe that consensus will raise sales estimates by low single-digits.&lt;/p&gt;&lt;table id="bm-img-40add2b9-99de-4b08-97bf-42168638880c" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/company-name/Equity-research/2026/2/skolon---continues-to-execute-well/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 19 Feb 2026 08:00:07 GMT</pubDate>
      <isin>SE0017615784</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Ovzon - Better than expected across the line</title>
      <description>&lt;a id="bm-comp-42065bb5-4e86-473f-a503-09f1448535bb" name="bm-comp-42065bb5-4e86-473f-a503-09f1448535bb" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="42065bb5-4e86-473f-a503-09f1448535bb" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Sales +159% y-o-y on recent orders; +18%/+16% vs. ABG/cons&lt;/li&gt;&lt;li&gt;EBIT was +83% vs. ABG and +82% vs. cons&lt;/li&gt;&lt;li&gt;Expect cons to raise '26e EBIT 5-10%, share to outperform today&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-e815122d-6f65-4f60-bf0d-0213336ed00c" name="bm-comp-e815122d-6f65-4f60-bf0d-0213336ed00c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="e815122d-6f65-4f60-bf0d-0213336ed00c" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4 results&lt;/h3&gt;&lt;p&gt;Sales SEK 277m (18% vs ABGSCe 234m and 16% vs cons 239m), adj. EBIT 74m (83% vs ABG 41m and 82% vs cons 41m). As expected, NWC trends remained favourable, resulting in FCF of SEK 133m (vs. SEK 52m in Q4'24). This resulted in a NIBD of SEK 252m, down from 642m in Q4'24. The order book stood at a robust SEK 1.0bn by the end of Q4, driven by recent orders, including a terminal order from FMV and a milestone contract with a NATO customer (60% of which comprised terminals and 40% SATCOM).&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Q4 thoughts&lt;/h3&gt;&lt;p&gt;After quiet period in terms of order announcements, this improved markedly in Q4. Furthermore, sales continued to improve, driven by deliveries of recent orders. Here, SATCOM revenue was slightly ahead of our forecast (SEK 177m vs. ABGSCe SEK 169m), but the main sales beat came from higher terminal sales, amounting to SEK 100m (ABGSCe SEK 65m) and accounting for 36% of Q4 revenue. Although gross margins declined sequentially amid mix effects and the ramp-up of expanded third-party capacity (related to the SEK 1bn FMV order from mid-25), this was expected, and the Q4 level of 58% was better than our forecast 54%. In terms of outlook, Ovzon highlights a growing demand, particularly in Europe. Furthermore, it says that it is entering 2026 with a strong momentum, underpinned by the robust backlog that provides multi-year revenue visibility.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Estimate changes&lt;/h3&gt;&lt;p&gt;At a first glance, we expect consensus to raise '26e EBIT by 5-10%, mainly driven by higher gross margin assumptions. All in all, another strong report, and we expect the share to outperform the market today. The stock is trading at 20x '26e EV/EBIT on our unrevised estimates. There is a conference call 10.00 CET &lt;a data-bm-trackable="false" href="https://www.youtube.com/live/w7UBbvxRfJE" target="_blank"&gt;(link)&lt;/a&gt;.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-fc075d38-0feb-47d4-bc1e-e6040a4b52a0" name="bm-comp-fc075d38-0feb-47d4-bc1e-e6040a4b52a0" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="fc075d38-0feb-47d4-bc1e-e6040a4b52a0" style="vertical-align: top; width:100.000000%;"&gt;&lt;table id="bm-img-658b5d09-c6fc-43cb-8ab8-18cce2682f24" class="bm-img-table xslt-img-empty xslt-img-include"&gt;&lt;tr&gt;&lt;td class="xslt-img-caption"&gt;Deviation table&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td class="xslt-img-source"&gt;Source: ABG Sundal Collier, company data, Modular Finance for cons&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/ovzon/equity-research/2026/2/ovzon---better-than-expected-across-the-line/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Thu, 19 Feb 2026 07:45:05 GMT</pubDate>
      <isin>SE0010948711</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Catella - A promising 2026 outlook</title>
      <description>&lt;a id="bm-comp-26540093-9037-4d7c-94f6-5f001f098d0c" name="bm-comp-26540093-9037-4d7c-94f6-5f001f098d0c" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="26540093-9037-4d7c-94f6-5f001f098d0c" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;&lt;font color="#000000"&gt;Q4 a bump in the road but we &lt;font color="#000000"&gt;remain optimistic on&lt;/font&gt; outlook&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;Estimates down given a lower AUM base&lt;/font&gt;&lt;/li&gt;&lt;li&gt;&lt;font color="#000000"&gt;2026e-27e EV/EBIT of 3-5x with easy comps&lt;/font&gt;&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-a7fb2f31-67d7-4f41-b069-1b2d01c7d636" name="bm-comp-a7fb2f31-67d7-4f41-b069-1b2d01c7d636" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="a7fb2f31-67d7-4f41-b069-1b2d01c7d636" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Q4 softer than expected&lt;/h3&gt;&lt;p&gt;Catella's Q4 results were below both ABGSC and FactSet consensus expectations, with EBIT coming in at SEK 11m (63m) compared to ABGSCe of SEK 101m. The results were negatively impacted by a SEK 151m impairment of K&amp;#246;Tower, one of Catella's Principal Investments, following an updated property value assessment. The underlying performance within Investment Management and Corporate Finance stood out positively in the quarter. As such, we see the negative share price reaction of -14% as unjustifiably harsh. We remain optimistic about 2026 given the macro backdrop, with variable fees within Investment Management expected to pick up as transaction activity gradually increases. This should drive both improved margins and bottom-line earnings growth in the coming quarters.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Lower AUM base cuts our 2026-27 forecasts&lt;/h3&gt;&lt;p&gt;As AUM in Q4 came in 3% below our forecast, we have cut our AUM estimates, which lowers our earnings forecasts within Investment Management. In sum, our group EBIT estimates are reduced by 14% for 2026 and 7% for 2027 following the report. Despite lower estimates, we continue to forecast strong earnings growth in the coming years, with the help of market activity picking up.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;2026e-27e EV/EBIT of 3-5x with dividend yield of 4-8%&lt;/h3&gt;&lt;p&gt;Despite Q4 falling short of our expectations, we think the company has many attractive fundamentals, including an impressive track record within Investment Management. The balance sheet remains strong, with a cash position of SEK 1.6bn (~85% of market cap), providing Catella with the necessary resources should the right opportunities arise. The comps are easy, and we believe the transaction activity outlook is promising. When applying our latest revisions, Catella is trading at an EV/EBIT of 3-5x for 2026e-27e and a dividend yield of 4-8%.&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a href='https://cr.abgsc.com/foretag/catella/Equity-research/2026/2/catella---a-promising-2026-outlook/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 18 Feb 2026 10:45:07 GMT</pubDate>
      <isin>SE0000188518</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Embellence Group - Largest DTC platform to be upgraded in H1</title>
      <description>&lt;a id="bm-comp-0cc2fe68-0f64-4f75-bda1-56cb7b53dfab" name="bm-comp-0cc2fe68-0f64-4f75-bda1-56cb7b53dfab" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="0cc2fe68-0f64-4f75-bda1-56cb7b53dfab" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Good underlying growth, investing for the future weighs on margin&lt;/li&gt;&lt;li&gt;DTC could accelerate in 2026&lt;/li&gt;&lt;li&gt;The share is trading at 7x-6x '26e-'27e EV/EBITA&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-876da480-0f01-4982-b5d5-57ad5e6f0660" name="bm-comp-876da480-0f01-4982-b5d5-57ad5e6f0660" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="876da480-0f01-4982-b5d5-57ad5e6f0660" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;Investing for the future&lt;/h3&gt;&lt;p&gt;Embellence Group's Q4 report showed strength for the Nordic parts of the business, and Artscape performed well considering the tough comparable growth figure, while Cole &amp;amp; Son and Wall &amp;amp; Dec&amp;#243; faced softer demand. It has taken action to turn the trend - Cole &amp;amp; Son's managing director has been replaced and the German sales agents for Wall &amp;amp; Dec&amp;#243; have been as well. Overall, the organic growth was 0.5%, reduced by ~4pp from the tough Artscape comp. The underlying momentum thus seems healthy. Gross margins improved by 120bp, but Embellence Group also invested more in, e.g., platform upgrades and hospitality sales to drive growth for a net -60bp margin growth y-o-y.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;More numbers on DTC - looks promising&lt;/h3&gt;&lt;p&gt;Embellence Group's strategic investments continue; in Q4 it upgraded its Cole &amp;amp; Son website after the successful upgrades of its Artscape and Pappelina websites. While the DTC share is still small, 40% y-o-y growth for Artscape+Pappelina in the DTC part of the business is a promising signal as Embellence Group prepares to upgrade its Bor&amp;#229;stapeter website. In 2025 as a whole, Embellence Group's DTC business grew 18% organically y-o-y, and website upgrades did not start until the summer. Bor&amp;#229;stapeter is ~2x larger than Artscape and Pappelina combined - so this upgrade is likely to have a larger impact on growth than the previous ones.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;The share is trading at 7x-6x '26e-'27e EV/EBITA&lt;/h3&gt;&lt;p&gt;The Embellence share is trading at 7x-6x our '26e-'27e EV/EBITA. We leave our fair value range unchanged at SEK 36-43, which corresponds to 8x-9x NTM EV/EBITA vs. its L3Y trading range of 7x-8x NTM. The negative estimate revisions relate to FX. While the rough capex guidance for 2026 was higher than our previous estimate to ramp up upgrades in the Bor&amp;#229;s factory, we estimate a 10-13% FCF yield '&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/embellence-group/Equity-research/2026/2/embellence-group---largest-dtc-platform-to-be-upgraded-in-h1/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 18 Feb 2026 07:15:06 GMT</pubDate>
      <isin>SE0013888831</isin>
      <category>Analys</category>
    </item>
    <item>
      <title>Infrea - Progress on most fronts, M&amp;A now more likely</title>
      <description>&lt;a id="bm-comp-cbbcc6b5-50a2-4181-b031-7162be988fcd" name="bm-comp-cbbcc6b5-50a2-4181-b031-7162be988fcd" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="cbbcc6b5-50a2-4181-b031-7162be988fcd" style="vertical-align: top; width:100.000000%;"&gt;&lt;ul&gt;&lt;li&gt;Solid earnings momentum in Paving services&lt;/li&gt;&lt;li&gt;Divestment brings net cash position and dividend&lt;/li&gt;&lt;li&gt;M&amp;amp;A and more internal improvements to come&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;a id="bm-comp-bdc5a275-e0b6-459b-99ab-e060ca51c582" name="bm-comp-bdc5a275-e0b6-459b-99ab-e060ca51c582" class="BMCustomAnchor"&gt;&lt;/a&gt;&lt;table&gt;&lt;tr&gt;&lt;td bm-component-id="bdc5a275-e0b6-459b-99ab-e060ca51c582" style="vertical-align: top; width:100.000000%;"&gt;&lt;h3 class="bm-h3"&gt;First quarter with Water &amp;amp; Segment out of the numbers&lt;/h3&gt;&lt;p&gt;In Q4'25, Infrea sold its Water &amp;amp; Sewage segment. We included the segment in the comparable numbers for '24, while it is shown as an asset held for sale in the Q4'25 numbers. Infrea delivered a Q4 with sales growth in both remaining segments: +5% y-o-y in Land &amp;amp; Construction (L&amp;amp;C) and +4% Paving Services (PS). Organic sales growth was +2.5% y-o-y (0% Q3'25), while total sales were -4% due to the divestment. EBITA improved in PS by SEK 8m, to SEK 25m, driven by more good results in Asfaltsgruppen while EBITA in L&amp;amp;C declined SEK 3m, to SEK 11m, due to a SEK 8m reservation. Cash flow was weak at ~75% of adj. EBITA due to customer discussions, that is estimated by Infrea to be solved in '26, yielding a net cash position of ~SEK 3m, which enables a DPS of SEK 0.65 (SEK 0.5 '24)&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Varied performance in the group but overall positive&lt;/h3&gt;&lt;p&gt;We raise '26e-'27e EBITA by 8-11% on continued progress in PS, where we argue that Duo Asphalt will have a better '26 than '25, and in L&amp;amp;C now that Mikaels Gr&amp;#228;vtj&amp;#228;ns is off the books. Infrea continues to focus on internal efficiency and margins over volumes. We think improving margins should support SEK 63m EBITA in '26e and a 13% CAGR '24-'27e. The net cash position makes us more confident that Infrea could add growth through potential M&amp;amp;A.&lt;/p&gt;&lt;h3 class="bm-h3"&gt;Margins to improve and FCF to stabilise&lt;/h3&gt;&lt;p&gt;We believe that Infrea is well-positioned to grow organically and improve its margins given its exposure to underlying demand and to public customers (~55%), as well as support from M&amp;amp;A (13% sales CAGR in '21-'24). For '25-'28e, we expect Infrea to deliver profitability growth and FCF above peers but with slightly lower margins and sales growth. The share is trading at 5-4x adj. EBITA on '26e-'27e with a 31-12% lease-adj. FCF yield, while peers a&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;...&lt;/table&gt; &lt;a target='_blank' href='https://cr.abgsc.com/foretag/infrea/Equity-research/2026/2/infrea---progress-on-most-fronts-ma-now-more-likely/'&gt;Läs mer på ABG Sundal Collier&lt;/a&gt;</description>
      <pubDate>Wed, 18 Feb 2026 06:15:06 GMT</pubDate>
      <isin>SE0010600106</isin>
      <category>Analys</category>
    </item>
  </channel>
</rss>